|
|
·|û¡G¦ÌÄ_10132489 µoªí®É¶¡:2017/7/15 ¤W¤È 08:08:23
|
¤½¥q¬ãµoµ¦²¤¦b©ó»P¤@¯ëÃļt°µ©úÅã°Ï¹j¡A ¤£¥HÄvª§¿E¯P¤§©ú¬PºZ¾PÃÄ¥«³õ¬°¾É¦V¡A ¦Ó¥H³Ð·s«äºû¿ï¾Ü§Q°ò¥«³õ¤Á¤J¡A«Ø¥ß¨ã¯S¦â¤Î·s ¿o©Ê¤§»sÃÄÃöÁä§Þ³N¥¥x¡A¨Ã¤À¬ãµo¤è¦V¶i¦æ¡K ¦h¦~¨Ó¤½¥q¦b¨S¦³¦W¤H¥úÀô¥[«ù¤Î¤j°]¹Îª÷´©¤U ¤´¤@¨B¤@¸}¦Lªº¥H§xÃø¾Ç¦WÃĤΤfªA§Þ³N·sÃÄ¥¥xÂù¥D¶b¦P¨Bµo®i ¦b10¦h¦~ªº§V¤O¤U¡Aº¥º¥ªº¤]¬Ý¨ì¤F¤@¨Ç¦¨ªG ¥¼¨Ó1~3¦~¤ºÈ±o´Á«Ýªº¶i®i¦³: ¹Å¦h©ú¨ú±o¬ü°êÃÄÃÒ ¦]¸¿Õ¥X³f¤g¦Õ¨ä¤Î¥Ó½Ð¬ü°êÃÄÃÒ Carvedilol CR ¶i¦æ30¤H¥ÍÅé¬Ûµ¥©Ê¹êÅç¡B±ÂÅv¤Î¥Ó½Ð¬ü°êÃÄÃÒ Gemcitabine Oral ¶i¦æÁ{§É¤G´Á¤Î±ÂÅv µu´Á«h¬O¦³´¶Àù¨O¡B¹Å¦h©ú¡B¹Å¦hµø«Ø¡B¦]·ü¹çµ¥ÃĪ«°^Äm°ò¥»À禬 °£°ê¤ºÀ禬«ùÄò¦¨ªø¥~¥ç³°Äò»P¦U°ê¬¢Ã±¸g¾P¦X¬ù¡K ´Á¬ß¤½¥q¯à°÷¤@¨B¤@¸}¦L¿v¹Ú½ñ¹ê§¹¦¨ªÑªF·|³q¹L¤§¦U¶µÁZ®Ä«ü¼Ð |
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/8/19 ¤U¤È 10:33:10²Ä 333 ½g¦^À³
|
108 1H Á«·l²Å¦X¹w´Á 0.68¤¸ (47,814,000)(107 0.67¤¸), ¨ä¤¤¬ã¨sµo®i¶O46,217,000¸û107H1¼W¥[7,543,000(16.3%),¬ãµo¶µ¥Ø¤S¦³¤ñ107H1¤W¤É, 108H1Àç·~¦¬¤JÁöµM¸û107H1¤U°,¦ý¬Oì¦]¦b¤µ¦~ªì´N¤w¸g¤½§G¬O¦]¬°´¶Àù¨O¾P³fµ¹°·³ì¬O§ï¥Î¨C¤ë¹ê»Ú¾P³f¥æ©öÃB,¦Ó¤£¬O¹L¥h¤@¦~1©Î2µ§»{¦C,¾ãÅé¤W¥H¤W¥b¦~ªº´¶Àù¨O¾P³f¶q¹w¦ô¥þ¦~¬O¤ñ107¦~¥þ¦~¦¨ªø,¤ò§Q²v¤]¥Ñ 34%¤W¤É¦Ü 38% 108 2H BH4¾P³f»{¦C, ¤Î±N·|¦³C08001Åv§Qª÷(1,000¸U¤H¥Á¹ô,¦]¬°¾ãÅé±ÂÅv¬O 4,500¸U¤H¥Á¹ô¤À¶i«×»{¦C,©Ò¥HÁÙ¬O¦³¥i¯à¦~©³«e·|¦³·sªº¶i«×¥i¥H¤À¨É), ¦A¦³¤fªA¯Ø®q¯ÀN11005°Êª«¸ÕÅç«á¡A¨ú±o²Ä¤@µ§¨½µ{¸Oª÷¦¬¤J, ©Ò¥H 108 H2¬O¥i¥HÂàÁ«¬°¬Õªº, ¦pªGÅã¼v¾¯©Î¨ä¥L±ÂÅv¯à¥X¨Ó, ¾ã¦~«×ªºÂà¬Õ¬O¥i¥Hªº |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/8/14 ¤U¤È 09:32:56²Ä 332 ½g¦^À³
|
¦]µØ¥b¦~³ø¥X¨ÓÅo! ¦³¿³½ìªº¥i¥H¥h¬Ý. ¦CÁ|¤@¨Ç§Úı±o¦³½ìªº¦a¤è. p17 :¦]¤C¬P»{¦CªºÁ«·l¬°114¸U¤C¤d, ¥h¦~¦P´Á¬O¤»¦Ê¦h¸U. (¤C¬PªºÀç·~ÃB¥Ñ¥h¦~¦P´Áªº¤T¤d¦h¸U¼W¥[¨ì¤C¤d¦h¸U) p25:¤ä¥X¶µ¥Ø Á{§É¹êÅç¶O¬ù¤E¦Ê¤K¤Q¦h¸U,©e¥~¤@¤d¤T¦Ê¦h¸U(¤Uz), ¦pªG©ú¦~¤£°µÁ{§É,¥b¦~¬Ù¤@¤d¸U,¥þ¦~¬Ù¨â¤d¸U¥ª¥k p28:©e°Uµ¹¤C¬Pªº¬ã¨s©M§÷®Æ¶O¤j¬ù¤@¤d¨â¦Ê¦h¸U, ¦]µØ²£«~½u¸ò¤C¬P¦³Ãöªº´N¬OBH4©MÅã¼v¾¯,¤jÁx°²³]³o¬OÅã¼v¾¯·s«~¶µªº¬ã¨s¶O p29: ³o¤@±øÁÙ¦b,§Úı±o³o¬O©MªF¥ÍµØC08001¬ÛÃöªº±ø¬ù(ªF¥ÍµØ¯à®³¨ìªºÆZ¦³ªº) ¥»¤½¥q»P¥Ò¤½¥qñq²£«~ÂàÅý¨óij¡A¨ú±o¨äì©e¥ô¶}µo¨óij¤¤¤§ÃÄ«~©Ò ¦³¤§Åv§Q¡C¨Ì¬ù¥»¤½¥q©ó¦V¥DºÞ¾÷Ãö´£¥X°õ¦æÃÄ«~¥ÍÅé¬Ûµ¥©Ê¸ÕÅç¥Ó½Ð ²Ý¤é¡B¨ú±oÃÄ«~³\¥iÃҲݤé¡A¤À§O»Ýµ¹¥I±Mªù§Þ³Nª÷¡A¨ä¦Xp¬°$5,700¡A ¦©°£¤w¤ä¥I´Ú¶µ¡B¥¼¨Ó¨Ì¨½µ{¸O¹F¦¨¶i«×¡A©|¶·¤ä¥I$3,000¡C¥t¡A¥¼¨Ó ¨C¦~»Ý¨Ì·í´Á¤§ÂåÀø³q¸ô²b¾P°âÃBµ¹¥I 5%¤©±ÂÅv¤è¡A¤ä¥I¤W¬° $16,100¡C (³æ¦ì¬O¤d¤¸) p30 : ³oÓ¦a¤è³Ì¦³½ì ¥»¤½¥q¦]Àç¹B¸êª÷³W¹º©Ò»Ý¡A©ó¥Á°ê 108 ¦~ 7 ¤ë¥X°â©Ò«ù¦³¤§¤C¬P¤Æ¾Ç»sÃÄ ªÑ¥÷¦³¤½¥qªÑÅvp 315 ¥aªÑ;±N¥»¥æ©ö±Ä¥ÎÅv¯qªk¤§§ë¸ê³B¤À³¡¦ì¤§±b¸ü ª÷ÃB¡A´î°£¨ú±o»ù´Ú«á¡A¹wp»{¦C¨ä¥L§Q¯q¤Î·l¥¢p$8,392¡C ¨S²z¸Ñ¿ùªº¸Ü´N¬O¦]µØ¤C¤ë½æ¤F¤C¬P315±i,ÁȤF¤K¦Ê¦h¸U,¦¨¥»¬O¨CªÑ95¤¸,¥[¤W¦¨¥»©Ò¥H³oµ§¥æ©öÀ³¸Ó¥i¥H¦¬¨ì¤T¤d¤K¦Ê¦h¸U p27: ¤½¥q¤W¥b¦~¦V¤C¬P¶i³f¤F214¸Uªº²£«~,³sµ²¨ì¤C¤ëBH4ì®ÆÃĪº¦¬¤J,¬O¤£¬O·Pı¦³ÂI¦nÁÈ. ¤U¥b¦~ÁÙ¦³Ã±¬ùª÷,¤C¤ëªº¦¬¤J¤]ÁÙ¨Spºâ¶i¨Ó,¥[¤W½æ±¼¤C¬P®³¨ìªº¿ú,§Ú·Q¥H²{ª÷¨Ó¬Ý,¦]µØ¤µ¦~À³¸Ó¬O¥¿ªº,¤£·|¦³°]°È¦M¾÷¤~¹ï. |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/8/6 ¤W¤È 10:52:39²Ä 331 ½g¦^À³
|
¬O§r,³o¦¸¥u¬O¬°¤F¥Ó½ÐÃÄÃÒªº¸Õ¶q²£µ{§Ç©Ò»Ýªºì®ÆÃÄ»ùÓ´N°ª¹Fªñ900¸U,(¥B¨Ì6/15°qÁ`©Ò¨¥,BH4ì®ÆÃħQ¼í¬ù45%), ³o¦¸ì®ÆÃĦ¬¤J¤J±b¥Nªí¤F2Ó·N¸q, 1. BH4,³æ»ù°ª§Q¼í¤]°ª,¤¤°ê¦]¬°¦³»Ý¨D¬F©²¸É§U©Ò¥H¬Û¹ï»Ý¨D·|¸ûéw¤]°ª,Á`©MÀò§Q¤]·|«Ü¤£¿ù(¦Ó¥BBH4ÁÙ¥i¥H¨É¦³¦¨«~ÃĪº¾P°â¤À¼í,¤@³½2¦Y,½æì®ÆÃÄÀò§Q,¦¨«~¦A©â¦¨) 2.¤w¸g¨ì¥Ó½ÐÃÄÃÒªº¸Õ¶q²£µ{§Ç,(¦Ó¥BBH4¤£¬O·s¶}µoÃÄ,¥u¬OÂಾ²V¦¨¤À¸Ë»s³yªº¦aÂI),©Ò¥HÂ÷¥¿¦¡®³¨ìÃÄÃÒ¶q²£¥X³f®É¶¡¤£»· (©Ò¥H¦]µØ²{¦bnÄw¸ê(¼W¸ê)¨ÓÁʶRì®Æ) |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/8/5 ¤U¤È 04:31:20²Ä 330 ½g¦^À³
|
¤C¤ëÀ禬¤½¥¬¤F 1208¸U, ¦©±¼¨CÓ¤ë°ò¥»ªº´¶Àù¨O¦¬¤J330¸U¥ª¥k,¤j·§¦³¤K¦Ê¦h¸U¬OBH4ì®ÆÃÄ´£¨Ñªº. ¦³¤@«h·s»D´£¨ì¥h¦~·s®É¥NÃÄ·~¤w¸g¥I¤F¤@¤d¸U¥ª¥k¦X¬ù¬ÛÃö¶O¥Î, ¥[¤W³]¼t,¥Í²£³]³Æ,§Ú·Q·s®É¥NÃÄ·~¤w¸g¬°¤FBH4ªá¤F«Ü¦h¿ú¤F,À³¸Ó·|«D±`¿n·¥¦a·QºÉ§Ö¶q²£. ¦]µØ©ú¦~ªºª¬ªp¯uªº«Ü¥O¤H´Á«Ý. |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/8/3 ¤W¤È 12:11:19²Ä 329 ½g¦^À³
|
·PÁÂC¤jªº»¡©ú,Å¥°_¨ÓµÎªA¦h¤F ½Í¨ì©ú¦~ªº¸êª÷»Ý¨D,¬ðµM·Q°_Åã¼v¾¯ªº¨Æ±¡. ³Ìªñ¦b¬Ý«ô¦Õªº¦~³ø,Magnevist(¹Å¦h©úªºì¼tÃÄ)¤w¸g«Ü¦h¦~¨S¦³©ñ¦b¦~³ø¤W¤F, ¤Ï¦Ó¬OGadavist(Gadobutrol)¥h¦~¦³366M ¼Ú¤¸ªºÀ禬. Gadobutrol¬Û¹ï©óGadopentetate dimeglumine(§Y¹Å¦h©ú)¬r©Ê¸û§C,¦³¨Ç¦a°Ï¤w¸g¸T¥ÎGadopentetate dimeglumine¤F. °O±o¥h¦~§Ú¦³¤À¨É¹L¤@«hºô¸ô·s»D Enzychem, InnoPharmax strike $75.3-million deal for MRI contrast agent ³o¬O»¡¦]µØ±q2020¦~¶}©l¸òEnzychemñ¤F¤@µ§75.3M¬üª÷ªº¤j³æ(¤À10¦~),¶i¤fGadobutrolªºì®ÆÃÄ. ±q¦]µØ¦~³ø©ÎªÑªF·|³£¦³´£¨ì¦]µØ¥¿¦b¶}µoÅã¼v¾¯ªº·s«~¶µ,§Úı±o´N¬OGadobutro. §Ú¬O§Æ±æ¦]µØ¦³ÀqÀqªº¦b¶}µo³oÓªF¦è,¤]¦³¤@¨Ç¦X¬ù¦ýÁÙ¤£¯à¤½¶}. ³o¼Ë´N§ó¥i¥H¸ò¸êª÷»Ý¨D·f¤W½u¤F. ¯¬¤j®a¬ü¹Ú¦¨¯u. |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/8/2 ¤U¤È 11:19:26²Ä 328 ½g¦^À³
|
¦U¦ì¤j¤j, ¹ï©ó³o¦¸ªº¹w´Á¼W¸ê,¤p§ÌˬO«O«ù¤ñ¸û¥¿±ªº¬Ýªk,²z¥Ñ¬O, 1. ÁöµM¤µ¦~¤U¥b¦~¬O¦³¦¬¤J,BH4°âì®ÆÃÄ,C08001Åv§Qª÷¦¬¤J(¥Ø«e¦³¤½§iªº,¥u«Ý½T»{¤J±b¤ë¥÷), ¤fªA¯Ø®q¯ÀN11005°Êª«¸ÕÅç«á¡A¹wp¦~©³¨ú±o²Ä¤@µ§¨½µ{¸Oª÷¦¬¤J(¥¼¤½§i,¬O·s»D½Z,¦ýªº½T¦³Ã±±ÂÅv¦X¬ù,¥u¬O¦¬¿ú¤é´ÁÁÙ¨S¤½§i),³o¨Ç¥[°_¨ÓÀ³¸Ó¥i¥HÅý¦]µØ¤µ¦~¦³¾÷·|ÂàÁ«¬°¬Õ,¦ý¬O³oÓ¬Õ¦©°£¤µ¦~2019¦~ªº°ò¥»¤ä¥X³Ñ¤UÀ³¸Ó¥u¦³¤@ÂIÂIÂI,¤½¥qÁÙ¬O¥u³Ñ¤U¤µ¦~ªìªº³Ñ¾l¸êª÷¬ù1Ó»õ 2. ©ú¦~¤W¥b¦~ªº¦¬¤J¤j¬ù¹w¦ô¥u¯à¬OÅã¼v¾¯ÃÄÃÒ¨ì¤â,»PD07001 ¤H2±ÂÅvª÷,³o¨Çµo¥Í®É¶¡³£¤£¯à«Ü©ú½T,¦ý¬O©ú½Tªº¬O¤½¥qªº°ò¥»¤ä¥XÁÙ¬O¦s¦b,¦pªG¤´ÂÂ¥H¤µ¦~¾ê¸`ªº¤è¦¡¹L¤é¤l¤ä¥X0.4~0.5Ó»õ®t¤£¦h 3.¦ý¬O©ú¦~«×«ÀYÀ¸BH4¤sªFÃÄ·~¥¿¦¡¶q²£,¨Ì¤W¦¸ªÑªF·|®É±À¦ô®É¶¡À³¸Ó·|¬O¦b¦~¤¤¶¡(3©uªì),¦pªG³o¼Ë¥Nªí¤µ¦~©³©ú¦~ªì´NÀ³¸Ó¹ïBH4ì®Æ¤Uq³æ¶Rì®Æ¦^¨Ó¦X¦¨·Ç³Æ¥X³f,BH4ªºì®Æ»ù®æ¬O«D±`ªº°ª,©Ò¥HnÀ³¥I¤sªFÃÄ·~º¦¸¶q²£À³¸Ó¬On¦³¤jµ§ªº¹w³Æª÷¥i©PÂà.¦Ó¥B¦pªGÅã¼v¾¯¤µ¦~©³©Î©ú¦~®³¨ì¬ü°ê©Î¥[®³¤jÃÄÃÒ,¤]¬O¶}©l»Ýn¤jµ§¶gÂàª÷¨Ó³ÆÃÄ«~ì®Æ 4.¤µ¦~2019ªº´¶Àù¨Oªºì®ÆÃĬO°Ê¥Î»P¥üÂ׻ȦæɶUª÷¨Ó¹B¥ÎÁʶRì®Æ,«Ý»s¦¨¦¨«~³c½æÀç§Q«á¦AªðÁÙ,©ú¦~À³¸Ó¤£¦Aª±³oӤ覡¤F§a.......... 5.²{ª÷¼W¸ê¦b°]°È¤WÁÙ¬O¦³¥¦ªº¦n³B..¼W¸ê¦b10¤¸¥Nªí¤½¥qµu´Á»Ýn¸êª÷¹B§@¦n³B¥u¦³·~°È¹B§@ªº¦¬¯q, ¼W¸ê¦b10¤¸¥H¤W,¤£¶È¸êª÷¥i¥H·~°È¨Ï¥Î,¦b10¤¸¥H¤Wªº³¡¤ÀÁÙ¥i¥Hª½±µ¼W¥[¤½¥q²bÈ,(²{¦b¤½¥q²bÈ7.7¤¸),¦pªGn¥Ó½Ð¤WÂdÁÙ¬On¦³²bÈ10¤¸¥H¤W¤ñ¸û¦n 6.¨Ì·Ó¤µ¦~5¤ë15¤é,ªÑªF¤j·|¤W°qÁ`¤Î½²°]°Èªø·¥¤O»¡©ú¤µ¦~2019¦~¦]µØµ´¹ï¤£·|¦³°]°È²{ª÷¤Wªº°ÝÃD¦Ó¥B·|¦³¦¬¤J,¦ý¬O¤µ¤Ñ8/2¤½§i¸³¨Æ·|¤½§i¼W¸ê,¨º¥u¯à»¡¦³«D¤½¥q°ò¥»¤ä¥Xªº¸ê¥»n¨Ï¥Î,©Ò¥H¦³¥H¤W±À½×,¦Ó¥B¸ê¼W»ùµ´¹ï¤£¯à¤]¤£¥i¥H¦b10¤¸¥H¤U,(10¤¸¥H¤U·|©ì«±²bÈ),¤ë°ª¹ï²bȼW¥[´N¶V¦³§Q |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/8/2 ¤U¤È 10:09:59²Ä 327 ½g¦^À³
|
¦]µØ¤Sn²{¼W¤F, ©È©È. ¦]µØ²{¼Wªº¶Â¾ú¥v : 105¦~²{¼W, ìq»ù®æ40, ¤½¥¬®ø®§«áªÑ»ù¤@¸ô¶^,«á¨Ó²{¼W»ù®æ§ï¬°32 106¦~²{¼W, ìq»ù®æ23, ¤½¥¬®ø®§«áªÑ»ù¤@¸ô¶^,«á¨Ó²{¼W»ù®æ§ï¬°18 °ò¥»¤W¦pªG¤½¥q¤½¥¬²{¼W»ù®æ¬°A,¤j³¡¤Àªº¤H³£·|ı±o¤½¥q·|±±½L¦bA¤§¤W,«O«ù¤@¨Ç»ù®tÅýªÑªF¦³»{ªÑ·NÄ@. ¦ý¨â¦¸¦]µØ³£¦b¤½§G®ø®§«á¶}©l¤j¶^,¨¬°¶ÌªÑªFªº§Ú¨â¦¸³£¨ü¶ËºG«,©Ò¥HÅ¥¨ì¤Sn¼W¸ê·P¨ì®`©È. ¨ä¹ê¥O¤H·P¨ìºÃ´bªº¬O,¤µ¦~´Nºâ¨S¦³¨ä¥Lñ¬ùª÷ªº¤J±b,´¶Àù¨O,C08001ªºÃ±¬ùª÷,¥[¤WBH4¸Õ²£ì®ÆÃĪº¥X³f,ºâ°_¨ÓÀ禬¤j·§¦b¤@»õ¤W¤U. ¸êª÷¯Ê¤f¤j·§´N¨â¤T¤d¸U. ¦pªGD07001¶¶§Q±ÂÅv,©ú¦~¤ä¥X¤]·|¤ÖÓ¨â¤T¤d¸U,²{¦b³oÓ·í¤U,¤½¥qÀ³¸Ó¨S¨º»ò¯Ê¿ú¤~¹ï. (¦pªGD07001n¦Û¤v¨Ó,³o¦¸ªº¼W¸êª÷ÃB¤]¤£°÷§a! ¤G´ÁnÅxªº¿ú»·¤j©ó¤@´Á) (¥B¨ì©ú¦~©³«e¦Ü¤ÖÁÙ¦³D07001ñ¬ù,Åã¼v¾¯ÃÄÃÒ,BH4ÃÄÃÒ,N11005¶i¤HÅé¹êÅ稽µ{ª÷¥i¥H´Á«Ý) ·íµM¥¿±`¨Ó»¡,¼W¸ê»ù®æ¦b10~18, ªÑ»ù¦Ü¤Ö¤]n©Ô¨ì11.5~20,ÅýªÑªF¦³¨Ç²¢ÀY¤~¦³»¤¦]. ´N¤£ª¾¹D¤½¥q¸¬Äª¸Ì½æ¤°»òÃÄ! §Æ±æ¤½¥q¯à°÷»¡©ú,¤£n¥Î¥R¹êÀç¹B°òª÷³oºØ©x¤è»¡µü¨Ó¼Ål. |
|
|
·|û¡GChen10137456 µoªí®É¶¡:2019/8/2 ¤U¤È 05:29:38²Ä 326 ½g¦^À³
|
¥»¸ê®Æ¥Ñ¡@ (¿³Âd¤½¥q) ¦]µØ¡@¤½¥q´£¨Ñ §Ç¸¹1 µo¨¥¤é´Á108/08/02 µo¨¥®É¶¡16:46:57 µo¨¥¤H°q¬°µØ µo¨¥¤H¾ºÙÁ`¸g²z µo¨¥¤H¹q¸Ü02-87977607 ¥D¦® ¤½§i¥»¤½¥q¸³¨Æ·|¨Mij¿ì²z²{ª÷¼W¸êµo¦æ·sªÑ®×¡C ²Å¦X±ø´Ú ²Ä9 ´Ú ¨Æ¹êµo¥Í¤é108/08/02 »¡©ú 1.¸³¨Æ·|¨Mij¤é´Á:108/08/02 2.¼W¸ê¸êª÷¨Ó·½:¿ì²z²{ª÷¼W¸êµo¦æ´¶³qªÑ¡C 3.µo¦æªÑ¼Æ(¦pÄݬվlÂà¼W¸ê¡A«h¤£§t°tµoµ¹û¤u³¡¥÷):10,000,000ªÑ¬°¤W¡C 4.¨CªÑ±ÃB:·s¥x¹ô10¤¸¡C 5.µo¦æÁ`ª÷ÃB:¥H±ÃB10¤¸pºâ¡Ap·s¥x¹ô¤W100,000,000¤¸¡C 6.µo¦æ»ù®æ:¼È©w¨CªÑµo¦æ»ù®æ±ÂÅv¸³¨Æªø©ó·s¥x¹ô10¤¸¦Ü18¤¸¤§»ù®æ°Ï¶¡¤º¡A°Ñ°u ¥«³õµo¦æª¬ªpq©w¤§¡C 7.û¤u»{ÁʪѼƩΰtµoª÷ÃB:«O¯d¼W¸êµo¦æªÑ¼Æ¤§15%p1,500¥aªÑ¥Ñ¥»¤½¥qû¤u»{ÁÊ¡C 8.¤½¶}¾P°âªÑ¼Æ:¤£¾A¥Î¡C 9.ìªÑªF»{ÁʩεLÀv°tµo¤ñ¨Ò(½Ðµù©ú¼È©w¨C¥aªÑ»{ÁʩΰtµoªÑ¼Æ):¼W¸êµo¦æªÑ¼Æ¤§ 85%p8,500¥aªÑ¡A¥ÑìªÑªF«ö·Ó»{ªÑ°ò·Ç¤éªÑªF¦W¥U°O¸ü¤§ªÑªF¤Î¨ä«ùªÑ¤ñ¨Ò»{ÁÊ¡C 10.·î¹sªÑ¤Î¹O´Á¥¼»{Áʪѥ÷¤§³B²z¤è¦¡:¤£¨¬¤@ªÑ¤§·î¹sªÑ¡A¦Û°±¤î¹L¤á¤é°_5¤é¤º¥Ñ ªÑªF¦Û¦æ¨Ö´ê¡FìªÑªF¤Îû¤u©ñ±ó»{ªÑ¤§ªÑ¥÷©Î¨Ö´ê¤£¨¬¤@ªÑ¤§·î¹sªÑ¡A±ÂÅv¸³¨Æ ªø¬¢¯S©w¤H«öµo¦æ»ù®æ»{ÁÊ¡C 11.¥»¦¸µo¦æ·sªÑ¤§Åv§Q¸q°È:»Pìµo¦æ¤§´¶³qªÑªÑ¥÷¬Û¦P¡C 12.¥»¦¸¼W¸ê¸êª÷¥Î³~:¥R¹êÀç¹B¸êª÷¡C 13.¨ä¥LÀ³±Ô©ú¨Æ¶µ: (1)¥»¦¸²{ª÷¼W¸êpµe¥Dn¤º®e¡A¥]§t¦ý¤£©ó©Ò»Ý¸êª÷ª÷ÃB¡B¨CªÑµo¦æ»ù®æ¡Bpµe ¶µ¥Ø¡B¹wp¶i«×¡B¹wp¥i¯à²£¥Í®Ä¯q¤Î¨ä¥L¦³Ãö¨Æ©y¡A¦p¦³¦]¥«³õª¬ªp¤Î¥DºÞ¾÷ Ãö«ü¥Ü×¥¿¦Ó»Ý×¥¿ªÌ¡AÀÀ½Ð¸³¨Æ·|±ÂÅv¸³¨Æªø¥þÅv³B²z¡C (2)²{ª÷¼W¸ê¤§µo¦æ·sªÑ»{ªÑ°ò·Ç¤é¡B»{ªÑ´Á¡Bú´Ú´Á¶¡¡B¼W¸ê°ò·Ç¤é¡B¹ê»Úµo¦æ »ù®æ¡B¹ê»Úµo¦æªÑ¼Æ¤Î¨ä¥L¥¼ºÉ¨Æ©y¡A´£½Ð¸³¨Æ·|±ÂÅv¸³¨Æªø¥þÅv³B²z¡C |
|
|
·|û¡GChen10137456 µoªí®É¶¡:2019/7/30 ¤W¤È 09:47:33²Ä 325 ½g¦^À³
|
¡q2019¥Í§Þ®i¡r°ê»Ú´C¦X¡B¼t°Ó¼Æ³Ð·s·ß Ѻª`¥x¼tÀç¹B¬¡¤ô¦³·P ¹d¦ëºô°OªÌ¨HßNºÕ ¥x¥_2019/07/28 09:300 ¤µ¦~¨È¬w¥Í§Þ¤j·|¨Ï¥Î¤F 1700 ÓÅu¦ì¡A¨ä¤¤ªñ 3 ¤À¤§ 2 ³£¬O°ê¥~¼t°Ó¡F45 ³õ¦¸½×¾Â¤¤¡A¦³¤@¥b¥H¤W¥Ñ°ê»Ú«¶q¯Å¹Å»«¾á¥ô¥DÁ¿ªÌ¡A¬O¥xÆW 16 ¦~¨ÓÃø±o¤@¥óªº¥ÍÂå²±·|¡A¥D¿ì³æ¦ì²Îp¡A¤µ¦~°ê»Ú´C¦X»P°Ñ®i¼t°Ó¼Æ³Ð·s°ª¡A¥x¼t¬Òªí¥Ü¡A¦¹¦¸ªº®iÄý²±ªpªÅ«e¡A¹ïÀç¹B¥i±æ¦³ÅãµÛѺª`¡C ¥x±d¥Í (6589-TW) °ÆÁ`±i§Óºa«ü¥X¡A쥻´N»P¤é¥»¤jÃļt¬¢½Í°Ó·~¦X§@¡A°£¨ü´f¤éÁú¶T©ö¾Ô¡A¤µ¦~¥Í§Þ®iÅýÂù¤è¦b©e¥~»s³y·~°È¤W§óºò±K¡A¦¹¥~¡A¦³§ó¦hªº°ê¥~¼t°Óµnªù¸ß°Ý¡A«~µP¯à¨£«×¤j´T´£¤É¡C ¥x·~ªÌ¶i¤@¨B«ü¥X¡A¤µ¦~¥Í§Þ®i¥i¿×²±ªpªÅ«e¡A®iÄý«e 2 ¤Ñ´X¥G¦£©ó±µ«Ý¥~°ê¼t°Ó¡Bªk¤Hµ¥¡A¹ï«áÄòÀç¹B¥i´Á¡C °ê»Ú¦X§@¤è±¡A°ê®a¥Í§Þ¶é°Ï¦¨¥ßº¡¤@¶g¦~¡A¾A³{¥Í§Þ¤j·|¡A¤À§O»P¤é¥»´ð«n°·±d³Ð·s¶é°Ï¡B°ê»ÚÃļtªü´µ¯S±¶§Q±d¤½¥qñ¸p¦X§@³Æ§Ñ¿ý¡A¥´³y¨È¤Ó³Ð·s¥ÍÂå¬ã¨s¥ÍºA°é¤Î±Ò°Ê°ê¤º¥ÍÂå²£·~¥[³t¾¹¡C ªk¤H»{¬°¡A¤µ¦~¤@¹ï¤@°Ó·~´C¦X·|¬ð¯} 2000 ³õ¡A³Ð·s·ß¡A°£´£¤É¬J¦³ªº¥x¼tª¾¦W«×¡B¥[³t°Ó·~¦X§@¡A§ó¯à¦³®ÄѺª`Àç¹B¬¡¤ô¡A¦Ó¹ï©ó·s³Ð¹Î¶¤¦Ó¨¥¡A«h³z¹L¬F©²°ê»Ú¦X§@¡A¥[³t²£·~Ãì¡C ¤µ¦~¥Í§Þ®i¤¤¡A¤£¤Ö¥x¼t¤]ÄÀ¥X§Q¦h®ø®§¡A¥]§t§ö°ê (4192-TW)¡B¦]µØ (4172-TW)¡B¥x±d¡BÃĵØÃÄ (6446-TW) µ¥¹ï«á¥«¦hªíºA¬Ý¦n¡A¥i±æ¦]¦¹±À¤ÉÀç¹B°Ê¯à¡C §ö°ê¯ØŦÀù·sÃÄ SB05PC¡u±a¥¿¹qµµ§ü¾J·L¯×Åé¡v¡Aªñ¤éÀò¤¤°ê¤@½u¥ÎÃĤT´ÁÁ{§É¸ÕÅç¡A¥Ø¼Ð¦~©³«e±Ò°Ê¦¬®×¡A³Ì§Ö©ú¦~²Ä 1 ©u¶i¦æ´Á¤¤¤ÀªR¡Aªk¤H¦ô¡A·sÃÄ¥¬§½¶i®i¤U¡AÀç¹B¥i±æ¤@¦~¤ñ¤@¦~¦n¡C ¦¹¥~¡A¤µ¦~¥D¿ì³æ¦ì¤]Á|¦æ°ê»Ú¯ØŦÀù½×¾Â¡AÁܽХxÆW¡B¬ü°ê¡Bªk°ê¡B¦I¤ú§Q¤ÎÁú°êµ¥ 5 °ê¯ØŦÀùªvÀø±M®a¨Ó¥xºtÁ¿¡B¶i¦æÂå¾Ç¥æ¬y¡C ¥x±d¥Í®³¤U 2019 »O¥_¥Í§Þ¼ú·s³Ð§Þ³N¼ú¡A¨ä¤¤¦Û¦æ¶}µoªº¨ÅÀù¥Íª«¬Û¦üÃÄ¡A¹w´Á©ú¦~ªì¯à§¹¦¨¦¬®×¨Ã¦¬°e¬ü°ê FDA ¼f¬d¡A³W¹º 2022 ¦~¤W¥«¡AÀç¹B±N¦³ÅãµÛ¦¨ªø¡C ¼C³ìºX¤U¤l¤½¥q¦]µØ¡A¥Ñ·s¥ôÁ`¸g²z°q¬°µØ»âx°Ñ®i¡A¥Ø«e¥Dn¦³ 3 ¶µ·sÃÄ¡A¥]¬AªvÀøfଧ¿¯fªº¨u¯f¥ÎÃĦ]¸¿Õ¡B¤fªA¯Ø®q¯À·sÃÄ N11005 ¤Î°ª¦åÀ£·sÃÄ C08001¡A¨ä¤¤¦]¸¿Õ¥h¦~¨ú±o 300 ¸U¤H¥Á¹ô (¬ù·s¥x¹ô 13.7 »õ¤¸) ±ÂÅvª÷¡A¨Ã©ó¤µ¦~¤U¥b¦~³°Äò¥X³f¡AY©ú¦~¶¶§Q¨ú±o¤¤°êÃÄÃÒ¡AÀç¹B¦³¾÷·|ÂàÁ«¬°¬Õ¡C |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/7/29 ¤U¤È 10:13:44²Ä 324 ½g¦^À³
|
¤£¦Pªº·s»D¸ê°T¨Ó·½,¤£¦Pªº«ÂI§e²{,¤£¹L¤@¼Ë³£¬O¦n®ø®§,¥u¬O¦³¤ñ¸û²M´·ªº®É¶¡ ¦]µØ¯Ø®q¯À·sÃĮƦ~©³Àòºµ§¨½µ{¸Oª÷¡F©é¤fªAÃĶ}µo MoneyDJ·s»D 2019-07-26 11:06:06 °OªÌ ·s»D¤¤¤ß ³ø¾É ¦]µØ¥Í§Þ(4172)ªí¥Ü¡A¤½¥q¾ú¸g¤@¦~¦h¤§¾ã¹y«á¹ð³Ð¨ÎÁZ¡A¤fªA¯Ø®q¯À·sÃÄN11005¦b¥h(2018)¦~±ÂÅv¤©¦X§@¹Ù¦ñ«á¡A¹wp¤µ(2019)¦~©³§¹¦¨¸Ó°Êª«¸ÕÅç«á¨ú±o²Ä¤@µ§¨½µ{¸Oª÷¡F¤µ¦~«h¦A±N°ª¦åÀ£·sÃÄ-C08001±ÂÅv¥þ²y¥«³õ¤©¤sªF·s®É¥NÃÄ·~¡A¨Ã¶}©l§ë¤J¤fªAÃĪ«¤§·s«~¶µ¶}µo¡A©µÄò¬ãµo°Ê¯à¡A³v¨B¹ê½î¤½¥q¬°§Þ³N¥¥x¶}µo¤½¥qªºÀç¹Bµ¦²¤¡C ¦]µØ«ü¥X¡A¦b¥h¦~¤½¥q«·s¾ã¹y«á¡A¥Ñì¬ãµoªøº[¤½¥q³Ð¿ì¤H¤§¤@ªº°q¬°µØ±µ¥ô·s¥ôÁ`¸g²z¡A¦b°·³ì(4114)¶°¹Î¸³¨ÆªøªL´¼·u¤§¤ä«ù¤U¡A¾ú¸g¤@¦~¦h¤§¾ã¹y¡A¤½¥q¹ð³Ð¨ÎÁZ¡CÄ~¥h¦~±NN11005±ÂÅv¤¤°ê¦X§@¹Ù¦ñ«á¡A¤µ¦~¦A±N°ª¦åÀ£·sÃÄ-C08001±ÂÅv¥þ²y¥«³õ¤©¤sªF·s®É¥NÃÄ·~¡C¦]µØ¤T¶µ¥Dn¶}µo¤¤ªº·sÃÄ¡A¤w¦¨¥\±ÂÅv¨â¶µ¡C¤½¥q¤]©ó¤µ(2019)¦~¶}©l§ë¤J¤fªAÃĪ«¤§·s«~¶µ¶}µo¡A©µÄò¬ãµo°Ê¯à¡A¥H³v¨B¹ê½î¤½¥q¬°§Þ³N¥¥x¶}µo¤½¥qªºÀç¹Bµ¦²¤¡C ¦]µØ«ü¥X¡AN11005¦b¥h¦~±ÂÅv¤©¦X§@¹Ù¦ñ«á¡A¤w´£¨ÑÁ{§É¸ÕÅç¥ÎÃĨѨä©ó¤¤°ê¤j³°¶i¦æªø´Á¬r²z©Ê¤§°Êª«¸ÕÅ礤¡A¹wp©ó¤µ¦~©³§¹¦¨¸Ó°Êª«¸ÕÅç«á¨ú±o²Ä¤@µ§¨½µ{¸Oª÷¡A¨Ã¦b§¹¦¨·s¾¯«¬·sÃĬã¨s¥Ó½Ð(IND)«á±N¥¿¦¡¶i¤J¤HÅéÁ{§É¸ÕÅç¡CN11005¥ç©ó¤µ¦~¨ú±o¼Ú·ù¦U°ê¤§±M§Q¡A¹ï¤½¥q¥¼¨Ó±À°Ê¼Ú¬ü¨ä¥L¦a°Ï¤§¥«³õ±N·¥¦³À°§U¡CC08001¦b¤µ¦~7¤ë±ÂÅv¤©¤j³°¤sªF·s®É¥NÃÄ·~«á¡A°£¦¬¨úñ¬ùª÷¥~¡A±N¥Ñ¤sªF·s®É¥NÃÄ·~«ùÄò§ë¤J¥ÍÅé¬Ûµ¥©Ê¸ÕÅç(BE)¡A¹wp§¹¦¨¬ÛÃö¤HÅé¸ÕÅç«á¡A³°Äò¥Ó½Ð¦U°êÃÄÃÒ¡C ¦¹¥~¡A¦]µØ¤]«ü¥X¡A¥Ø«e¥Ñ¤½¥q«ùÄò¶i¦æ¤HÅéÁ{§É¸ÕÅ窺¤fªA§ÜÀù·sÃÄ-D07001¡A¤w§¹¦¨4Ó¾¯¶q²Õ¤§¯f¤H¦¬®×¡A±N©ó¤µ¦~§¹¦¨³Ì«á¤@Ó¾¯¶q²Õ¤§¯f¤H¦¬®×«á¥¿¦¡¶i¦æ¤U¤@¶¥¬q¤§Á{§É¸ÕÅç¡A¨Ã¿n·¥»P¦³·NÄ@¤§¦X§@¹Ù¦ñ¶i¦æ±ÂÅv¬¢½Í¤¤¡C ¦]µØ¨Ãªí¥Ü¡A¦bªvÀøfଧ¿¯f¤§¨u¯f¥ÎÃÄ-¦]¸¿Õ©ó¥h¦~±ÂÅv¤sªF·s®É¥NÃÄ·~©ó¤j³°¤Î¦è¯Z¤ú¥«³õ«á¡A¸Óì®ÆÃĩ󤵦~2¤ëµn¿ý¬ü°êì®ÆÃÄ¥DÀÉ®×(Drug Master File;DMF)¡A¦]µØ©ó¤µ¦~7¤ë¤w§¹¦¨ì®ÆÃĶq²£¥X³f¤©·s®É¥NÃÄ·~¡A¹wp±N³z¹L¤sªF·s®É¥NÃÄ·~¦b¤j³°¥Ó½ÐÃÄÃÒ¡A«Ý·s®É¥NÃÄ·~¨ú±oÃÄÃÒ«á¡A±N¨Ì¾Ú¦X¬ù¤Î¹ï¤èq³æ¶i¦æ¨Ñ³f¡C¸Óì®ÆÃÄ¥Dn¥Ñµ¦²¤§ë¸êÃļt-¤C¬Pt³d¥Í²£¡A¨¬¨£¦]µØÁp¤â°·³ì¾ã¦X¤W´å¼t°Ó¤§§ë¸ê¡A¥ç³v¨B®i²{ºî®Ä¡C |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/7/28 ¤U¤È 11:09:53²Ä 323 ½g¦^À³
|
Jack ¤j, ¤p§Ì«D±`ÃÙ¦PM¤jªº¸Ñ»¡,¦]µØ±q²{¦b¶}©lªº°ò¥»±¬Ý¨Ó¬O·U¨Ó·U²M´·,¯à°÷¶}©l¦³¹ê½èªº¦¬¤J¤]¬O·U¨Ó·U©ú½T.2019~2120¬Ý°_¨ÓÀ³¸Ó¬O¦]µØªº°_¸¦~¡C ¦ý¬OªÑ»ù¤£¬O¥u¦³±q°ò¥»±¨Ó¬Ý,¦b³o¤@ªi§Q¦h«Å¥¬¤§«á쥻¤p§Ìªº¹w´ÁªÑ»ù¤]¬O¹w¦ôn¤ñ²{¦b°ª¤@¨Ç¨Ç,µL©`ªº¬O¦³´X¤è¸û¤jªº¶Õ¤O½Õ¾ãªÑ²¼«ù¦³¼Æ, ¦p²Î¤@·s¥x¤¤³o®a¨é°Óªº¤j¤j,«ê¦b³o®É½Õ¸`«ùªÑ¼Æ¶q,±q5/10°_¶}©l¸û©úÅ㪺½Õ¸` 5/10~7/26 ¶R¶i 237 ½æ¥X 1765 ,²b½æ 1528, 7/4 ~7/26 ¶R¶i 139 ½æ¥X 1327 ,²b½æ 1188,(7/4 ®t¤£¦h¬O¥»ªi°_º¦ÂI(ªÑ»ù¦¬9.38 ),7/8¤½¥¬ C08001±ÂÅv¦X¬ù), ±q2019/1/2 ¶}¥«¶}©l¨ì 7/26 ¨Ó¬Ý²Î¤@·s¥x¤¤³o®a¨é°Óªº¤j¤j,²b½æ¶W1619±i,©Ò¥H¬Ý¨Ó²Î¤@·s¥x¤¤¤£¬O¦]¬°¦]µØ«Å¥¬§Q¦h¤~¶}©l¥X²æªÑ²¼,¦Ó¬O¦b³o¤§«e´N¦³pµeªº½Õ¸`¤â¤W«ùªÑ¼Æ,¥i¯à¬OÓ¤H²z°]³W¹º§a. ¬°¦ó·|´£²Î¤@·s¥x¤¤³o®a¨é°Óªº¤j¤j,¦]¬°±q¥i¬dªº¾ú¥v¤§®Æ¨Ó¬Ý 2016/1/4~2019/7/26¶R¶i 10142 ½æ¥X 8122 ,²b¶R 2020, ²Î¤@·s¥x¤¤«D±`³ßÅw¦b¥«³õ¶i¥X¦]µØ³o¤äªÑ²¼,¥i±¤ªº¬OÆ[¹î°_¨ÓÀ³¸Ó¬O§¹¥þ¨SÁȨì¿ú, 2016/1/4 ~2016/12/30¶R¶i 1960 ½æ¥X 892 ,²b¶R 1068 ,(ªÑ»ù 52¶^¨ì30) 2017/1/3~2017/12/29¶R¶i 4011½æ¥X 2048 ,²b¶R 1563 ,(ªÑ»ù 30¶^¨ì18) 2018/1/2~2018/12/28¶R¶i 3076½æ¥X 2068 ,²b¶R 1008 ,(ªÑ»ù 18¶^¨ì7.3) 2019/1/2~2018/7/26¶R¶i 1095½æ¥X 2714 ,²b½æ 1619 ,(ªÑ»ù 7.3º¦¨ì10.6) ©Ò¥H¬Ý°_¨ÓÀ³¸Ó¬O²Î¤@·s¥x¤¤³o®a¨é°Óªº¤j¤jÓ¤H²z°]³W¹º,¦Ó¤£¬Oª¾¹D¬Æ»òn©ßªÑªº®ø®§....¦Ó¥B³Ìªñ¨ä¥L¤jªÑªF¤Î¸³ºÊ¨Æ§¹¥þµL©ßªÑªº²{¶H¤Ï¦Ó¦³¼W«ùªºª¬ªp(2019¶}©l ¥ÃÂת÷´°«n ¶R¶W 727 ,¤é²±´º¬ü534 , ³Í°ò¥x«n 252 ),³o¨Ç´¿«ùµ§¥æ¦hªº´N¬O©w»ù§C±µ(¥ÃÂת÷´°«n´N¬O³Ì¨å«¬ªº¨Ò¤l,µ´¤£°l»ù), ³o¼Ëªºª¬ªpªº½T´N§Î¦¨¤F§Q¦hº¦¤£°Êªºª¬ªp,¤]±a¥X¤F«Ü¦h¤j¤j¤@¤é©ßªÑªºª¬ºA(´N¬O¥u¦³¥X²{¤@¤Ñ½æªÑ²¼,±i¼ÆÁÙ»á¦h,«ùªÑ³£¦³1~2¦~,·í¤é¤£p»ù¦ìª½±µ½æ±¼),³o¨Ç¤j¤jÀ³¸Ó³£¬O½ß¿ú¥X³õ,¬ÝµÛªÑ»ùÁ`º¦¤£°Ê,¤S¦³¤j¤á¨C¤Ñ½æªÑ,©Ò¥H°Ê·n«H¤ßı±o³Ìªñ¦Ü¤Ö¦¨¥æ¶q¸û¤j®e©ö¥X²æªÑ²¼,´N½æªÑ¤F(¥É¤sÂù©M89 ,¸s¯qªF´ò33,´I¨¹¥xªF30,¤¸¤j¤j¦P23..............),³o¼Ë¤SÅýªÑ»ù¤S¦h¤F¤@¼hªýê.......... ªÑ»ùªº¤ä¼µº¥ý´Nn¬Ý²Î¤@·s¥x¤¤¬O§_¤w¸g½Õ¸`§¹²¦,ÁקK¥Lªº½Õ¸`¤S±aµÛ¨ä¥L¤j¤j¥X²æ«ùªÑ, ¦A¨Ó´N¬O«Ü«n«Ü«nªº,¦]µØ²{ª÷¦ó®É¸¨³U , BH4ì®Æn½æÃĦ¬¤J, C08001Åv§Qª÷¦¬¤J,¤fªA¯Ø®q¯ÀN11005°Êª«¸ÕÅç«á¡A¨ú±o²Ä¤@µ§¨½µ{¸Oª÷¦¬¤J,³o¨Çª÷ÃB³£¦³¦p´Á¤J³U,³o¼ËªÑ²¼§ë¸êªÌ¤~·|»{¬°®ø®§¬O¨Æ¹ê,§_«h¦]µØ³o¨Ç¦~ªº¶}µo¤@ª½¦³¹w´Áªº§Æ±æªÑ»ù«o¤£Â_¯}©³´N¬O¤@ª½¨S¦³¹ê½èªº¦¬¤J,¬Æ¦Ü¦b¤µ¦~¦~ªìÁÙ¥O§ë¸ê¤H»{¬°«Ü¦³¥i¯à¥X²{¸êª÷¦Yºòªºª¬ºA,¾ÉPªÑ»ù¤j¶^¦Ü6¦rÀY, ²Ä¤T´N¬O·sÃĪº®ø®§±,¦]µØY¯à§ó¿n·¥ªº¤½§i¶i«×,Åý¤j®aª¾¹D,·sÃĶ}µoªº«ùÄò¶i«×,ªÑ»ù«H¤ß«×À³¸Ó¯à§ó¦n.... ³Ì«á¸É¥R¤@¤U,Ãö©óBH4¤¤°ê¾P°âªº¬Ýªk,¦]¬°BH4¦b¤¤°ê¤w¸g¦C¬°ªÀ«O¤§¥~¤¤°ê¬F©²¸É§U³¡¤À¥ÎÃĶO¥Îªº¨u¨£¯e¯f¥ÎÃÄ,©Ò¥H¦³³o¼Ëªº¬F©²¸É§U²{ª÷,¦b¥|氢¥Íª«½ºËï¯Ê¥F¯gªº¯f±w¨Ï¥Î·NÄ@¤WµL½×¬OÂi±¤W©ÎÂi±¤U³£¯à¤ñ²{¦bªº¦ôÈn°ª«Ü¦h,¦Ó¥B¤¤°ê¶}©ñ2Lªº¬Fµ¦¤U,¬Û¦Pªº¥X¥Í±w¯f¤ñ,¦³»Ý¨Dªº±wªÌ¤S¤ñ²{¦ôÈ§ó°ª |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2019/7/28 ¤U¤È 01:32:40²Ä 322 ½g¦^À³
|
M¤j¤j¡AÁ¿ªº«Ü°È¹ê¡A¤£·|¸Ø¤j¿±·¡A«Ü´Î¡AÁÂÁÂ! |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/7/28 ¤W¤È 12:11:02²Ä 321 ½g¦^À³
|
·PÁÂC¤j,§Ú¤]¬Ý¨ì³o«h·s»D,¸ò¤W«h¦³¨âÓ§ó·s,²Ä¤@Ó¬OBH4¸Õ²£¥ÎÃĤC¤ë¥i¤J±b(¤]¤£±Æ°£°OªÌ¼g¿ù), ¥t¤@Ó¬OBH4¥¼¨Ó¤W¥«,°£¤Fì®ÆÃĪº¦¬¤J¥~,§ó¥i¨ú±o¾P°â¤À¼í, §Úı±o³oÓ«Ü«n,¦pªG¥uÁÈì®ÆÃĪº¿ú,¤C¬P©M·s®É¥NÃÄ·~¥i¯à·|ÁȤñ¦]µØ¦h,³o´N¤£Àu¤F. ¥t¥~Jack¤j, §Ú¦Û¤v¬O¦ô´XÓn¦¨¥\¥i¯à·|±a¨ÓªºÀ禬(Àù¯gÃÄ©M¯Ø®q¯Àn¦¨¥\¨S¨º»ò®e©ö¥ý¤£¦ô) C08001 : ¤p¦¨¥\´XÓ»õ(¦Y¤U¤¤°ê¥«³õ),¤j¦¨¥\¤Q´X»õ~´X¤Q»õ(¦Y¤U¥þ²y¥«³õ) BH4 : ¤p¦¨¥\´X¤d¸U,¤j¦¨¥\´XÓ»õ¨ì¤Q´X»õ(§Ú¬Oı±o¤¤°ê¤j³°À³¸Ó¥u¦³¤@³¡¤Àªº¯f¤H¥i¥H±o¨ìªvÀø,ÁöµM¥«³õ«Ü¤j,¦ý¯à½æ¥Xªº¶qÀ³¸Ó¥u¬O¤@³¡¤À,¤£¹LC¤j¤§«e¦³¤À¨É¹L,¾ãӻݨD¼ç¦bªº¥«³õ«D±`¤j) Åã¼v¾¯ : ¥[®³¤j¦¨¥\´X¤d¸U ¬ü°ê¦¨¥\´X¤d¸U¨ì´X»õ ªvÀùÃÄ : ¤Q»õ¬üª÷µ¥¯Åªº(¦ý¾÷²v¤£°ª,Ävª§ªÌ¦h) ¤fªA¯Ø®q¯À : ¦Ê»õ¬üª÷µ¥¯Åªº(¾÷²v«Ü§C,¦h¤ÖÃļt«e¤²«áÄ~³£°µ¤£¥X¨Ó,¤@¦ý¦¨¥\,·íªÑ¤ý¨S°ÝÃD) ´¶Àù¨O : ¨C¦~´£¨Ñ¥|¤¤d¸UÀ禬,Ãêº ¨S´£¨ìªº,©¬ª÷¤ó¯g¥ÎÃÄ,ÄáÅ@¸¢¥ÎÃÄ,·sªºÅã¼v¾¯«~¶µ,·sªº¤fªA²£«~(¬Ý°_¨Ó¤½¥q¹ï¦¹±H»P«p±æ,¦ýÀ³¸ÓÁÙ¨S¦³¨ãÅ馨ªG,©Ò¥H¥Í§Þ®i¨S´£¨ì). ²{¦bªÑ»ù¤ÏÀ³ªº¤j·§´N¬O¦]µØ¤w¸g¹ê²{ªº¦¨ªG:´¶Àù¨O,¦UÓñ¬ùª÷ªº¦¬¤J(¤£§t¥¼¨Óªº´Á³\),¤C¬Pªº¥«È. ªÑ»ùn¦A¤j¶^,¤j·§´N¬O¤W±ªº²£«~¥þ³¡¥¢±Ñ§a! ¤]¦³¥i¯à,³o´N¬O¤@Ó½äª`. ²{¦b¥«³õ¹ï¥Í§ÞªÑªºµû»ù«D±`ÄYV,°£¤F¤j¦³¨ÓÀYªº¸gÀçªÌ©Î¤jªÑªF¥~¥i¥H¨É¸û°ªªº¥»¹Ú¤ñ¥~, ¨ä¥L¤½¥q³£¨S¦³¥»¹Ú¤ñ¥i¨¥,¥«³õ¬Ýªº´N¬O¹ê½èÀò§Q©M¯u¥¿Ã±¬ùªº»ùÈ,¹ï·sÃĪѽѦh¤£§Q,¦]µØ´N¬O¨ü®`ªÌ. §Úı±o¥i¥H©ê°Õ! ¤U¤@Ó¤ÞÃzÂI¥i¯à¬OD07001ªº±ÂÅv,¦]¬°¦]µØ¬Ý°_¨Ó¤£·Q¦Û¤v§Ë¤G´Á,¶Õ¥²n§â¥L±ÂÅv¥X¥h,´N¤£ª¾¹D½Íªº±ø¥ó¦n¤£¦n. |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2019/7/27 ¤U¤È 06:41:57²Ä 320 ½g¦^À³
|
Cstang¤j¤j±z¦n¡A§Ú«Ü»{¦P¦]µØ¯à±ÂÅv¦¨¥\¡A¦Ó¥B¬O¤GÓ±ÂÅvª÷¥i®³!!! ¦b·sÃĪѥi»¡«D±`«D±`¤£®e©ö¡A¦ý§Ú¦³¤@ÂI¤£²z¸Ñ¡A¬°¤°»òªÑɲ¤~10¤¸!? ³o»ò§C???¯à½Ð±ÐC¤j¤j©ÎM¤j¤j¡A±z̦³²`¤J¬ã¨s¡A¸ÑµªºÃ°Ý¤@¤U¦n¶Ü?ÁÂÁ±zÌ¡C |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/7/27 ¤U¤È 04:39:01²Ä 319 ½g¦^À³
|
¦]µØ±q¤µ¦~¤§«áéwªº¦¬¯q´N¥ý¾a BH4 , C08001,©T©wªºì®Æ¥X°â¤Î²£«~¾P°â¤À¼í,(·íµM³Ì¦n¬OÅã¼v¾¯¤]¯à¨Ì´Á¦³ÃÄÃÒ¦n®ø®§¯à¼W¥[¾P³f¦¬¯q),À³¸Ó´N¯à³Ð³y¥¿¦VÀç§Q........ ETtoday °OªÌ«À´f¯ø¡þ¥x¥_³ø¾É °·³ìºX¤U¦]µØ¥Í§Þ¡]4172¡^¤µ¦~¥Ñ·s¥ôÁ`¸g²z°q¬°µØ»âx°Ñ®i2019¥Í§Þ¤j®i¡A¤µ¡]26¡^¤é±µ¨ü³X°Ýªí¥Ü¡A¦]µØ¥Ø«e¤T¶µ¥Dn¶}µo¤¤ªº·sÃÄ¡A¤w¸g¦¨¥\±ÂÅv2¶µ¡A¥h¦~±ÂÅvªº¨u¯f·sÃÄ¡A¥»¤ë¥X³f®³¨ì²Ä¤@µ§ì®Æ¶O¥Î¡A¨Ã±N§ë¤J¤fªAÃĪ«·sÃĶ}µo¡A³v¨B¹ê½î§Þ³N¥¥x¶}µoªºÀç¹Bµ¦²¤¡C °q¬°µØªí¥Ü¡AªvÀøfଧ¿¯fªº¨u¯f¥ÎÃÄ¡u¦]¸¿Õ¡v¡A¥h¦~±ÂÅv¤sªF·s®É¥NÃÄ·~¦b¤j³°©M¦è¯Z¤ú¥«³õ«á¡A¸Óì®ÆÃĩ󤵦~2¤ëµn¿ý¬ü°êì®ÆÃÄ¥DÀÉ®×(Drug Master File;DMF)¡A¨Ã¦b¤µ¦~7¤ë§¹¦¨ì®ÆÃĶq²£¥X³f¡A¹wp³z¹L¤sªF·s®É¥NÃÄ·~¦b¤j³°¥Ó½ÐÃÄÃÒ¡A³Ì§Ö©ú¦~´N¥i¥Ó½Ð®³¨ìÃÄÃÒ¡C °q¬°µØ«ü¥X¡A¡u¦]¸¿Õ¡v¥h¦~±ÂÅvª÷´N®³¨ì300¸U¤H¥Á¹ô¡A°£¤Fì®Æ¨Ñ³f¤§¥~¡A±µ¤U¨Ó¦b¨ú±oÃÄÃÒ«á¡A±N¨Ì¾Ú¦X¬ù¤Î¹ï¤èq³æ¶i¦æ¨Ñ³f¡A²£«~ÁÙ¥i¥H¥t¥~¤À¼í¡A¬°¦]µØ¥Í§ÞÀç¹BѺª`éw°Ê¯à¡A¥B¸Óì®ÆÃÄ¥Dn¥Ñµ¦²¤§ë¸êÃļtt³d¥Í²£¡AÅ㨣¦]µØÁp¤â°·³ì¾ã¦X¤W´å¼t°Óªº§ë¸ê¡A³v¨B®i²{ºî®Ä¡C ¦]µØ¥Í§Þ¥h¦~±ÂÅvµ¹¤¤°ê¤j³°¦X§@¹Ù¦ñªº¤fªA¯Ø®q¯À·sÃÄ¡uN11005¡v¡A°q¬°µØ«ü¥X¡A¥Ø«e¤w´£¨ÑÁ{§É¸ÕÅç¥ÎÃÄ¡A¨Ñµ¹¤j³°¶i¦æªø´Á¬r²z©Êªº°Êª«¸ÕÅç¡A¹wp¤µ¦~©³§¹¦¨¸Ó°Êª«¸ÕÅç«á¡A¨ú±o²Ä¤@µ§¨½µ{¸Oª÷¡A¨Ã¦b§¹¦¨·s¾¯«¬·sÃĬã¨s¥Ó½Ð¡]IND¡^«á±N¥¿¦¡¶i¤J¤HÅéÁ{§É¸ÕÅç¡C ¦P®É¡A°q¬°µØ«ü¥X¡A¦]µØ¤T¶µ¥Dn¶}µo¤¤ªº·sÃÄ¡A¤µ¦~¦A±N°ª¦åÀ£·sÃÄ¡uC08001¡vªº¥þ²y¥«³õ¡A±ÂÅvµ¹¤sªF·s®É¥NÃÄ·~¡A°£¦¬¨úñ¬ùª÷¥~¡A±N¥Ñ¤sªF·s®É¥NÃÄ·~«ùÄò§ë¤J¥ÍÅé¬Ûµ¥©Ê¸ÕÅç¡]BE¡^¡A¹wp§¹¦¨¬ÛÃö¤HÅé¸ÕÅç«á¡A³°Äò¥Ó½Ð¦U°êÃÄÃÒ¡C °q¬°µØªí¥Ü¡A¥Ø«e¥Ñ¦]µØ«ùÄò¶i¦æ¤HÅéÁ{§É¸ÕÅ窺¤fªA§ÜÀù·sÃÄ¡uD07001¡v¡A¤w§¹¦¨4Ó¾¯¶q²Õªº¯f¤H¦¬®×¡A±N¦b¤µ¦~§¹¦¨³Ì«á¤@Ó¾¯¶q²Õªº¯f¤H¦¬®×«á¡A¥¿¦¡¶i¦æ¤U¤@¶¥¬qªºÁ{§É¸ÕÅç¡A¨Ã¿n·¥»P¦³·NÄ@ªº¦X§@¹Ù¦ñ¶i¦æ±ÂÅv¬¢½Í¡A¨Ã¹wp«ùÄò§ë¤J¤fªAÃĪ«·sÃĪº¶}µo¡A©µÄò¦¨ªø°Ê¯à¡C |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/7/25 ¤W¤È 10:36:37²Ä 318 ½g¦^À³
|
¦]µØ¥Í§Þ¡]4172¡^¦b¥h¦~«×¤½¥q«·s¾ã¹y«á¡A¥Ñì¬ãµoªøº[¤½¥q³Ð¿ì¤H¤§¤@¡Ð°q¬°µØ±µ¥ô·s¥ôÁ`¸g²z¡A¦b°·³ì¶°¹ÎªL´¼·u¸³¨Æªø¤§¤ä«ù¤U¡A¾ú¸g¤@¦~¦h¤§¾ã¹y¡A¤½¥qÀç¹B¹ð³Ð¨ÎÁZ¡CÄ~¥h¦~±N¤fªA¯Ø®q¯À·sÃÄ-N11005±ÂÅv¤¤°ê¦X§@¹Ù¦ñ«á¡A¤µ¦~¦A±N°ª¦åÀ£·sÃÄ-C08001±ÂÅv¥þ²y¥«³õ¤©¤sªF·s®É¥NÃÄ·~¡C¦]µØ¤T¶µ¥Dn¶}µo¤¤ªº·sÃÄ¡A¤w¸g¦¨¥\±ÂÅv¨â¶µ¡C¤½¥q¤]©ó¤µ¦~¶}©l§ë¤J¤fªAÃĪ«¤§·s«~¶µ¶}µo¡A©µÄò¬ãµo°Ê¯à¡A¤w³v¨B¹ê½î¤½¥q¬°§Þ³N¥¥x¶}µo¤½¥qªºÀç¹Bµ¦²¤¡C¦¹¦¸¦]µØ¥Í§Þ¤]°Ñ¥[2019¨È¬w¥Í§Þ¤j®i¡A°Ñ®iÅu¦ì¸¹½X¡GÂåÃÄ»PÂå§÷°ÏM612A¡C Á`¸g²z°q¬°µØ¦b¥h¦~¤W¥ô«á¡A§Y°µ¤F´X¶µ«¤jÅܲ¡C¥ý±N¦]µØ¥Í§Þ©ú½T©w¦ì¬°§Þ³N¥¥x¶}µo¤½¥q¡A¦P®É¤]¥H¨ä¬ãµo§Þ³NI´º¿Ë©º·~°È²Ä¤@½u¡A¦¨¥\¨ú±o¤fªA¯Ø®q¯À·sÃÄ-N11005±ÂÅv¤¤°ê¦X§@¹Ù¦ñ¡A¤µ¦~§ó¦¨¥\±N°ª¦åÀ£·sÃÄ-C08001±ÂÅv¥þ²y¥«³õ¤©¤sªF·s®É¥NÃÄ·~¡C°£¤FÅý¤½¥q¦³©ú½T¦¬¯q¤§¥~¡A«áÄòªº«ùÄò§ë¤Jªº¸ÕÅç¡A¤]¥i¥Ñ³Q±ÂÅv¤½¥qÄ~Äò°õ¦æ¡C °q¬°µØªí¥Ü¡AN11005¦b¥h¦~±ÂÅv¤©¦X§@¹Ù¦ñ«á¡A¦]µØ¤w´£¨ÑÁ{§É¸ÕÅç¥ÎÃĨѨä©ó¤j³°¶i¦æªø´Á¬r²z©Ê¤§°Êª«¸ÕÅ礤¡A¨Ã¦b§¹¦¨·s¾¯«¬·sÃĬã¨s¥Ó½Ð¡]IND¡^«á¡A±N¥¿¦¡¶i¤J¤HÅéÁ{§É¸ÕÅç¡C¦P®ÉN11005¥ç©ó¤µ¦~¨ú±o¼Ú·ù¦U°ê¤§±M§Q¡A¹ï¤½¥q¥¼¨Ó±À°Ê¼Ú¬ü¨ä¥L¦a°Ï¤§¥«³õ±N·¥¦³À°§U¡C ¥t¥~°ª¦åÀ£·sÃÄ-C08001¦b¤µ¦~7¤ë±ÂÅv¤©¤j³°¤sªF·s®É¥NÃÄ·~«á¡A°£¦¬¨úñ¬ùª÷¥~¡A±N¥Ñ¤sªF·s®É¥NÃÄ·~«ùÄò§ë¤J¥ÍÅé¬Ûµ¥©Ê¸ÕÅç¡]BE¡^¡A¹wp§¹¦¨¬ÛÃö¤HÅé¸ÕÅç«á¡A³°Äò¥Ó½Ð¦U°êÃÄÃÒ¡C Á`¸g²z°q¬°µØ´£¤Î¡A¥Ø«e¥Ñ¤½¥q«ùÄò¶i¦æ¤HÅéÁ{§É¸ÕÅ窺¤fªA§ÜÀù·sÃÄ-D07001¡A¤w§¹¦¨4Ó¾¯¶q²Õ¤§¯f¤H¦¬®×¡A±N©ó¤µ¦~§¹¦¨³Ì«á¤@Ó¾¯¶q²Õ¤§¯f¤H¦¬®×«á¡A¥¿¦¡¶i¦æ¤U¤@¶¥¬q¤§Á{§É¸ÕÅç¡A¨Ã¿n·¥»P¦³·NÄ@¤§¦X§@¹Ù¦ñ¶i¦æ±ÂÅv¬¢½Í¤¤¡C ¦¹¥~¡A¦bªvÀøfଧ¿¯f¤§¨u¯f¥ÎÃġЦ]¸¿Õ¡A©ó¥h¦~±ÂÅv¤sªF·s®É¥NÃÄ·~©ó¤j³°¤Î¦è¯Z¤ú¥«³õ«á¡A¸Óì®ÆÃĩ󤵦~2¤ëµn¿ý¬ü°êì®ÆÃÄ¥DÀɮס]Drug Master File¡FDMF¡^¡A¦]µØ©ó¤µ¦~7¤ë¤w§¹¦¨ì®ÆÃĶq²£¥X³f¤©·s®É¥NÃÄ·~¡A¹wp±N³z¹L¤sªF·s®É¥NÃÄ·~¦b¤j³°¥Ó½ÐÃÄÃÒ¡A«Ý·s®É¥NÃÄ·~¨ú±oÃÄÃÒ«á¡A±N¨Ì¾Ú¦X¬ù¤Î¹ï¤èq³æ¶i¦æ¨Ñ³f¡C¸Óì®ÆÃÄ¥Dn¥Ñµ¦²¤§ë¸êÃļt¡Ð¤C¬Pt³d¥Í²£¡A¨¬¨£¦]µØÁp¤â°·³ì¾ã¦X¤W´å¼t°Ó¤§§ë¸ê¡A¥ç³v¨B®i²{ºî®Ä¡C (¤u°Ó®É³ø) ¤½¥q·s»D¥X¨Ó¤F¡A¸ò¤W¦¸ªÑªF·|Á¿ªº®t¤£¦h |
|
|
·|û¡GChen10137456 µoªí®É¶¡:2019/7/25 ¤W¤È 07:29:40²Ä 317 ½g¦^À³
|
¦]µØ°Ñ¥[2019¨È¬w¥Í§Þ¤j®i¡A¦³¥h°ÑÆ[ªº¤j¼wÌ¥i¤À¨É¤ß±o¶Ü?ÁÂÁ |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2019/7/24 ¤W¤È 11:40:52²Ä 316 ½g¦^À³
|
·sÃĪѫܦh¡A¯à¦³¹ê½è±ÂÅvª÷ªº¨S´X®a¡A¦]µØ¯à±ÂÅv«Ü¼F®`¡A¥[ªo¤F¡C |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/7/23 ¤U¤È 01:31:16²Ä 315 ½g¦^À³
|
·PÁ²Τ@·s¥x¤¤¡A¤j¤O¤ä«ù½ß°âªÑ²¼¨Ñµ¹³f·½¡A¦b³oªi¤¤´£¨Ñ¸û«K©yªºªÑ²¼¤d¾l±iÅý¨ä¥L¤H»{ÁÊ¡A¤£µMÁÙ¯u¶R¤£¨ì |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/7/13 ¤U¤È 12:07:26²Ä 314 ½g¦^À³
|
±þ½L¥D¦]ÁÙ¬O¨Ó¦Û©ó²Î¤@·s¥x¤¤³o¦ì¤j¤j.³o¨â¤ÑˤF4¦Ê¦h±i§a.(¥L¤â¤W¦Ü¤ÖÁÙ¦³¨â¤d¦h±i) ¦³½ìªº¬O7/8·í¤Ñ¥LÁÙ¥ý½æ¤F1¦Ê¦h±i,7/8¦¬½L«á®ø®§¤~¤½¥¬,ªí¥Ü¥L½æ¤F1¦Ê¦h±iµ¹§C±µªº¤H. 9~10¨â¤ÑªÑ»ù³Ì°ªªº®ÉԤϦӳ£¨S½æ,³Ì«á¨â¤Ñ¤S½æ¤F¥|¦Ê¦h±i. °£«D«Ü·|ºt,§Úı±o¥L¬O«D¤½¥q¬£ªº¥D¤O,¤]¨S¿ìªk´x´¤³Ì·s®ø®§. ¹ï³o¦ì¤j¤jªº°µªk¤]¤£¯à»¡¤°»ò,§Æ±æ¤j®a²z©Ê¬Ý«Ý¦]µØªº°ò¥»±,¤]´Á«Ý¥Í§Þ®i«e«á¯àÂÛ¥X§ó¦h¦n®ø®§. |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/7/12 ¤W¤È 10:07:11²Ä 313 ½g¦^À³
|
¬Ý¨ì³o¨â¤Ñªº±þ½L,°£¤FµL¨¥ÁÙ¬OµL¨¥,©Î³\«Ü¦h¤j¤jı±o²×©ó¦³¦¨¥æ¶q¯à¥X²æªÑ²¼¤F§a,¦ý¸Û¦pChen¤j¤j©Ò»¡,¥H¦]µØ¥Ø«eªºÀç¹Bª¬ªp¨Ó¬Ý¬O±q¹L¥h¥H¨Ó³Ì¦nªº®É¨è¶}©l¤F.........²`·P»{¦P C08001ªºÃ±¬ùªº½T¥X¥G·N®Æ,¤£¬O¦b쥻ªÑªF·|¤WÀç·~ª¬ªp·|¤¤ªº³ø§i¤¤ªº¶µ¥Ø,©Î³\´N¬O°qÁ`»¡ªº¼È®É¤£¯à»¡ªº¦n®ø®§,¤]¬O¥i¥H§áÂà¦]µØ¤µ¦~¥i¥HÂàÁ«¬°¬Õªº§U¤O,¦]µØ¥h¦~µ|«áÁ«·l0.86»õ,¤µ¦~«×¦b«ùÄòÁY´î¶O¥Îªºª¬ºA¤U¤ä¥X·|¤ñ¥h¦~§ó§C, ¤£¹L¦¬¤J¤W´N¤£¦P¤F, 1.´¶Àù¨O¦]¬°¾AÀ³¯g¼W¥[,©Ò¥HÀ禬¤]¬O³v¦~¼W¥[(½T©wªº) 2.C08001±ÂÅv¦¬¯qñ¬ùª÷ 1000¸URMB, (¬ù4,500¸UNTD) 3.BH4, ²Ä¤@¦¸¤¤°ê(¤sªFÃÄ·~,¥Ó½Ð¤¤°êÃÄÃÒ¥Î)¥X³fÀç·~ª÷ÃB,³o¬O¤¤°ê¦Û»s²Ä¤@¤äBH4ªvÀøÃĪ«,¤¤°ê¨C¦~¦ôp¦³ªñ¦Ê»õ¥x¹ôBH4ªº¥ÎÃĻݨD,¦Ó¥B¤¤°ê¬F©²¹ï©ó¦¹¥ÎÃĬO¦³¥Á²³¸É§Uª÷,©Ò¥H³oÓ¦¬¤J¤£¶È¬O¤µ¦~ªº¦¬¤J,©ú¦~¶}©l·|¦³³sÄò©Êªº¦¬¤J 3-1BH4 ¥Ó½ÐÃÄÃÒ¨½µ{ª÷ 4. ¤¤°ê¤fªA¯Ø®q¯À¤HÅé¸ÕÅç¶}©l¨½µ{¸OÅv§Qª÷(À³¸Ó´N¦b³Ìªñ) 5. Åã¼v¾¯¬ü°êÃÄÃÒ¨½µ{¸OÅv§Qª÷¤ÎÀç·~ÃB 6. Åã¼v¾¯¥[®³¤jÃÄÃÒ¨½µ{¸OÅv§Qª÷¤ÎÀç·~ÃB 7. ¤g¦Õ¨äBH4 ¦¹®É¥X²æªÑ²¼ªº¤j¤jÌ,¥[ªo,³q±`ªÑ¥«¤£´N¬O¦p¦¹,µ¥«Ý¬O·Î¼õªº,¶}ªá¬O¦u¤£¦íªº,·íªÑ²¼·Pı®e©ö½æ±¼ªº®ÉÔ¨º¬Û¹ï´N¬O¨ä¥L¤HÄ@·N¶Rªº®ÉÔ |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/7/11 ¤W¤È 09:50:38²Ä 312 ½g¦^À³
|
¤£¦n·N«ä,§Ú¬Q¤Ñªº¼Æ¾Ú©¿²¤¤F¾Ç¦WÃĪº½ÄÀ». Coreg¾Ç¦WÃÄ2007¦~°Ý¥@, 2006¦~GSK Coreg¦~¾P°â¬ù779M¼Ú¤¸, 2007¦~587M¼Ú¤¸,·í¦~¼Ú¤¸ªº¶×²vÀ³¸Ó¤ñ¸û¤j. §Ú§ä¤£¨ì¥Ø«e¾Ç¦WÃÄ©Ò¦û¤ñ¨Ò¦h¤Ö(¦ü¥Gn¶R¥I¶Oªº³ø§i¤~¦³), ¤S§ä¨ì¤@¥÷³ø§i,2006¦~carvedilol ¦b¬ü°ê³B¤è¼Æ¬°11.03M, 2016«h¬°23.34M. ©Ò¥H¦]¬°¾Ç¦WÃÄ¥X²{,carvedilolªº»ù®æ¤@©w·|±¼,¦ý¬Ý°_¨Ó¨Ï¥Îªº¼Æ¥ØÁÙ¼W¥[¤£¤Ö. Á`¤§¾ãÓ¥«³õÀ³¸Ó¤ñ§Ú¤W½g¦ôªº47»õ¥x¹ôÁÙ¦h¤£¤Ö(¦]¬°©¿²¤ªº¾Ç¦WÃÄ¥«³õ). ¤½¥q¦b¦~³ø64¶´£¨ìcarvedilol¥þ²y¦~¥«È³Ì°ª¹F16.7»õ¬üª÷. §Ú¥u¬O§â¥i¥H§äªº¸ê®Æ¾ã²z¥X¨Ó,§Æ±æ³o¶µ²£«~¥i¥H¦¨¥\ |
|
|
·|û¡GChen10137456 µoªí®É¶¡:2019/7/11 ¤W¤È 08:43:39²Ä 311 ½g¦^À³
|
·PÁÂmogwai¤j¤jªº¤À¨É¡A¬Ý°_¨Ó¦]µØ¥Ø«eªºÀç¹Bª¬ªp¸û2¦~«e¨ú±o·|p®v¤º±±³ø§i(«á¨Ó¤WÂd¥Ó½Ð¦]¬G¥¼°e¥ó)®É¦n¤Ó¦h嘞¡AªÑ»ù¤]«K©y«Ü¦h¡ACarvedilol CR(C08001)®×±aµ¹¦]µØ¤@¤ù¥ú©ú©M§Æ±æ¡C§Æ±æ°qÁ`¦³§ó¤jªº¥ø¹Ï¤ß¡A¦n¦n§ïµ½°]°Èµ²ºc¡A¦¤é¤WÂd¡C |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/7/10 ¤U¤È 11:49:39²Ä 310 ½g¦^À³
|
×¥¿¤@¤U¤W¤å,¼Ú¤¸¶×²vºâ¿ù, ¬ü°ê¥«³õ³W¼ÒÀ³¸Ó¬O30»õ~47»õ¥x¹ô |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/7/10 ¤U¤È 11:31:55²Ä 309 ½g¦^À³
|
¦A²á¤@¤UCarvedilol CR(C08001), ¦pªG¤@¤Á¶¶§Qªº¸Ü¦]µØ±q·s®É¥NÃÄ·~¥i¥H®³¨ì4500¸U¤H¥Á¹ô, §é¦X¥x¹ô¬ù¨â»õ. ¥H¦]µØªÑ¥»¤C»õ¨Ó¬Ý,¤£¦Ò¼{ªF¥ÍµØªº¤À¼í¤U,¤j·§´Nȧ֤T¶ô,¸ò³o¨â¤Ñªºº¦´T¬Û²Å. èè¥hGSK(coreg CR ì¼t)ºô¯¸¬Ý, ¦³´£¨ì³o¥y Coreg franchise sales declined 63% AER, 63% CER following a generic Coreg CR entrant to the US market in Q4 2017 ·N«ä¬O Coreg¦]¬° Coreg CRªº¤Þ¶i,¦b2018¦~¬ü°êªº¾P°âÃB±¼¤F63%. ®t¤£¦h¥i¥H»¡Coreg CR¦Y±¼Coreg(«D½wÄÀª©¥»)¦b2017¾P°âªº63%. ¤SCoreg 2018 ¾P°â50M ¼Ú¤¸ ¦^±À¦^¥h Coreg CR 2018¾P°â¬ù85M¼Ú¤¸,¬ù38»õ¥x¹ô. ¾ãÓCoreg(CR+«DCRª©¥»)ªº¾P°â¬ù135M¼Ú¤¸,¬ù60»õ. ¥H¬ü°ê¥«³õ½×,C08001¥i¥HÄvª§ªº¥«³õ³W¼Ò´N¬O38»õ~60»õ¥x¹ô. ¤×¨ä¦]µØ«ÅºÙC08001®ÄªG¤ñCoreg CR¦n. ·íµM¤¤°ê¤j³°©M¥xÆWªº¥«³õ³W¼Ò¤ñ¸û¤£²M·¡. ¤£¹L³oÃĦ¨¥\ªº¸Ü,¥un¯à¥´¤J¬ü°ê¥«³õ¨C¦~À³¸Ó¥i¥H±a¨Ó¦n´X»õªºÀ禬§a!(¦Ò¼{©w»ùµ¦²¤¤Î¦]µØ¥u®³¤@³¡¤À), ´Nºâ¥u¦Y¤U¥xÆW©M¤j³°¥«³õ,°^ÄmÀ³¸Ó¤]¤£¤Ö. |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/7/8 ¤U¤È 08:51:26²Ä 308 ½g¦^À³
|
¸É¥R¤@«h·s»D ªF¥ÍµØ:¥»¤½¥q¼W¸É»P¦]µØ¥Í§Þñq¤§CRTA²£«~®ü¥~±ÂÅv®Ñ ²Ä10´Ú 1.¨Æ¹êµo¥Í¤é:108/07/08 2.«´¬ù©Î©Ó¿Õ¬Û¹ï¤H:¦]µØ¥Í§Þ»sÃÄ(ªÑ)¤½¥q¡C 3.»P¤½¥qÃö«Y:µL¡C 4.«´¬ù©Î©Ó¿Õ°_¨´¤é´Á¡]©Î¸Ñ°£¤é´Á¡^:108/07/08 5.¥Dn¤º®e¡]¸Ñ°£ªÌ¤£¾A¥Î¡^:¥»¤½¥q±ÂÅv¦]µØ¥Í§Þ»P²Ä¤T¤è¶i¦æ±ÂÅv¤ÎÃÄ«~¶}µoµ¥¡C 6.¨î±ø´Ú¡]¸Ñ°£ªÌ¤£¾A¥Î¡^:µL¡C 7.¹ï¤½¥q°]°È¡B·~°È¤§¼vÅT¡]¸Ñ°£ªÌ¤£¾A¥Î¡^:¨Ì¦X¬ù¹ï±ÂÅv«á¤À¼í¤º®e«O±K¡C 8.¨ãÅé¥Øªº¡]¸Ñ°£ªÌ¤£¾A¥Î¡^:±ÂÅv¥þ²y¥«³õ¶}µo¡C ¬Ý°_¨ÓªF¥ÍµØ¥i¥H±q¤¤¶¡¼´¤@µ§, ¦ý¬O¥Ñ¦~³ø¨Ó¬Ýp.130 3.¥»¤½¥q»P¥Ò¤½¥qñq²£«~ÂàÅý¨óij¡A¨ú±o¨äì©e¥ô¶}µo¨óij¤¤¤§ÃÄ«~©Ò ¦³¤§Åv§Q¡C¨Ì¬ù¥»¤½¥q©ó¦V¥DºÞ¾÷Ãö´£¥X°õ¦æÃÄ«~¥ÍÅé¬Ûµ¥©Ê¸ÕÅç¥Ó½Ð ²Ý¤é¡B¨ú±oÃÄ«~³\¥iÃҲݤé¡A¤À§O»Ýµ¹¥I±Mªù§Þ³Nª÷¡A¨ä¦Xp¬°$5,700¡A ¦©°£¤w¤ä¥I´Ú¶µ¡B¥¼¨Ó¨Ì¨½µ{¸O¹F¦¨¶i«×¡A©|¶·¤ä¥I$3,000¡C¥t¡A¥¼¨Ó ¨C¦~»Ý¨Ì·í´Á¤§ÂåÀø³q¸ô²b¾P°âÃBµ¹¥I 5%¤©±ÂÅv¤è¡A¤ä¥I¤W¬° $16,100¡C (§Ú²q³o±ø´N¬OC08001»PªF¥ÍµØ¬ÛÃöªº±ø´Ú) ¬Ý°_¨Óµ¹ªF¥ÍµØªºª÷ÃB¤ñ°_®³¨ìªº¤Ö«Ü¦h,¨S¦³«¤j¼vÅT. ³oÓ·s»D¯u¬O¤Ó¦n¤F,¦]µØ´X¥G±q¨Ó¨S¦³§â¦X¬ùª÷¤º®e¼gªº¦p¦¹²M·¡ªº±ø¬ù. ¬Ý°_¨Ó¤µ¦~¥i¯à¥i¥HÂàÁ«¬°¬Õ,¥B³oµ§Ã±¬ùª÷ªº«áÁ®t¤£¦h´N¬O¦]µØ¤@¦~ªº¤ä¥X. ³o¨â¤T¦~³£¤£»Ý¬°¸êª÷·Ð´o¤F. ±µ¤U¨Ó´N¬Ý³o»ò¦h²£«~½u¦p¦ó¤@´Î±µ¤@´Îªº¶}ªáµ²ªG¤F. |
|
|
·|û¡GºCºC¶]10142302 µoªí®É¶¡:2019/7/8 ¤U¤È 03:52:34²Ä 307 ½g¦^À³
|
1.¨Æ¹êµo¥Í¤é:108/07/08 2.«´¬ù©Î©Ó¿Õ¬Û¹ï¤H:¤sªF·s®É¥NÃÄ·~¦³¤½¥q 3.»P¤½¥qÃö«Y:µL¡C 4.«´¬ù©Î©Ó¿Õ°_¨´¤é´Á(©Î¸Ñ°£¤é´Á):108/07/08 5.¥Dn¤º®e(¸Ñ°£ªÌ¤£¾A¥Î):¥»¤½¥q»P¤sªF·s®É¥NÃÄ·~¦³¤½¥q(¥H¤U²ºÙ·s®É¥NÃÄ·~) ñ¸pC08001·sÃÄ¿W®a±ÂÅv¥þ²y¥«³õ¦X¬ù¡C 6.¨î±ø´Ú(¸Ñ°£ªÌ¤£¾A¥Î):µL¡C 7.¹ï¤½¥q°]°È¡B·~°È¤§¼vÅT(¸Ñ°£ªÌ¤£¾A¥Î):¥»¤½¥q±NÀò±oñ¬ùª÷1,000¸U¤H¥Á¹ô(·s®É ¥NÃÄ·~©óñ¬ù«á45¤Ñ¤º¤ä¥I)¡A¥t¦³3,500¸U¤H¥Á¹ô¤§¨½µ{¸Oª÷¥H¤Î¨Ì¾P°âª÷ÃB¦¬¨ú ¤§Åv§Qª÷¡C¥¼¨Ó±N¥Ñ·s®É¥NÃÄ·~t¾á¸Ó¶µ¥Ø¦b¥þ²yªº¤HÅéÁ{§É¸ÕÅç¶O¥Î»PÃÄ«~µù¥Uµ¥ ¬ÛÃö¶O¥Î¡A¨Ã©óÀò±o§åã¤W¥««á¡At³d¸Ó¶µ¥Ø¦b¥þ²yªº°Ó·~¤Æ±À¼s¡C 8.¨ãÅé¥Øªº(¸Ñ°£ªÌ¤£¾A¥Î):¨ó§U¥»¤½¥q¶}µo°ª¦åÀ£¥ÎÃÄ¥«³õªk³W®Öã¤Î°Ó«~¤Æ¬¡°Ê¡C 9.¨ä¥LÀ³±Ô©ú¨Æ¶µ: ·s®É¥NÃÄ·~¬°¤j³°¾|«n»sÃĶ°¹Î¤Uªº¥Dn¤½¥q¤§¤@¡C¨ä©ÒÁõÄݶ°¹Î¡Ð¾|«n»sÃĶ°¹Î¬O ¤j³°»sÃĤ½¥qÄvª§¤O±Æ¦W²Ä28¦W¤§¤½¥q¡A´¿³Q¤j³°»{©w¬°°ê®a³Ð·s«¬¥ø·~¡B°ê®a§Þ³N ³Ð·s¥Ü½d¥ø·~¤Î°ê®a¤õ¬²p¹º«ÂI°ª·s§Þ³N¥ø·~¡A¦~¾P°âÃB¶W¹L¤H¥Á¹ô104»õ¡A¥D¤O ²£«~¤§¤@¬°¤ß¦åºÞ¥ÎÃÄ-ªY±d¡A¦~¾P°âÃB±µªñ¤H¥Á¹ô15»õ¡C ¨Ã©óÀò±o§åã¤W¥««á¡At³d¸Ó¶µ¥Ø¦b¥þ²yªº°Ó·~¤Æ±À¼s¡C¦n³Y²§½æµ¹¤j³°¤½¥q¥þ²y·|¾P°â |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/7/5 ¤U¤È 04:31:57²Ä 306 ½g¦^À³
|
·íªìªÑªF·|®É,°qÁ`¬O¦³´£¨ì³o´XÓ¤ë§V¤O¤@¤U,§Æ±æ¥i¥H¦b¥Í§Þ®i§ËÓ¤p«¬ªk»¡, ¥]¬A·s²£«~©M¥Ø«e²£«~ªº³Ì·s¶i«×. ¤£¹L³o¸ÜÁ¿±o¤ñ¸û«O¦u,¦³ªº¸Ü´N¤j¥[¤À,¨S¦³ªº¸Ü´N¤]¤£¥Î¤Ó¦b¥G. ªÑ»ù¤~º¦¤@¨â¤Ñ,³£¨S®ø®§ªº´eµÛº¦¤ñ¸û¦n,®ø®§¥X¨Ó©¹©¹³£¨£¥ú¦º. ¤UÓ§«ô¦AÆ[¹î¬Ý¬Ý§a~ |
|
|
·|û¡GChen10137456 µoªí®É¶¡:2019/7/5 ¤W¤È 10:19:47²Ä 305 ½g¦^À³
|
¥xÆW¥Í§Þ¤ëº[¡u¨È¬w¥Í§Þ¤j·|¡v¡]BIO Asia¡^±N©ó7¤ë24¤é®i¶}¡A¦]µØ¦³§Q¦h¶Ü? |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/6/21 ¤W¤È 01:37:37²Ä 304 ½g¦^À³
|
¤µ¤Ñ¦]µØ§ó·s¤F¥xÆWÁ{§É¹êÅçºô¯¸, §âD07001 ¤¤°êÂåÃĤj¾Çªþ³]Âå°|,¤Î¦¨¤jÂå°|ªºª¬ªp§ï¦¨©Û¶Ò¤¤. ¦pªG¤£¬O³æ¯Â¤å®Ñ§@·~ªº¸Ü,ªí¥Ü¦³©Û¶Ò§ó¦hªº¯f¤H¶i¨Ó¹êÅç,¤]ºâ¬OÓ¥¿±ªº®ø®§ |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/6/5 ¤W¤È 11:42:30²Ä 303 ½g¦^À³
|
²³æ¦^ÂФ@¤U ¤ÀªR³o´X¶gªº¨é°Ó¤ÀÂI©MªÑÅv¤À§Gµo²{ ¤¸¤j´_¥_À³¸Ó¬O±q200~400¯Å¶Z°¨ì50~100±i, ¥ÃÂ×´°«nÀ³¸Ó쥻´N¬O¤d±i¥H¤W¤j¤á,¦Ó¥B«ù¦³«D±`¤[¤F. ®ç¶é§»»·±`±`¶i¶i¥X¥X,¤ñ¸û¨S¦³¥Nªí©Ê. ²Î¤@·s¥x¤¤«ù¦³±i¼Æ«D±`¦h,¦ý¬O«D±`³ßÅw¶i¥X,¬Ý¥Lªº¶i¥Xªkªø´Á¥H¨ÓÀ³¸Ó¬O¤pÁ«,¤£ª¾¹D¦b·Q¤°»ò. µM«á°·³ì«Ü¦¥H«e´N¶}©l9±i9±i½æ¤F,¤ñ§Ú̳oÓ°Q½×¦ê¤@¶}©l´£¥Xªº®É¶¡ÁÙ¦(»·¦©ó18¶ô¼W¸ê®É). ©Ò¥H§Ú¤~·|»¡°·³ì²{¦bªº«ùªÑ³£¬OÁȪº.(¦³¿³½ì¥i¥H½¦]µØ¾ú¦~¦~³ø¥DnªÑªFªºªÑÅv¤À§G). §Ú¦³¹q¸Ü¸ß°Ýbh4ì®ÆÃÄ©M¬r²z¤ÀªR¨½µ{ª÷¤J±b°ÝÃD,±o¨ìªºµª®×¬O¦b¶]µ{§Ç¤¤, ¦pªG¬O5¤ë¤J±b,ªÑ»ùÀ³¸Ó¤£·|³o»ò®t§a! |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/6/4 ¤U¤È 11:19:51²Ä 302 ½g¦^À³
|
¦U¦ì¤j¤j, ¸g¹L¤FªÑªF·|¤Î5¤ë³øµ|©u¤§«á,¦]µØªºªÑ»ù¦ü¥G¤S§e²{¤@ªi¤£Ã©wªºª¬ºA, ¤ñ¸û¶°¤¤ªº¥X³f¤jP¶°¤¤¦b, ¤¸¤j´_¥_ 5/2~6/4 ¥X 197 ±i(¨ä¤¤5/15«á¥X¤F164±i), 5/31¶}©l´N¨S¦A¥X¹L¤F ²Î¤@·s¥x¤¤ 5/2~6/4 ¥X 152±i(¨ä¤¤5/15«á¥X¤F114±i), ¤£¹L¦³ªB¤Í«o¦b¦¹¶}©l§C»ù¦Y³f ¥ÃÂת÷´°«n, 5/2~6/4 ¶R 318±i(¨ä¤¤5/15«á¶R¤F307±i),´X¥G¬O¤Ñ¤Ñ¶R¶i,À³¸Ó¬O¦³¥h°Ñ¥[5/15¦]µØªºªÑªF·|«á¥b³õÀç¹B»¡©ú·|§a..... §»»·®ç¶é, 5/2~6/4 ¶R 70±i(¨ä¤¤5/15«á¶R¤F40±i), ¤jP¤W»¡¨Ó, ¤¸¤j´_¥_, ²Î¤@·s¥x¤¤ªº½æ¥X°ò¥»¤W¬O³Q¥ÃÂת÷´°«n, §»»·®ç¶é§C±µ¨«¤F Ãö©ó²Î¤@·s¥x¤¤¤j¤j,¹ï©ó¦]µØªÑ²¼¤@ª½¤j¦h¯¸¦b¦h¤è,«ùªÑ¼Æ±À´ú¤£¤Ö,«ù¦³®É¶¡¤]«Üªø, ¥t¥~¹ï©ó°·³ì¦b¹L¥h«e¨â¦¸¦]µØ¼W¸ê®É½æ¥X¼W¸ê»{ªÑªº¨Æ±¡,¤p§Ì°µ¤F¤@¤U¥\½Ò,°ò¥»¤W¬O³o¼Ë¬Ý«Ý,¥H«e¦¸¼W¸ê18¤¸¨Ó¬Ý 106¦~ªº¼W¸ê®×,±q106¦~3¤ë¤½§i¨ì6¤ë©³¼W¸êµ²§ô,°·³ìì¥i»{ÁʼW¸êªÑ¥u¦³939±i,³Ì«á»{Áʦ]¬°¤pªÑªFÌ©ñ±ó»{ÁÊ3,329±i,Åܦ¨¶WÃB»{ÁÊ4,268±i(¶WÃB¬ù6¤d¸U¤¸),°·³ì¬O¤@¶¡¤WÂd¤½¥q,³oºØÁ{®ÉÃB¥~ªº¶O¥Î¬On¸³¨Æ·|¦P·N¦Ó¥BªÑªF·|¤£·|³Q½è¸ß¤~¦æªº,¤£¹L°·³ì(¦]µØ³Ì¤jªÑªF)¦pªG¤£»{·|«ç¼Ë©O?¥L¥i¥H¤£»{ªº©Î¬O¸³¨Æ·|¨ä¤¤¦³¸³¨Æ¬O¥i¥H¤Ï¹ïªº,¨º¦]µØ´Nn¶}¤Ñµ¡¤F,©Ò¥H¹ï©ó°·³ì18¤¸¶R¶i¼W¸ê«á¨C¤é9±i½æ¥X¦b·í®Éªº°]°Èª¬ªp¬O¤£¥i³Qµû½×ªº,¤£¹L°·³ì¤]¨Ã¨S¦³¥þ³¡½æ¥X¶WÃB»{ÁʪѲ¼,¥u½æ¥X1,346±i,¼W«ù¤Fªñ2,000±i ¥Ñ«D¿W¥ß¸³ºÊ«ùªÑ¤ñ¨Ò¥i¥H¬Ý¥X«ùªÑ¤ñ¬O¤W¤Éªº 2018/03 24.8% ¼W¥[¤F2%«ùªÑ 2017/12 25.2% 2017/11 25.4% 2017/10 25.7% 2017/06 29.6% ¦]µØ¥H¨CªÑ18¤¸¼W¸ê 2017/05 22.8% 2017/03 22.8% ¥þÅ鸳ºÊ«ùªÑ¼Æ±q2018/3«á´N¦A¤]¨S½æ¹L«ùªÑ¤F,¥u¦³2018/7°qÁ`¼W«ù 549±i ¥H¥Ø«e¤½¥qªºª¬ªp¨ä¹ê¸êª÷¤]¤£¬O¤Ó¤jªº°ÝÃD, ¥X¤J¦³, 1.»È¦æÉ´Ú-------n¥I§Q®§¤ÎÁÙ¥»ª÷ 2.©è©ã¤C¬P-------n¥I§Q®§¤ÎÁÙ¥»ª÷ 3.½æ¥X¤C¬P-------½æµ¹°·³ì,ÁÙ¬O¯à«O»Ù¥X³f 4.¦V°·³ìÉ´Ú 5.¼W¸ê-------- ¤U¤Uµ¦,ªÑ»ù¤Î²bȧC,¼W¸ê°Æ§@¥Î¤Ó¤j 6.µ¦²¤Áp·ù------¤U¤Uµ¦,ªÑ»ù¤Î²bȧC,¼W¸ê°Æ§@¥Î¤Ó¤j 7.ÁÈ¿ú´£°ªªÑ»ù¦A¼W¸ê----- ¬Ý¨Ó¬O³Ì¨Î¿ï¾Ü ©Ò¥H¥B¬Ý«Ý°qÁ`©ó5/15¸¹µoªíªº³o¥¼¨Ó1¦~¦]µØÀç¹B¦¬¤äÅé²{ 1.BH4²Ä¤@¦¸¤¤°ê¥X³fÀç·~ª÷ÃB (ªñ´Á) 2.¤fªA¯Ø®q¯À¨½µ{¸OÅv§Qª÷(ªñ´Á) 3.Åã¼v¾¯¬ü°êÃÄÃÒ¨½µ{¸OÅv§Qª÷¤ÎÀç·~ÃB(2020¦~¤W¥b¦~) 4.BH4ÃÄÃÒ¨½µ{¸OÅv§Qª÷¤ÎÀç·~ÃB(2020¦~¤W¥b¦~) 5. D07001 Gemcitabine ¤fªA¾¯¤HÅé2´Á±ÂÅv¦X¬ùª÷(2020) |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/5/21 ¤W¤È 09:46:13²Ä 301 ½g¦^À³
|
±k¬P¤j¥¼¨D³Ó¥ý¼{±Ñ,ªGµM¸ò§Ú»{ÃѪº¤@¨Ç§ë¸ê°ª¤â¤@¼Ë,«D±`ª`«°]°È±. ¥ý²á¤@¤UªL¸³, ±qªÑªF·|ªººA«×¥i¥Hª¾¹DªL¸³«Ü¹³¬O§âªÑªF·|·í¨Ò¦æ¤½¨Æ,¨S§ëª`¼ö±¡¦b¦]µØ¤W. °·³ì±q¦]µØªÑ»ù¤»¤C¤Q¶ô¶}©l½æ¨ì20¶ô¥ª¥k,¾ú¦¸¼W¸ê¤]³£¦³¥ý½æ«á»{, §Úı±o°·³ì±q¦]µØ¨¤W¦´NÁÈ¿ú¤F,²{¦bªºªÑ¥÷¥u³Ñ20%¥ª¥k,³£ºâ¬O¦hÁȪº. n°·³ì§ë¤J¤j¶q¸êª÷¥h§ß´Ó¦]µØ,§Úı±o¬O¤£¤Ó¥i¯à, °qÁ`¹Î¶¤¤]¬O¨Ì³o¼Ëªº«e´£¤U¥hÀÀ©w¤½¥qµ¦²¤,ºÉ¶q¨Ì¾a¥~³¡¸ê·½¨Ó¶}µo,³oÂI§Ú¬O¥i¥HÅé½Ìªº. ¦pªG°·³ì¶°¹ÎÄ@·NÅx¤j¿ú¦b¦]µØ¨¤W,¥þ¤O½Ä¨ë,¤½¥qªÑ»ù¤]¤£·|¬O³oӼˤl§a :) ¾ú©¡ªÑªF·|§Ú¥u¥h¤F³o¤@¦¸,«ÜÃø§PÂ_³o¦¸¤½¥qºA«×¦³¨S¦³¯S§O»{¯u, ¤£¹L¦³´XÓcheck point§ÚÌ¥i¥H¥hÀˬd¬Ý¬Ý³o¦¸·|¤£·|¤S¥þ³¡¸õ²¼. ·¥µu´Á:(³o¤@¨âÓ¤ë) BH4 ¸Õ²£¥Îì®ÆÃĦ³¨S¦³¥X³f Oral insulin 28¤Ñ¬r²z¹êÅçµ²§ô«á¦³¨S¦³®³¨ì¨½µ{ª÷ ³o¨âÂI³£·|¤ÏÀ³¦bÀ禬¤W,«Ü¦nÀˬd µu´Á:(¤µ¦~©³©Î©ú¦~ªì«e) Gem Oral¤@´Áµ²§ô«e«á¦³¨S¦³±ÂÅv¥X¥h§@2/3´Á,¦P®É®³¨ìñ¬ùª÷ BH4 ¤¤°ê¥«³õ¦³¨S¦³°eÃÄÃÒ Åã¼v¾¯¦³¨S¦³®³¨ì¬ü°ê©Î¥[®³¤jÃÄÃÒ Oral insulin ¦³¨S¦³¶}©lÁ{§É¹êÅç ¤¤´Á©Î¥¼©w: OralPas¨ä¥L«~¶µªº¶}µo¤Î±ÂÅvª¬ªp Åã¼v¾¯¨ä¥L«~¶µªº¶}µo¤Î±ÂÅvª¬ªp Åã¼v¾¯¦³¨S¦³¤j¶q¥X³f(§Æ±æ³Ì±ß©ú¦~¤W¥b¦~) BH4ì®ÆÃĦ³¨S¦³¤j¶q¥X³f(§Æ±æ³Ì±ß©ú¦~¤W¥b¦~) Carvedolil CR¦³¨S¦³±ÂÅv¥X¥h ªø´Á : Gem OralªºÁ{§É¹êÅçµ²ªG Oral insulin ªºÁ{§É¹êÅçµ²ªG ¥t¥~°qÁ`´£¨ì³o¦¸ªºBio Asia (À³¸Ó¬O¤C¤ë), ¦]µØ§Æ±æ¯à´£¥X¤@¨Ç¶i®i¶}Ó¤p«¬ªk»¡·|,¤]¥i¥Hµy·L´Á«Ý¤@¤U. ³Ì«á¦A´£¤@¤UGem Oral, ¥Ø«e¬O°µ¨ì80mg (À³¸Ó¬O³o´X¤Ñ§¹¦¨),§Ú¬Ý¨C¤@Ó¾¯¶q³£n¤TӤ륪¥k, ¦pªG¨S¦³´£«eµ²§ô,ÁÙn°µ120mg,160mg,¦b3Qµ²§ôÀ³¸Ó¦³Ãø«×. §Æ±æ¤µ¦~¯uªº¥i¥H³°Äò¶Ç¨Ó¦n®ø®§,ÅýªÑ»ù¤@¦R«è®ð. |
|
|
·|û¡G¥Õ¦â±k¬P10148144 µoªí®É¶¡:2019/5/20 ¤W¤È 11:16:31²Ä 300 ½g¦^À³
|
·PÁÂM¤jC¤jªº¤À¨É ¨ä¹ê ³o¦¸ªÑªF·|Á¿ªº ¸ò©¹¦~ ®t²§¤£¤j§a? §Ú¨ä¹ê¬Ý§¹°]³ø ¨S¬Æ»ò¬Ý¦~³ø¤F ¤§«e¹ï³o¤½¥q¬ã¨s¤F¸Ñ«á ¤]´N§â³o¦¸§ë¸ê·í¶R¤@¦¸¸gÅç¤F(Å¥¤H»¡¦Ó¨S¥ý¬ã¨sªº¸gÅç) ¤Ï¥¿³oªÑ»ù¦A¦³·N¥~ ¤]¨SÔ£·l¥¢ ´N©ñµÛ ¬Ý¬Ý¬O§_þ¤Ñ¯u¯à¸ò¦U¦ì¤@°_Äг½Â½¨µo¤j°]§a ¤@¨ÇÓ¤H¬ã¨s«áªº¸gÅç ºâ¬O¤À¨Éµ¹¤j®a: 1.ªÑªF·|¬Ý¨Ó»¡¤F«Ü¦h ¦ý¬O¦b§Ú¬Ý¨Ó´N´X¥Gµ¥©ó¨S»¡ ¸ê¥»³W¹º¤~¬O«ÂI ¦p¹w´Á ·íµM¨S°ÝÃD ¦pªG¤£¦p¹w´Á ¤½¥q°f· °]°È¯à¼µ¦h¤[ ³W¹º¤S¬O¤°»ò? ¬Ý°_¨Ó ¤½¥q¹ï©ó¥i¯àªºt±½ÄÀ» §¹¥þÁצӤ£½Í ³oºØ±¡§Î Ó¤H¬O¨S¦³«ùÄò¥[½Xªº«H¤ß 2.§ä¤F¤@¤Uºô¸ô¸ê°T °µ¨Ç¥æ¤e¤ñ¹ï µo²{¤½¥q¦Û±q¤W¿³Âd«á ¸ê¥»¥«³õ¾Þ§@¨Ã¤£¤Î®æ ¼W¸ê®ÉÂI±`±`¸¨¦b¤j½L¨¦©³ ³y¦¨ªÑ¥»½Ä°ª¦Ó²{ª÷¤ô¦ì¨Ã¤£²z·Q ¥i¨£±o¤½¥q¸³¨Æ°ª¼h¹ï©ó¥Í§Þ·~ªº¸ê¥»»Ý¨D»{ª¾Á¡®z ¶}µo·sÃĺ«»È¼u ¤~¯à¤ñ®ðªø ³o¬Oºn±ø¥ó ¦]¦¹ Ó¤H¹ï©ó¤½¥q°ª¼hªº³B²z¯à¤O·P¨ìÃhºÃ §óÂ÷©_ªº¬O ²{¦b¤½¥q¦³¸êª÷»Ý¨D ¹³M¤j¤§«e¤]¦³´£¹Lªº ¤C¬Pªº§ë¸êÓ¤H»{¬°À³¸Ón¦¬¦^¦Û¥Î Á¿¥Õ¤@ÂI ¸³¨Æªø³£¦P¤@Ó¤H ¦Ó°·³ì¤]¤£¬O¨S¿ú ¶R¨«¦]µØ§ë¸êªº³¡¦ì ¤£·|¼vÅT¦]µØ¦b¤C¬Pªº±M®×¶i«×(§ó¦óªp °]³øÅã¥Ü ¦]µØÁÙ¥I¥X¤£¤Ö¶}µo¶O¥Îµ¹¤C¬P) ³o¼Ë ¦]µØµu´Á2¦~¤º²{ª÷³£¬O¬O¤j°ÝÃD¤F ¦Ó¥B Á¿±o§ó¥Õ¸Ü ¦]µØªº§ë¸ê¤ñ¨Ò ®Ú¥»¹ï¤C¬P¨S¦³¼vÅT¤O ¤½¥q°ª¼h¤£³o»ò°µ «on¦]µØ¥h¸ò»È¦æÉ¿ú ¯u¬O°Z¦³¦¹²z 3.¦^Âk¤½¥q¥»·~ ¼Ðº]¶}µo505(b)2©M¤@¨Ç¯S§OªºÃÄ«~ °ò¥»¤W§Úı±oOK ³o»â°ì ¥»¨Ó´N¬O§Þ³N»¡¸Ü ¼µ°_¤@¤ù¤Ñ ¥u¬O Ó¤H§ë¸ê¸gÅç(°ê¤º¥~³£¤@¼Ë) 505(b)2À³¸Ó¬O¶}µo´Á¤ñ·sÃĵu ¤]¬O¥¦³Ì©úÅ㪺Àu¶Õ ¤½¥q¨ì²{¦b «o¨S¤@Ó²£«~¦³©úÅã¶i®i(¨ì«á´Á©Î¤w¥Ó½Ð©Î¤W¥«)¦Ó¦P¼Ë«~¶µ«oÁÙ¦b«ùÄò¶i¦æ ³o¯u¬O¤£¥i«äij ¥´¯}§Ú¹ï505(b)2ªº»{ª¾ ¥u¯à²q·Q ¤½¥q¨S»¡ªºÃäÃ䨤¨¤ ¥i¯à¤~¬OÃöÁä §Ú¦^±À¤F¤@¤U ¨ä¹ê ¤½¥qªº²£«~¶}µo ¦s¦b«¤j¯Ê³´ ¤£¦b§Þ³N ¦Ó¦b¸êª÷ ¹ï¤ñ¤½¥q¦b¤fªA§ÜÀùÃĸò¤fªA¯Ø®q¯Àªº¶}µo¤W ¯à®³±o¥X¨Óªº¸ÕÅç¼Æ¾Ú©Î¬OÁ{§É¼Æ¾Ú¹é¹é¥i¼Æ ¦b¦b¦LÃÒÓ¤H«e±´£¨ì ¤½¥q¸ê¥»¥«³õ¾Þ§@¤£¤Î®æ ¨S¸êª÷¦bµu´Á¤º¶}®i¦hÓÁ{§É¥[¥HÅçÃÒÃÄ«~Á{§É®ÄªG ¤~³y¦¨²£«~¶}µoÀt³t«e¶i ³o³s±aªº¬O ¥«³õ°Ó¾÷¥i¬O¤£µ¥¤H ¦Ó³oºØ±¡§Î Ó¤H¦b§ë¸ê°ê¥~¥Í§Þªº®ÉÔ ¬Ý±o¦h¤F ¦]¦¹ ¤½¥q¬JµM¦b¥h¦~Á`¸g²z¤U¥x(¬Ý¤F¤@¤U ÁÙ¬O¤½¥q³Ð¿ì¤H) ´NÀ³¸Ó§ó¤j¯}¤j¥ß ¶°¤¤¸ê·½ ²{ª÷ »°§Ö»°²£«~¶i«× µ²ªG ²{¦b¬Ý¨Ó ¤½¥q°ª¼h¤´µM¦Ñ¯Z©³ ¦Ñ§@¬° ¯uªº¬O¨S¬Æ»ò¥i´Á«Ý ÁÙ»¡n¦A¥Î¦Û¦³§Þ³N¶}µo·sªº«~¶µ µ²½×¬O ¦³¿ú¶Ü? ½Í¦X§@¶}µoªº¸Ü ¨º´N¬OCRO ¦Ó¤£¬O·sÃĶ}µo¤½¥q ¾ãÓn¥t¥~°Q½×¤F 4.³Ì«á M¤jC¤j´£¨ì¤½¥q²{¦bµ¹ªº»¡ªk ¬O§ï¬°±Mª`¤¤°ê¥«³õ ³o¤]OK ¥u¬O ²{¦b¤¤¬ü¶T©ö¤j¾Ô ´NÓ¤H¤F¸Ñ ¤¤¤è¥«³õ±q¥h¦~¶}©l ¤]¶}©l«O¦u¦ÓºòÁY ¦pªG¯uªº¬O³o¼Ë ¤½¥q¤S¦ó¥h¦ó±q Ó¤H¤£¤~ ¥Í§Þ°é¤º(²£·~¸ò³Ð§ë)¤]»{ÃѤ£¤Ö¤H Ãö©ó¤½¥q°ª¼h¹L¥h¶Â¾ú¥v»P·®æ ¸ò²{¦b¸gÀç¹Î¶¤±a»â¤Uªº¥ø·~¤å¤Æ ³£±q°¼±¤F¸Ñ¦LÃÒ¤F«e±Ó¤H¬ã¨s¤ß±o ¤Ï¥¿¤]´N³o¼Ë¤F ©ñµÛ ©ñ¤U µ¥°_·§a |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/5/17 ¤W¤È 10:00:17²Ä 299 ½g¦^À³
|
©µÄò¤@¤UªÑªF·|ªºÄ³ÃD, °qÁ`±µ¥ô«á,¦]µØ¾ãÓµ¦²¤¦³«Ü¤jªº§ïÅÜ,°£¤F¿n·¥»P¤¤°ê¤j³°Ãļt¦X§@¥~, ¤]³z¹L±ÂÅvªº¤è¦¡§â¸ê¥»¤ä¥X¾ãÓ±N¤U¨Ó, ²{¦b³Ì©úÅ㪺´N¬O¤fªA¯Ø®q¯Àªºª¬ªp,³z¹L±ÂÅv,Åý©y©÷ªF¶§¥úªø¦¿ÃÄ·~À°¦£°µ¾ãÓÁ{§É¹êÅç, °£¤F¬Ù¿úÁÙ¥i¥H®³¨ì±ÂÅvª÷,§÷®Æ¶Oµ¥. µ¥¨ìD07001(Gem Oral) 3Q¤@´Áµ²§ô«á,2/3´Á¤]³z¹L±ÂÅv¥X¥h«á,¾ãÓÁ{§Éªº¶O¥Î´N¥i¥H¬Ù¤U¨Ó¤F. (°ò¥»¤W2/3´Áªºªá¶O¤]¤£¬O¤½¥q²{ªp¦Yªº¤U¨Óªº), ¥h¦~¤½¥qÁ{§É¶O¥Î¤j·§ªá¤F2¤d¦h¸U,¬ãµo§÷®Æ¬ù¤@¤d¸U, Á{§É±ÂÅv¥X¥h«á¨C¦~ªá¶OÀ³¸Ó¥i¥H¦A¬Ùªñ¤T¤d¸U§a! ¥unBH4 ©ÎÅã¼v¾¯¦³¶¶§Q¥X³f©Î¥ô·N¨ä¥L²£«~¦³Ä~Äò±ÂÅv¥X¥h,¥i¥H´Á«Ý©ú¦~´N¶}©lÁÈ¿ú. ¥Ø«e¦]µØ©|¥¼±ÂÅv¥X¥hªº²£«~ÁÙ¦³(¥H¥¿¦¡Ã±¬ù®³¨ìñ¬ùª÷¬°¥D) 1. Gem Oral 2. Carvedolil CR 3. Åã¼v¾¯¨ä¥L«~¶µ 4. OralPas ¤§«á³°Äò¶}µoªº·s²£«~ ¥Ø«e¤w±ÂÅv¥X¥hªº¤]¥i¯à¦b¨ä¥L¥«³õ±ÂÅv. §Ú·Q³o»ò¦h¾÷·|,¥ô·N¹F¦¨´XÓÀ³¸Ó¬O¥i¥H¹w´Áªº |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/5/16 ¤U¤È 10:23:34²Ä 298 ½g¦^À³
|
¦U¦ì¤j¤j, ¤µ¦~ªÑªF·|¸g°qÁ`¦V»P·|ªºªÑªF³ø§i¦]µØ·~°Èª¬ªp¤º®e,¤p§Ì°w¹ï©ó¦]µØªº¶Àª÷¥k¸} OralPAS ©`¦Ì¦Û·L¨Å¤Æ§Þ³N¥¥x ª¬ªp¤º®e¤@¨Ç¤p¤p¤ß±o¸ò¦U¦ì¤À¨É,OralPAS§Þ³N¬O¤@Ó§ïÅÜÃĪ«¨Ï¥Î¤è¦¡ªº¤j¥¥x,¥H¥Ø«e¤½¥q¶}µoªºD07001 Gemcitabine ¤fªA¾¯«¬¨Ó¬Ý,OralPAS±N쥻ì¼t¬°Â§¨ÓÃļt(EliLily)ºX¤Uªº[°·¾Ü](Gemzar)ª`®g¾¯«¬§ï¬°¤fªA,©Ò¥H¬O±N²{¦æªºÃĪ«°µ¤F¨Ï¥Î¤è¦¡ªº§ïÅÜ,¦¹§ïÅܹï¯f±w§Î¦¨¤F2¤j¦n³B,¤@¬O¯f±w¥i¥H¦b®aªø´ÁªºªA¥ÎÂå®v³B¤èÃĪ«´î¤Ö²{¦æ¥²¶·¨ìÂå°|ª`®gÃĪ«ªº¤£«K,¤G¬O¸g¥Ñ¤@¦¸°ª¾¯¶qª`®g§ï¬°¦h¦¸§C¾¯¶q¤fªA¥i¥H±N쥻§ÜÀùÃĪ«±aµ¹¯f±wªºª`®g°ª¾¯¶qÃĪ«²£¥Íªº°Æ§@¥Î(¦p±þ¦ºÅ餺¥Õ¦å²y,¬õ¦å²y,°§C©è§Ü¤O,¦åºÞ¯Ü¤Æµ¥µ¥°Æ§@¥Î)°§C¬Æ¦Ü®ø°£,¦h¦¸§C¾¯¶qªºªA¥Î¥i¥Hºû«ùÃĪ«¦bÅ餺¿@«×ªº©w¶q(¦p¦P¦Y·P«_ÃĤ@¯ë)§ó¦³®Äªº±±¨î¬Æ¦Ü®ø·ÀÀù²ÓM,¦b¹L¥h2016¦~¦]µØªk»¡·|¤W´£¥Xªº¦]µØ¹êÅç³ø§i¤¤, ¥H¬Û¦PªºÀù¯gÃĪ«´ú¸Õ,¦h¦¸§C¾¯¶qªºªA¥Î¤fªAÀù¯gÃĪ«ªº½T¤ñª`®g§ó¯à±±¨î¸~½Fªº¼Æ¶q, ¦b¹L¥h¤Î²{¦b¤]¬O¦³«Ü¦hÃļt§ë¤J¦b¬ã¨s¤fªA¦¡Àù¯gÃĪ«,¦ý¬O¬ÛÃö©ó¦¡³J¥Õ½èÃĪºª`®gÃĪ«¦¨®Ä³£¤£¨Î,¦b¦ì¨B´N³QG»Ä¤À¸Ñ³J¥Õ½è,¸z¹DµLªk§l¦¬¨ìÃĪ«(¦³ÂI¹³¯q¥Íµßªº·§©À),³y¦¨¤HÅéµLªk¥þ³¡§l¦¬¦Ó±Æ¥X¬Æ¦ÜÅܦ¨ÃĪ«±Æ¥X¦Ã¬V,¦]µØªº OralPAS ©`¦Ì¦Û·L¨Å¤Æ§Þ³N¥¥x ´N¬O¸Ñ¨M³oÓ°ÝÃD±NÃĪ«¬ï¹LG»Ä©è¹F¸z¹D§l¦¬,³oÓ§Þ³N¤w±o¨ì¥xÆW,¿D¬w,¤¤°ê,¤é¥»,¯Ã¦èÄõ,«Xù´µ,·s¥[©Y,¯Q§JÄõ,«n«D,»´äµ¥µ¥¦U°ê±M§Q¦b®× ¦b2005/11/30¤HÅé¤@´Á²Ä1~10(2~80mg)¦¸¸ÕÅ秹¦¨, ¨äµ²ªGµL½×¦bÁ{§É¤ÎÃĪ«°Ê¤O¾Ç¬Ò²Å¦X¹w´Á(Àu©ó²{¦bª`®g¤è¦¡),¦¹¦¸¸ÕÅç¬O¨Ì·Óì¼t§¨Ó¨Ï¥Îª`®g¤è¦¡ªº¾¯¶q¤Î¨Ï¥Î¨î©w¶qÃĪ««á¥²¶·°±ÃĤ@Ó´Á¶¡±ø¥ó¤U¹ê¬I ¦bFDAªº±j¤O«Øij¤U,¦]µØ±µ¨üÄ~Äò°µ¤HÅé¤@´Á phase1(b) 1~6(~~160mg)´ú¸Õ,¥Ø«e¤w¸g§¹¦¨²Ä4¦¸80mg¸ÕÅç,´ú¸Õµ²ªGÀu©ó¹w´Á,µL°Æ§@¥Î,¥B¸~½Fªº±±¨î¤]Àu,¦¹¦¸¹êÅç¥Øªº¦b©ó§ïÅܤfªAªAÃĤ覡¬°³sÄòªA¥Î,¨Ã¥B©¹¤W´ú¸ÕªA¥Î¦Ü160mg(«e¦¸ªº2¿¾¯¶q),¨ä¥Øªº¬On½T»{¥[¤j¾¯¶q´M¨D¹ï¸~½F±±¨î¬Æ¦Ü¬OÀ£¨îªº¦³®Ä¥i¦æ©Ê,³oÓ¬Oª`®g¤è¦¡¿ì¤£¨ìªº,¦]¬°¤@¦¸ªº¤j¶qª`®g¤HÅéµLªk©Ó¨ü,¦pªG¦]µØªº¤fªA¦¡¥[¤j¾¯¶q¤À¦¸ªA¥Î¨ã¦³©úÅã§ïµ½±±¨î¸~½F,¨º±N¬O¦bÀù¯gªvÀø¤W³Ð¤U·sªº¤@¶ OralPAS ©`¦Ì¦Û·L¨Å¤Æ§Þ³N¥¥x ´N¤£¬O¶È¶È¯à·í¦¨¯ØŦÀùªº¸ü¨ã,¦b³o¦¸ªº¸ÕÅ禨¥\«á,¥un¬O³J¥Õ½èÃĪºª`®gÃĪ«³£¦³§ï¦¨¤fªAªº¥i¯à©Ê,©Ò¥H¦b¤fªA¯Ø®q¯Àªº³¡¤À¤w¸g»P»P©÷ªF¶§¥úªø¦¿ÃÄ·~ªÑ¥÷¦³¤½¥qñq¤fªA¯Ø®q¯À¶µ¥Ø±ÂÅv¦X¬ù®Ñ,³o³¡¤À¤]¤w¸g§¹¦¨¬r²z¸ÕÅç,·Ç³Æ©¹¤U¤@Ó¨½µ{«e¶i,¦b³oÓ³¡¤À¨C¤@Ó¨½µ{¸O³£¬O¦³Åv§Qª÷¥i¥H¶i±bªº,µÛÓ´N¬O OralPAS ©`¦Ì¦Û·L¨Å¤Æ§Þ³N¥¥x ªº¶Àª÷¤§³B................. D07001 Gemcitabine ¤fªA¾¯«¬¨Ì·Ó²{¦bªº§¹¦¨«×±À¦ô,À³¸Ó¬O¦b¤µ¦~ªº²Ä3©u«e¥i¥H§¹¦¨¦Ü160mgªº¸ÕÅç,§Æ±æ¤µ¦~¥i¥H§¹¦¨³ø§i,¥HD07001ªº¶µ¥Ø¦Ó¨¥2016¤wÀò±o¬ü°êFDA©t¨àÃÄ»{ÃÒ,¥BD07001²Å¦X505(b)(2),(¬O¹ï¤w§å㪺ÃĪ«µ¹Ãij~®|ªº§ïÅÜ,©Ò¥H¤£»Ý°µ¦AìÃĪ«(§¨ÓÃļt(EliLily) [°·¾Ü](Gemzar)ª`®g¾¯«¬)ªº¬ÛÃö´ú¸Õ,¥i¥H¤j¤jªºÂêµu¥BÁY¤p¤HÅé phase2/3¸ÕÅ窺®É¶¡¤Î³W¼Ò,¦p¦¹¨Ó¬Ý,¨ã¦³«Ü¤jªºÂåÀø§ïÅܮĪG¥B¥i§¤¸û²©öªº¤HÅé phase2/3¸ÕÅç, OralPAS ©`¦Ì¦Û·L¨Å¤Æ§Þ³N¥¥x ªº§Þ³N±ÂÅvÀ³¸Ó¦b¤£»·³B¤F.. ¦]µØ¦³¤F¶Àª÷¥k¸} OralPAS ©`¦Ì¦Û·L¨Å¤Æ§Þ³N¥¥x ªº§Þ³N,¤S¦³¤F¶Àª÷¥ª¸}ªºBH4±M§Q»s³yì®Æ§Þ³N,¥B¤w»P¤sªF·s®É¥NÃÄ·~¦³¤½¥q¤wñqBH4¦]¸¿Õ§Þ³N±ÂÅv,¨Ã¥H¹wp¤µ¦~©³¥i¥H§¹¦¨¥Ó½Ð¤¤°êÃÄÃҥӽФu§@,¥¼¨Ó±N¥i¥H¤j¶q¥Xì®Æµ¹¤sªF·s®É¥NÃÄ·~¦³¤½¥qÀò§Q, ¥H¤½¥q¦p¦¹¦hªº§Q°ò¦Ó¨¥,¥Ø«eªºªÑ»ù¯u¬O«Üåx©}§r.......... ¥H¤W¬O¸g¹L¥»¬OªÑªF·|¤Î¹L¥h¤½¥qñqªº§Þ³N·~°È¦X¬ù¾ã²zªº¤p¤p¤ß±o¨Ñ¦U¦ì¤j¤j°Ñ¦Ò¤§ |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/5/15 ¤U¤È 11:46:54²Ä 297 ½g¦^À³
|
¸Û¦pcstang¤j©Ò¨¥,¤µ¤Ñ°qÁ`±aµÛ«Ü¿³¾Äªº»y®ð¸òªÑªF̤À¨É¦U¶µ²£«~ªºª¬ªp, ¦pªG¤@¤Á¶¶§Q,¤µ¦~À³¸Ó·|³°Äò¶Ç¨Ó«Ü¦h¦n®ø®§. ¥t¥~·Q¸ò¤j®a¤À¨É,°·³ì²Ä¤@©u°]³ø¥XÄl, ¤C¬P»sÃIJĤ@©uÀ禬ªñ¤T¤d¤E¦Ê¸U,Àò§Q¤¦Ê¦h¸U. ¤Àµ¹¦]µØÀ³¸Ó¦³¤@¦Ê¸U¥ª¥k§a! ÁöµM¥i¯à¬O©Ô³f®É¶¡ÂI³y¦¨ªºÀò§Q,¦ý¤]ºâ¦n®ø®§¤@«h. |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/5/15 ¤U¤È 10:07:59²Ä 296 ½g¦^À³
|
¦U¦ì¤j¤j, ·PÁÂmogwai ¤j¤j¸Ô²Ó¼¶¼g¤µ¤Ñ¤½¥qªºªÑªF·|«á,¥Ñ°qÁ`¦V»P·|ªºªÑªF³ø§i¦]µØ·~°Èª¬ªp¤º®e,¸g¹L³o¨Ç¦~,¦n¤£®e©ö¤µ¤ÑÅ¥¨ì¤½¥q¯à¥Î¤ñ¸û°í©wªº,excitingªº¤f§k¨Ó¬Ý«Ý¤µ¦~¤U¥b¦~¶}©lªº·~°È·~ÁZ, ¦b¤µ¦~¤U¥b¦~¶}©l¤½¥qªº·~°ÈÀ³¸Ó¬O¥¿¦VªºÅܤÆ,¤]·|¼W¥[°£¤F´¶Àù¨O¥H¥~ªº¦¬¤J,¸Û¦pm¤j©Ò±Ôz¤½¥q»{©w¦]«D¿Õ,¡¦¤fªA¯Ø®q¯À,Åã¼v¾¯,³£·|¦³©ú½Tªº¶i®i ¨Ã¥B³o¨Ç¶i®i·|±aµ¹¤½¥q¬Û¹ï§Q¯q,¬Æ¦Ü¥i¥H¸ÑŪ¦¨¤½¥q¦b¤U¥b¦~¶}©l¥i¥H¦b°]°È¤W¥X²{¸û¤jªº¥¿¦VÅܤÆ.......... ¤p§Ì¹ï©ó¤µ¤ÑªÑªF·|·|«á³ø§i¤º®eı±o¥¿¦VªÖ©w......´Á«Ý¤µ¦~¤U¥b¦~¥ÎÀ禬¨ÓÃÒ©ú¤½¥qªº¶i¨B ¤£¹L¤µ¤ÑÁÙ¬O¦³¶W¯Å¤j¤j¤£µ¹¤O,¤µ¤Ñª½±µµ¹¥L½æ¶W¶^§C©ó9¤¸....40±i,¼K¼K |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/5/15 ¤U¤È 03:08:37²Ä 295 ½g¦^À³
|
¤µ¤ÑÁÙ¬O©âªÅ¤@¦¶}¨®¹L¥h°Ñ¥[, ³oÃä³ø§i¤@¤UªÑªF·|ª¬ªp,«Ü¦h¥¼¨Ó¥i¯àªº¶i®i¤£¤è«K»¡,³oÃäÁ¿¤@¤U¤ñ¸û½T©wªº¨Æ¶µ. 1.¤½¥q¦©°£°ò¥»¦¬¤J(´¶Àù¨O?),¸g¹L¼Á¸`«á,¨C¤ë¬ù¿N500¸U,¦~ªì²{ª÷¦³¤E¤d¦h¸U,¸êª÷°ÝÃD¼È®É¤£ÄY« 2.¤½¥q¹w´Á¤µ¦~·|¦³¦hµ§±ÂÅvª÷/ùµ{ª÷ªº¦¬¤J. 3.Gem Oral ¥Ø«e°µ§¹40mg,60mg,80mg¤TÓ¾¯¶q,¨S¦³«¤j°Æ§@¥Î,¹wpQ3°µ§¹1b 4.BH4 ¬ü°êDMF«ØÀɦ³§U©óì®ÆÃÄ©ó¬ü°êªº¾P°â(¦]¸¿Õ¥»¨µLªk¾P¬ü°ê,¦ýì®ÆÃÄ¥i¥H) 5.Åã¼v¾¯(¹Å¦h©ú)¦b¬ü°êFDA³Ì«áªº¸É¥ó²×©ó°e¥X,´Á«ÝºÉ§Ö®³¨ìÃÄÃÒ 6.Carvedilol CRªº²£«~½u¤´¦b,¤½¥qÁÙ¦b§V¤O±ÂÅv¤¤. 7.¤¤°ê¤j³°¨â®a±ÂÅvªº¤½¥q·s®É¥NÃÄ·~,©y©÷ÃÄ·~³£«Ü¿n·¥¸ò¦]µØ¦X§@¤¤,¿n·¥¶i¦æ¸Õ²£©M¹êÅ礤 (³oÓ«Ü«n,쥻¾á¤ß³o¨â®a¤½¥q¨S¤°»ò¦b°Ê,¦ýÅ¥°qÁ`»¡©ú©ñ¤ß³\¦h) ¤§«e«ÜºÃ´b¬°¦ón«°µ¤@´Á,©M1b¬°¦ó©M¤§«e¤@´Á¦³¾¯¶q«½Æªºª¬ªp,³o¦¸ªÑªF·|ªº»¡©ú¤]¸Ñ°£¤FºÃ´b. 쥻¤@´Áªº¹êÅç¸òì¼tªº¹êÅç¼Ò¦¡Ãþ¦ü,³£¬OÅý¯f¤H¦Y¤FÃÄ«á¥ð®§¤@°}¤l¦A¦Y,¦ý¦Y¨ì80mg(ì¤@´Áªº³Ì¤j¾¯¶q)ÁÙ¬O¨S¦³©úÅã°Æ§@¥Î. ³o¦¸FDA«Øij§ï¦¨³sÄò¦Y,¨ä¹ê¤]¤ñ¸û¯àµo´§Gem Oral쥻¹w´Áªº¤Ö¶q³sÄòªA¥Îªº¥Îªk. ¨ì¥Ø«e¦Y¨ì80mg¤]¨S¦³«¤j°Æ§@¥Î. ¤£¹LÁÙ¬O¦p³o¦¸ªÑªF·|¬Y¿n·¥µo¨¥ªºªÑªF©Ò¨¥,¤½¥qªº©Ò¦³pµe³£¯Ê¥F©ú½Tªº¼Æ¦r(¤é´Á,ª÷ÃBµ¥), §Ú·Q±M·~§ë¸êªÌÀ³¸Ó«Ü¬Ý«¥i¥H¶q¤Æªº«ü¼Ð,¥«³õ§ë¸ê¼Ðªº«Ü¦h, ÁöµM¦]µØªºp¹º«Ü¬ü¦n,¦ý¯Ê¥F¥iµû¦ôªº«ü¼Ð,±M·~§ë¸êªÌ¤j¥i§ä¾A¥Î¥L̼ô±xªº¤è¦¡¥i¿z¿ï¥XªºªÑ²¼¨Ó§ë¸ê. ³Ì«áÁÙ¬O´Á«Ý¤½¥qªº¦U¶µpµe¯àºÉ§Ö¶}ªáµ²ªG |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/5/14 ¤W¤È 10:00:32²Ä 294 ½g¦^À³
|
©ú¤ÑªÑªF·|........§Æ±æ¯à¦³¦n®ø®§ |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/5/8 ¤W¤È 10:17:12²Ä 293 ½g¦^À³
|
¤j®a¦n, ¤pµ²¤@¤U¦~³ø¤@¨Ç¸ê®Æ Gemcitabine 2008¦~¾P°â°ª®p¸¨¦b17.2»õ¬üª÷ Carvedilol ¦~¾P¬ù16.7»õ¬üª÷ ¥Ø«eªºÅã¼v¾¯²£«~ª§¨ú40»õ¥x¹ôªº¥«³õ(¨Æ¹ê¤W¹Å¦h©úì¼t3»õ¬üª÷,¹Å¦hµø°·ì¼t2.3»õ¬üª÷) BH4ì¼tÃÄ(Kuvan) ¥h¦~¾P°â4.3»õ¬üª÷ ¥h¦~À禬¦³72.29¢H¥Ñ´¶Àù¨O°^Äm, ñ¬ùª÷µ¥¦û20.08% ´¶Àù¨O¾AÀ³¯g·s¼W¤H¼Æ¨C¦~¦³¼W¥[ªºÁͶÕ,ªí¥Ü´¶Àù¨OªºÀ禬À³¸Ó·|Ä~Äò¦¨ªø ¤@¨Ç¤p·P·Q, (1)«e´X¤Ñ¶Ç¥XÃĵØÃĨú±o¤fªA¼Ú¬wµµ§ü¾JªºÅv§Qª÷¼Æ¥Ø(º´Á200¸U¬üª÷,Á`ÃB700¸U¬üª÷,±ÂÅv¦a°Ï¬°¥xÆW·s¥[©Y¤Î¶V«n), ¥ÑÃĵØÃĦb¥xÆWt³dÁ{§É¹êÅç. §Ú¦b·Q¼Ú¬wµµ§ü¾J©MgemcitabineÀ³¸Ó¬O¾P°âÃB®t¤£¦h¯Å¼Æªº§ÜÀùÃÄ, ¥ú¥xÆW·s¥[©Y¶V«nªº±ÂÅv´N¥i¥H¨ì200¸U+500¸U¬üª÷ªºµ¥¯Å,¦Ó¥BÁ{§ÉÁÙn¦Û¤v°µ. ¦]µØªºgemcitabine oral ªº±ÂÅv¯uªºn¥[¥[ªo, gemcitabine¥i¥H¨Ï¥Î©ó¯ØŦÀù,«D¤p²ÓMªÍÀù,¤Î¥Ø«e¹êÅ礤ªºÁxºÞÀù, ¦b¸êª÷¦Yºòªºª¬ªp,±ÂÅvµ¹¨ä¥L¤½¥q°µ¥t¥~ªºÁ{§É¹êÅçÀ³¸Ó¬O¤ñ¸û²z·Q. (2)carvedilol ì¼t¤]¦³±À¥X½wÄÀ«¬,¤]¾P°â¤¤,¦ý¦]µØ¤§«e³£»¡ carvedilol CR¤ñì¼tªº½wÄÀ«¬®ÄªG¦n, ¬JµM³o»ò¦n,´Nºâ³QªF¥ÍµØÂ\¤F¤@¹D,¨ä¥L°ê®aÀ³¸Ó¤]±ÂÅvªº¥X¥h§a! (3)´¶Àù¨O¥[¤W±ÂÅvªº¦¬¤J¦û¤F¥h¦~À禬¶W¹L92%,ªí¥Ü¨ä¥L²£«~¾P°â¥u¦û¤£¨ì8% §Úı±o³o¬O³Ì¤jªº°ÝÃD,°ê¤ºÅã¼v¾¯¥«³õ¥ú¹Å¦hµø°·ì¼t´N¦³¬ù40¸U¬üª÷,§Ú¤§«e¦³¦³§ä¹LKuvan°ê¤ºªº¾P°â¤]¦³´X¤d¸U¥x¹ô. ¥[¤W¦]·ü¹ç©M¿¯S¹ç,©Ò¦³«D´¶Àù¨Oªº²£«~³ºµM¥u¦³½æ¤j·§400¸U¥x¹ô,¨ä¤¤À³¸ÓÁÙ¥]¬Aµ¹¥~±ªº¹êÅç¥ÎÃÄ,¤Î¥~¾P³¡¤À. °ê¤º¥«³õ³£½æ¦¨³o¼Ë,§â²£«~©¹¥~±À¾P®ÉÃø¹D¤£·|³Q½èºÃ¶Ü? ³oÃä¤]¤@°_¦^Âбk¬P¤jªº°ÝÃD, ¤½¥q¥Ø«e³Ì¤jªº°ÝÃD´N¬O¤½¥qªº²£«~¬Ý°_¨Ó³£«Ü¦n,¥«³õ¤]«Ü¤j, ¦ý´N¬O®³¤£¨ì«Ü¦nªº±ÂÅv±ø¥ó©Î¬O±ÂÅv¤£¥X¥h. °ê¤º¥«³õ¤S½æ±o¤£¦n,Åý¤HÃhºÃÃĬO¤£¬O¦³³o»ò¦n. ¦b¥»¹Ú¤ñ®É¥N,¤½¥qªÑ»ù¤@«×¶W¹L90¶ô, ¹L¤F³o»ò¦h¦~,³¡¤À²£«~¬ãµo¶i«×¦´N¤ñªÑ»ù90¶ôªº®ÉÔ¶W«e¤£¤Ö. ªÑ»ù¬°¤°»ò·|³o»ò§C,§Ú·QÅã¼v¾¯©Mcarvedilol CRªºª¬ªp¬O¤@¤jì¦], ¥»¨Ó¤½¥q¦³«Ü¦h¹Ú,¤j¹Ú¦pgemcitibine oral, oral insulin, carvedilol¥þ²y¾P°âµ¥ ¤p¹Ú¦p carvedilol¥xÆW¥«³õ,Åã¼v¾¯¬ü°ê¥«³õ, BH4µ¥, ¦ýcarvedilol CR³QªF¥ÍµØ¨ú®øÃÄÃÒ¥Ó½Ð,¤½¥q¤]¨S¦³«áÄò³B²z, Åã¼v¾¯¬ü°êÃÄÃÒ¤]¥Ó½Ð¤F«Ü¦h¦~³£¨S®³¨ì, ¤£¸TÅý¤HÃhºÃ³o¨ÇÃĬO¤£¬O¦³¤£¬°¤Hª¾ªºÁô±¡. ¥»¨Ó²z·Q¤¤carvedilol CR¥xÆWÃÄÃÒ,¹Å¦h©ú¬ü°êÃÄÃÒ®³¨ì,ÁöµM¤£¨£±o·|ÂàÁ«¬°¬Õ,¦ý¤½¥qªº¸ê¥»¤ä¥X´N¤£·|¨º»ò¦Yºò. ¦Ó¥B³o¨â¼Ë¦³¥X¨Ó,ªÑ»ù´N¤£·|¨º»ò§C,¼W¸ê¤]´N®e©ö¤F¦h¤F. ·íµM¥Ø«e¥H·sÃÄ(Ãþ·sÃÄ)ªºªÑ²¼¦Ó¨¥,¦]µØªÑ»ùºâ¬O³Ì§Cªº,§@ªº¹Ú¤]¬Ý°_¨Ó¦³¨Ç§Æ±æ, ¥H¥»¹Ú¤ñªºÆ[ÂI¨Ó¬Ý,¬O«Üȱo«ù¦³. ¦ý²{¦b¥«³õ¶}©l°l¨D¥»¯q¤ñ,¥u¦³¤Ö¼Æ¦³¤j¤H¦bÅUªº·sÃĪÑÁÙ¥i¥H«O«ù¤£¿ùªºªÑ»ù, ¦ý¦]µØªº¤j¤H¬Ý°_¨Ó¬O¤£°÷±j. ¤½¥q¤@ª½¥H¨Ó¶q³£¤£·|¤Ó¤j,¥u¦³¤Ö¼Æ°ª®p´Á·|Ãz¶q,¶R¤F´N´Á«ÝÃz¶q¤Wº¦¬O¤H¤§±`±¡,¦ý¤]¨S¨º»ò®e©ö. ©Ò¥H«ù¦³ªÌ¥u¯àµ¥§a!,¬Ý¬Ý¤µ¦~·|¤£·|¦³³¡¤À¦n®ø®§¥X¨Ó. ¦@«j¤§ |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/5/7 ¤U¤È 06:01:37²Ä 292 ½g¦^À³
|
¦~³ø¥X¨ÓÅo!¦³¿³½ìªº¥i¥H¥ý¬Ý |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/5/7 ¤U¤È 02:43:48²Ä 291 ½g¦^À³
|
4¤ë¥÷À禬ºû«ù420¸U¡A¦~¼W561¢H,¬Ý°_¨Ó¨Ì¤½¥q»¡ªk¬O¤@Pªº¡A±NÀ禬¥¤À¦Ü¦U¤ë¤¤¡A¨Ã¥B¦¨ªø |
|
|
·|û¡G¥Õ¦â±k¬P10148144 µoªí®É¶¡:2019/5/7 ¤W¤È 09:28:59²Ä 290 ½g¦^À³
|
¤j®a¦ ¬Ý¤F³o¤@¨â¤Ñªº¦¨¥æ¼Ò¦¡ ·Pı§NÄBÄB ¥»¨Ó¬Q¤Ñ¥H¬°¦b¤jÀô¹Ò¤£¨Îªºª¬ªp¤U ¶qÁÙ¤£¿ù µ²ªG¦¨¥æ¶q¦³60±i¶W¯Å¶°¤¤ À³¸Ó¬Oú³°Ó¦Û¤v¾Þ§@§a? (1~2¤ÀÄÁ¤º) ¤µ¤Ñ¤S¬O¶}½L¨S¶q (¹sªÑ©Ô»ù) Ãø¹Dn½Æ»s¬Q¤Ñ±¡§Î? ³oÀɯuªº¨S¼ö«×¤F? |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/5/2 ¤U¤È 04:03:14²Ä 289 ½g¦^À³
|
«Ø³ì§â³o¦¸ªÑªF·|ªºÄ³¨Æ¤â¥U¤Î·|ij¸É¥R¸ê®Æ©ñ¤W¥h¤F, ¨S¥J²Ó¬Ý,¦ý¦³µo²{´XÂI¦³·N«äªº¦a¤è. 1. ºX¤Uì®ÆÃļt¤C¬P¤Æ¾Ç¡A¥ç³q¹L FDA ¬d¼t¡A¦¨¬° TEVA¡B½÷·çµ¥°ê»Ú Ãļt¨ÑÀ³°Ó¡A«~½è²`ÀòªÖ©w¡C ==>©Ò¥H¤C¬PÀ禬¼W¥[ªºì¦]¦b³o 2.´£°ªI®Ñ«OÃÒÃB«× : Á`ÃB ²bÈ20%->40% ³æ¤@¤½¥q 10%->20% 3.¤½¥q¶U´Úµ¹¨ä¥L¤½¥q :¦UºØÃB«×¦³©úÅã´£°ª,¥Bק綠¥q«ù¦³50%¥H¤W¤§¤l¤½¥q,§â50%§R°£. ªí¥Ü°·³ì¥i¥HÀ°¨ä¥L¤½¥qI®Ñɨì§ó¦h¿ú,¤]¥i¥Hɵ¹¨ä¥L¤½¥q§ó¦h¿ú. ³o¨Ç±ø´Ú¥¼¥²¬O¬°¦]µØ§ïÅÜ,¦ý¦Ü¤Ö¦]µØ·Q¥Îªº®ÉÔ¥i¥H¥Î±o¨ì. ¦³¿³½ì©Î¬O¹ï±ø¤å§ó¼ô±xªº¤j¤j¥i¥H¥h¬Ý¬Ý,µM«á¤À¨É¤@¤U¤ß±o. |
|
|
·|û¡G¤pÀs¤k10146282 µoªí®É¶¡:2019/5/1 ¤U¤È 05:58:12²Ä 288 ½g¦^À³
|
¬O§r!¨º¬O2016¦~ªº·s»D¤F¡A²{¦b¬O2019¦~¤½¥qÀ³¸ÓÂצ¬¤@¨ÇªF¦è¤F¡C ªÑ»ù¤£¨ì10¶ô¡A¦]µØ¤½¥q¥¬§½³o»ò¦h°ê®a¡A¥¼¨Ó²£«~¤]·|³°Äò¥X¨Ó¡C ¥Ø«e¥xÆW¥Í§Þ§½¶Õ¤£¬O«Ü¦n¡A5¦~«á¥Í§Þ¤]µ´¹ï¤£¬O¨¦©³¡A¦]µØ¨º®ÉÔ¤]¤WÂd¤F¡C |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/5/1 ¤U¤È 04:57:44²Ä 287 ½g¦^À³
|
¦U¦ì¤j¤j, ¥H¤U°·³ì(4114)©xºô¤¤¹ï©ó¤C¬P²Å¦XFDA¤Î¦]µØÅã¼v¾¯§º¬ü¥Ó½ÐÃÄÃÒ2016¦~ªº³ø¾É µo¥¬¤é´Á: 2016.03.24 °·³ì(4114)¤µ«Å§GÄâ¤â¦]µØ¥Í§Þ(4172)¦@¦P¨ÖÁʤC¬P¤Æ¾Ç»sÃÄ¡A¥¿¦¡¸ó¨¬ì®Æ¼t»â°ì¡A¥H¨CªÑ·s¥x¹ô95¤¸¨ÖÁʹF¤C¦¨ªÑÅv¡A¸Ó¶µ«¶q¯Åªº««ª½¾ã¦X§ë¸ê®×¡A¬°¥Í§Þ»sÃIJ£·~ª`¤J·s¶}³Ð±¦V¡C ¥þ²yì®ÆÃĨÑÀ³¥Dn¥H¤¤°ê¤j³°¡B¦L«×¦û¤ñ¸û¤j¡A¤¤°ê¥Í²£¤§ì®ÆÃÄ¡A¥]¬A¤W´åªº¤Æ¾Ç¤¤¶¡Åé¡AµL½×¬O¾·¦ì¥H¤ÎÁ`È¡A¥Ø«e³£¬O¥þ²y³Ì°ª¡A±©¦]§Þ³N¼h¦¸»P³æ¦ì»ù®æ¸û§C¡A¶È¤Ö¼Æ¥i¨ú±o¼Ú¬ü¬F©²»{ÃÒ¡C¦L«×ªº§Þ³N¯à¶q¡A²£«~«~½èÁö¤ñ¤¤°ê¤j³°¤ô·Ç¬°°ª¡A¦ý¦]¤º»Ý¥«³õ¤]¤j¡A¬°¯àÝÅU°ê¤º¥~¥«³õ¡A¤j¦hÂê©w¸û¤j©vªº¤¤»ùÃÄ«~¡C ®Ú¾ÚThe Global Active Pharmaceutical Market²Îpªº¸ê®ÆÅã¥Ü¡A¥þ²yì®ÆÃÄ¥«³õ²£È¦b2014¦~¶W¹L1300»õ¬ü¤¸¡A¬ù¦û¾ãÓ»sÃIJ£·~¤§²£Èªº15%¡A¥B¥H¨C¦~¹O7%¤§¦¨ªø²v³v¦~¤W¤É¡C¥þ²yì®ÆÃļt¤w¨ú±o¬ü°êFDA¬d®Öªºì®ÆÃļt¬ù¤G¦Ê¾l®a¡C¥xÆWì®ÆÃļt¦]§Þ³N¯à¤O°ª¡B½è¶q°ª¡AÃÄ«~¦h¥H¥~¾P¬°¾É¦V¡A¦U¼t°ò©ó¸gÀÙ³W¼Ò¡A¦h±Ä«~¶µ¤Ö¡B§å¶q¤j¤§ÃÄ«~¬°¶}µo¶q²£¡A¥H¦]À³¥þ²y¥«³õ»Ý¨D¡C ¨ÌTFDA¤½§i¡A°ê¤º²Å¦XPIC/S GMPì®ÆÃļtp¦³21®a¡A¤C¬P¤Æ¾Ç»sÃĪѥ÷¦³¤½¥q§Y¬°¨ú±oµûŲªº²Ä¤@®a¡C¸Ó¼t¦¨¥ß©ó¥Á°ê51¦~¡A¬°²Å¦X¬ü°êFDA DMF³W½d¤§ì®ÆÃļt¡A99%ÃÄ«~¥~¾P¡A°£²{¦³ÃÄÃÒ¤w¶q²£¾P°â¥~¡A2009¦~©M¦]µØ¥Í§Þ¦@¦P¦X§@¶}µo¤§Åã¼v¾¯(Gadopentetate Dimeglumine)¡A·~¤w°e¥ó¿ì²z¬ü°êÃÄÃҥӽФ¤¡A¹wp©ó²Ä¤G©u±µ¨üFDA¨Ó¥x¬d®Ö¡C ¦]µØ¥Í§ÞÂê©wÅã¼v¾¯ÃÄ«~µo®i¡A¤w¨ú±o¹Å¦h©ú¤Î¹Å¦hµø°·¤G±iÃÄÃÒ¡A¨ä¤¤¹Å¦h©ú¤w»P¬ü°ê¸g¾P°Ó-Akorn(¬ü°ê¨º´µ¹F§J¤W¥«¤½¥q)©ó2012¦~¥¿¦¡Ã±¸p¬ü°êÅã¼v¾¯¨Ñ³f¦X¬ù¡A¸ÓÃÄ«~¦¨¥÷¬°Gadopentetate Dimeglumine¡A¦]¶}µo§Þ³N°ª¥B¥þ²y¨Ñ³f·½¤Ö¡A¸g¦]µØ§¹¦¨¥ý´Á¶}µo«á¡AÂऩ¤C¬P¤Æ¾Ç§¹¦¨¸Õ¶q²£¡A¸Óì®ÆÃĨ֦P»s¾¯¤w©ó2014¦~5¤ë¦V¬ü°ê°e¥ó¥Ó½ÐÃÄÃÒ¡A¹w¦ô2016¦~¨ú±oÃÄÃÒ¡C ªk¤H«ü¥X¡A¦]À³¥þ²y°ªÄ֤ƤH¤f¤ñ¨Ò³v¦~´£°ª¡A¬ÛÃö·ÓÅ@¥²n©Ê©ñ®g¬ìÀˬd¤ÎªvÀø¿E¼W¡A¸ÓÃþÃÄ«~¶}µo¡Bì®Æ¶}µo¨ÑÀ³§¡Å㤣¨¬¡C°·³ì¶°¹ÎÂê©w¤C¬P¤Æ¾Çµo®i¬°Åã¼v¾¯±Mªùì®ÆÃļt¡A¬O¤Q¤Àµ¦²¤©Êªº¬Ýªk¡C °·³ì¶°¹Î¸³¨ÆªøªL´¼·uªí¥Ü¡A¶°¹Î¦h¦~¨ÓP¤O©ó¦P·~¾ã¦X¡A³Ì¤jªº¥Ø¼Ð´N¬OÅý¶°¹Î·¥¨ã°ê»Ú¥«³õÄvª§¤O¡A¦¨¬°¥xÆWź¶Æªº¤j«¬»sÃĤ½¥q¡C¥»¦¸¦V¤W¾ã¦X¨ÖÁÊì®ÆÃļt¡A¦®¦b¥[³t±À°Ê¦]µØ¤w°e¥ó¤§Åã¼v¾¯ÃÄ«~¥¼¨Óµo®i¡A¹ê¬°µÛ®Ú©ó¶°¹ÎÂê©w¯S®í¥ÎÃÄì®Æ¦Û¦æ¶}µo¬°®Ú°ò¡A¥H¹F¨ì«~½è¡B³t«×¤Î¾ã¦Xºî®Ä¬°¦Ò¶q¡A¦ÓÂk¨ä²×¡A¶°¹Îªº³Ì¤j¥Ø¼Ð¡A¤D¬°°ê¤º¥Í§Þ»sÃÄ«ùÄòµo®i¡B°ö¨|¤H¤~¬°³Ì¤j©v¦®¡C |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/4/29 ¤W¤È 10:17:29²Ä 286 ½g¦^À³
|
M¤j¤j¡A¬Oªº¡A¤C¬P¬d¼t¬O2016¦~4¤ëªº¨Æ¡A©Ò¥H¤pÀs¤k¤j¤j±À¦ôªºÅã¼v¾¯ÃÄÃҮɶ¡¤]¬O¦X²z |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/4/29 ¤W¤È 08:33:50²Ä 285 ½g¦^À³
|
to C¤j, ¥i±¤§Ú¦í±o»·À³¸Ó¨Sªk¥h°Ñ¥[ªÑªF·|, ¤£µMˬO«Ü·QÅ¥¤@¤UOral Gemcitabine ªºª¬ªp, ¤W¤@¦¸PhaseI,¤½¥q¨C¹j¨â¤TÓ¤ë·|«Å¥¬¬Y¤@¾¯¶qªºª¬ªp, ¦ý³o¦¸±q¶iPhase1b/PhaseII°_,¤½¥q´N¨Sµo§G¥ô¦ó®ø®§¤F,³o¬O¤½¥q§ëª`³Ì¦h¸êª÷ªº²£«~,³B²zªº«o¤£©ú¤£¥Õªº. nª¾¹Dgemcitabine§ï¦¨¤fªA«áªº¤@¤jÀuÂI´N¬O°Æ§@¥Î¤p, ´Nºâ³Ì²×ÁxºÞÀùªº¤@½u¥ÎÃĤ£¬OD07001,¦ýD07001+¤@½u¥ÎÃÄ¥i¥H¹F¨ì§ó¦nÀø®Ä®É,¦b°Æ§@¥Î¤pªº±¡ªp¤U,ÁÙ¬O¥i¯à¦¨¬°¼Ð·ÇÀøµ{¥ÎÃÄ. ¥t¥~¤µ¤Ñ¦³¤@«h·s»D ì®ÆÃÄ·~ ±È¤@±øÀs¾ã¨Ö ¥Í§Þ²£·~¤¤³Ì¨ãÄvª§¤Oªºì®ÆÃIJ£·~¤ÑÅúÅÜ¡I¤@¤Ï¹L¥h¿W¦uì®ÆÃÄ¡B¤¤¶¡Å鵦²¤¡Aªñ¦~¥¿±È°_¤@±øÀs¾ã¨Ö·¼é¡A°£¤F¤¤¤Æ¥Í¡B¥Í®õ¡B¥Ã¤éµ²¦X¥À¶°¹Î¡A¶}µo»s¾¯ÃÄ«~¶ix¤é¥»¥«³õ¥~¡F¯«¶©¡B¥xÄ£¡B®i©ôµ¥¤½¥q¡A«h¬Ý¨ì¥þ²y°w¾¯¥«³õªº¯Ê¤f¡A¦Û«Ø°w¾¯¼t·mq³æ¡C ¥t¥~¡A¦³Å²©óì®ÆÃļtªº¦æ±¡¬Ýº¦¡AÑÔ¼w¡B°·³ì©M«n¥ú³£¬O±q»s¾¯¼t¦V¤W´åì®ÆÃļt¾ã¦X¡C ±N²×¤î¤WÂdªº¦w¦¨ÃÄ¥ý«eªk»¡·|§Yªí¥Ü¡A¾Ç¦WÃļt¸gÀç·U¨Ó·U§xÃøì¦]¡A¤W´åì®Æ¨ÑÀ³°Óªº««ª½¾ã¦X¡A¹B¥ÎÃöÁäì®Æ´x´¤Àu¶Õ¡A¥´¶i«áºÝ»s³yÃÄ»ùÈÃì¡A¬O«Ü¤jªºÃöÁä¡C ªk¤H»{¬°¡A°ê¤ºì®ÆÃIJ£·~°ê»ÚÄvª§¤O±j¡A¤j³£¥H¥~¾P¬°¥D¡A¥B¦U®a¤½¥q¦U¨ã¯S¦â¡A¨Ò¦p¦°´I´N¬O³o¤@ªi¬ü°ê¤j³Â¦X¤Æªkªº¤jĹ®a¡F¤¤¤Æ¥Í§K¬Ì§í¨î¾¯»D¦W¥þ²y¡F¥xÄ£Áx©T¾JÁC»ÄÆQì®ÆÃÄ¡B®i©ô±M§ðªº§Ü¥Í¯À³£²`¨ã§Q°ò¡C¦Ó³o¤@ªiì®ÆÃļtªº¾ã¨Ö¼é¡A¹w´Á±N¦³¥[¤À®Ä¯q¡C ¥h¦~¤~§ë¸ê¤JªÑ«Ø½Ëªº«n¥ú¡A¥Ø«e¥[p«n¥úÁ`¸g²z¤ý¥ÉªMªº®a±Ú¡A¦Xp«ùªÑ¹O15¢H¡A쥻«n¥ú¥u¬O¯¸¦b§ß«ù·s³Ð¤½¥q¦Ó§ë¸ê¡A«o¦]«Ø½Ë³Ð¿ì¤H¶À¥þ¼w2¤ë¦]Àù¯g¹L¥@¡A¤ý¥ÉªMÁ{¦M¨ü©R¡A±µ´x¸³¨Æªø¨ÃÝ¥ôÁ`¸g²z¡F¦b¿n·¥½Õ¾ãÀç¹Bµ²ºc¤U¡A·~¬É»{¬°¡A¥H«n¥ú¶}µoªº°w¾¯¥Ø«e¤w¥´¶i¤é¡B¬ü©M¤j³°¥«³õ¤U¡A2015¦~8¤ë¤~³Ð¥ßªº«Ø½Ë¡A¤]¥i±æ¦]«n¥úªº¥[«ù¡A§Ö³t³Ð³y¼¼Æ®Ä¯q¡C ¥Hµo»Ã¬°®Ö¤ß§Þ³Nªº±oºa¡A2010¦~¥ÑÑÔ¼w¶°¹Î¨ÖÁʾã¹y«á¡A¤]©ó2012¦~µn¿ý¿³Âd¡A2017¦~¦A»P±M§ð¯q¥ÍµßªºÂ׵ئX¨Ö¡CÂ׵ظ³¨Æªø³¢¥ò°¶»{¬°¡A¤j°·±d²£·~¬OÑÔ¼wÃÄ·~¶°¹Îªº«ÂI¯Ñ¯Ð¶µ¥Ø¡AÂ׵ػP±oºa¦b¤W´å¥\¯à©Ê¯q¥Íµßµß¯»¬ãµo¡B¶q²£¤Î«áºÝºÞ²z¡B¦æ¾Pµ¥¦U¦³Àu¶Õ¡A³z¹L¸ê·½¾ã¦X¡A±N¦³®ÄÂX¤j¯q¥Íµß¯»ì®Æ¥Í²£³W¼Ò¸gÀٮįq¡C ¥t¥~¡A°·³ì«hµ²¦XºX¤Uªº¦]µØ¥Í§Þ¡A¦b2016¦~³z¹L¤G½üªº¸êª÷§ë¸ê¡A¥H¦Xp¬ù9.28»õ¤¸¨ÖÁʳХ߹O50¦~ªº¦Ñì®ÆÃļt¢w¤C¬P¤Æ¾Ç¡C ¤C¬P¹L¥h¥Í²£ªºì®ÆÃij£¥H¥~¾P¬°¥D¡Aªñ¦~¦]¶°¹Î®Ä¯q¾ã¦X¡A¥Ø«e¤]¶}©l¶}µo¦]µØªºÅã¼v¾¯ì®ÆÃÄ¡C ¤£ª¾¹D°OªÌÁ¿ªº¦³¨S¦³¿ù,«Ü¤[¥H«e¤C¬P´N³Q¬d¼t¹L¤F,À³¸Ó¦´N¨ã³ÆÅã¼v¾¯ì®ÆÃĪº¥Í²£±ø¥ó¤F,«ç»òÁÙ¬O¤~¶}©l¶}µo? ÁÙ¬O¶}µoªº¬O¥t¥~¤£¦PªºÅã¼v¾¯²£«~? |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/4/28 ¤U¤È 03:06:08²Ä 284 ½g¦^À³
|
M¤j¤j, ¤p§Ì¤]ı±o¤¤°ê¤sªF·s®É¥NÃÄ·~¦³¤½¥qBH4¦]¸¿Õ§Þ³N±ÂÅv¶i«×¬O¦³ÂIºC,¤£¹L¦pªG³oÓ¦X¬ù¬O«ùÄò¦b¶i¦æªº, ¥BBH4¦C¬°¤¤°ê°ê®a²Ä¤@§å¨u¨£¯e¯fµo¥¬n¿n·¥¶}µo¥Ø¿ý 107/3/26ñq±ÂÅv¦X¬ù ,108/8¤ë¦¬±ÂÅvª÷§ÞÂà¶}©l,ªñ´Á¦pªG¯à°e¥Ó½Ð¤¤°êÃÄÃÒ,¨º´Nªí¥Ü¤sªF·s®É¥NÃÄ·~³]³Æ¤]¶R¤F,¤u§Ç¤]¶]¹L¤F,¦¨«~¤]¥X¨Ó¤F,¨ºªí¥Üªº´N¬O·~ÁZªº¼É½Ä¤µ¦~¨S¦³¨º©ú¦~¤]¬O·|¦³ªº........²{¦bªºªÑ»ù9¤¸¬O.........ªº ©Ò¥H108/5/15¤W¤È9ÂIªºªÑªF·|¬Oȱo¥hťťªº, ¬JµM¤½¥q¤]§â¤sªF·s®É¥NÃÄ·~¦³¤½¥qBH4¦]¸¿Õ§Þ³N±ÂÅv¥Ó½Ð¤¤°êÃÄÃÒ¦C¶i108¦~¤½¥q¤u§@nÂI.... 108/5/15¤W¤È9ÂIªÑªF·| |
|
|
·|û¡G¥Õ¦â±k¬P10148144 µoªí®É¶¡:2019/4/27 ¤U¤È 04:41:48²Ä 283 ½g¦^À³
|
·PÁÂM¤jªº¸ÑÄÀ §Ú¥[³oÀɨS¦h¤[®É¶¡ ¨S¦³¹ï¤C¬P¤F¸Ñªº³o»ò¥J²Ó ÁÂÁ»¡©ú ¦pªG¯uªº¬O³o»ò«nªºµ¦²¤©Ê§ë¸ê ·íµM¤£n»´¨¥©ñ±ó(¤£¹L 20%«ùªÑºâ¤£¤W¦nµ¦²¤ ÁöµM¨ä¥L¬Ý¨Ó³£¦b°·³ì¤â¤W ¦ý¬O°·³ì¤]¥u«ù¦³¦]µØ20%¥ª¥k ³£¤£ºâéw«ù¦³ªÑªF) ¥u¬O ¦pªG¬O³o¼Ë ¨º¯uªº¥¼¨Ó¸êª÷³W¹º¤@©wn«Ü©ú½T ¤£µM´N¯uªº¸m¤½¥qÀç¹B¦b¦MÀIÃä½t |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/4/27 ¤W¤È 11:59:46²Ä 282 ½g¦^À³
|
to ±k¬P¤j, ³oÃäµy·L²á¤@¤U¤C¬P»sÃÄ, ¤C¬P»sÃĦb¹Ãĸp®Ö㪺«~¶µ¦³ (1)Gadopentetate Dimeglumine (½Ã¸pÃÄ»s¦r²Ä052457¸¹)¡B (2)Glyceryl Guaiacolate (½Ã¸pÃÄ»s¦r²Ä001181¸¹)¡B (3)Methocarbamol (½Ã¸pÃÄ»s¦r²Ä028259¸¹)¡B (4)Methocarbamol DC 90% (½Ã¸pÃÄ»s¦r²Ä049499¸¹)¡B (5)Sapropterin Dihydrochloride (½Ã³¡ÃÄ»s¦r²Ä059807¸¹) ¨ä¤¤(1)¬OÅã¼v¾¯ì®ÆÃÄ (5)¬O¦]¸¿Õì®ÆÃÄ ·íªìªL¸³¨M©w¥Ñ°·³ì©M¦]µØ¦@¦P¦¬ÁʤC¬P»sÃĬO¬°¤FÅý¤§«á¦]µØªºÅã¼v¾¯©MBH4¦³Ã©wªº³f·½. ¤C¬P¥Ø«e¸ê²£Á`ÃB¤j¬ù13»õ¦h(¥Dn¬O«D¬y°Ê¸ê²£), ¥Ñ¦]µØ¦ûªºªÑÅv¨Ó¬Ý,¤j·§¦³3»õ¤¤d¸U¥ª¥kªº¸ê²£,·íµM°£¤F°·³ì,¤£®e©ö§ä¨ì¨ä¥L¶R®a,¨ä¥L¶R®anªá¦h¤Ö¿ú¶R¤]¬O°ÝÃD. ¤C¬P106¦~À禬¤»¤d¦h¸U,Á«·lªñ¤¤d¸U 107¦~À禬¤@»õ¤@¤d¦h¸U,Á«·l¤T¤d¤»¦Ê¦h¸U. ¬Ý¨ÓªL¸³¤]¦³³]ªkÀ°¤C¬P§ïµ½Åé½è. ¦^¨ì¦]µØ,³Ì²z·Qªºª¬ªp¬O¦]µØÅã¼v¾¯©M¦]¸¿Õªº¥Í·N°_¨Ó,±a°Ê¤C¬PªºÀ禬¤]°_¨Ó,¤C¬PÀò§Q°·³ì©M¦]µØ¤]¦P»X¨ä§Q. ÁöµM¤C¬Pªº¤ò§QÀç·~¶O¥Îªºª¬ªp«Ü¤£©ú®Ô,¦ý§Ú·Q¦]µØ¦Ü¤Ön¦V¤C¬P©ÔÓ¤@¨â»õªº³f¤~·|Åý¤C¬PÁÈ¿ú§a! ¦b³oÓª¬ªp¤U¦]µØ¥»·~À³¸Ó¤]¥i¥HÀò§Q¤F(²`²`´Á«Ý) ©Ò¥H¥X°â¤C¬P¬O¦]µØ³Ì«á¤]³Ì¤£·Qnªºª¬ªp,¥Nªí¦]µØ¤Þ¥H´Á«Ýªº¨â¤j¥Í²£½uµu´Á°_¤£¨Ó. §Ú¤@ª½´£¬O·Q»¡¦]µØ¨ä¹êÁÙ¦³¥i´£¨Ñ¥»¨¿N¤T¦~¥ª¥k«eªº¦Ñ¥»,·íµM°·³ìnÀ°¦£¤~¦æ. ¤£¹L§Ú¤]ÃÙ¦¨±k¬P¥SÁ¿ªº,¦]µØn§â¥¼¨Ó¸êª÷¨Ó·½Á¿²M·¡¤~¦n. |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/4/26 ¤W¤È 10:25:25²Ä 281 ½g¦^À³
|
c¤j§A¦n, §Úı±oºÃ´bªº¬O¥H¤U³o¬q(ºK¦Û¤µ¦~ªºÄ³¨Æ¤â¥U¤Î·|ij¸É¥R¸ê®Æ) ¤G¡B108 ¦~«×Àç·~p¹º·§n (¤@)¸gÀç¤è°w: ¥»¤½¥q 108 ¦~«×¤§Àç·~¤è¦V¡A°£¥N²z¶i¤f¤§²O¤ÚÀù·s¦¨¥÷·sÃÄ-´¶Àù¨O©ó 108 ¦~À禬¤] ±N«ùÄò§eéwªº¾P°â¥~¡AD07001 ±N©ó 108 ¦~«ùÄò¶i¦æÁxºÞÀù¤HÅéÀø®Ä¡BÃĪ«°Ê¤O¾Ç ¤Î¦w¥þ©ÊÁ{§ÉàPÅç¡C¦Ó»P¤¤°ê¤sªF·s®É¥NÃÄ·~ñq¦]¸¿Õ¤§§Þ³N±ÂÅv¦X¬ù¡A±N¶i¦æ¦b ¤j³°¤§ÃÄÃҥӽСA¤Î¥»¤½¥q¹B¥Î·s¤@¥Nªº³J¥Õ½è¤fªAÉx¥x§Þ³N¶}©Ý¤§·s²£«~-N11005 (¤fªA¯Ø®q¯À)¤]±N«ùÄò¥Ñ±ÂÅv¹ï¶H-©y©÷ªF¶§¥úªø¦¿ÃÄ·~¶i¦æÁ{§É«e°Êª«àPÅç¡C¦¹ ¥~¡A¤½¥q¥ç±N«ùÄò§ë¤J¶}©Ý¿z¿ï«á¤§·s«~¶µ¡C ÅãµM¦]¸¿ÕªºÃÄÃÒÁÙ¥¼¥Ó½Ð,·íµMÃÄÃҥӽФ]·|²o§è¨ì¬d¼t©M¥Í²£¬yµ{²Å¦X³W©w. ¦ý±q¥h¦~¤T¤ë§Ë¨ì²{¦b,§Úı±o¶i«×¬OºC¤FÂI. §Æ±æ¤½¥q¥i¥H¥[±j¤O¹Dpush¤@¤U¤sªF·s®É¥NÃÄ·~ªº¶i«×. ¤@ª½¥H¨Ó¤½¥q°£¤F¥N²zªº´¶Àù¨O,¨ä¥LÃÄ«~ªº¶i«×Á`¬O¨S¦³¤@Ó©ú½Tªºµ²ªG,³£¬Oñ¤@¨Ç¬ù,®³¨ì¤£¤j¤£¤pªºÅv§Qª÷. ¦Ü¤Ö§Æ±æªñ´Á¥i¥HÅ¥¨ì¤sªF·s®É¥NÃÄ·~°eÃÄÃҥӽЪº®ø®§§a! |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/4/26 ¤W¤È 10:11:43²Ä 280 ½g¦^À³
|
¦U¦ì¤j¤j, ¤p§Ì¤ñ¸û·P¨ì¦³·N«äªº¬O³oÓª¬ºA,¥H¤U¶È¨Ñ°Ñ¦Ò,Ó¤H¨£¸Ñ¤Îºô¸ô·j´M¸ê®Æ 3/26 »P¤¤°ê¤sªF·s®É¥NÃÄ·~¦³¤½¥qñqÆQ»Ä¨F¤þ³ãËï¤ù¾¯(BH4¡F¦]¸¿Õ)§Þ³N±ÂÅv¦X¬ù®Ñ , 8¤ë¥÷«h¬°»{¦C»P¤sªF·s®É¥NÃÄ·~ªºÃ±¬ùª÷¬ù500¸U, ¥h¦~5/23 BH4¤S¦C¬°¤¤°ê°ê®a²Ä¤@§å¨u¨£¯e¯fµo¥¬¥Ø¿ý(5/23¤½§i),n¿n·¥¶}µo,¦Ó¥BÃÄÃÒ¼f¬d·|¥H³Ì§Ö®É¶¡(¤×¨ä¬O¤¤°ê»sªº¼f¬d§ó¬O§ß´Ó«ÂI) ¼f¬d®É¶¡¦ôp¬O¦b1¦~¤º,´N¦]µØ»P¤sªF·s®É¥N±ÂÅv»s³yª¬ªp,ºâºâ®É¶¡©ú¦~108¦~¤¤«áÀ³¸Ó´N¯à³°Äò¦¬¨úÅv§Qª÷¤Îì®Æ¾P°âª÷ÃB ¤@¨ÇÃö©óBH4¯Ê¥F¯g¦b¤¤°êª¬ªp·j´M½Ð¦U¦ì¤j¤j°Ñ¦Ò¤@¤U......... (¹ï©ó¤¤°ê¤sªF·s®É¥NÃÄ·~¦³¤½¥q¶}µo¦¹ÃÄ«~¦b¤¤°ê¦n¹³¬O«e±Æ.......) ¥|氢¥Íª«½ºËï¯Ê¥F¯g³q过对·s¥Í¤I进¦æ¯e¯f筛¬d¡A检¥X°ªf¤þ®ò»Ä¦å¯g¦Z¥i±o¨ì进¤@¨BÚÌ诊¡C¦b¤¤国¤j陆¦a区¡A·s¥Í¤I°ªf¤þ®ò»Ä¦å¯gªº发¯f²v约为1.1ÉE¤À¤§¤@¡F¦Ó¦b°ªf¤þ®ò»Ä¦å¯g¤¤约¦³ªñ两¦¨¬OBH4¯Ê¥F¯g¡C«ö这个发¯f²v计ºâ¡A¦b¤¤国¨C¦~约2000ÉE·s¥Í¤I¤¤¥i¯à±wBH4¯Ê¥F¯gªº为100~200¤H¡C¥Ñ¤_BH4¯Ê¥F¯g¤À经¨å«¬©M«D经¨å«¬两Ïú¡A¦]¦¹¦´Á«Ü®e©ö误诊¡C ÕuNGO组织ªº¤£§¹¥þ统计¡A¥Ø«e国内约¦³12ÉE¦WPKU±w¤I¡A¨ä¤¤BH4¯Ê¥F¯g±wªÌ¤j约9600¦W¡A¦bªv¸sÊ^仅1ÉE¦h¤H¡Aªñ10ÉE¤Iµ£¤w经©Î濒临瘫痪边缘¡A还¦³«Ü¦h没统计¥X来ªº±wªÌ¡C专®a«ü¥X¡A¤@¤è±¡A¨u见¯f药ª«¨Ï¥Î¤H¸s¤Ö¡A开发¦¨¥»©~°ª¤£¤U¡F¥t¤@¤è±¡A国®a¨u见¯f帮§ß¬Fµ¦还¬OªÅ¥Õ¡A§Ú国¦}没¦³对¨u见¯f进¦æ¥ßªk¡A¯Ê¥F¤@个§¹µ½ªº±Ï§UÊ^¨t¡F¦A¦¸¡A医«O¨î«×¦}没¦³纳¤JPKUªv疗¡CPKU±wªÌ¨É¨ü¤£¨ì°ò¥»医疗«O»Ù¡A处¹Ò艰难¡C ¦¨¤H©M¤Iµ£BH4¯Ê¥F¯g±wªÌªº°_©l剂¶q为2-5mg/kgÊ^«¡A¨C¤é1¦¸¡C剂¶q调¾ã¥i¦Ü20mg/kg/¤Ñ¡C¤]¥i¥H®ÚÕu»Ýn将¨C¤é总剂¶q¤À为¨C¤Ñ2¦¸©Î3¦¸ªA¥Î¡A¥Hɬ¤Æªv疗®ÄªG¡C ¦ôºâ¤@¤U,¨Ì·Ó5/23¤¤°ê°ê®a¥X¥xªº©t¨àÃĵo®i¤Î¯f±w¸É§UÂX¤j¥ÎÃĪº¾÷·|¨Ó¬Ý, ¤¤°ê¥Ø«e¦³BH4¯Ê¥F¤H¤f¬ù10,000¤H,¨C¤H¨C¤é»ÝªA¥ÎÃĪ«¬ù300mg/30kg/¤Ñ¥H¤W,¨C³æ¦ìÃĬ° 100mg/900¤¸¥x¹ô(¤j³°¤ÎÁú°ê°â»ù§ó°ª) 10000x3x900x365=985,500¸U¤¸¥x¹ô/¦~ ¦]µØ»P¤¤°ê¤sªF·s®É¥NÃÄ·~¦³¤½¥q§Þ³N¦X§@¶Õ¥²®e©ö·f¤W¦¹¦¸¤¤°ê°ê®a©t¨àÃÄ¿n·¥µo®i¬Fµ¦,¥un¯à®³¤U³¡¤Àªº»Ý¨D,´N¬O¤£±o¤FÀ禬¤F |
|
|
·|û¡G¥Õ¦â±k¬P10148144 µoªí®É¶¡:2019/4/26 ¤W¤È 09:13:47²Ä 279 ½g¦^À³
|
¦³¤j®aªº¬dÃÒ»P»¡©ú´N²M·¡¦h¤F ²{¦b¥u§Æ±æ²£«~¶}µo»P±ÂÅv¨B½Õ ¤£n¦A¸õ²¼¤Ó¦h ¦]¬°¸êª÷¤ô¦ì©úÅ㤣°÷ ´Nºâ107´Á¥½²{ª÷9900¸U É¿ú¶R³f´Nªí¥Ü¦Û¤v¤]ª¾¹D¤âÃän¯d²{ª÷ (¹L¥h´X¦~¶R³f¤]¨S¨£¹LÉ¿ú°Ú) °£«D¤µ¦~¦³¤jµ§¶i±b©Î¦A¦³¥t¤@ªi¾ê¸` ¤£µM¤ñ·Ó107¦~ ¤µ¦~¤]¹wp¦A¿N8000¸U...³o«Ü®£©Æ ɶU¤£¬O¿ìªk ¤½¥qÀ³¸Ó¦bªÑªF·|§i¶DªÑªF¥¼¨Ó¤@¨â¦~¸êª÷³W¹º,²¦³º¤â¤W²{ª÷¯uªº¤£¦h ÁÙ¦³, ¦pªG¹³M¤j»¡ªº,¦b¤C¬P§ë¸ê¤]¦³¦n´XÓ»õ(?),³o¦b¦Û¤v¤½¥q¦³¼ç¦b²{ª÷¯Ê¤fª¬ªp¤U,«ç»ò¬Ý³£À³¸Ó¬O¦¬¦^¦Û¥Î¤ñ¸û¦X²z§a?¤£¬O«ÜÀ´¤½¥q³B²zÅÞ¿è.... |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/4/25 ¤U¤È 11:40:04²Ä 278 ½g¦^À³
|
·PÁÂc¤jªº®ø®§, ¤½¥q¥h¦~©³®w¦s¼W¥[,¤Î¤µ¦~«e¤T¤ëÀ禬ª¬ªp³£±o¨ì¦X²z¸ÑÄÀ. ¥Ñ$17,368(¤d¤¸)¤ä¥I´¶Àù¨O1¤ë¥÷70%ªº¶i¤f³f´Ú,±À¦ô¤µ¦~¦Ü¤Ö·|¶i¤f¨â¤d¦h¸Uªº´¶Àù¨O,½æ¥XÀ³¸Ó¤]·|¦³¥|¤d¦h¸U. ¥t¥~ªÑªF·|ªº³¡¤À¤º®e©ñ¨ìºô¸ô¤W¤F, ¦³´XÓ«ÂI 1.×q¥»¤½¥q¡u¨ú±o©Î³B¤À¸ê²£³B²zµ{§Ç¡v: ³o¥u¬O¦]À³·sªk³Wªº×¥¿,À³¸Ó¨S¦³¤°»ò 2.¦³´£¨ì»P¤¤°ê¤sªF·s®É¥NÃÄ·~ñq¦]¸¿Õ¤§§Þ³N±ÂÅv¦X¬ù¡A±N¶i¦æ¦b ¤j³°¤§ÃÄÃÒ¥Ó½Ð, ªí¥ÜÁÙn¸g¹LÃÄÃҥӽгoÃö,n´£¨Ñ¤j¶qÀ禬¥i¯àn¦Aµ¥µ¥. 3.¦³´£¨ì¤½¥q¥ç±N«ùÄò§ë¤J¶}©Ý¿z¿ï«á¤§·s«~¶µ, §Ú·Q¤½¥q§â¤fªA¯Ø®q¯À±ÂÅv¥X¥h¥Ñ©y©÷ªF¶§¥úªø¦¿ÃÄ·~¶i¦æ¹êÅç«á,À³¸Ó¦³ªÅ¥X¤@¨Ç¤H¤O¥i¥HÄ~Äò¬ãµo·s²£«~. 4.c08001¤w¸g¨S¦A´£°_¤F,¤£ª¾¹D¬O³Q©ñ±óÁÙ¬Onµ¥¤§«á¦³¸êª÷¦AÄ~Äò. ¥t¥~°·³ì¤µ¦~ªºªÑªF·|¨ä¤¤¤@¼ËijÃD¬O×q¥»¤½¥q¡u¸êª÷¶U»P¥L¤H§@·~µ{§Ç¡v³¡¤À±ø¤å®×, ¤£ª¾¹D¬O¤£¬OnÉ¿úµ¹¦]µØ :) ¤½¥qªÑ»ù¤@¸¨¤d¤V«á,¼W¸êÀ±¸ÉÁ«·lÅܱo¤£¥i¦æ,«ÝÀ±¸ÉÁ«·l¤@ª½²Ö¿n¦³ÂI®£©Æ. °£¤F¤w´£¨ÑÀ禬ªº¥»·~¥~,¤µ¦~¥i¯à·|Àò±oªº¸êª÷¦³ 1.Åã¼v¾¯¨ú±oÃÄÃÒ«á,¥ÑAvir, Akorn´£¨Ñªº¨½µ{ª÷. 2.¦]¸¿Õ¨ú±oÃÄÃÒ®³¨ìªº¨½µ{ª÷ 3.¤fªA¯Ø®q¯À¶iINDÀ³¸Ó¤]·|®³±o¨ì¨½µ{ª÷ 4.¤fªAÀù¯gÃıÂÅvª÷(§Æ±æºÉ§Ö®³¨ì¤@ÓÀu´ìªº±ÂÅv±ø¥ó) 5.¸ò°·³ìÉ 6.¥X°â¤C¬PªÑÅvµ¹°·³ì(À³¸Ó¦³¤T»õ¥ª¥k) ´N§Æ±æ¦U«~¶µ¶}µo©Î¨ú±oÃÄÃүබ¶¶§Q§Q,¤£n¹³C08001¤T´Áµ²§ô«áµ²ªG¤°»ò³£¨S¦³. |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/4/25 ¤U¤È 04:22:01²Ä 277 ½g¦^À³
|
¦U¥~¤j¤j, Ãö©ó°]³ø°ÝÃD¸g¤p§Ì¦V¤½¥q¸ß°Ýµª®×,¤½¥q¥DºÞ¤w¥H¹q¸ÜÁpµ¸¦^ÂЦp¤U,½Ð°Ñ¦Ò, °ÝÃD1. >> ¦b¤½¥q°]°È¦p¦¹Á}Ãø¦Ó¥B¦b107¦~«×¤½¥q¾ê¸`¤H¨Æ¤Î¦U¶µ¶O¥Îªº®ÉÔ,«o¥X²{¦p¦¹¥i©Èªº±Ôz ¸³¨Æ¹Sª÷°ª¹F19,469¤d¤¸,½Ð°Ý¤½¥qªº»¡ªk¬O¤°»ò? ¤½¥q¦^ÂÐ: ¸g¤F¸Ñ¡A¬OñÃÒ·|p®v¨Æ°È©Ò¡Ð¸ê¸Û¡A±N°]³ø¤§©ú²Óªí»~´Ó¡A107¦~¤§Á~¸ê¶O¥Î¤Î¸³¨Æ¹Sª÷¤§¼Æ¦rÀ³¸Ó$31,428¥a¤¸¤Î$1,496¥a¤¸¡AµM¨ä»~´Ó¬°$13,428¤Î19,496¡A§Ṳ́w½Ð¸ê¸Û§ó¥¿¡A±N¥H«¤j°T®§§ó¥¿ °ÝÃD2. >> ¤½¥q¦]À³Àç¹B»Ý¨D¡A©ó 108 ¦~»P¥üÂ×°ê»Ú°Ó·~»È¦æÄò¬ù´£°ª±Â«HÃB«×¡AÁ` p$50,000¡A¨Ã¤w©ó¥Á°ê 108 ¦~ 1 ¤ë 18 ¤é°Ê¥ÎÉ´Ú$17,368(¼Ú¤¸$492,000)¡C ¤½¥q¦^ÂÐ: ¼Ú¤¸É´Ú¥Dn¬°¥Î©ó°Ê¥Î»È¦æÁÊ®ÆÉ´ÚÃB«×¡A¤ä¥I´¶Àù¨O1¤ë¥÷70%ªº¶i¤f³f´Ú, ¥t¥~,¦bì®Æ±ÄÁʤξP°â¤W,¤½¥q¦b·|p¤W¾l108¦~°_°µ¤FÅܧó,¹L¥h¬O¤@µ§ª÷ÃB¶R¤Jì§÷®Æ«áª½±µ¥X³fµ¹°·³ì°µ¤À´Á¾P°â,©Ò¥H³q±`¦b¨C¦~ªº¦~©³¦~ªì·|¥X²{¤@Ó©Ô³fªºÀç·~ÃB,¤£¹L108¦~°_×¥¿¦¨¤½¥q¤À´Á¥X³f,©Ò¥H¾P³f³¡¤À´N¤£·|¥X²{¬Y¨Ç¤ë¤À°ªª÷ÃB,¦Ó¬O§¡Åu¦b¨CӤ뤺,¤£¬Oq³æ¬y¥¢,³oÓ±q1~3¤ëÀç·~ÃB´N¥i¬Ý¥X,¬Û¹ïªº´N¥i¥H¬Ý¨ì¥t¤@Ó´N¬Oì§÷®Æªº®w¦s¼W¥[¤F¡C °ÝÃD3.>> ¤C¬P¤Æ¾Ç»sÃÄ,107¦~¤C¬PÀç·~¦¬¤J113,666¤d¤¸¸û106¦~¦¨ªø75%,«o«ùÄòÁ«·l,¨Ã¥B»Ýn¤½¥q»{¦C¤C¬PÁ«·l,½Ð°Ý¥H¤½¥q¥Ø«eª¬ªp³o¼Ë¦X¾A¶Ü? ¤½¥q¦^ÂÐ: ¥Ø«e¤C¬PªºÁ«·l¤w³v¨BÁY¤p¡AÀ³¸Ó³v¨BÂàÁ«¬°¬Õ¡A¥i°Ñ¦Ò°]³ø²Ä11¶ºî¦X·l¯qªí¡AÀç·~¥~¦¬¡Ð±ÄÅv¯qªk»{¦C¤§ÃöÁp¥ø·~·l¯q¤§¥÷ÃB¡A¤w¥Ñ$13,963¥a¤¸¤U°¬°107¦~¤§$8,911¥a¤¸ °ÝÃD4.>> ÁöµM¤½¥q¦b¥h¦~¤O¦æ¤F¸`¬ù¬Fµ¦,¦ý¬O²{ª÷ÁÙ¬O¤£Â_¬y³u,³o¬O¥²µMªº,½Ð°Ý¤@¤U³o¼Ëªºª¬ºA¤U(107¦~´Á¥½¬ù·í²{ª÷69,338¤d¤¸),ÁÙ¦³¥¼¥I±b´Ú,½Ð°Ý¤½¥qªº²{ª÷³W¹º¬O? ¤½¥q¦^ÂÐ: 107¦~¤§´Á¥½²{ª÷¾lÃBÀ³¬°$99,540¥a¤¸¡A¦]IFRS¬Fµ¦¡A±N3Ó¤ë¥H¤Wªº»È¦æ¦s´Ú«¤ÀÃþ¦Ü¡¨«öÅu¾P«á¦¨¥»¿Å¶q¤§ª÷¿Ä¸ê²£-¬y°Ê¡¨ ¥t¥~,¹L¥h¤½¥q¤½§iªº¤@¨Ç¦X§@·s»D,³o¨Ç®ø®§¤j®a¤]¦bª©±¤W°Q°Ý«Ü¦h¦¸,¤j®a¥i¥H©¹«eª¦¤@¤U¤å,·PÁ mogwai¤j¤j, ¤pÀs¤k¤j¤j, ·J¾ã ¦ü¥GÀ³¸Ó¨ì¤F¤µ¦~¦~¤¤¥H«á®É¶¡¤W³£À³¸Ón¶}ªá¤F,´Á«Ý¤½¥qªº§V¤O¯à¶}ªáµ²ªG,§ÚÌ´Á«Ý¦n®ø®§§a! ¦bÄw½X±¤W,²Î¤@·s¥x¤¤,¸s¯qª÷¹©¥ÁÅv,¤é²±´º¬ü¦b¦~«á³£¦^¸É¤F¦Ê±i¥H¤W,«ùªÑ¤d±i¥H¤WªºªÑªF(11¤H)±q¹L¦~«á¦Ü¤W©P30,060±i¤@¸ô¼W¥[¦¨30,850±i,¥[ªo§a!! |
|
|
·|û¡Ginnopharma10146547 µoªí®É¶¡:2019/4/25 ¤U¤È 12:43:47²Ä 276 ½g¦^À³
|
18/04/2019 ¦]µØ¥¿¦¡±o¨ì¨â¶µUSA±M§QPOA³qª¾¡G(2017¦~©³¥u¬OUSA±M§Q¤½§i) 1.Oral Administration of Unstable or Poorly-Absorbed Drugs 2.Metronomic Oral Gemcitabine for Cancer Therapy ½Ð°Ñ¦ÒWIPO±M§QÀ˯Áºô¯¸ ¥i¥H¬Ý¨ì¦]µØ¨C¶µ¦U°ê±M§Q¥Ó½Ðªº¶i«× ¤d¸U¤£n¤p¬Ý¥¦¤F |
|
|
·|û¡G¥Õ¦â±k¬P10148144 µoªí®É¶¡:2019/4/24 ¤W¤È 10:33:22²Ä 275 ½g¦^À³
|
ÁÂÁÂmogwai, §Ú·Q¤]¬O, À³¸Ó¬O»~´Ó ¤£¹L·Ó³o¥§¡¨C¤ë¿N¿úªº³t«×, ¤âÀY²{ª÷¦A¥[¤W¸ò¥üÂ×ɪº¿ú, °£«D¤µ¦~¤¤¤w¸g¦³§â´¤ªº¤jµ§¦¬¤J¨Ó·½(±ÂÅv?), ¤£µMÀ³¸Ó¬O¼µ¤£¨ì¤µ¦~©³°Ú~~ ¦óªp, É¿ú¬OnÁÙºw.... ¤£ª¾¹D¤½¥q¥´ºâ¬O¤°»ò |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/4/23 ¤U¤È 12:16:20²Ä 274 ½g¦^À³
|
±k¬P¥S¬Ý±o«Ü²Ó:) ¤£¹L§Ú¬Ý¤F¨ºÓªí®æ,û¤uÁ~¸ê¥u¦³2544(¤d)+13428(¤d),»P¨ä¥L¦a¤è¦C¥Xªº35468(¤d)©úÅ㦳»~, ¹ï¤ñ¥h¦~Á~¸ê40274(¤d),ÁöµMû¤u±q38´î¬°25¤H,Á~¸ê¤ä¥XÀ³¸Ó¤£·|®t¨º»ò¦h¤~¹ï. ©Ò¥H§Úı±o¸³¨Æ¹Sª÷©MÁ~¸ê¶O¥ÎÀ³¸Ó¬O¼g¿ù¤F,¬Ý¬Ý¤½¥q·|¤£·|§ó§ï. |
|
|
·|û¡G¥Õ¦â±k¬P10148144 µoªí®É¶¡:2019/4/23 ¤W¤È 11:53:05²Ä 273 ½g¦^À³
|
·PÁÂmogwai°T®§!! °]³ø¤W, ¥O¤H³Y²§ªº¬O, ªí¤Q´£¨ì107¦~¸³¨Æ¹Sª÷¹Gªñ1¤d9¦Ê¦h¸U, ¦Ó106¦~¤~1¦Ê4¤Q¦h¸U..¤½¥q¤£¬O¦b¾ê¸`¶Ü? |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/4/23 ¤W¤È 09:19:59²Ä 272 ½g¦^À³
|
¤½¥q¥h¦~°]³ø¥X¨ÓÅo!, §Úı±o¤ñ¸û¦³·N«äªº¦³¨âÂI 1. p40 ¤Q¤@¡B«¤j¤§´Á«á¨Æ¶µ ¥»¤½¥q¦]À³Àç¹B»Ý¨D¡A©ó 108 ¦~»P¥üÂ×°ê»Ú°Ó·~»È¦æÄò¬ù´£°ª±Â«HÃB«×¡AÁ` p$50,000¡A¨Ã¤w©ó¥Á°ê 108 ¦~ 1 ¤ë 18 ¤é°Ê¥ÎÉ´Ú$17,368(¼Ú¤¸$492,000)¡C À³¸Ó¬O¤½¥q´£°ª¤¤d¸UÃB«×¨Ã¤wɤF¤@¤d¦h¸U 2.¦s³f³¡¤À 107¦~©³¦s³f(¦¨¥»)¹F¨â¤d¤K¦Ê¦h¸U,¥«È¹F¥|¤d¤¦Ê¦h¸U. ¹ï¤ñ106¦~©³¦s³f(¦¨¥»)¹F¤E¦Ê¦h¸U,¥«È¹F¤@¤d¤C¦Ê¦h¸U. ¤£ª¾n¸ÑÄÀ¦¨¤½¥q¥«³õ¹w¦ô¹L©ó¼ÖÆ[,ÁÙ¬O³o¬Oªñ´Á½æ±o±¼ªº²£«~,§Ú¬O±q¦n³B·Q°Õ! ´£¨Ñµ¹¤j®a°Ñ¦Ò |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/4/7 ¤U¤È 09:13:38²Ä 271 ½g¦^À³
|
·PÁ¤pÀs¤k¤j¤jªº®ø®§, ¤£¹L§Ú¸É¥R¤@¤U, ¤fªA§ÜÀùÃĤ§«e¤@´Á¤wµ²§ô,¥Ø«e¦b°µ1b/2´Á. («°µ1b¥B1b©M¤§«e1´Á¾¯¶q¦³«½Æ³¡¤À¥O¤H¤£¸Ñ¥B¥¢±æ,¥i¥H¬Ý§Ú¤§«eªº¤å³¹) ¥xÆWÁ{§Éºô¯¸©Î¬ü°êÁ{§Éºô¯¸¸ê®Æ³£ÁÙ¨SÅã¥Ü1b¤w§¹¦¨. Åã¼v¾¯¥[®³¤jÃÄÃÒ¥»¨Ó§Ú¬O¹w¦ô³o¤@¨âÓ¤ën®³¨ì,¤£µM´Nªí¥Ü¹J¨ì§xÃø,¤½¥q¦ô¦~©³¥i¯à¯uªº¹J¨ì§xÃø§a! ¤fªA¯Ø®q¯À¬OÓ¦~¾P¶q¥i¥H¯}¦Ê»õ¬üª÷ªº¶W¯Å¤jÃÄ,¦ü¥G¨C¦¸¦³¤H°Ý¤½¥qÁ`¬O»¡¦~©³¶i¤@´Á,§Æ±æ¤µ¦~¬O¯uªº§a! ¨ä¹ê§Úı±o¦³¤@ÂI«Ü©_©Ç,¤½¥q¬°¤°»ò«æµÛ4/1¤¤¤È´N¤½¥¬¤T¤ëÀ禬.¦³¤°»ò§@±b»Ý¨D¶Ü? |
|
|
·|û¡G¤pÀs¤k10146282 µoªí®É¶¡:2019/4/3 ¤W¤È 11:24:36²Ä 270 ½g¦^À³
|
¦]µØ³Ñ8¶ô¦h¡A¤]³\¥«³õ§ë¸ê¤Hµ¹¥¦¥Ø«eªºµû»ùº¡§Cªº¡C ¬Q¤Ñ¤]¦³ºÃ°Ý©Ò¥H¤]¥´¥h¤½¥q°Ý¤@¤U²£«~¶i«×¦p¦ó¡C¤µ¦~¦³¦ó¶i®i? ¤@¡B ¤fªAÀù¯gÃĤHÅé¤@´Áµ²§ô¡A¨B¤J2-3´Á¡]©t¨àÃÄ¡^ ¤G¡B ¤fªAÀù¯g½Í±ÂÅv±N¦³±ÂÅvª÷ ¤T¡B ¤fªA¯Ø®q¯À¦~©³°Êª«´ú¸Õµ²§ô¶i¤J¤HÅé¤@´Á ¥|¡B Åã¼v¾¯¤@²£«~¶i¤J¬ü°ê¥Ó½Ð¤w¥|¦~¡A¹wp¤µ¦~®³¨ì(®i©ô¥¦°ö«n¤]¬O°e¬ü°ê¥Ó½ÐÃÄÃÒ¥|¦~¤µ¦~®³¨ì) ¤¡B Åã¼v¾¯¤@²£«~¶i¤J¥[®³¤j¥Ó½Ð¤w¤@¦~¡A¦³¥i¯à¤U¥b¦~®³¨ì ¿³Âd®ø®§¨S¦³¤W¥«Âd³ø¾É¨º»ò¦h¡A³£»Ýn¦Û¤v¥´¹q¸Ü¥h¤½¥q¬d¸ß¡A§Æ±æ¦³À°§U¨ì¤j®a |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/3/25 ¤U¤È 09:10:57²Ä 269 ½g¦^À³
|
°·³ì¡]4114¡^¿n·¥¾ã¨Ö°ê¤ºÃÄ·~¡A¤µ¡]25¡^¤é«Å¥¬¥H1.9»õ¤¸¦¬ÁÊ·ç¦w¤jÃļt¡]¥H¤U²ºÙ¡u·ç¦w¡v) 67.73%ªÑÅv¡A¨CªÑÁʶR»ù®æ8.05¤¸¡A·ç¦w±N¦¨¬°°·³ìÂà§ë¸ê¤½¥q¡C °·³ì«ü¥X¡A·ç¦w¬°°·³ì¨ÖÁʪº²Ä¤»¶¡°ê¸êÃļt¡A¥i¥[¦¨©¼¦¹¦b²£«~²Õ¦X»P²£¯à¤¬¸Éªººî®Ä¡C°·³ì¶°¹Î¨´¤µ¤w¦¨¥\¦¬ÁÊ3®a¥~¸ê¦b¥x¤l¼t¡B6®a°ê¸ê»sÃļt¡A«ùÄò±j«lªº¨ÖÁʰʯà¡A2020¦~±N¬O°·³ìªº¨ÖÁʮįqÃzµo¦~¡C ·ç¦w¦¨¥ß©ó¥Á°ê77¦~¡A¬°°ê¤º²Å¦XPIC/S GMP»{ÃÒªºª¾¦W¾Ç¦WÃļt¡AºX¤U¾Ö¦³°ê¤ºÃÄÃÒ¬ù150±i¡A°ê¥~³\¥iÃÒªñ30±i¡A§t¬A¤é¥»»P¤¤°ê¤j³°¥«³õ¡AºX¤U²£«~½u¥]¬A¥Ö½§¬ì¥ÎÃÄ¡B¸zG¹D¨t²Î¥ÎÃÄ¡B¤¤¼Ï¯«¸g¨t²ÎÃĪ«¡B§Ü¥Í¯À»s¾¯¡B¦Û¶O¥«³õ²£«~¡A¥H¤Î¾Ö¦³¦h°ê±M§Qªº¦Û»s°©¬ìÂåÀø¾¹§÷µ¥¡C¦bÀ禬ªí²{¤W¡A±q2016¦Ü2018¦~¥§¡¦~À禬¬ù·s¥x¹ô2.86»õ¤¸¡AÀç¹Béw¡C¡@¡@ °·³ìªí¥Ü¡A·ç¦wºX¤UÃÄÃҨ㦳¬Û·í»ùÈ¡A¦¹¦¸¤J¥D·ç¦w¡A¤DµÛ²´©ó°·³ì¶°¹Î¾ãÅé²£«~¥¬§½¡A·ç¦w¦b¥Ö½§¬ì¡B¤¤¼Ï¯«¸g¨t²Î¡BG¸z¹D¨t²Î»P§Ü¥Í¯À¥ÎÃÄ¡A¥i»P°·³ì¬J¦³²£«~¬Û»²¬Û¦¨¡A¬J¥iµ²¦X²£¯à¡A¥çÅý²£«~²Õ¦X§ó¦h¤¸§¹¾ã¡A¸g¥Ñ¥»¦¸¨ÖÁÊ¡A°·³ì¶°¹Î¤]ÂX¼W°©¬ìÂåÀø¾¹§÷»â°ì¡A¾ã¦X±À®i°·³ì¦Û¨°©¬ì¥ÎÃIJ£«~¦p¦ã´µ¬ü¯S¡BªA¼Ö¾Aµ¥¡A»²¥H°·³ì¶°¹Î©ó¨â©¤¤T¦aªºÀç·~¦æ¾P¸ê·½¡A¬Û«H¯à¤j´T´£¤É¬ÛÃö»â°ìªºÃÄ«~¥«¥e¡A±À¤É¸Ó¼tÀ禬¦¨ªø¡Aµo´§ÂùÃä¦X§@ºî®Ä¡C °·³ì¶°¹Î¦h¦~¨ÓP¤O©ó¾ã¦X°ê¤º¦P·~¸ê·½»P»s³y¯à¶q¡A¤w¦ì©~°ê¤º³Ì±jªº¾P°â¹Î¶¤¤§¦C¡A¥H°ê¤º¥Í§Þ»sÃIJ£·~¥ÃÄòµo®i¬°©À¡A§Æ±æ¾ã¦X±j¤Æ¦P·~¶¡ªº¦X§@»P±M·~¸ê·½¤À¤u¡A¨´¤µ¤w¦¨¥\¦¬ÁÊ3¶¡¥~¸êÃļt¦b¥x¤l¼t¡A¥]¬A«e¼w°ê¦ÊÆF¨ÎÃļt¡B«e¬ü°ê§¨ÓÃļt»P«e·ç¤h¿ÕµØÃļtªº¦b¥x·s¦Ë¤l¼t¡F¨ÖÁÊ»P¤J¥Dªº°ê¸êÃļt«h¥]¬A«H¤¸¤Æ¾Ç»sÃÄ¡BÀu¨}¤Æ¾Ç»sÃÄ¡B°·±d¤Æ¾Ç»sÃÄ¡B¤C¬P¤Æ¾Ç»sÃÄ¡B´º¼w»sÃÄ»P·ç¦w¤jÃļt¡A«ùÄòÁʨ֪º±j«l°Ê¯à»P¨ÖÁʮįq±N¦b2020¦~Ãzµo¡C ªk¤H¹w¦ô¡A¦¹¦¸¤J¥D·ç¦w±N¦³§U°·³ì¶°¹Î¾ãÅ馨ªø¡A°£¤F±j¤Æ²£«~²Õ¦X®Ä¯à¡A¾ã¦X²£«~²£¯à»P¥[³t²£½uµo®i¡A¨Ã©Ý®i¦Ü¡u¥Í°©´À¥Nª«¡vÂå§÷»â°ì¡AÅý¶°¹Î²£«~¥¬§½¨ã¦³§ó¦h¤¸µo®iªÅ¶¡¡A¹F¨ì·¥¤jªº¤¬¸É®Ä¯q¡A¥[³t¦¨ªø«l¹D¡C ¬Ý°_¨Ó¥À¤½¥qÁÙ¦³¿ú...... |
|
|
·|û¡G¤pÀs¤k10146282 µoªí®É¶¡:2019/3/22 ¤U¤È 03:17:03²Ä 268 ½g¦^À³
|
¥Í§Þ±Ú¸s¤w²æÂ÷ªÅÀYÁͶաA¤µ¦~¦³¥i¯à¬O¥Í§Þ¦hÀY¦~¡A¤j®a¦n¦n§â´¤ |
|
|
·|û¡G¤pÀs¤k10146282 µoªí®É¶¡:2019/3/20 ¤U¤È 02:37:17²Ä 267 ½g¦^À³
|
¸g¾ú¥Í§Þ¤jªÅÀY4-5¦~¡A³Ì®tªº±¡ªp´N³o¼Ë¡A³o¤G¦~¤º¤U¿³Âd10-20®a¥Í§Þ¤½¥q¡A¦]µØ³£¤w¸g¼õ¹L¨Ó¤F¡A¨SÔ£»ò¹ï¦]µØ¦³Ô£»ò¨S«H¤ßªº¡C¥i¥H¼µ¹L¨Ó³£«Ü§Q®`ªº¡A¦nÀI¦³¥À¤½¥q°·³ì¬Û®¼¡AÅý¦]µØªÑªFÌ®¼¹L¤U¿³Âd·¼é¦M¾÷¡C |
|
|
·|û¡G¤pÀs¤k10146282 µoªí®É¶¡:2019/3/20 ¤W¤È 10:20:42²Ä 266 ½g¦^À³
|
«Ü¦hÀɳ£§ð¨ì¦~½uªþªñ¡A¦]µØ¬OÄݩ󸨫᪺¡AÀ³¸Ó·|¸ò¤W¡C¤µ¦~À³¸Ó·|¦³¤@¨Ç¦n®ø®§ |
|
|
·|û¡Ginnopharma10146547 µoªí®É¶¡:2019/3/15 ¤U¤È 02:22:26²Ä 265 ½g¦^À³
|
¬ü°ê°ê·|¤s²ø¡]3/ 13¡^³q¹L¤@¶µ«nªºªk®×¡X¡¨Cancer Drug Parity Act¡¨¡]Àù¯gÃĪ«µ¥»ùµ¹¥Iªk¡^.Åý¬ãµo¤fªAÀù¯g·sÃÄ¥¥xªº¦]µØ¥Í§Þ§óÑ¥«³õ»ùÈwww.genetinfo.com/investment/featured/item/24293.html |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/3/11 ¤U¤È 04:35:15²Ä 264 ½g¦^À³
|
×¥¿¤@¤U¤W¤@½gªº»¡ªk, ¤C¬P¤¸¤ë¦¨ªø309%,¦ý¤C¬P2018¤¸¤ëÀ禬¤£¨£±o¥þ¥X³fµ¹¦]µØ,Y2019¦~¼W¥[¥D¦]¬O¦]¬°¥X³fµ¹¦]µØ, ¨º¦]µØÀ禬¼W¥[¶q´N«Ü¥iÆ[, ¨Æ¹ê¤W¤µ¦~¦]µØ¦³¤¤°ê¤j³°¦]¸¿Õ¤Î³o¤@¨âÓ¤ë¥[®³¤jÅã¼v¾¯ÃÄÃÒ¥i¯à±a¨ÓªºÀ禬¦¨ªø, °t¦X¤C¬Pªº®ø®§,¤Q¤À¥O¤H´Á«Ý |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/3/11 ¤U¤È 03:02:12²Ä 263 ½g¦^À³
|
¬Ý¨ì¤@«h¸ò°·³ì¦³Ãöªº¦³½ì·s»D,¨ä¤¤´£¨ì °·³ìºX¤UÃö«Y¥ø·~¥ç¦n®ø®§ÀW¶Ç¡A¤C¬P¤Æ¾Ç2018¦~¥¿¦¡¨ú±oFDA®Ö¥i¡A¦Û2016¦~¨ÖÁʫ᪺¼Æ¦~¯Ñ¯Ð¡A¥h¦~¥þ¦~«×ªºÀ禬¤ñ2017¦~¦¨ªø73%¡A2019¦~¤¸¤ë¬Û¸û¥h¦~¦P´Á§ó¦¨ªø309%¡A¥æ¥X«GÄR¦¨ÁZ¡C º¥ý¦]µØ¥ç¬O¤C¬Pªº¤jªÑªF,Y¤C¬P¶}©lÁÈ¿ú,¦]µØ¤]¨ü¨ä´f. www.fda.gov.tw/TC/siteListContent.aspx?sid=2067&id=3719 ¥t¥~±q¥xÆWFDAºô¯¸¬Ý°ê¤ºÃļt¤¶²Ð,¤C¬P®Ö㪺«~¶µ¬° (1)Gadopentetate Dimeglumine (½Ã¸pÃÄ»s¦r²Ä052457¸¹)¡B (2)Glyceryl Guaiacolate (½Ã¸pÃÄ»s¦r²Ä001181¸¹)¡B (3)Methocarbamol (½Ã¸pÃÄ»s¦r²Ä028259¸¹)¡B (4)Methocarbamol DC 90% (½Ã¸pÃÄ»s¦r²Ä049499¸¹)¡B (5)Sapropterin Dihydrochloride (½Ã³¡ÃÄ»s¦r²Ä059807¸¹) (1)©M(5)³£¸ò¦]µØ²£«~¦³Ãö,¤¸¤ë¤C¬P¦¨ªø309%,Y¬O¥X³fµ¹¦]µØ,³oªí¥Ü³o¨Çì®ÆÃĤ§«á·|¤ÏÀ³¦b¦]µØªºÀ禬. ÁöµM¹ï¦]µØ¦Ó¨¥¤£ºÞ¬OÅã¼v¾¯©Î¦]¸¿Õ¦¨ªø309%³£¤£ºâ¦h, ¦ý³o¥Nªí¤½¥q°£¤F¥N²zªº´¶Àù¨O¥~,¦Û¦æ¶}µoªºÃĤ]²×©ó¦³¨ãÅé¤@ÂIªº¦¨ªG¤F. §Æ±æ¤½¥q¤µ¦~¥i¥H¦¨¬°¥¿¦¡°_¸ªº¤@¦~ |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/3/8 ¤U¤È 11:16:49²Ä 262 ½g¦^À³
|
²Î¤@·s¥x¤¤¡H |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/2/24 ¤W¤È 09:58:35²Ä 261 ½g¦^À³
|
¤£¦n·N«äC¤j, §Úı±o²Ä¥|±ø²Ä¤G¶µ©Ò¨¥¤w²[»\©Ò¦³¸ê²£ªº±ÂÅvÃB«×¤Î¼h¯Å¤F. ¤G¡B±ÂÅv¼h¯Å ¥»³B²zµ{§Ç©Ò©w¸ê²£¤§¨ú±o©Î³B¤À¡A±ÂÅv¸³¨Æªø¦b·s¥x¹ô¤¤d¸U¤¸ ¥H¤º¨M¦æ¡A·s¥x¹ô¤T¤d¸U¤¸¥H¤W¡A¤¤d¸U¤¸¥H¤U¨ÃÀ³¨Æ«á´£³ø¼fp ©eû·|¤Î¸³¨Æ·|°l»{¡A¶W¹L·s¥x¹ô¤¤d¸U¤¸ªÌ¡AÀ³¸g¼fp©eû·|¤Î ¸³¨Æ·|³q¹L«á¿ì²z¡A¥tÀ³¥R¤À¦Ò¶q¦U¿W¥ß¸³¨Æ¤§·N¨£¡A¨Ã±N¨ä¦P·N ©Î¤Ï¹ï¤§©ú½T·N¨£¤Î¤Ï¹ï¤§²z¥Ñ¦C¤J¸³¨Æ·|¬ö¿ý¡C ¤§«e³£¬O½Õ¾ã§ë¸êÃB«×³o¤@¶µ,¤]ı±o¥u¦³³o¶µµw¨î¤ñ¸û»Ýn½Õ¾ã, ¤£¹L¤½¥q²{¦b¤]¨S¿ú¥h¶R¶W¹L§ë¸êÃB«×ªºªF¦è,´N¤£ª¾¹D¸¬Äª¸Ì½æ¤°»òÃÄ. |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/2/24 ¤W¤È 01:56:10²Ä 260 ½g¦^À³
|
¤å¤¤¨S¦³³W½d¨ìªº´N¬O²Ä¥|¤j¶µµL§Î¸ê²£¡A±M§QÅvªº¶R½æ¡]¤À¨É¨üÅv¡^ªº¤À¼h¥DºÞÅv«h¼h¯Å |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/2/23 ¤W¤È 12:16:50²Ä 259 ½g¦^À³
|
¤½¥q¤½¥¬n¶}ªÑªF·|¤F, ¨ä¤¤¤@ÓijÃD¬O 1.×q¥»¤½¥q¡u¨ú±o©Î³B¤À¸ê²£³B²zµ{§Ç¡v®×¡C ¤§«e¤½¥q¤]¦³×q¬O¬°¤F¦¬ÁʤC¬P»sÃĪºªÑÅv, ¥»¨Ó§Ú·Q³o¦¸À³¸Ó¬O¬°¤F³B¤À¤C¬PªºªÑÅv¨ÓÄw¿ú©Ò¥Hn§ó§ï, ¦ý¬Ý¦]µØ¥Í§Þ»sÃĪѥ÷¦³¤½¥q ¨ú±o©Î³B¤À¸ê²£³B²zµ{§Ç www.innopharmax.com.tw/ImgInnoPharmax/20160715163709.pdf ¬Ý¤£¥Xn³B¤À¸ê²£¦³¤°»ò»Ýn§ï±ø¤åªº,Á`¤£·|¤Sn¶R§a! ½Ð¹ï¬ÛÃö±ø¤å¦³¸gÅ窺¤j¤j¤À¨É¤@¤U§a~ |
|
|
·|û¡GWang10140164 µoªí®É¶¡:2019/2/21 ¤U¤È 09:28:09²Ä 258 ½g¦^À³
|
·PÁ mogwai¤j¸Ô²Óªº¸Ñ»¡ |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/2/21 ¤U¤È 07:54:52²Ä 257 ½g¦^À³
|
®Ú¾Ú¬ü°êªºÁp¨¹ºÞ²zªk(Code of Federal Regulation;CFR)²Ä 210 ¤Î²Ä 211 ±ø¤§³W©w¡A ¥ô¦ó¶i¤J¬ü°ê¥«³õªºÃÄ«~(¥]¬Aì®ÆÃÄ)³£¶·¦V¬ü°ê FDA ¥Ó½Ðµù¥U¨Ã»¼¥æ¬ÛÃö¸ê®ÆÀɮסA ¥H«K©ó FDA ¹ïÃĪ«©ÎÃÄ«~¦³¥þ±ªºÁA¸Ñì®ÆÃĸê®Æ¥i»PÃÄ«~¬dÅçµn°O¥Ó½Ð®×¤§¸ê®Æ¤@ ¨ÖÀË°e¡A©Î¥i»¼¥æ¤@¥÷ DMF ÀÉ®×µ¹ FDA¡A¦¹¥Ñ¥Í²£¼t´£¨Ñì®ÆÃĥͲ£¹Lµ{¥]¬A¥Í²£¡B ¥[¤u¡B¥]¸Ë»PÀx¦sªº¸ê®Æ¡A¥H½T©wì®ÆÃĪº¥Í²£¹Lµ{¬O²Å¦X¬ü°ê cGMP ªºn¨D¡A¬O¬°¦¨ «~»s¾¯¨ú±o®Ö㤧°ò¦¡C ¬Ý°_¨Ó¦]µØ¬O°µ¨ì¥H¤U³o¨B FDA ¦¬¨ì DMF ÀɮץӽЪí»P¶·´£¨Ñ¤§¸ê®Æ«á¡A·|¶i¦æªì¨B¼f¬d¡A§PÂ_¨ä¬O§_²Å¦X À³´£¨Ñ¤§®æ¦¡(format followed M4Q:CTD-Quality)»P¤º®eªº³Ì§Cn¨D¡A³B²z®É¶¡¤j¬ù 2-3 ¶g¡C¦pªG¥Ó½Ð¸ê®Æ²Å¦Xn¨D¡AFDA ±N¦^°õ¥Ó½ÐªÌ»¡©ú¤w¦¬¨ì¥Ó½Ð¸ê®Æ¡A¨Ãµ¹¸Ó¥Ó½Ð¸ê®Æ ¤@Ó DMF ÀÉ®×½s¸¹¡C §Úªº²z¸Ñ¬O¦]µØ¤w¸g·Ç³Æ¦n¦]¸¿Õ²£½u¬ÛÃöªº¤å¥ó(²Å¦X¬ü°êcGMPªºn¨D)¥æµ¹FDA,FDAÀ³¸ÓÁÙ¥¼¯uªº¼f¬d¤º®e. ±µ¤U¨Ó´N¬O¬Ý¦]µØ·|¤£·|´£¥X¦]¸¿ÕªºANDA¥Ó½Ð©Î±ÂÅvµ¹¨ä¥L¤½¥q¥Ó½Ð. ¦pªG¦³ªº¸Ü,FDA´N·|¥hª½±µ¼f¬dDMF©Ò´£¨ìªº¤º®e.¬Ù¥h¤@¨Ç¤½¤å©¹ªðªº®É¶¡. §Ú¦Û¤v¬O·Q¦]µØ¦b¥Ó½ÐÅã¼v¾¯ªº¹Lµ{¤¤¾Ç¨ì¤F¤@¨Ç¸gÅç,µn°ODMFÀ³¸Ó¬O¨ä¤¤¤@¼Ë. ÀR«Ý¨ä¥L¦¨ªGÅã²{§a~ |
|
|
·|û¡GWang10140164 µoªí®É¶¡:2019/2/21 ¤W¤È 08:44:40²Ä 256 ½g¦^À³
|
¡i¤½§i¡j¦]µØ¦¬¨ì¬ü°êFDA³qª¾¡A¦]µØ¶}µoªvÀø¨u¨£¯e¯ffଧ¿¯g¤§ì®ÆÃÄÀòãì®ÆÃÄ¥DÀÉ®×(Drug Master File)¤§«Ø¥ß 2019/02/20 18:34 ¤¤¥¡ªÀ ¤¤¥¡ªÀ ¤é¡@¡@´Á¡G2019¦~02¤ë20¤é ¤½¥q¦WºÙ¡G¦]µØ (4172) ¥D¡@¡@¦®¡G¦]µØ¦¬¨ì¬ü°êFDA³qª¾¡A¦]µØ¶}µoªvÀø¨u¨£¯e¯ffଧ¿¯g¤§ì®ÆÃÄSapropterin DihydrochlorideÀòãì®ÆÃÄ¥DÀÉ®×(Drug Master File)¤§«Ø¥ß µo¨¥¤H¡G°q¬°µØ »¡¡@¡@©ú¡G 1.¨Æ¹êµo¥Í¤é:108/02/20 2.¤½¥q¦WºÙ:¦]µØ¥Í§Þ»sÃĪѥ÷¦³¤½¥q 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©ÎÁpÄݤ½¥q):¥»¤½¥q 4.¬Û¤¬«ùªÑ¤ñ¨Ò(Y«e¶µ¬°¥»¤½¥q¡A½Ð¶ñ¤£¾A¥Î):¤£¾A¥Î 5.µo¥Í½t¥Ñ:¥»¤½¥q©ó¥»¤é¦¬¨ì¬ü°êFDA¡]Food and Drug Administration¡F¹«~¤Î ÃĪ«ºÞ²z§½¡^³qª¾¡A¥»¤½¥q¶}µo¨ÑªvÀø¨u¨£¯e¯ffଧ¿¯g¤§ì®ÆÃÄ Sapropterin Dihydrochloride Àòãì®ÆÃÄ¥DÀɮס]Drug Master File¡^ ¤§«Ø¥ß¡ADMFªºÃÒ¸¹¬°: MF033553¡C 6.¦]À³±¹¬I:¦¹¥÷DMF¥i´£¨Ñ¥»¤½¥q¥Ó½Ð¬ü°ê ANDA(Abbreviated New Drug Application) ¨Ï¥Î¡A»²§U¨ä¦bFDA§Þ³N¤å¥ó¼f¬d¡C¦¹±N¦³§Q©ó¥»¤½¥q¸Ó²£«~¦b°ê»Ú·~°È ¤§±À®i¡C 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL¡C ½Ð°Ý³oÓ°T®§ªº·N«ä¬O¥Nªí¤°»ò©O? tw.stock.yahoo.com/news/%E5%85%AC%E5%91%8A-%E5%9B%A0%E8%8F%AF%E6%94%B6%E5%88%B0%E7%BE%8E%E5%9C%8Bfda%E9%80%9A%E7%9F%A5-%E5%9B%A0%E8%8F%AF%E9%96%8B%E7%99%BC%E6%B2%BB%E7%99%82%E7%BD%95%E8%A6%8B%E7%96%BE%E7%97%85%E8%8B%AF%E9%85%AE%E5%B0%BF%E7%97%87%E4%B9%8B%E5%8E%9F%E6%96%99%E8%97%A5%E7%8D%B2%E5%87%86%E5%8E%9F%E6%96%99%E8%97%A5%E4%B8%BB%E6%AA%94%E6%A1%88-drug-master-103430197.html |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/2/20 ¤U¤È 07:02:15²Ä 255 ½g¦^À³
|
pchome.m.megatime.com.tw/news/cat1/20190220/9700004172201902204.html |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/1/15 ¤W¤È 09:33:16²Ä 254 ½g¦^À³
|
¬Ý¤@¤U¤W§«ô¤À¯ÅªºÄw½X¤ÀªR ¤j©ó1000±i 43.32% ---> 42.86% (¬ù322±i, ²Î¤@·s¥x¤¤¥X¤F218±i) 800~1000 ¨SÅÜ 600~800 ¨SÅÜ 400~600 ¨SÅÜ 200~400 6.08%~6.05% ¬ù21±i 100~200 7.76%~7.69% ¬ù49±i 50~100 9.03~9.31 ¼W¥[¬ù196±i ¾ãÓºâ°_¨Ó ¤j©ó50±i 77.44%-->77.16% ´î¤Ö¬ù196±i ©Ò¥H»¡¤j©ó50±i´î¤Öªº¶q»P²Î¤@·s¥x¤¤½æ¥Xªº¶q®t¤£¦h ²³æ¨Ó»¡´N¬O²Î¤@·s¥x¤¤ªºÄw½X³Q¬~±¼¤F. n«ç»ò¸ÑŪ´N¤j®a¦U¦Û²q·Q¤F. |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/1/14 ¤U¤È 10:22:31²Ä 253 ½g¦^À³
|
¬d¬Ý¤F¤@¤U³o¦¸¤Wº¦ªº¸û¤jÄw½Xª¬ªp,±q¤W©P1/7¶}©l¸û¤jªºÄw½X´£¨Ñ©ÎªÌ¬O¶R¤J³£¬O¥H¤T¤j»²¾É¨é°Ó¬°¥D1/9~1/10ÁÙ¹F¨ì50%ªºÄw½X¥æ´«¦Ó¥BÅýªÑ»ù¤Wº¦,±À´ú¨ä¹ê¤T¤j¨é°Ó§@¦h¤ßºA«Ü©ô²±, ¥u¥i±¤1/10, ²Î¤@·s¥x¤¤½æ¥XÄ~«e¤@¤é1/9½æ¥X116±i«á¤S½æ¥X102±i,§¡»ù9.6,¦Ó¥BÀ³¸Ó¬O¤ñ¸û¶°¤¤¦b½L¤¤«á¬q½æ¥Xªº,¦]¬°·í¤é¶}«Ü§Ö´N¯¸¤W10¤¸¦Ó¥B§¡»ù¤]¯¸¤W10¤¸,¬O«á¬q¤~±þ¤U¨Ó¦Ó¥B§¡»ù¶^¯}10¤¸¦¬¦b9.81,¦ý¬O1/10¦¬½L»ù«o§ó§C,§C©ó¦¬½L§¡»ù,³y¦¨1/11¤@¶}½L´N¦n¹³¤j¶^ªº°²¶H,§Î¦¨¤j®a½æªÑ ¤£¹L²Î¤@·s¥x¤¤³o¤@¦~¨Ó¶R¶W§¡»ù16.23(985±i), ¤G¦~¨Ó¶R¶W§¡»ù19.82(2268±i),«ç»ò½æ³£¬O¸y±Ù¦b½æ¤X..........¤£¹L¨Ì¹L¥hªºª¬ªp,²Î¤@·s¥x¤¤¦b½æ±¼ªÑ²¼¹L¤@°}¤l¤S·|¤j¶q¶R¦^ªÑ²¼,(¥u¬O»¡¹L¥hªºª¬ºA³á,§Æ±æ³o¦¸¤]¯à°±½æ¥B¾¨§Ö¶R¦^.........)²¦³ºªÑ»ù³o»ò§C¥B¬Ý°_¨Ó¤T¤j»²¾É¨é°Ó§@¦h¤ßºA«Ü©ô²± ´£¿ô¤@¤U,©ú¤é¶}½L»ù8.31(1/14¥æ©ö§¡»ù) ¤ñ°_¤µ¤é®É¦¬½L»ù7.98°ª«Ü¦h,b¦pªG©e¶R½L¥X²{¤µ¤Ñ¹ê¦¬½L»ùªº¸Ü¤S·|¦³¤@¶}½L´N¦n¹³¤j¶^ªº¿ùı(-3.97%),¤j®a¤£n¤SÀ~¤@¸õ............. ¤U±¼Æ¾Ú¨Ñ°Ñ¦Ò.................. 1/7(¤@) ¶}7.34(»P«e¤é¦¬¤ñ¶}¶^), °ª7.45 ,§C7.3, §¡¦¬7.41(+0.07), ¦¨¥æ¶q50±i 980T¤¸¤j¦ÛÀç ¶RÄw½X 5 ½æÄw½X 6 884T¥É¤s¦ÛÀç ¶RÄw½X 0 ½æÄw½X 0 592T ¤¸´I¦ÛÀç ¶RÄw½X 18 ½æÄw½X 18 1/8(¤G) ¶}7.41(»P«e¤é¦¬¤ñ¶}º¦), °ª8.63 ,§C7.31, §¡¦¬7.97(+0.56), ¦¨¥æ¶q179±i 980T¤¸¤j¦ÛÀç ¶RÄw½X 0 ½æÄw½X 30 884T¥É¤s¦ÛÀç ¶RÄw½X 37 ½æÄw½X 47 592T ¤¸´I¦ÛÀç ¶RÄw½X 30 ½æÄw½X 32 1/9(¤T) ¶} 7.97(»P«e¤é¦¬¤ñ¶}¥), °ª9.3 ,§C8.55, §¡¦¬8.93(+0.96), ¦¨¥æ¶q605±i 980T¤¸¤j¦ÛÀç ¶RÄw½X 134 ½æÄw½X 132 884T¥É¤s¦ÛÀç ¶RÄw½X 84 ½æÄw½X 85 592T ¤¸´I¦ÛÀç ¶RÄw½X 85 ½æÄw½X 85 1/10(¥|) ¶} 8.93(»P«e¤é¦¬¤ñ¶}¶^), °ª10.52 ,§C8.98, §¡¦¬9.81(+0.88), ¦¨¥æ¶q504±i 980T¤¸¤j¦ÛÀç ¶RÄw½X 91 ½æÄw½X 72 884T¥É¤s¦ÛÀç ¶RÄw½X 71 ½æÄw½X 75 592T ¤¸´I¦ÛÀç ¶RÄw½X 98 ½æÄw½X 95 1/11(¤) ¶} 9.81(»P«e¤é¦¬¤ñ¶}º¦), °ª9.39 ,§C8.58, §¡¦¬9.0(-0.81), ¦¨¥æ¶q142±i 980T¤¸¤j¦ÛÀç ¶RÄw½X 42 ½æÄw½X 39 884T¥É¤s¦ÛÀç ¶RÄw½X 17 ½æÄw½X 14 592T ¤¸´I¦ÛÀç ¶RÄw½X 15 ½æÄw½X 15 1/14(¤@) ¶} 9.0(»P«e¤é¦¬¤ñ¶}¶^), °ª9.01 ,§C7.77, §¡¦¬8.31(-0.69), ¦¨¥æ¶q215±i 980T¤¸¤j¦ÛÀç ¶RÄw½X 35 ½æÄw½X 25 884T¥É¤s¦ÛÀç ¶RÄw½X 47 ½æÄw½X 50 592T ¤¸´I¦ÛÀç ¶RÄw½X 31 ½æÄw½X 26 1/9(¤T) ²Î¤@·s¥x¤¤½æ¥X116±i,§¡»ù8.91 ¸s¯qª÷¹©¥ÁÅv½æ¥X90±i,§¡»ù9.01 1/10(¥|) ²Î¤@·s¥x¤¤½æ¥X102±i,§¡»ù9.6 1/14(¤@) ²Î¤@·s¥x¤¤½æ¥X62±i,§¡»ù8.46 ¸s¯qª÷¹©¥ÁÅv¦b2018/11/07¦]µØ¶^¯}10¤¸¥H«á¶R¶W55±i§¡»ù8¤¸, ²Î¤@·s¥x¤¤¦b2018/11/07¦]µØ¶^¯}10¤¸¥H«á¶R¶W41±i§¡»ù8.36¤¸ ¸s¯qª÷¹©¥ÁÅv2018/01/2~2019/1/17¶R¶W308±i§¡»ù14.71¤¸ ²Î¤@·s¥x¤¤2018/01/2~2019/1/17¶R¶W985±i§¡»ù16.23¤¸ |
|
|
·|û¡G·RŪ®Ñ10030395 µoªí®É¶¡:2019/1/14 ¤U¤È 07:20:30²Ä 252 ½g¦^À³
|
¤jªÑªF |
|
|
·|û¡Glee60100110147800 µoªí®É¶¡:2019/1/14 ¤U¤È 12:26:10²Ä 251 ½g¦^À³
|
¦n¤£®e©öª¦¤W10¤¸.¬O¦ó¤H¤S¦A±þ¦]µØ¤F |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/1/7 ¤W¤È 09:16:48²Ä 250 ½g¦^À³
|
µy·Lª¦¤F¤@¤U¥[®³¤j¾Ç¦WÃĪº³W©w,¦p¤U ANDS submission is filed with the Canadian Reference Product with NOC/c status. The submission then undergoes screening. Screening time is 45 days following 10 days of processing days. If the submission is not acceptable for review, a screening deficiency notice may be issued; or, if the submission is acceptable, the submission will enter review. Review target is 180 days. Possible outcomes following review are: NOC (without conditions), a NON, NOD, or an NOC/c-QN. If the outcome of the review is NOC without conditions, the CRP¡¦s NOC/c commitments have been fulfilled during the ANDS review period. If the outcome of the review is an NOC/c- QN, the response must be filed within 30 days (with a review target of 30 days), upon which the NOC with conditions may be granted. ¬Ý°_¨Ó¶i¤J¼f¬d«eÁÙ¦³Screening ©M processingªº®É¶¡ ¦@45+10¤Ñ. ¼f¬dªº¥Ø¼Ð®É¶¡¬O180¤Ñ, Yscreening¨S°ÝÃDªº¸Ü,À³¸Ó¬O¤KӤ륪¥k¦³µ²ªG,©Ò¥HÅã¼v¾¯¥[®³¤j¥Ó½Ð¤j·§¬O¤T¤ë©³¥ª¥k¶}¼ú§a! µ¹¤j®a°Ñ¦Ò¤@¤U. |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2019/1/6 ¤U¤È 04:05:45²Ä 249 ½g¦^À³
|
¥Í§Þ±Ú¸s,¤×¨ä¬O©|µLÀç·~ÃBªº·sÃĶ}µoªÑ,±q2017¦~ªì¯E¹©¯Î±Ò´f®×¶}©l¤£Â_¦a¦V¤U±´©³,¾ã¾ã2¦~¥Í§Þ±Ú¸s¹³©t¨à¤@¯ëµL¤H¥´²z,µL½×ªÑ¥«±j¦æ¯¸¤W¸UÂI17Ó¤ë,¥Í§ÞªÑ¾ãÅéªí²{Á`¤£¦p¤H·N,¥Í§Þ¿³Âd§ó¬O¥´w½ö¥¦b¦a....... ÀHµÛ2019¦~¨ì¨Ó,2018/12/28§P¯E¹©¯Î±Ò´fµL¸o,¹ªÀy¤F¥Í§Þ§Þ³N§ë¸ê, 209/1/4ÑÔ¼w¡]4123¡^°Ñ»P¥Í±±°ò¦]10¸U±iªÑ²¼¨p¶Ò®×¡A¨ú±o¹O6¦¨«ùªÑ¡AªLºaÀA¨Ã±N·s¥ô¸³¨Æªø¡A¥[³t·sÃĪ©¹Ï, ÑÔ¼w§ë¸ê¶R¤U¦]¸êª÷¯Ê¤f¤U¿³Âdªº¥Í±±°ò¦]¯Ç¤JÑÔ¼wºX¤U,¦ü¥G¥i¥H¬Ý¨ì¥Í§Þ±Ú¸sªºÀÆ¥ú¤w³z¥X ¦]µØ¬O·¥¨ä¤Ö¼Æ¥Í§ÞªÑ·í¤¤,ÁÙ¦b¿³Âd´N¤w¸g¨ã¦³À禬¥B¾Ö¦³ÃÄÃÒ³c°â·sÃĪº¤½¥q,2018¦~¦~À禬0.565»õ¦~¼W28.6%, ¥i¬O©~µM¥X²{¦b¿³ÂdªÑ¤¤ªÑ»ù§C©ó¤½¥q²bȪºª¬ªp......... ´Á«Ý2019¦]µØ¯à¨Ì¹w©w¦apµe§¹¦¨·sÃħÞÂà»{ÃҤηsÃĪº¦U°êÃÄÃÒ¥Ó½Ð,±N¤â¤WªºÃÄ«~¦b¥þ²y½æ¥X¥h,¿ú¦¬¶i¨Ó, |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2019/1/4 ¤U¤È 04:30:51²Ä 248 ½g¦^À³
|
¤½¥q¤½¥¬12¤ëÀ禬¤F¦@925.4¸U,´¶Àù¨Oªº·s¾AÀ³¯g±a¨Ó¤F¤@¤d¸U¥ª¥kªºÀ禬. ¥þ¦~À禬5649¸U,¤ñ¥h¦~¼W¥[1¤d¨â¦Ê¦h¸U. Áٺ⤣¿ùªº¶i¨B. ¤£¹L¤½¥qªº¿ú§Ö¿N§¹¤F,¥O¤H´Á«Ý(¤S©È¨ü¶Ë®`)¤½¥q¦p¦óÄw±o¤µ¦~ªºÀç¹B¶O¥Î. Gadopentetate Dimeglumineªº¥[®³¤jÃÄÃÒ¤]§Ö¶}¼ú¤F,¥H¤Uµy·L¸É¥RÅã¼v¾¯ªº¥«³õª¬ªp,¦³»~ªº¸Ü±æ½Ð¤©¥H§ó¥¿. ¥þ²yÅã¼v¾¯¥«³õ¬ù7»õ¬üª÷,¥úGadopentetate Dimeglumine¤j·§´N¦³1»õ¬üª÷ªº¥«³õ. ¬ü°ê¬ù24»õ¥x¹ô,¥[®³¤j¤H¤f¬ù¬ü°êªº1/10,¥«³õ³W¼Ò©Î³\¤]¬O1/10¥ª¥k. ¬ü°ê¤è±,Gadopentetate Dimeglumine¦³Authorized Generic (ì¼t¾Ç¦WÃÄ)¦b¥«³õ³c½æ, ¦]µØY¯uªº¤W¥«»Ýn¸òì¼t¤Îì¼t¾Ç¦WÃÄÄvª§. ¥[®³¤j³¡¤À¥Ø«e¦³Jubilant´£¨Ñªº¾Ç¦WÃÄ(¥[®³¤jFDA¬d¸ß±oª¾),¦]µØÅã¼v¾¯¤W¥««á¤]¶·»P¨äÄvª§. ¥[®³¤j¥«³õ¤ñ¸û¦³·N«äªº¬O¤@¥¹ÃÄ«~¥X²{¾Ç¦WÃÄ,¥L̪º°·«O¨î«×´N·|¥þ±±Ä¥Î¾Ç¦WÃÄ¥H°§C¦¨¥». ©Ò¥H¦]µØ¤@¥¹¦b¥[®³¤j¤W¥«,¥unAvir¥«³õ¯à¤O°÷ªº¸Ü,À³¸Ó¯à¦Y¤U¤£¤Öªº¥«³õ. ¥t¥~¦]µØ°£¤F¤w¤W¥«ªºÅã¼v¾¯²£«~°£¤F¹Å¦h©ú©M¹Å¦hµø°·¥~,¥t¦³¨âÓÅã¼v¾¯«~¶µ¥¿¦b¶}µo. §Ú²q¨ä¤¤¤@Ó¬OGADAVIST (gadobutrol )ªº¾Ç¦WÃÄ,¦¹ÃÄÀ³¸Ó¦b2021¦~±M§Q¨ì´Á. §Æ±æ¦]µØ¤â¸}¥i¥H§Ö¤@ÂI,ºÉ§Ö¦w±ÆÃÄÃÒ¼f¬d. §Ú¬ÝJubilantªº¾Ç¦WÃĤj·§¦b2014¦~´N¤W¥«¤F,è¦n¬OMagnevist±M§Q¹L´Áªº¨º¦~. ¦]µØ¤]¦b·í¦~©e°UAkorn¥Ó½ÐÃÄÃÒ,¦ü¥G¦³ÂI±ß¤F. ·sªº¤@¦~§Æ±æ¦]µØ¯à±q¹L¥h¨V¨ú¸gÅç,°µ¦n¦U¶µÃÄ«~¶}µo¥Ó½ÐÃÄÃÒªº³W¹º. §Æ±æ¤µ¦~¬O°_¸ªº¤@¦~. |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/12/10 ¤U¤È 10:20:38²Ä 247 ½g¦^À³
|
·Q½Ð°Ý¤@¤U¤¸¤j¤K¼w(¥_¥«¤K¼w¸ô)±þ¥XªÑ²¼ªºªB¤Í«Üªø¤[¥H¨Ó§A̳£¬O«e¤@¤Ñ¶R¶i¹j¤@¤Ñ½ß¿ú½æ±¼,¦pªG¬O¶R¿ùªÑ²¼,¤@¦¸´NÁٺ⥿±`,³sÄò°µ´X¦¸´N¤£¤Ó¦n§a!¯àÅý§ĄC¤Ñ¦ÛÄ@½ß¿úªº¶i¥XªÑ²¼¬O¤°»òì¦]©O?·Q¶X¶Ã±þ§CÁÙ¬O¦³¤°»ò°ê¤³®a«ën¦p¦¹ÁVÁϦۤvªº¿ú?¤W¶g4.5¶R30³¹¤µ¤Ñ¤S¥X30±i........ü! |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/12/7 ¤W¤È 10:52:47²Ä 246 ½g¦^À³
|
§Úı±o§ë¸ê·sÃĤ½¥q¹ï¦ÑÁ󤽥q¤U¤@¨B«ç¨«¦p¤£²`¤JÁA¸Ñ?³o¬O«Ü¦MÀIªº! §YµM¦³¤ßn§ë¸ê¡A´N«Øij§ä®É¶¡¨ì¤½¥q¹ê¦a«ô³X¡B¹ê»ÚÁA¸Ñ¡C§_«h¶^¨ì7-8¤¸¡A±zÌ»¡¬ãµo¦h/´Á«Ý³o»ò¦h¦³¥Î¶Ü?ªÑ»ù²{¹ê¬O¸y±Ù¦A¸y±Ù¡A³o¼Ë¦X²z¶Ü? |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/12/7 ¤W¤È 09:50:40²Ä 245 ½g¦^À³
|
§Ú¥»¨Ó¤]¬O«Ü¾á¤ß¦]µØµu´Á¤º·|§â¿ú¿N§¹, ¤£¹L«á¨Ó·Q·Q,¥un°·³ì§â¦]µØ¤C¬PªºªÑÅv¦Y¤U¨Ó,¦]µØÀ³¸ÓÁÙ¥i¥H¤J±b¨â»õ¦h,¥[¤W¥Ø«e²{ª÷¤S¥i¥H¿N¨â¦~. À³¸Ó¥i¥H¼µ¨ìD07001¤G´Á§@§¹. §Ú·QªL¸³À³¸Ó¤£·|§âW¤ß¸gÀç³o»ò¦h¦~ªº¦]µØ©ñ±ó±¼§a~ |
|
|
·|û¡G¦¿¤j¤á10140161 µoªí®É¶¡:2018/12/5 ¤W¤È 09:40:42²Ä 244 ½g¦^À³
|
²{ª÷³Ñ¥b¦~¦h¡A¦A¤£¼W¸ê¡A·çÄ_¥Í±±¨Ò¤l´N¦b²´«e |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/12/4 ¤U¤È 04:56:40²Ä 243 ½g¦^À³
|
§Ú¸É¥R¤@¤UD07001ªº¹êÅ示®e ¥ý«eªºPhase1, °µ2~80mgÁ`¦@10Ó¾¯¶qªº¹êÅç,¦¬®×¥[¤W¹êÅç¼Æ¾Ú¾ã²zªá¤F§Ö¤T¦~ ³o¤@¦¸ªºPhase1, °µ40,60,80,120,160mg¦@5Ó¾¯¶qªº¹êÅç. ¹êÅ窺¬yµ{¨â¦¸Phase1À³¸Ó¬O¤@¼Ëªº,¥[¤W¦]µØ¤w¸g¦³¸gÅç¤F,¦pªG¦¬¯f¤Hªº¹Lµ{¶¶§Qªº¸Ü,§Úı±oPhase1À³¸Ó¤£·|¶W¹L¤@¦~¥b. PhaseII«h®Ú¾ÚPhaseIªºµ²ªG¬D¨âÓ¾¯¶q¨Ó¹êÅç,¬Ý¤º®e¬O¦P®É°µ. ¦pªG¯f¤Hªº©Û¶Ò¶¶§Qªº¸Ü,Á{§É¹êÅç®É¶¡À³¸Ó¤£·|ªá¤Ó¦h. ©Ò¥H¦b¨â¦~¥ª¥k§¹¦¨¤@¤G´Á¬O¥i¥H´Á«Ýªº. ©Ò¥H¦]µØµu¤¤ªø´Á¥i¥H´Á«Ýªº¦³ 1. µu´Á : ´¶Àù¨O·s¾AÀ³¯g±a¨ÓªºÀ禬(11¤ëÀ禬¤w¤½¥¬2¦Ê¦h¸U,¬Ý¬Ý12¤ëÀ禬¬O§_¼W¥[) 2.¤¤´Á : ¤¤°ê¥«³õ¨ä¥L«~¶µªºÃ±¬ù®Ä¯q,Åã¼v¾¯¥[®³¤jÃÄÃÒªº¥Ó½Ðª¬ªp,¤ÎBH4¨Ñ³f¬O§_¼W¥[ 3.ªø´Á : D07001¤G´Á¹êÅ窺µ²ªG ¤µ¤ÑªÑ»ùµy·L¦³¦^¨Ó¤@ÂI,§Æ±æ¤£n¦]¬°11¤ëÀ禬¨S¦³¤j´T¼W¥[¦Ó¤S¶^¤U¨Ó. §Æ±æC¤j±a¨Ó¦]µØªº®ø®§¯à¦b©ú¦~¤W¥b¦~µo»Ã. |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/12/4 ¤U¤È 12:46:29²Ä 242 ½g¦^À³
|
·sÃĪѦ³Ã±¬ùª÷¥i®³ªº¤£¦h¡A¦]µØ¦³ªí¥Ü¤@ºØªÖ©w¡A¦ýªÑɲ¤~7.5¤¸¡A¹ê¦b·Q¤£³q¡A¤½¥qn¥[ªo°Õ!¤£n¤Ó¦Û¨p¤£ÅUªÑªF¦º¬¡§r!? |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/12/3 ¤U¤È 05:13:52²Ä 241 ½g¦^À³
|
¦U¦ì¤j¤j¦n, §Ú§â¤½¥q¥Ø«e©Ò¦³²£«~½uºô¸ô¤W¤Î¤½¥q¤½¥¬ªº²{ªp§@¤@µf¾ã²z,§Æ±æ¹ï¤j®a¦³À°§U D07001 ñ¬ù¼t°Ó Symbio(¦X§@³Æ§Ñ¿ý) PhaseI ¸zG¹DÀù 40 60 80 120 160mg ¤Ó¾¯¶qªº¹êÅç PhaseII ÁxºÞÀù ¹wp2020 ¤¤ë§¹¦¨ (¤§«ephase ¢× 2013/Apr~~ 2016/Mar 2~80mg) ¯ÊÂI:ÁxºÞÀù©t¨àÃĬù¦³9®a¼t°Ó,FDAÁ{§É¹êÅ礤¤G´Á¥H¤W¦³66Ó¹êÅ祿¦b¶i¦æ¤¤(phase3+4 15Ó) ÀuÂI:gemcitabine¥»¨Ó´N¬OªvÀùªº¤jÃÄ,³z¹LªA¥ÎºÞ¹Dªº§ïÅÜ,¦¨¥\²vÀ³¸Ó¤ñ¸û¤j Åã¼v¾¯ ±ÂÅv¼t°Ó Akorn, Avir,¤¤°ê²`¦`ù¯ÀÂåÃÄ,Jubilan(¦X§@³Æ§Ñ¿ý) ¬ü°êÅã¼v¾¯¥«³õ¬ù1»õ¦h¬üª÷ Akorn´£¥XÅã¼v¾¯¾Ç¦WÃĥӽФw¤[¦ý³£¨S½T¤Á®ø®§ Avir³¡¤À¾ÚC¤jªº®ø®§Y¨S³Q°h¦^À³¸Ó¥b¦~¤º·|¦³®ø®§ ȱoª`·Nªº¬O©MAvirñ¬ùªºÅã¼v¾¯¤£¥u¹Å¦h©ú©M¹Å¦hµø°·,©|¥]§t¨ä¥L¨âºØ,¤½¥q«Ü¤Ö´£¨ì ´X¦~«e´¿¸g®³¨ì200¸U¬üª÷ªºÅU°Ý¶O,¦ý®ø®§«Ü¤£©ú½T,¤½¥q¦~³ø¤]¨è·N¤£«ü¦W¬Oþ¤@®a¤½¥q¥Iªº °ê¤º¥«³õÀ³¸Ó¦³¤d¸U¥x¹ôµ¥¯Å¥H¤W BH4 ±ÂÅv¼t°Ó Glenmark Pharmaceuticals Inc,Áú°êBL&H, ¼Ú¨È³q¸ô, ¤¤°ê¤sªF·s®É¥N ¬ü°ê¥«³õ¤è±,¥Ñ©óKuvanì¼t³]¤U¼h¼h±M§Q»Ùê,¥Ø«e¨Ã¨S¦³¥ô¦ó¾Ç¦WÃÄ©ó¬ü°êµo°â ¥«³õ³W¼Ò©M²{ªpC¤j¼gªº«Ü²M·¡´N¤£¥tÂØz¤F ì¼tÃİꤺ¥«³õÀ³¸Ó¤]¦³¤d¸U¥x¹ôµ¥¯Å¥H¤W ´¶Àù¨O ¥h¦~Àç·~ÃB¬ù3¤d¸U,¤µ¦~¼W¥[·s¾AÀ³¯g«á®Ú¾Ú©MSymbio®³³fªºª¬ªp¦ôp¥i¥H¹F4¤d¸U ¨Æ¹ê¤W2015,2016³£¦³¨ì¥|¤d¸U,¬O¥h¦~¤ñ¸û§C N11005 ñ¬ù¼t°Ó Jubilan(¦X§@³Æ§Ñ¿ý),©y©÷ªF¶§¥úªø¦¿ÃÄ·~ ¦Ê¦~ÃøÃD,¥Ø«e¦n¹³¥u¦³OramedªºÃĤñ¸û¦³§Æ±æ(phase2b) ¤@¯ë¦Ó¨¥,¤fªA¯Ø®q¯Àn§JªAªºÃö¥d¦³¨â¹D,²Ä¤@¹D¬O¤£³QG»Ä¯}Ãa,²Ä¤G¹D¬O¯à¶¶§Q³q¹L¸z¾À¨ì¹F¦å²G¤¤,§Ú²q¤½¥q¥Ø«e¬O¥d¦b²Ä¤G¹D C08001 carvedilol CR, ±Ncarvedilol쥻¤@¤Ñ¨â¦¸§ï¦¨¤@¤ÑªA¥Î¤@¦¸ªº½wÄÀª©¥» ¬ü°ê¥«³õ¹w¦ô¶W¹L¨â»õ¬üª÷ »P¬ü°êFDA¶}·|«á½T»{¡A°õ¦æ¥ÍÅé¬Ûµ¥©Ê¸ÕÅç«á§Y¥i¦b¬ü°ê´£¥X·sÃĥӽР¥h¦~ªF¥ÍµØ¤ù±¨ú®ø¥xÆWÃÄÃҥӽЫá,¥Ø«eª¬ªp¤£©ú ¨ä¥LÃÄ ¦]·ü¹ç¡G¦³®É·|´£¨Ñ³¡¤ÀÀ禬,¦³»PStocosil Incñ¬ù ÄáÅ@¸¢¥ÎÃÄ : ¤§«e®³¨ì600¸Uñ¬ùª÷ ©¬ª÷¤ó¯g¥ÎÃÄ ³Ì«á¤½¥q¥h¦~¤W¥b¦~û¤uºÖ§Q¤ä¥X¬ù¨â¤d¤¦Ê¦h¸U,¤µ¦~¤ä¥X¨â¤d¤@¦Ê¦h¸U, ¹ï¤ñû¤u45->33¤H(ÁÙ¥]¬A«e³\Á`),·Pı¤ñ¨Ò¤W¤£¤Ó¹ï, §Ú²q´ú¥i¯à¦³¸ê»º¶O¥Îªº¤ä¥X¦b¸Ì±, ¤U¥b¦~°]³ø¥X¨Ó¤j®a¥i¥HÆ[¹îºÖ§Q¤ä¥X¬O§_¹F¨ì§ó¦nªº®ÄªG. ¤µ¤Ñ¥xªÑ¤jº¦¦ý¤½¥qÁÙ¬O«ù¥,¤j®a¨¯W¤F¤]´Á«Ý¤½¥q¯àºÉ§Ö±a¨Ó¦n®ø®§ |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/12/1 ¤W¤È 11:10:55²Ä 240 ½g¦^À³
|
¥H§ÚÓ¤Hªº²z¸Ñ¬O2018¦~¦]µØ²Õ´¦A³yªº¤jì«h¬OÂÔ·V°È¹ê,¶}µo°Ó¾÷make money ,¥i¥H²z¸Ñªº¬O¦³½Õ¾ã¤½¥q¾ãÓµo®i¤è¦V,¸`¬ù¸g¶O,¿n·¥¶}³Ð·sªº°Ó¾÷, ©Ò¥H, 1. ¤½¥q²{¦æ¤â¤Wªº¶}µo®×,À³¸Ó¦³°µ½Õ¾ã§â¸ê·½¶°¤¤¦b¤w¸g¦³©ú½T¤è¦¡ªº®×¤l,´î¤Ö·s®×¶}µo,¦]¬°¥Í§Þ²£·~¸ò3C²£·~¤£¦P,¨C¶}µo¤@Ó·s®×n§ë¤Jªºªì´Á¸êª÷³£«Ü¤j¦Ó¥B®É¶¡«Üªø,©¹©¹¶}10Ӯפl³£¤£·|¦³¤@Ó¯àÄ~Äò¤U¥h,©Ò¥H¥H¤½¥q¥Ø«eªººn¥Ø¼Ð¬OÁÈ¿ú¨Ó¬Ý,«O¯d·s®×¼È°±¶}µo¶Õ¥²ªí²{¥X¨Óªº´N¬O·|´î¤Ö¥DºÞ¯Åªºû¤u,¦]¬°³q±`¤@¦ì¥DºÞ¯Åû¤u¨¤W³£·|It¤@Ó±Mªø·s®× 2. ¿n·¥¶}³Ð·sªº°Ó¾÷¤WÀ³¸Ó¬O§â·sÃĪº°Ó·~¥Ø¼ÐÂà¦V¤¤°ê¥«³õ,(³oÓ°qÁ`¦b¤W¦¸ªº¦^«H¤¤¦³ªí¹F),¦]¬°²{¦b¥þ¥@¬É¦³¿n·¥¦V¥~´M¨D·sÃĶ}µo¦X§@ªº¬O¤¤°ê¥«³õ,¦Ó¥B¨ã¦³«æ¢©Ê,¦b¥[¤W¤@¯ë¤¤°ê¥ø·~¥I´Ú¤ñ¸û¤j¤è,©Ò¥H«·sÂà¦V¤H¤f¸û¦hªº»Ý¨Dºò«æªº¤¤°ê¥«³õÀ³¸Ó·|¬O¤£¿ùªº¿ï¾Ü, ©Ò¥H¥Ø«eªº¤Hûºë²,¶°¤¤¤õ¤O,¬°¦Û¤v¶}µo¦³§Q¥«³õ(¤×¨ä¬O¤w¸g¶}µo¦nªºÃÄ«~),À³¸Ó¬O¦]µØªº¥Ø¼Ð§a!,Make Money ! ¦b³oÂà°©Åܤj¤Hªº®É´Á,¶Â·t»P°}µh¬O¥²µMªº ¥H¤W¯ÂÄÝÓ¤H¨Ì¤â¤W¸ê®Æªº§PÂ_,¥i¥H¤£¬Ý¤£«H,½Ð¤Å¤Þ°_»~·|©Î¬Oðã½|.......ÁÂÁ |
|
|
·|û¡GÀ³µL©Ò¦í10144738 µoªí®É¶¡:2018/11/30 ¤U¤È 11:57:17²Ä 239 ½g¦^À³
|
¤jªi¬q¤U¶^¡A¥O¤H§x´b ¦³§ë¸ê¥ý¶iÁA¸Ñ¡A¬°¦ó¦~³ø¤¤Åã¥Ü¬ãµo¤Hû¸û¥h¦~¤Ö6¤H(22-->16) page 89 ±q·~¤Hû¦Cªí¤¤¡A¥DºÞ¤Hû¤Ö¤F11¤H(16-->5) ¦]¬°±q«¤j°T®§¬Ý¤£¥X©Ò¥HµM¨Ó |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/11/30 ¤U¤È 11:33:10²Ä 238 ½g¦^À³
|
¤j®a¦n, ¥H¤UÆ[ÂI¯ÂÄÝ¥»¤Hªº±À½×,¸ò¦U¦ì¥ý¶i°Q½×¤@¤U, º¥ý½×¨ì¤½¥q¬°¦óµLªk¦³®ÄªºÅ@¦íªÑ»ù,§Úı±o¦³3¤è±¦]¯À: 1.¤½¥q¬O¿³Âd¤½¥q,¿³Âd¤½¥q´N¤ñ¸û¹³¬O©Ò¿×ªº³Ð·~ªO¤½¥q,¦³·Qªk,§Þ³N,±M§Q,¦ý¬O¸êª÷¤ñ¸û¦Yºò,»Ýn¥Ñ¼W¸ê¦V¥«³õ¶°¸ê,¦]µØ¦b¹L¥hªº´X¦¸¼W¸ê¬O¤£²z·Qªº,´X¥G¬O·Q¨ìþ¼W¨ìþ,´X¥G¨C¦~³£¼W¸ê,¼W¸ê»ù®æ¤@¦¸¤ñ¤@¦¸§C,¤£¹L«o©¿²¤¤F¼W¸ê³£¬O¸òì©lªÑªF¼W¸ê,¨C¦¸¤@¼W°ÑªÑªº¸êªÑªF³£®M¨c,¤[¦Ó¤[¤§´N§Î¦¨¤F¼W¸ê¤£©ö(¥u¯à¤pÃB¼W¸ê),Äw½Xâ¶Ã¤Î¤½¥q¤º³¡²{ª÷¬y¶q¥u¯àÀ³¥I¤½¥q¥»¨¶}¾P, --------->©Ò¥H¤£¥i¯à¦bªÑ»ù³o»ò§Cªº®ÉÔ¶RªÑÅ@½L 2.¤½¥q¹L¥hªº¾P°â©Î±ÂÅv¤è¦V¦ü¥G¦³¨Çªýê,¦b¤µ¦~ªìºÞ²z¼h§ï²Õ¥ÑªL¸³,°qÁ`¾á¥ô«á,µo®i±ÂÅv¤è¦V¶}©lÅÜ°Ê,¶È³o¤@¦~´N¦³¤U¦C·sªºÅܤÆ, 2-1 3/26 »P¤¤°ê¤sªF·s®É¥NÃÄ·~¦³¤½¥qñqÆQ»Ä¨F¤þ³ãËï¤ù¾¯(BH4¡F¦]¸¿Õ)§Þ³N±ÂÅv¦X¬ù®Ñ , 8¤ë¥÷«h¬°»{¦C»P¤sªF·s®É¥NÃÄ·~ªºÃ±¬ùª÷¬ù500¸U,BH4¤S¦C¬°¤¤°ê°ê®a²Ä¤@§å¨u¨£¯e¯fµo¥¬¥Ø¿ý(5/23¤½§i),n¿n·¥¶}µo,è¦n¦]µØ»P¤sªF·s®É¥N´N¬O±ÂÅv»s·Ó,ºâºâ®É¶¡©ú¦~108¦~¤W¥b¦~À³¸Ó´N¯à³°Äò¦¬¨úÅv§Qª÷¤Îì®Æ¾P°âª÷ÃB 2-2 4/17»P©y©÷ªF¶§¥úªø¦¿ÃÄ·~ªÑ¥÷¦³¤½¥qñq¤fªA¯Ø®q¯À¶µ¥Ø±ÂÅv¦X¬ù®Ñ,³o³¡¤À¤]¦b¬°¬r²z¸ÕÅç¥ÎÃÄ°µÃÄ«~¥Í²£¤¤, 2-3 ÄáÅ@¸¢ªÎ¤j¥ÎÃÄ-Dutasteride©ó©ó7¤ë¥÷ñq±ÂÅv¦X¬ù¨Ã¨ú±o±Âª÷600¸U 2-4 7/25»PAvir©Òñq¤§¥[®³¤j²£«~±ÂÅv¦X¬ù¤§¨ä¤¤¤§¤@²£«~¡Ð¹Å¦h©ú¥ç©ó7¤ë©ó¥[®³¤j´£¥XÃÄÃÒ¥Ó½Ð, ¨Ì¾Ú¥[®³¤j¹ï©ó¾Ç¦WÃļf¬dªº³W©w¿ì²z¡A¥¿¦¡´£¥X²£«~ªºANDS°e¥ó¥Ó½Ð ,¦bANDSªº¾Ç¦WÃļf¬d³W©w¤¤,¦pªG45¤Ñ¤º¨S³Q°h¥ó©În¨D¸É¥ó,¼f¬dµ²ªG§YÃÄÃÒ¥i±æ©ó6Ӥ뤺§¹¦¨,³oÓ³¡¤À¸g¹L«e¦¸°e¬ü°ê¥Ó½ÐÃÄÃÒ¤£Â_ªº¸É¥ó«áÁÙªñ3¦~µLµ²ªGªº¸gÅç«á,¥[®³¤jÂåÃĤ½¥qAvir ¦b105/4/14»P¦]µØñ¬ù«á¤£¥i¯à¦b¨S§â´¤¤UÁÙ¦b¤µ¦~7/25¶TµM°e¥ó¥Ó½Ð§a! 2-5 Gemcitabine oralªºÁ{§É¸ÕÅç¤]¤w©ó8¤ë¥÷¶}©l©óºaÁ`¶}©l¦¬¯f¤H,°µ¤HÅé2´Á¸ÕÅç,±µ¨ü¸ÕÅ窺Âå°|¦³¥x¤j,¥_ºa,¦¨Âå,¤¤°êÂåÃÄ,³oÓ³¡¤À¬O¦]µØ³Ì¤jªº¹Ú,¥un§¹¦¨¤G´Á¤HÅé¸ÕÅç¥B²Å¦X¹w´Á,¨ä«áÄò±ÂÅvµo®i±N«D±`¥iÆ[. -------->©Ò¥H²{¦b¤½¥qÀ³¸Ó¬OÀn¤l¦E¤ôª¬ºA,¦³«Ü¦h·sªº¶i®i«oµLªk³ø§i,¨Ì®É¶¡±ÀÂ_,¦b108¦~¤W¥b¦~¥H«e´N·|³°Äòµo¥Í 3.³Ìªñ¤@¦~ªÑ»ù¤@ª½½L¶^,¤j·§´N±qºÞ²z¼h²Õ´Åܰʶ}©l¤£Â_½L¶^ª½¦Ü³Ìªñ¶^´T¥[¤j¥[§Ö,¥i¬O§Ú̱q³øªí¤W¬Ý¨ìªº¬O107/2 ¤ë¶}©l¨ì²{¦b¯à¬Ý¨ìªº¸ê®Æ¥þ³¡¸³ºÊ¥[¤WÃö«Y¤H¥u½æ¥X23±i(2¤ë18±i,6¤ë5±i), «ùªÑ800±i¥H¤Wªº¤jªÑªF(§t¥þ³¡¸³ºÊ),±q¤µ¦~2¤ë¨ì¤W©P,«ùªÑ¼Æ±q3,1800±i¼W¥[¦Ü33,320±i(¦û¦]µØªÑÅv47.6%),¤Ï¦Ó¼W«ù¤F1,520±i,ªÑªF¥Nªí¤H¼Æ14¤H ³Ìªñ¤@Ó¤ë½æ¥XªÑ²¼¤ñ¸û¶°¤¤¤j¶qªº¬O¤¸´IªQ¼w,¤¸¤j¤K¼w,³Í°òÁ`¤½¥q,¥~¸êµ¥µ¥³£½æ¥X¶W¹L¦Ê±i¥H¤W,¤£¹L«ùªÑ800±i¥H¤WªºªÑªF«o¬O¼W¥[«ùªÑªº,¥t¥~,³æ¬Ý¤µ¦~¤@¦~,«ùªÑ¥X²æªº¤]¤ñ¸û¶°¤¤¦b¬Y¨Ç¨é°Ó,ÁÙ¦³´N¬O¤½¥q²Õ´§ï³yªº¨ºÓ®É¶¡ÂI¶}©l,©Ò¥HÓ¤H±À´ú,è¶}©l®É¬O²Õ´§ï³yÂ÷¶}¤½¥qªºû¤u¦]¥Í²P³W¹º½æªÑ,µM«á¬OªÑ»ù¤U¶^§Î¦¨¤S¸I²Õ´Åܰʪº¾á¤ß½æ½Lª½¨ì³Ìªñ¬O¥~¸ê¥[¤W¤¸¤j¤K¼w11/28¤j¥X179±i................. ---------->´Á«Ý¦U¦ìªÑªF¯à¤T«ä...¬JµM§ë¸êªº¬O¿³Âd¥Í§ÞªÑ,µ¥«Ý´N¬O¥²©wªº¹Lµ{, ³Ì«á°J¤ßªº´Á±æ¤½¥qªº»²¾É¨é°Ó¤¸´I¦ÛÀç(592T),¥É¤s¦ÛÀç(884T),¤¸¤j¦ÛÀç(980T),¯àÀ°¦£¦³§Þ¥©ªº¤ä¼µªÑ»ù,¨ä¹êÓ¤H»{¬°,²{®ÉÂI,°£«D¤½¥q¦³¤£¬°¤Hª¾ªº°ÝÃD(¥i¬O¥þÅ鸳ºÊ»PÃö«Y¤H³£¨S½æ¥XÂàÅý½è©ãªÑ²¼,¥Nªí¤½¥q¦³°ÝÃDªº¾÷²v¤Ó§C¤Ó§C¤Ó§C¤F),¥unªÑªF̦³«H¤ß½æªÑ«e¤T«ä,À³¸Ó¥i¥HÅýªÑ»ù¤£n¦h±þ¦h¤F ¥H¤W¯ÂÄÝÓ¤Hªº§PÂ_,¥i¥H¤£¬Ý¤£«H,½Ð¤Å¤Þ°_»~·|©Î¬Oðã½|.......ÁÂÁ |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/11/30 ¤U¤È 06:27:12²Ä 237 ½g¦^À³
|
Hi Jack¤j, §Úı±o¦]µØ¥Ø«eªºª¬ªp¤ñ¥h¦~¤WÂd®×¨ú®ø,³\Á`Â÷¾,C08001³QÂ\¤F¤@¹D®É¦n, ¨º®ÉÔÁÙ¦³20´X¶ô,²{¦bÅܦ¨7¶ô. ¥H´¶Àù¨O¨Ó»¡,¥h¦~¦Vsymbio®³¤Fªñ¤@¤d¤C¦Ê¸Uªº³f,°^ÄmÀ禬¬ù3¤d¸U, ¤µ¦~®³¤Fªñ¨â¤d¨â¦Ê¸Uªº³f,¦ôp°^ÄmÀ禬¬ù¥|¤d¸U. ¥[¤W¤§«e®³¨ìªºÃ±¬ùª÷¸ò¨ä¥LÃÄ«~ªº¦¬¤J,¤µ¦~Á`À禬À³¸Ó¥i¥H¦¨ªøªñ20¢H§a! °qÁ`¤µ¦~ªº³W¹º¹Á¸Õ¤F·s¤è¦V,ȱoÆg½à(¤£¹L¤]Áô§t¤§«eªº¦X¬ù¶i®i¤£¶¶§a!) ¤§«e±ÂÅvµ¹Akorn,Avir,¨ä¹ê¤]³£¦³®³¨ì±ÂÅvª÷,¦ý²£«~ªº¾P°âÁÙ¬O¨S¦³¶i®i. §Æ±æ¤¤°ê¤j³°¥«³õªº¶}©Ý¥i¥H¶¶§Q¤@ÂI. ²{¦b³Ì³Â·Ðªº¤Ï¦Ó¬OD07001,§Ú·Q¤½¥q¦b³oÓ²£«~¤W±¤w¸g¿N¤F10»õ¥H¤W¤F§a! ¶i¤G´Á¤§«á¨C¦~n¿Nªº¿ú´N§ó¦h¤F. µM«á¤½¥q¥Ø«e¤âÀY¤Wªº²{ª÷À³¸Ó³»¦h¦A¿N¤@¦~. ³oªí¥Ü¦pªG¤½¥q¨ä¥L²£«~½u¨S¦³§Ö³t¦¨ªø¨Ó³»³o¥÷¤ä¥X, ©ÎD07001¨S¦³®³¨ì±ÂÅv,¤½¥q´N³Q¢n¦A¥h§ä¿ú, ªÑ»ù³o»ò§C,¼W¸êªº®Ä¯q«Ü®t,¦³ÂI¹³¬O´c©Ê´`Àô. ³o´N¬ÝªL¸³°qÁ`¦p¦óµo´§¥L̪º¤j´¼¼z¨Ó¤Æ¸Ñ³oÓ¦M¾÷. ¦M¾÷¤Æ¸Ñ¤FªÑ»ùÀ³¸Ó·|¦³¤£¿ùªº¶i®i. |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/11/30 ¤W¤È 11:40:50²Ä 236 ½g¦^À³
|
M¤j¤j¡A¨Ì°qÁ`»¡ªk¡A¦]µØÀ³¤£ºâ¤Ó®t¡A¦ý¬°¦ó·|¶^¨ì7¤¸? ¦Ó¤½¥q«oµL¯à¤O§ïµ½ªÑɲ¤Ó§Cªº°ÝÃD¶Ü? 10¤¸¥H¤UªÑɲ¡A³o¹ï¤½¥q§Î¶H¤£¦n§a? |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/11/30 ¤W¤È 09:42:04²Ä 235 ½g¦^À³
|
§Ú±`¤Wfortunengine.com.tw¬Ýªk¤H¶i¥X¤Î¥D¤O¨é°Ó(¤j·§5:00«e·|§ó·s) fugle¤]¥i¥H¬Ý¨ì¥~¸ê¶i¥X©M¨é°Ó¤ÀÂI¶i¥X(¤j·§6:00«e·|§ó·s) ¨âÓºô¯¸ªº¥~¸ê¶i¥X¬O¤@Pªº,À³¸Ó¤£·|¦³¿ù§a.. |
|
|
·|û¡G¨½©ù10147830 µoªí®É¶¡:2018/11/29 ¤U¤È 10:00:58²Ä 234 ½g¦^À³
|
½Ð°Ýn«ç»ò¬d¦]µØªº¥~¸ê¶R½æªº? |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/11/29 ¤W¤È 07:11:15²Ä 233 ½g¦^À³
|
ÁÂÁÂM¤j¤j¤À¨É¡C |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/11/29 ¤W¤È 01:40:19²Ä 232 ½g¦^À³
|
Jack¤j¡A»²¾É¨é°Ó¦©±¼³Í°òÁÙ¦³¤T¶¡¡A¼È®É¤£¥Î¾á¤ß¡C ¤£¹L¬Q¤Ñ¥~¸ê¤S½æ¤F164±i¡]¤j«e¤Ñ20±i¡^¡AªÑ»ù¨S¦A¤j¶^¤£ª¾¬O§_¯à¸ÑÄÀ¬°Äw½X¥u¬O´«¤â¦Ó¤w¡C µS°O3¡A4¦~«e¤é²±¤Î¨ä¥L§ë¸ê¾÷ºc¦³¹ï·í®Éªº¦]µØ±À¦ô¦X²z»ù®æ¡A±q¤@¦Ê¦h¨ì¨â¦Ê¦h³£¦³¡C ¥H¤é²±¦Ó¨¥¡A¥úD07001,C08001,Åã¼v¾¯¤T´ÚÃÄ´NÅý¥L¦ôºâ¦]µØ¦³243¶ôªº»ùÈ¡C ·íµMªÑ»ù¨«¨ì¥Ø«e³oÓª¬ªp¡A§Ú·QÀ³¸Ó¦³«Ü¦h¶}µo¬O¤£¦p¹w´Á©Î¬Æ¦Ü¤w¸g¥¢±Ñ¡A ¦ý¤½¥q±q¤£Ä@³zÅS¥ô¦ó®ø®§¡A¬Ý°_¨Ó¥u¬OÅý§ë¸êªÌ§ó®`©È¦Ó¤£´±«_µM§ë¸ê¡C ¤£¹L´N©ê¦]µØ¤w¸g«Ü¤[ªºªÑªF¡A¤£§K¤´ÃhµÛ¤½¥q¦U¶µ²£«~ªº¶}µo¯à«¤Wy¹Dªº¹Ú·Q¡A³o¼Ë´Á¬ßªÑ»ù¯}¦Ê¤]¤£ºâ¹L¤À§a¡I |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/11/28 ¤U¤È 01:52:59²Ä 231 ½g¦^À³
|
©_©Ç¤F¡A¦]µØ¦b20®É¦³¤H²q·|¨ì¤W¦Ê¡A§ÚÁÙ½|¹L¤½¥q³£¤£Á¿¸Ü¡A¦óW²_¬°¤½¥qÀ°¤â?²{¦b7¤¸¡A°qÁ`¥X±Á¿¸Ü¡A¤j®a¤Ï¦Ó©È¤F?¯u·o¤£À´¤F¡A°ªÂI¤£©È¡A§CÂI©È¤F¶Ü¡H |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/11/27 ¤U¤È 02:17:25²Ä 230 ½g¦^À³
|
Cstang¤j¤j¡A½Ð±Ð³Í°ò°h¥X»²¾É¨÷°Ó¡A²{ÁÙ¦³´X®a»²°Ó¡A°÷¤£°÷²Å¦Xªk³W³W©w¼Æ?Å¥±zPO°qÁ`¤å¡A¦]µØ·Pı¤£¿ù¡A¦ý¬°¦ó¤@ª½¶^?¥B¤½¥q¤Î°qÁ`µL¯à¬°¤O¶Ü? |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/11/26 ¤U¤È 10:49:35²Ä 229 ½g¦^À³
|
C ¤j±z¤@©w¬O¥®É¦³¿N»¡A¤½¥qÄ@·N¦^§A §Ú±H¤F¦n´X¦¸¡]¥h¦~¤]±H¹L«H¡^¤½¥q±q¨Ó¤£Ä@·N²z§Ú¡A §Úªº«H¥ó¦p¤U¡A¤]¤£©È¤½¥qª¾¹D§Ú¬O½Ö¤F ¡§ ¿Ë·Rªº¦]µØ¤½¥q±z¦n, ¤½¥qªÑ»ùªñ´Á¶^¨ì10¤¸¥H¤U, ¤ÀªRÄw½X±À³¬O¥~¸ê½æ¥X150±i(¥ç¦³»¡¬O³Í°òÃã¥h»²¾É¨é°Ó¦Ó½æ¥X), ¦ý¥H¤½¥q¦U¶µ²£«~ªº¶}µo¤Î²{¦³²£«~ªºªº¾P°âª¬ªp,ªÑ»ù¦p¦¹¥O¤Hı±o¤£¥i«äij. ¤½¥q³Ìªñ´X¦~¦æ¨Æ§C½Õ,ÂA¤Ö°Ñ¥[ªk»¡©Î¦V´CÅéÁܬù³X°Ý. ªÑªF¶È¯à´N¦~³ø,¤ë³ø,©u³ø¤Î¤½¥q¤½§G®ø®§¨Ó±ÀºV¤½¥q¦U¶µ²£«~ªº¶i«×. ¦ýÁ`¬O¦³³\¦hµLªkª¾¾åªº³¡¤À. ¯÷´N§Ú©Ò·Q¤F¸Ñªº³¡¤À´£¥XºÃ°Ý,»P¦V¤½¥q´£¥X¤@¨Ç«Ø¨¥,±æ¤½¥q¯à°÷¦^µª. 1.Åã¼v¾¯ªº¶i«× ¤½¥q2014¦~©e°UAkorn¤½¥q¦V¬ü°êFDA´£¥X¾Ç¦WÃÄ¥Ó½Ð,¹L¤F³\¦h¦~©|¥¼¨ú±oÃÄÃÒ. ¥h¦~¦³¼ö¤ßºô¤Í¸ß°Ý±oª¾FDA¦³¦V¤½¥q¬d¼t,¦ý¤§«á´N¨S¦³¤U¤å¤F. ½Ð°ÝAkorn³o¥ó¥Ó½Ð®×¥Ø«eªº¶i«×¬°¦ó?¦³³Q²×¤î¶Ü? ÁöµM¤µ¦~¦³©e°UAvir¦V¥[®³¤j¥Ó½ÐÃÄÃÒ,¦ý¥[®³¤j¥«³õÁÙ¬O¸ò¬ü°ê¥«³õ³W¼Ò¦³¤@¬q®t¶Z. 2.C08001ªºª¬ªp C08001³QªF¥ÍµØ¤ù±¤¤¤îÃÄÃҥӽЫá(³s±a¼vÅT¤½¥qªº¤WÂd®×), ¤½¥q¤µ¦~ªº¦~³ø³ºµM¼g®³¨ìÃÄÃÒ¤F!¦ý±q¹Ãĸpºô¯¸¨S¦³¬d¨ì¦¹ÃÄÃÒ,¤½¥qÀ禬³¡¥÷¤]¨S¬Ý¨ì¦¹¶µªº¦¬¤J. ½Ð°Ý¦¹²£«~¦³®³¨ìÃÄÃÒ¶Ü? Y¨S¦³¦b¬ü°ê©Î¥xÆW¦¹²£«~«áÄòªº³B²z¤è¦¡·|¦p¦ó? Y·Ó¤½¥qÄÀ¥Xªº®ø®§,¦¹ÃĤñì¼tªº½wÄÀ«¬²£«~ªºÃÄ®ÄÁÙ¦n,À³¸Ó¬O«D±`¦³Ävª§¤O. 3.¥h¦~ASCO¦~·|¤¤´¿´£¹LN11005¤µ¦~¦³¾÷·|¶i¤JÁ{§É, µM«á¤µ¦~¦¹²£«~±ÂÅvµ¹¤j³°Ãļt,Å¥¤§«eªL¸³ªº³X½Í¦³´£¨ì¬r²z¥ÎÃÄ¥¿¦b¥Í²£¤¤, ½Ð°ÝN11005¤µ¦~©Îªñ´Á¦³¾÷·|¶i¤JÁ{§É¶Ü? «áÄòÁ{§É·|¥þÅv¥æµ¹ªø¦¿ÃÄ·~¶Ü? 4.BH4³¡¤À, ¤§«e¦³´£¨ì¶i¤J¼Ú¨È³q¸ô(§ó¦ÁÙ¦³¤g¦Õ¨ä¬Æ¦Ü¬ü°ê¤è±ªº³q¸ô®ø®§), ¤µ¦~±ÂÅvµ¹¤sªF·s®É¥NÃÄ·~, ½Ð°Ý¦³¹w¦ôªº¥«³õ³W¼Ò¶Ü? 5.¨ä¹ê«Ü·Qª¾¹D¤½¥q³Ìªñ¨âµ§±ÂÅvª÷ªº²Ó¸`,¦p¦U¶¥¬qªº¨½µ{ª÷©M§Q¯q¤À°tªº¤ñ¨Ò. ¥i¥Hµ¹ªÑªF¤@¨Ç«H¤ß 6.³Ìªñ³Í°ò(©Î¥~¸ê)ªº¥X²æ¦³¤°»ò¯S®íªºì¦]¶Ü? ¥t¥~¦³ÃöÅã¼v¾¯¦³¨â«h¦bºô¸ô¬Ý¨ìªº®ø®§¤£ª¾¯u°°,¤½¥q¥i¥H¥[¥H¼á²M¶Ü? 1.2016¶Ç¥X¦]µØ¨ú®øEstechÅã¼v¾¯ì®Æ¤j³æªº®ø®§,§Ú¦Û¤vÃhºÃ¬O¦]¬°¬ü°êÃÄÃҥӽФ£¶¶©ÒP. 2.¤µ¦~¶Ç¥X¦]µØ»PEnzychemñqÅã¼v¾¯¬°´Á10¦~ªº¤j³æ,±q2020¦~¶}©l, ºô¸ô®ø®§¬O¤½¥q»P¤£¯à³zÅSªº¬ü°ê¤½¥q¥¿¦b½Í,¤£ª¾¦¹¨Æªº¯u°°? ³Ì«á´£¥X¤@¨Ç«Ø¨¥ 1.¤½¥q³Ìªñ¾aµÛ¾ê¸`,¥i¥HÅý¤½¥q¸êª÷ºû«ù§ó¤[ªº®É¶¡, ¦ýY¤½¥qµu®É¶¡¨S¿ìªkÁÈ¿ú,À³¸ÓÁÙ¬On·Q¿ìªk¦V¥~Äw¸ê, ªÑ»ù§CÄw¸ê¤èªk´N§ó¨ü¤F,¤½¥qÀ³¸Ó¦h°Ñ¥[ªk»¡©Î¦V´CÅéÁܬù³X½Í,´£°ª¤½¥qª¾¦W«×, ³o¼Ë¤~·|¦³§ó¦h§ë¸êªÌÄ@·N§ë¸ê,ªÑ»ù°ª¼W¸êÀò±oªº¸êª÷¤~·|°ª. 2.¤½¥qªºOralPas¬O¤@¶µ«D±`¦nªº§Þ³N,·íªì¤½¥q¦³·Q¹L»P¨ä¥LÃļt¦X§@¶Ü? ¤½¥q»P¥~¼t¦X§@¶}µo·sªºª`®gÂà¤fªAÃÄ, ¤½¥q¶}µo¤H¨Æµ¥¦¨¥»´N¥Ñ¥~¼tÅv§Qª÷¤ä¥I,®³¨ìÃÄÃÒ«á,¦]µØÀò¨ú³¡¤Àªº¾P°â§Q¼í. ³o¼Ë¤½¥q¥i¥H¥Î³Ì¤Öªº¦¨¥»Àò¨ú¥i¯àªºÀò§Q,³o¼Ë¤ñ§¹¥þ¦Û¦æ¶}µo·ÀI¤pªº¦h. µS°O´X¦~«e¤é²±´¿¸gµû¤ñ¤½¥qªÑ»ùÀ³¦³¤@¦Ê¦h¶ô,¦h¦~¤§«á¤½¥q¦U¶µ²£«~¦¹®ø©¼ªø Áö¦³´X¶µ²£«~¤£¦p¹w´Á,¦ý¤]¦³¨ú±o¤£¿ù¶i®iªº²£«~, ¦ýªÑ»ù³º¥Ñ90´X¤@¸ô¶^¨ì8¶ô,³o¤£¸Ó¬O¤½¥q¯u¥¿ªº»ùÈ ¼g¤F³o»ò¦h,§Æ±æ¯à±o¨ì¤½¥qªº¦^À³. ¯¬¤½¥q¤@¤Á¶¶§Q,¦U¶µ²£«~¦¤é¶}ªáµ²ªG¡¨ |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/11/26 ¤U¤È 09:43:05²Ä 228 ½g¦^À³
|
¦U¦ì¤j¤j. ¥H¤U¶K¤å¬O¤p§Ì¦b¤µ¤Ñ¦¬½L«á¸ß°Ý¦]µØ°qÁ`¸g²z¹ï¥Ø«e¤½¥qÀç¹B¤Î¤½¥qªÑ»ùªº¬Ýªk,°qÁ`¥ß§Y°µ¥Xªº¦^À³,µ¹¦U¦ì¤j¤j°Ñ¦Ò,¦pªG¦U¦ì¤j¤jÁÙ¦³¨ä¥L°ÝÃD,§Ú·Q¦U¦ìÀ³¸Ón¿Ë¦Û°Ý°Ý¦A°µ¥´ºâ,¤d¸Un¥ý²M·¡¦A¨Ó¨M©w......... Dear c ¥ý¥Í, ¦b¦¹¥ý¦V§Aªí逹«Ü²`ªººp·N, ¹³±z»¡ªº¤@¼Ë¦b³o¤@¦~¤¤¤½¥qµL½×¦b±ÂÅv¤Î¶i«×¤W³£¦³«Ü¦nªº¶i®i, ¦ÓªÑ²¼É]³õ¬°¦ó¦p¦¹¤ÏÀ³¤]¬O§Ú§¹¥þ·Q¤£³qªº¡C±z¤]¥i¥H¥h½T»{¤@¤U§ÚªºªÑ¼Æ¡A §Ú¤µ¦~¤U¥b¦~¼W¥[¤¦Ê¦h±iªºªÑ²¼¡A ¨CªÑ¥§¡»ù¬ù¬°11.5¥ª¥k¦V¤½¥q»{Áʪº¨îªÑ²¼, Y¤½¥qÀç¹B¤£¨}©Î¤£¦p¹w´Á§Ú«ç¥i¯à·|§ë¸ê©O? ¨ì¥Ø«e¥ú³oµ§§ë¸ê§Ú´N·l¥¢¤F±µªñ250¸U¡A §ó¦óªp§Ú´X¥G¬O¤½¥qªºÓ¤H³Ì¤jªÑªF¡A¤w«ùªÑ¶W¹L¤F1500±i, ¾ãÅé·l¥¢§Ú·QÓ¤HªÑªF¬O§Ú·l¥¢³Ì¦h¡C§Ú¤]¨S¥X²æªÑ²¼¦]¬°§Ú¹ï¥¼¨Ó¦³«H¤ß¡A ²£«~½u¶V¨Ó¶VÂ×´I¡A §Ú¤]§â¾ãÓ¤½¥q³W¹º¤Î¦X§@ªº¤è¦V§ï¤j³°ÃÄ¥ø¬°¥D¡A¦p¦¹«K¯à¥[§Ö±ÂÅvªº¸}¨B¡A¥Ø«e¤]¦³¤£¤Ö¼t°Ó¦b¬¢½Í¤¤¡A ¥u¬O»Ýn®É¶¡¡A¦ý§Ú¤£ª¾¬°¦ó³o´Á¶¡¦b¨S¥ô¦ó¤£¨Î©Î¤£¦nªº°T®§¤§¤UªÑ²¼·|¤@ª½¶^¡A ¨Æ¹ê¤W¤§«e¤Q¦h¶ô®É§Ú·Q¸³¨Æªø¤]¬O¶i¤F¤£¤Ö¡A À³¸Ó¤]¬O¦³«H¤ß¡A ¦ýµL½×¦p¦ó¬°¤F¨ÏÉ]³õª¾¹D¦]µØ¯u¥¿ªº¥»½è¡A §Ú·|¥[§Ö±ÂÅv¤Î¤@¨Ç¦X§@®×ªº½Í§P¡A ´Á«Ý¯à¾¨§Öªº¦³¦n®ø®§¦^õXµ¹¦UÓ¤ä«ùªº§ë¸ê¤H, ¦b¦¹P¤W¸U¤Àªººp·N¡C °q¬°µØEva Hao President INNOPHARMAX, INC. 9F., No.22, Lane 478, Rueiguang Rd., Neihu District, Taipei 11492, Taiwan, R.O.C |
|
|
·|û¡Glee60100110147800 µoªí®É¶¡:2018/11/26 ¤U¤È 02:57:39²Ä 227 ½g¦^À³
|
¤µ¤Ñ¤S¦A§|±þ§ë¸ê¤H.n´N»°§Ö±þ¨ì1¤¸.¦A¨Ó¶R |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/11/26 ¤U¤È 02:12:35²Ä 226 ½g¦^À³
|
¬Ý±o¥X¨Ó¥Ø«e½L±ªº¤j¤á¤£¬O¤½¥q³ßÅwªº¡A ¤£µM«ç·|¤jÃÄD07001¶iÁ{§ÉI/II´Á¡A´X¦¸Åv§Qª÷ªº¦¬¤J¤½¥q³£¤£µo·s»D½Z¨Ó¹ªÀy¤@¤U¡C ²{¦b´N¬O¬Ý¤j¤á¼µ¤£¤U¥hÁÙ¬O¤½¥q°ò¥»±©úÅã¦nÂà³o¨â¥ó¨Æþ¤@¥ó¥ýµo¥Í¡C ¥i©Èªº¬OªÑ»ù¶^¦¨³o¼Ë¤]¨S¦³¼É¶W¤j¶q¡AÄw½X¤]¨S¯uªº´«¤â¡C ªL¸³ºNºN§Aªº¨}¤ß¹L·Nªº¥h¶Ü¡H ³Ì«á¤@ÓȱoÆ[¹îªºÂI¡A·Ó¥h¦~©³¤½¥¬ªº´¶Àù¨Oªºp¹º©M¸ò¦Vsymbio®³³fªºª¬ªp¡A ¦~©³«eÀ³¸Ón¦³¤@µ§¤d¸U¤¸¥ª¥kªº¦¬¤J¡A«ø¥Ø¥H«Ý§a¡I |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/11/22 ¤U¤È 10:22:00²Ä 225 ½g¦^À³
|
·Q½Ð°Ý¤@¤U¤µ¤Ñ±þ¥XªÑ²¼ªºªB¤Í,³o¤@©P¨Ó§A̳£¬O«e¤@¤Ñ¶R¶i¹j¤@¤Ñ½ß¿ú½æ±¼,¦pªG¬O¶R¿ùªÑ²¼,¤@¦¸´NÁٺ⥿±`,³sÄò°µ´X¦¸´N¤£¤Ó¦n§a!¯àÅý§ĄC¤Ñ¦ÛÄ@½ß¿úªº¶i¥XªÑ²¼¬O¤°»òì¦]©O? |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/11/15 ¤W¤È 10:53:46²Ä 224 ½g¦^À³
|
§ë¸ê¤H¦Û¤v¤f³Un¦Û¤v±Ï¡A¥u³Û¸Ü¨S¦³¥Î¡A«Øij¹ê»Ú¦æ°Ê¥´¹q¸Ü©Î¿Ë¦Û¨ì¤½¥qÁA¸Ñª¬ªp¡C |
|
|
·|û¡Glee60100110147800 µoªí®É¶¡:2018/11/15 ¤W¤È 10:31:16²Ä 223 ½g¦^À³
|
§|±þ.¦ó®É¤~¬O©³.¤½¥q¥X¨ÓªíºA¤@¤U§a |
|
|
·|û¡Gmollycoddl10146316 µoªí®É¶¡:2018/11/15 ¤W¤È 09:32:39²Ä 222 ½g¦^À³
|
®Ú¥»¨S¦³¬Æ»ò¤j¤á§a ¶^¦¨³o¼Ë¤@ÂI¸Û«H³£¨S¦³ ¨C¦¸¤@ºL´N¦³¤HÅ@¯è ¬OnÄF¦h¤Ö§ë¸êªÌ°Ú |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/11/15 ¤W¤È 12:15:04²Ä 221 ½g¦^À³
|
Hi C¤j¡A §Ú¬Ý¨ìªººô¯¸²Îp¥~¸ê«ùªÑ¬O°§Cªº¡A´N¤£ª¾¹D¬O¤£¬O¸Óºô¯¸²Îp¸ê®Æ¦³»~ |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/11/14 ¤U¤È 11:51:04²Ä 220 ½g¦^À³
|
mogwai¤j, ¬Ý¤F¤@¤U,¤µ¤Ñ½æ100±iªºÀ³¸Ó¬O³Í°òÁ`¤½¥q,Áp·Qªº´N¬O³Í°ò°h¥X»²¾É¨÷°Ó, ȱoÆ[¹îªº¬O¶R¤JªÌ ²Î¤@·s¥x¤¤ ¤µ¶R¶W 24±i, 2¶g¶R¶W 73±i, ¦~¶R¶W 1204±i, 2¦~¶R¶W 2591±i §»»·®ç¶é ¤µ¶R¶W 15±i, 2¶g¶R¶W 40±i, ¦~¶R¶W 506±i, 2¦~¶R¶W 647±i ¸s¯qª÷¹©¥ÁÅv ¤µ¶R¶W 15±i, 2¶g¶R¶W 22±i, ¦~¶R¶W 268±i, 2¦~¶R¶W 606±i ¤¸´I®H¨½ ¤µ¶R¶W 5±i, 2¶g¶R¶W 32±i, ¦~¶R¶W 37±i, ²Î¤@·s¦Ë ¤µ¶R¶W 0±i, 2¶g¶R¶W 50±i, ¦~¶R¶W 132±i, ¤¸¤j¤g«°¥Ã¹ç ¤µ¶R¶W 0±i, 2¶g¶R¶W 0±i, ¦~¶R¶W 232±i, 2¦~¶R¶W 232±i ¤j¤áÁÙ¬O«ùÄò¦b¥[½X,¬Ý¨ÓÀ³¸Ó¬O¨S¦³°ÝÃD, À³¯ÂÄÝÓ®× |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/11/14 ¤U¤È 05:00:51²Ä 219 ½g¦^À³
|
³o´X¤Ñ¦³¥~¸ê¤j¶q½æ¥X«ùªÑ, «e¤Ñ50±i,¤µ¤Ñ½æ¥X100±i, ¦Ü©ó¬°¤°»ò¦b³oӮɶ¡ÂI½æ¥X,ÁÙ·|¤£·|³°Äò¥X²æ,´Á«Ý¼ôª¾±¡ªpªººô¤Í¸ÑÄÀ,§Æ±æ¤£¬O¤°»ò¤£¦nªº®ø®§. |
|
|
·|û¡G·RŪ®Ñ10030395 µoªí®É¶¡:2018/11/13 ¤W¤È 10:43:12²Ä 218 ½g¦^À³
|
ü.................. |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/10/24 ¤W¤È 11:54:45²Ä 217 ½g¦^À³
|
¤p¤p§ó·s¤@ÂI®ø®§, Á{§É©xºô¤µ¤Ñ§ó·s,D07001ªºÁ{§É¹êÅçÂå°|¦h¼W¥[¤¤°êÂåÃĤj¾Çªþ³]Âå°| ²{¦bÁ`¦@¦³¥|¶¡, ¤w¸g¶}©l©Û¶Òªº¦³¥x¤jºaÁ`,ÁÙ¥¼ªº¦³¦¨¤jÂå°|¸ò¤¤°êÂå¤jÂå°|. ¥[ªo§a! |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/9/30 ¤U¤È 12:22:03²Ä 216 ½g¦^À³
|
ÁÂÁÂm¤j¼ö¤ß¸Ñµª¡A¦³4®a§Ú´N¥i¤jÁx¤@¨Ç¤F¡C |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/9/30 ¤W¤È 10:57:03²Ä 215 ½g¦^À³
|
Jack¤j§A¦n, èè¬d¤F¤@¤U,ÁÙ¦³¤¸´I,¤¸¤j,¥É¤s,³Í°ò¥|®a±ÀÂ˨é°Ó, ¥i¥H¨ìÂd¶R¤¤¤ß©xºô¬d¸ß. |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/9/30 ¤W¤È 10:07:12²Ä 214 ½g¦^À³
|
¦U¦ì¤j¤j¦n¡A½Ð±Ð¤@¤U¡A°ê®õºî¦XÃÒ¨÷6/20¡A´I¨¹ÃÒ¨÷9/20°_¤À§OÃã¥ô¿³Âd±ÀÂË°Ó¡A³o¹ï¦]µØ¼vÅT¦p¦ó?(§Ú°O±o«e¦]§»¦]¤@®aÃÒ°ÓÃã¥ô¡A¤£¨¬¤G®a¦Ó¤U)¡A¤£ª¾²{¦b¦]µØ³Ñ´X®a±ÀÂË°Ó¡A§Ú«Ü©Z¤ß³Ì«á·|¤£·|¤£¨¬¤G®a³Q¢¤UÂd/§Ú¦]¤£ÁA¸Ñ¤~½Ð±Ð¦U¦ì¤j¤j¡A¨S¦³¤£¨}¥ø¹Ï¡A½Ð°Ý¦U¦ì¤j¤jÁA¸Ñªº¯à¸Ñ»¡¤@¤U¡A¦]§Ú¬ÝªÑɲ§C¡A¦h¤Ö·Q§ë¸ê¤@ÂI¡AÁÂÁ¦U¦ì¤j¤j¡A·P®¦! |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/9/28 ¤W¤È 08:41:31²Ä 213 ½g¦^À³
|
·PÁ¿³Âd¤j¤jªº¸É¥R, ¸É¤@«h¤K¤ë¤E¸¹ªºÂ»D °·³ì«H¤¸¤Q¦~¥´©³ ¥þ±Ãzµo ¤C¤ë·~ÁZ¹F1.78»õ¥x¹ô ¨ä¤¤´£¨ì ¤sªF·s®É¥NÃÄ·~ªºBH4¥Ø«e¤]¦b¬°§ÞÂà°µ·Ç³Æ¡B©y©÷ªF¶§¥úªø¦¿ÃÄ·~ªºOral insulin¤]¦b¬°¬r²z¸ÕÅç¥ÎÃĥͲ£¤¤ ©Ò¥H¤fªA¯Ø®q¯ÀÀ³¸Ó·|¦b¡§©y©÷ªF¶§¥úªø¦¿ÃÄ·~¡¨¨ó§U¤U§@¹êÅç, §Ú²qY¤½¥q¸êª÷¤£¤Ó¨¬°÷ªº¸Ü©Î³\¥xÆW¤è±´N¤£°µÁ{§É¹êÅç¤F,³oºâ¬O¸`¤äªº¤@Ó¤â¬q. ©y©÷ªF¶§¥úªø¦¿ÃÄ·~¬O¤@®a¦³¦h²£«~½uªº¤½¥q,¤×¨ä¥L̦³«Ø¥ß¾ã®M¦U¦¡¦U¼Ë¯Ø®q¯Àªº²£«~½u, ½Ð¥L̨ó§U¶}µo¬OÓ¤£¿ùªº¿ï¾Ü. ¤fªA¯Ø®q¯À¥Ñ©ó¥«³õ¤j,«Ü¦h¤j¼t«e¤²«áÄ~§ë¤J³\¦hª÷¿ú¤ß¤O³£ój¦Ð¦ÓÂk. ³Ìªñ³Ì¬õªº¬OOramed³o®a¥H¦â¦C¼t°Óªº¤fªA¯Ø®q¯À¨t¦C²£«~,¤w¸g³q¹LFDA Phase IIa ´ú¸Õ,·Ç³Æ¶i¤@¨B´ú¸Õ, ³o®a¼t°Ó¤]¬O§ä¤¤°ê¤j³°ªºÃļtÃÙ§U,Äw¨ì¤F³\¦h¿ú, §Æ±æ¦]µØ¤]¯à¦¤é¸ò¤W. |
|
|
·|û¡G§Ú·R¿³Âd10147193 µoªí®É¶¡:2018/9/11 ¤U¤È 09:58:39²Ä 212 ½g¦^À³
|
¦ì¤j¤j, ¤p§Ì¦³¦V¤½¥q¸ß°Ý¥Ø«e¤½¥qª¬ªp¤Î7,8¤ë¤ÀÀ禬¨Ó·½,¨ä¤¤¦³¦n®ø®§8¤ë¤ÀÀ禬¬O¨Ó¦Û·sªºÃ±¬ù, ÄáÅ@¸¢ªÎ¤j¥ÎÃÄ-Dutasteride©ó7¤ë¥÷ñq±ÂÅv¦X¬ù¡A¨Ã¦¬¨ì²Ä¤@µ§Ã±¬ùª÷¡A8¤ë¥÷«h¬°»{¦C»P¤sªF·s®É¥NÃÄ·~ªºÃ±¬ùª÷(BH4) ¥t¥~,Gemcitabine oralªºÁ{§É¸ÕÅç¤]¤w©ó8¤ë¥÷¶}©l©óºaÁ`¶}©l¦¬¯f¤H ¨ä¦^´_¤j·§¤º®e¦p¤U,¨ä¤¤ÁÙ§t¤½¥q¥Ø«e¸êª÷¹B§@¤Î¥¼¨Ó¸êª÷p¹º, ±z̦n, º¥ýn·PÁªѪF¹ï¦]µØªº¤ä«ù¡A§Ṳ́µ¦~«×ªº½T¦b¹ï¥~Àç¹B©Ý®i¤W¦³©Ò¬ð¯}¡A³°Äò»P¤¤°ê¤sªF·s®É¥NÃÄ·~¤Î©y©÷ªF¶§¥úªø¦¿ÃÄ·~ªÑ¥÷¦³¤½¥q¤À§Oñq¦]¸¿Õ¤Î¤fªA¯Ø®q¯Àªº¤¤°êµ¥¦a°Ï±ÂÅv¦X¬ù¡A¥t¤@ÄáÅ@¸¢ªÎ¤j¥ÎÃÄ-Dutasteride¤]©ó±z¨Ó«H©Ò´£ªº©ó7¤ë¥÷ñq±ÂÅv¦X¬ù¡A¨Ã¦¬¨ì²Ä¤@µ§Ã±¬ùª÷¡A8¤ë¥÷«h¬°»{¦C»P¤sªF·s®É¥NÃÄ·~ªºÃ±¬ùª÷¡A¥B¦bGemcitabine oralªºÁ{§É¸ÕÅç¤]¤w©ó8¤ë¥÷¶}©l©óºaÁ`¶}©l¦¬¯f¤H¡A¨Ã¥B©ó2016¦~»PAvir©Òñq¤§¥[®³¤j²£«~±ÂÅv¦X¬ù¤§¨ä¤¤¤§¤@²£«~¡Ð¹Å¦h©ú¥ç©ó7¤ë©ó¥[®³¤j´£¥XÃÄÃҥӽСC¥Ø«e¤½¥qªº½T¦b¦U¤è±¥þ¤O½Ä¨ë¡A§Æ±æ¯à®i²{§óÀu¨qªºµ²ªGµ¹ªÑªF¡AµMê©ó¥Ø«e¥DºÞ¾÷Ãö¹ï¥Í§Þ¤½¥qµo§G·s»D¤Î«°T¤½§i¤§³W©w¸ûÄY®æ¡A§Ú̱N³\¦h¤½¥q¶i«×µo§G©ó¤½¥qºô¯¸¤W¤Î¥Dn¤½¥qªu²¦p¤U¦Cwww.innopharmax.com/Cht/ugC_News.asp¡A ¤µ¦~«×±N¬O¦]µØ¥þ¤O½Ä¨ëªº¤@¦~¡AªL¸³¨Æªø¸gÀç¥Í§Þ¶°¹Î¥ø·~¶W¹L30¾l¦~¡A´Á«ÝÁ`¸g²z¬O¥H𷪺¨B¥ï±a»â¤½¥q©¹«eÁÚ¶i¡A§ÚÌ·|¦b¾A·íªº®É¾÷µo§G¤½¥qªº¦n®ø®§¡A¤]ÂǦ¹»PªÑªF¥æ¬y¤½¥q¸gÀ礧¦¨ªG¡C ¦¹¥~¡A¥Ñ©ó¥Ø«e¾A¥Î·sª©IFRS¡A±N¤½¥q3Ó¤ë¥H¤W©w¦s¸êª÷¨Ì·|pì«h³W©w¤ÀÃþ¦Ü¡¨«öÅu¾P«á¦¨¥»¿Å¶q¤§ª÷¿Ä¸ê²£-¬y°Ê¡¨¡A¤½¥q¥Ø«eºI¦Ü8¤ë©³¤§¸êª÷³¡¦ì¬ù¬°$1.29»õ¡A¥B¤½¥q¹ï¥¼¨Óªº¸êª÷¥ç¦³³W¹º¡A¨Ã¤]¥þ¤O¦b½Ä¨ë¤Î§G§½¥Dn²£«~¤§±ÂÅv¬¡°Ê¡A§Æ±æ¥iÅý¤½¥qªºªí²{§ó¬°«G²´¡C ¦A¦¸²`²`·PÁªѪF¹ï¦]µØªº¤ä«ù¡A¨Ã¯¬ºÖ±zÌ©¯ºÖ¬üº¡¡A°]·½ºuºu¨Ó¡I |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/9/7 ¤U¤È 04:16:28²Ä 211 ½g¦^À³
|
·PÁÂm¤j¤j¸Ñ»¡¡A¤£¹L¤½¥q¤]«D±`¦³·N«ä¡A³q±`¤@¯ë¤½¥q¦¬¨ìÅv§Qª÷¤@©w¬O¤j¤jªº¤½§i¡A¤½¥q«o¥u¦b§÷³øÃä¤W¤p¤pª`°O¡A¦³¤j¤j¥i¥H¸ò¤½¥q«Øij¶Ü |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/9/7 ¤U¤È 12:36:21²Ä 210 ½g¦^À³
|
¦^c¤j ¦]µØ¤C¤ëÀ禬 «Y¦]»{¦C³n½¦»s¾¯§Þ³N²¾Âà±ÂÅvº´Á¨½µ{¸Oª÷, ¤K¤ëÀ禬 «Y¦]»{¦C»s¾¯§Þ³N±ÂÅvº´Á¨½µ{¸Oª÷ ©h¥B§â³o¨â¥ó±ÂÅv·í°µ¨â¦^¨Æ,¥ý´£»s¾¯§Þ³N±ÂÅvº´Á¨½µ{¸Oª÷ ¦^¨ì¥h¦~©³ªº·s»D ¦]µØ:¤½§i¥»¤½¥q»P¼Ú¨È¦a°Ï³q¸ô¤Î²£«~»s³y°Óñq¨Ñ³f¤Î¦X§@¦X¬ù¡A±Ò°Ê·~°È©Ý®i ¨ä¤¤ 3.¦X¬ù¥Dn±ø´Ú¡G§Ú¤èt³d¥D¦¨¤À¨Ñ³f¤Î»s¾¯§Þ³N²¾Âà¡A³q¸ô¤Î²£«~»s³y°Ót³d §Ú¦Û¤v»{¬°¦¹Åv§Qª÷¬O¦]¬°³oµ§¦X¬ù,³oªí¥Ü¼Ú¨È³oÓ³q¸ô¦³«Ü¤jªº¶i®i, ¥ú»s¾¯Âಾªºº´ÁÅv§Qª÷´N¤¦Ê¦h¸U,§Úı±o¬O¬Û·í¦³¸Û·N, µ¥¨ì²£«~¥i¥H¾P°â,´Á¶¡ªº±ÂÅvÅv§Qª÷©M¾P°âªºÅv§Qª÷À³¸Ó¬Û·í¥iÆ[. (·íµM³oµ§¤]¦³¥i¯à¬O»P¤¤°ê¤sªF·s®É¥NÃÄ·~ñ¬ùªº¨ä¤¤¤@±ø¥ó) ¥t¥~¤C¤ë³n½¦Ån§Þ³NÂಾ§Ú²q¤]¬O¬Yµ§¦X¬ùªº¨ä¤¤¤@±ø¥ó,¤£µM¤½¥q±q¥¼´£°_«o¬ðµM¦³µ§±ÂÅvª÷¹ê¦b©_©Ç£¿ ¦pªG¨S²q¿ùªº¸Ü,³n½¦Ån§Þ³N¬O¹B¥Î©óOralPas¥¥x¤W, ¥Ø«e¤wª¾ªºOralPas²£«~¦³¦]·ü¹ç,D07001,N11005, ¨CÓ³£¦U¦Û¦³±ÂÅvªº¦X¬ù,³oÓ¤ñ¸ûÃø²q,¤£¹L³£¬O¦n¨Æ. ¦]µØ©M¤j®a³£¥[ªo§a!ªÑ»ù¯uªº©e©}¤F |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/9/7 ¤W¤È 10:51:04²Ä 209 ½g¦^À³
|
¦]µØ 107¦~8¤ëÀ禬547¸U¡A²ÖpÀ禬4348¸U¡B¦~¼W14.74% 6¤ë467¸U 7¤ë612¸U 8¤ë547¸U ¤£¿ù³á,¶}©l¦³À禬¤F,¥[ªo |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/9/4 ¤U¤È 10:53:57²Ä 208 ½g¦^À³
|
³Ìªñ½æ³o»ò§C»ùÁÙ½æªÑ²¼ªº¤j¤j,¦h¬O«Ü¤[¨S¦³½æªÑ²¼ªº¤j¤j,«ùªÑ³£¶W¹L¥b¦~¥H¤W¨S½æªÑ¤F,·Q¨Ó¬Oµ¥¤£¦í¤F,¤j¦h½æ1¤Ñ¦Ü¦h 2¤Ñ´N¨S½æ¤F,µ¥¤F³o»ò¤[¦Û¤v±þ§C¨Ó½æ¦n¹³«Ü¥i±¤C!¿³ÂdªÑ²¼¤£´N¬O¿ï©w¼ç¤OªÑ,µM«á´N¬Oµ¥«Ý... ¤Wºô¬d¤F¤@¤U³Ìªñ¦]µØ¤]¨S¦³·s·s»D,©Ò¥H¨S¦³Ãa®ø®§,¨S®ø®§´N¬O¦n®ø®§,¥Nªí¤@¤Á¨Ì¶i«×«e¶i ªÑªF«ùªÑª¬ºA: 1000±i¥H¤W(8/31) 30,490 ¤ñ«e©P (8/24) 29,140 ¦h¥X1,350±i,³oÓÀ³¸Ó¬OÁ`¸g²z«ùªÑ±q800±iÅܦ¨1,350±i(¤º§t·s¼W¸êªº550±i) 800~1000±i (8/24~8/31) ³£¬O 2,830±i 400~800±i (8/24~8/31) ´î¤Ö820±i,´N¬OÁ`¸g²z«ùªÑ¼Æ²¾¦Ü 1000±i¥H¤W¦©°£¶q 200~400±i (8/24~8/31) ´î¤Ö10±i¥H¤U ©Ò¥H«ùªÑ¶q¸û¤jªºªÑªF(¥]¬A¸³ºÊ)Äw½X¨Ã¨S¦³ÃP²æ,¨S¦³½æªÑ¥X³õ ¦]µØ¨îû¤uÅv§Q·sªÑ8/28¿³Âd¶R½æ¨Ã±ÄµL¹êÅéµo¦æ,³oÓ³¡¤À¦b¯S©wªº±ø¥ó¹F¦¨¤§«e(¦p¤WÂd,·sÃÄ®³¨ìÅv§Qª÷.......)û¤u¬O¤£¯à¶R½æªº,¨äªÑ²¼¥Ø«e³£°O¸ü¦bÁ`¸g²zªº«ùªÑ¶q¤º(550±i),¤£±o¶R½æ ¦]µØ¦b¦¹®É¯à¼W¸êû¤u¯S§OªÑ(»{ªÑ«á¤£±o¶R½æ),À³¸Óªí¥Ü¤½¥q¤Îû¤u¹ïªñ´Á¤½¥qÀ³¦³·sªº®i±æ,·sÃĪº¶}µo¤Î³c°âªñ´ÁÀ³¦³·sªº¦¨ÁZ |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/8/23 ¤W¤È 08:57:55²Ä 207 ½g¦^À³
|
¦]µØD07001¤S¦V¹Ãĸp°e¥óÅo!³o¦¸¤£ª¾¹D·|¤£·|¦³¸û¤jªº¶i®i CDE ®×¸¹¡G106IND11260.2 |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/8/17 ¤U¤È 11:45:45²Ä 206 ½g¦^À³
|
¬ü°êÁ{§Éºô¯¸ clinicaltrials.gov/ct2/show/study/NCT03531320?term=Innopharmax&rank=1 ¦]µØ§âD07001ªºRecruitment Status §ï¦¨Recruiting ¥B·s¼W¦aÂI Locations Taiwan National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Chiun Hsu, M.D. Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 11217 Contact: Ming-Huang Chen, M.D. 886-2-28712121 ext 2508 Principal Investigator: Ming-Huang Chen, M.D. ¤§«eRecruitment Status³£¬ONot yet Recruiting. ¤£¹L¥xÆWÁ{§É©xºô¬O¨S¦³·sªº§ó·s. ¦Ü¤Ö½T©w¦¹¹êÅ禳¥¿¦¡©Û¶Ò¯f¤H¤F,ºâ¬O¦³ÂI¶i®i |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/8/16 ¤U¤È 07:10:38²Ä 205 ½g¦^À³
|
7¤ë¥÷Á`¸g²z«ù¦³¦]µØªÑ²¼²b¼W¥[549±i¡AÀ³¸Óû¤u»{ÁʯS©wªÑ³¡¥÷¡A³o¨Ç¬O¦³ÂêªÑªºªÑ²¼¡A¨S¦³¹F¦¨·~ÁZ¬O¤£¯à½æªº¡A¦]µØ¥[ªo |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/8/15 ¤U¤È 10:51:23²Ä 204 ½g¦^À³
|
¦U¦ì¤j¤j,¥H¤U¬O¤½¥q°w¹ï¦]¸¿Õ BH4 ¹ï¥~±ÂÅvªº¾ã²z, ¨Æ¹êµo¥Í¤é:107/03/26 (4172)¦]µØ-¤½§i¥»¤½¥q»P¤¤°ê¤sªF·s®É¥NÃÄ·~¦³¤½¥qñqÆQ»Ä¨F¤þ³ãËï¤ù¾¯(BH4¡F¦]¸¿Õ)§Þ³N±ÂÅv¦X¬ù®Ñ,¥]§tBH4¤§±ÂÅvª÷¤Î¥¼¨ÓBH4ì®ÆÃĨѳf±ø¥ó ¨Æ¹êµo¥Í¤é:106/12/11 (4172)¦]µØ¤½§i¥»¤½¥q»P¼Ú¨È¦a°Ï³q¸ô¤Î²£«~»s³y°Óñq¨Ñ³f¤Î¦X§@¦X¬ù¡A±Ò°Ê·~°È©Ý®i, §Ú¤èt³d¥D¦¨¤À¨Ñ³f¤Î»s¾¯§Þ³N²¾Âà¡A³q¸ô¤Î²£«~»s³y°Ót³d»s¾¯²£«~¥Í²£¡B¬dµn¡B¾P°â [106/07/12] ¥»¤½¥q©ó7/3»PÁú°êBL&H¤½¥qñq¦]¸¿Õ²£«~©óÁú°ê¦a°Ï¤§¨Ñ³f¦X¬ù ¥»¤½¥q©ó7/3»PÁú°êBL&H¤½¥qñq¦]¸¿Õ²£«~©óÁú°ê¦a°Ï¤§¨Ñ³f¦X¬ù¡C ¨Æ¹êµo¥Í¤é:106/03/09 (4172)¦]µØ-¤½§i¥»¤½¥q»P¬ü°êGlenmark Pharmaceuticals Inc.ñq¦]¸¿Õ(BH4)¤§²£«~±ÂÅv¤Î¨Ñ³fNon-binding term sheet, ¦]¸¿Õ(BH4)²£«~¤§¬ü°ê¤Î¥[®³¤j¥«³õ±ÂÅv¤Î¨Ñ³f¥Dn¥æ©ö±ø¥ó BH4(¦]¸¿Õ): ¥Ø«e BioMarin Pharmaceuticalªº Kuvan®¡A¬O°ß¤@°w¹ï»²酶¦X¦¨¯Ê¥F«¬fଧ¿¯g¡A¥H¤ÎÂù²B³ãËïÁÙì酶¯Ê¥Ffଧ¿¯g±wªÌªºªvÀøÃĪ«¡A¨Ã¦Û 2008 ¦~°_¤w¸g¦b¼Ú¬ü¥Dn¥«³õ®Öã¤W¥«¡A¨Ã¦b 2015 ¦~³Ð³y¬ù 2.6 »õ¬ü¤¸ªº¾P°âÃB¡C¥Ñ©ó¦¹²£«~q»ù¬Û·í©ù¶Q¡A¨CÁû100mg ¬°·s¥x¹ô 900 ¤¸¥ª¥k¡A¹ï¯f±w¨Ó»¡¥²¶·²×¨¨C¤é¨ÓªA¥Î¦¹ÃÄ¡A¬O¤@µ§¬Û·í¤jªº¸gÀÙt¾á¡C¤S¥Ñ©óì¼t³]¸m³\¦h±M§Q»Ùê¡A¦]¦¹³y¦¨¥«³õ¥Ñì¼t¹è¥eªº±¡§Î¡C¦ý¬O¦nªº¨Æ¬OKuvanªº¥«³õ¿W¦û´ÁÀ³¸Ó¬O¦b2017¦~´NºI¤î¤F, ©Ò¥H¤½¥q±q2017¦~ªì´N¶}©l¦V¥~±ÂÅv¦]«D¿Õ,¨Ã¥B¹ï¤¤°ê¤Î¤g¦Õ¨ä³£¦³¶}©l¤p¶q¥X³f,¥H®É¶¡¤W¨Ó¬ÝÀ³¸Ó¤µ¦~©³·|¦³¤@¨Ç¦n®ø®§¦^õX§a! ¥t¥~¦bÄw½X±¤W¨Ó¬Ý: ³Ìªñ¥X³f¤ñ¸û¦hªºÀ³¸Ó¬O ¤¸´IªQ¼w¤j¤j ¨C¤Ñ¥XÓ´X±i¤£¥ð®§,±q7/3~8/15¥X¤F93±i,³ÌªñªÑ»ù³o»ò§C°g,¥Xªº¦³¨Ç©e©}§a! ¤§«e¥X³f³Ì¦hªº ¤é²±¤g«° ¤¸¤j¤¯·R³Ìªñ³£¨S¦b¥X³f¤F,³ÌªñˬO§»»·®ç¶é §â¤§«e¥X³fªº¼Æ¶q¤S¥þ³¡³£¸É¦^¨Ó¤F..........©_ |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/8/14 ¤W¤È 12:27:00²Ä 203 ½g¦^À³
|
¦]µØ¤W¥b¦~°]³ø¥XÄl¤F,¥H¤UºKn 1.Á«·l0.67¤¸(106¦~Á«·l1.32¤¸) 2.¤ò§Q²v¸û¥h¦~¦P´Á¤U°(46.9%->34.2%), ¤£¹L¤£ª¾¹D²£«~²Õ¦X,Ãø¥Hµû¦ô¬O§_¯uªº²£«~¤ò§Q²v¤U° 3.Á«·l´î¤Ö¥Dn¬O¦]¬°Àç·~¶O¥Î´î¤Ö ´î¤Ö¤ñ¸û¦hªº¦³³Ò°È¶O,©e¥~¬ãµo¶O¥Î,¬ãµo§÷®Æ¶O ¼W¥[ªº¬OÁ{§É¸ÕÅç¶O 4.û¤u¤H¼Æ´î¤Ö¦Ü33¤H,¤§«eªL¸³¦³´£¨ì¦]µØ«¾ã«á±N«·s¥Xµo¡A¤ä¥X±N¼Á¸`,¤£ª¾¹D´î¤Ö¤Fþ¤@¤è±ªº¤H¤O? 5.¤C¬P»sÃÄ«ùÄòÁ«·l 6.Àç·~¦¬¤J¦³¤@µ§¨ä¥L¦X¬ù¦¬¤J131¤d¤¸,¤£ª¾¹D¬Oþ¤@µ§¦X¬ùªº¦¬¤J ¥t¥~,µo²{³\ªø¤s¦¨¥ß¤F¤@®a¤W®p¥Íª«¬ì§Þ¦³¤½¥q,§Æ±æ¹ï¦]µØ¤£·|¦³¤£¨}¼vÅT. ¦b¤ä¥X¾ê¸`«á,§Ú·Q¥unÅã¼v¾¯©ÎBH4¥ô¤@¶}©l·Óì¥ýpµe¨«,¤½¥qÀ³¸Ó´N¯à¶}©lÀò§Q. ¥[ªo§a~ |
|
|
·|û¡G§Ú·R¿³Âd10147193 µoªí®É¶¡:2018/8/9 ¤W¤È 09:48:31²Ä 202 ½g¦^À³
|
[2018/07/25] ¥»¤½¥q¤w¦V¥[®³¤j¹«~½Ã¥Í³¡´£¥X¾Ç¦WÃÄGadopentetate Dimeglumineª`®g¾¯¤W¥«¼f¬d¥Ó½Ð¡C ¢iµo¥Í½t¥Ñ¡G ¥»¤½¥q¤w§¹¦¨MRIÅã¼v¾¯Gadopentetate Dimeglumineª`®g¾¯10ml, 15ml, 20ml¾Ç¦WÃIJ£«~¶}µo¡A¨Ã¥Ñ¥[®³¤j¸g¾P-Avir Pharma¨Ì¾Ú¥[®³¤j¹ï©ó¾Ç¦WÃļf¬dªº³W©w¿ì²z¡A¥¿¦¡´£¥X²£«~ªºANDS°e¥ó¥Ó½Ð¡A¸Ó²£«~¹ï·Óì¼tÃĬ°Bayer(«ô¦Õ)ªºMagnevist¡C |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/8/7 ¤U¤È 01:35:46²Ä 201 ½g¦^À³
|
¤½¥q¤½§G¤C¤ëÀ禬612¸U, ¨ä¤¤¦³¤@¦æ³Æµù³Æµù:«Y¦]»{¦C³n½¦»s¾¯§Þ³N²¾Âà±ÂÅvº´Á¨½µ{¸Oª÷ °O±o¥h¦~©³AAPS ¦]µØ¦³¤@¶µ¾À³ø¤½§G Poster Abstract T3036 - Development and Optimization of Softgel Capsule Containing Hydrophilic Fill Formulation µM«á¤½¥q¤£ª¾¹D¤°»ò®ÉÔ¸ò¨ä¥L¤½¥qñ¤F±ÂÅv¦X¬ù . Y°²³]612¸U¤j³¡¤À³£¬O¦¹±ÂÅvªºÀò§Q,¨º¥i¥H±À¦ô¨½µ{ª÷¬ù20¸U¬üª÷. ¦AÀH«K§ä¤@®a°ê¤º¤½¥qÃþ¦üªº®×¨Ò ¡]2018¦~1¤ë16¤é¥x¥_°T¡^·sÃĬãµo¤½¥q¶¶¤ÑÂåÃĥͧޡ]¥H¤U²ºÙ¶¶ÃÄ¡A¥N¸¹6535¡^¦A«×¾ð¥ß¥xÆW·sÃĬãµo²£·~¨½µ{¸O¡C¶¶ÃÄ©ó¥xÆW®É¶¡1¤ë16¤é¤W¤È»P¬ü°ê°Êª«ÃÄ«~¶}µo¤½¥qSkyline Vet Pharma (¥H¤U²ºÙSVP)¡Añ¸pªø®Ä¤îµh·sÃĪº°Êª«ÃıÂÅv¨óij(§YCS011±M®×)¡C¶¶ÃıN¨ú±oSVP±ÂÅvª÷¡A¡]¥]¬Aº´Á¤§Ã±¬ùª÷20¸U¬ü¤¸¡A»P«áÄò¤§¨½µ{¸O´Ú¡AÁ`ª÷ÃB¥i¹F800¸U¬ü¤¸¡^¡A¤W¥««á¡A«h¥i«ö¾P°âÃB¤ñ¨Ò¨ú±oÅv§Qª÷¡C Y¦¹¦X¬ùÁ`ÃB¬O¦Ê¸U¬üª÷µ¥¯Åªº®×¤l,¹ï¤ñ¤½¥q¦~À禬ºâ¬O«Ü¤j¤@µ§¥Í·N,¤£ª¾¹D¬°¦ó¤£µo·s»D¥X¨Ó. ¹ï¤ñ¨ä¥L¤½¥q¬O¤£§[§â¦n®ø®§¤½§G,¦]µØÁ`¬O§C½Õ¤S§C½Õ. |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/7/23 ¤U¤È 10:04:11²Ä 200 ½g¦^À³
|
C¤j¨ä¹ê§Ú·Q»¡ªº¬O¥H¥Ø«eªÑ»ù¥[¤W¥i³B¤À»{ªÑªº±ø¥ó¦p¦¹ÄYV¡A û¤uªº»{ªÑ·NÄ@À³¸Ó¨S¨º»ò°ª¡A §Ú¤Ï¦Óı±o¤½¥qÀ³¸Ó¦bú´Ú¤é«e©Ô¤@¤UªÑ»ù´£°ªû¤u»{ªÑ·NÄ@¡A ¤£µM¹ê¦b¦³ÂIÃø¬Ý. |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/7/23 ¤U¤È 09:39:31²Ä 199 ½g¦^À³
|
¤j¤j¡A§Ú·|³o¼Ë°Ýªºì¦]¬O³Ìªñ¯}©³ªºì¦]¨Ã¤£¬O¦³Ãa®ø®§¡A¦Ó¬Oû¤u½æ¤â¤WªºªÑ²¼¥hú¨îªÑªÑ´Ú¡A©Ò¥Hú´Úµ²§ô½æÀ£À³¸Ó´Nµ²§ô¤F¡A¤d¸U¤£n¦A¸ò½æªÑ¤F |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/7/23 ¤U¤È 09:25:30²Ä 198 ½g¦^À³
|
¤å¤£¹ïÃD¦^À³¤@¤U, ®Ú¾Ú¤µ¦~ªº¦~³ø²Ä58¶ ¬J±o±ø¥ó (¤@)À³©ó¹ê»Úµo¦æ«á¡A¥¼¨Ó 7 ¦~¤º¹F¦¨¤U¦C¦U¶µÁZ®Ä«ü¼Ð: 1.¥þ¦~Àç·~ÃB¹F·s¥x¹ô¶L»õ³°¥a¸U¤¸¡A¥B¬Õ¾l¶W¹L·s¥x¹ô³ü¥a¸U ¤¸¡C 2.¤½¥q¦b¸³¨Æ·|®Ö¥i¤§¤W¥«©Î¤WÂd±ø¥ó¤U¡A¹F¦¨¤W¥«©Î¤WÂd¦¨¥\¡C 3.¤½¥q¤§ OralPASR §Þ³N»P¨ä¥L°ê¤º¥~¤½¥q¤Î¨ä¤l¤½¥q(¤½¥q¥«È ¦Ü¤Ö¬°¬üª÷¤T»õ¤¸¥H¤W¤§¤½¥q)ñ©w§Þ³N¶}µo¦X¬ù©Î¨ä¥L¸g¸³ ¨Æ·|¦P·N¤§¦X§@¤è¦¡¡C (¤G)¬J±o®ÉÂI¤Î¬J±o¤ñ¨Ò: 1.·íÁZ®Ä«ü¼Ð²Ä 1-3 ¶µ¤§¥ô¦ó¤@¶µ±ø¥ó¹F¦¨®É¡A¬J±o 50%¤§ªÑ¼Æ¡C 2.·íÁZ®Ä«ü¼Ð²Ä 1-2 ¶µ¤§¥ô¦ó¤@¶µ±ø¥ó»P²Ä 3 ¶µ±ø¥ó§¡¹F¦¨®É¡A ¬J±o 100%¤§ªÑ¼Æ¡C ¦~³ø¤U±ÁÙ¦³»¡©ú,¦b¹F¨ì¬J±o±ø¥ó«e,ªÑ²¼¬O±Ä«H°U¤è¦¡,·Pıû¤u¨Ã¤£®e©ö¦bµu´Á¶¡¦³³B¤Àªº¾÷·|. ¥ç§Y´Nºâ·Q½æªѮ³·sªÑ¤]n§â¸êª÷¥d«Üªø¤@¬q®É¶¡ , ³o¼Ëªºª¬ªp¤U§Úı±o°ò·Ç¤é¨ì¹F«áªÑ»ùÀ³¸Ó´N¤£·|¨ü¤Ó¤j¼vÅT. ¤£¹L¦]µØ³Ìªñ¦³¨C³{¼W¸ê¥²¯}©³ªº¶Ç²Î,¤]ÆZ¥O¤HµL¨¥ªº. |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/7/22 ¤U¤È 06:44:40²Ä 197 ½g¦^À³
|
½Ð°Ý¦U¦ì¤j¤j¡A¦³¤j¤jª¾¹D³o¦¸û¤u¯S©w¼W¸ê»{ªÑªº³Ì«áú´Ú¤é´Á¶Ü¡H |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/7/9 ¤W¤È 10:13:33²Ä 196 ½g¦^À³
|
¤½¥q¨Mij7/19¬°¤½¥q²Ä¤@¦¸¨îû¤uÅv§Q·sªÑªº¼W¸ê°ò·Ç¤é,µo¦æ»ù®æ¬°10¤¸. ¥ç§Yû¤u¥i¥H¥Î10¤¸»{ªÑ,¤½¥q§l¦¬»ù®t¦ýnºâ¦b¶O¥Î¤ä¥X¤W(¥i¥H¤À¦n´X¦~Åu´£) ¹ï¤½¥q¦Ó¨¥,À£¤@¤UªÑ»ù¥i¥H°§C¦¨¥», ¹ïû¤u¦Ó¨¥,»ù®t¤£°÷¤j§l¤Þ¤O¤£°÷, §Æ±æ³ÌªñªÑ»ù¬O³Q³o¥ó¨Æ±¡¼vÅT¦Ó¤£¬O¦³¤°»ò¤£¦nªº®ø®§. ¥t¥~¤½¥qD07001ªºÁ{§É¹êÅç¼W¥[¥x¤j©M¦¨¤j¬°¸ÕÅçÂå°|,¬Ý°_¨Ó¬O¦³¦b°Ê°_¨Ó,§Æ±æ¦¤é¦¬¨ì¯f¤HºÉ§Ö§¹¦¨¹êÅç |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/7/3 ¤W¤È 08:38:33²Ä 195 ½g¦^À³
|
¬Ý¤F¤@¤U®×¸¹¡A»PD07001ªº®×¸¹¥u®t.1¡AÀ³¸Ó¬°¨äªº«áÄòµo®i¦Ó¤w¡A¥Õ¶}¤ß¤F |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/7/2 ¤U¤È 08:54:21²Ä 194 ½g¦^À³
|
¤µ¤Ñ¦]µØ¦³¤@¥ó¥Ó½Ð®×³q¹L³Æ¬d TFDA ¤å¸¹¡G1076023780 CDE ®×¸¹¡G106IND11260.1 ¬Ý°_¨Ó¦³ÂI¹³Á{§É¹êÅç? Ãø¹D¬O¤d©I¸U³êªº¤fªA¯Ø®q¯ÀÁ{§É¹êÅç³q¹L¼f¬d¶Ü? |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/7/2 ¤W¤È 09:14:59²Ä 193 ½g¦^À³
|
·PÁ§ڷR¿³Âd¤j¤jªº»¡©ú, èè¬d¤F¤@¤UÄw½Xª¬ªp,¨º¦ì¤jªÑªF³Ìªñ½æ¤F¥|¦Ê¦h±i,¤â¤WÀ³¸Ó³Ñ¤U¤T¦Ê±i¥ª¥k(¦pªG¨S²q¿ù¤Hªº¸Ü), ¥L³o¼Ë½æ,¤½¥qÀ³¸Ó¤£·|©Ô°ªªÑ»ùÅý¥L½æ§a! ¥t¥~´N¦~³ø¨Ó¬Ý, ¤½¥q¤µ¦~¦Vsymbio¤w¸g¶i¤Fªñ¨â¤d¨â¦Ê¸Uªº³f,¥h¦~¬Oªñ¤@¤d¤C¦Ê¸U(§Ú¬Ýªñ¦~¨Ó³£¬O²Ä¤@©u´N·|¶i§¹³f), ªí¥Ü¤½¥q¹ï´¶Àù¨OªºÀ禬¬O¹w´Á¼W¥[ªº. ¤½¥q¥h¦~¤]¦³¦VÁú°êªºEnzychem¤½¥q¶i³f,Enzychem´N¬O¤§«e¦³ÓÅã¼v¾¯¶W¤j³æªº·s»D´£¨ìªº¤½¥q, §Ú·Q¨º«h·s»D©Î³\¬O¯uªº,¦ý¬O¯à¤£¯à¦¨¥ßn¬Ý¦]µØ¥»¤WÅã¼v¾¯¦b¬ü°êªºÃÄÃÒ¶i«×. ¦A¦^¨ì¦~³ø,¤½¥qªñ´X¦~¨Ó¦ü¥G¦]¸¿Õ©MÅã¼v¾¯³£¨S¦b°ê¤º¥X³f, ¾Ú¦~³ø©Ò»¡,°ê¤ºÅã¼v¾¯¬ù¦³40¸U¬üª÷ªº¥«³õ¥i¥HÄvª§. ¤â¤W¬d¥XKuvan¦b101~103¦~«×°ê¤ºªº¾P°âÃB¬O2¤d¦h¸U¨ì¥|¤d¦h¸U, §Ú·Q¦]µØÁÙ¬On¿n·¥±oª§¨ú°ê¤º¥«³õ,³o¼Ë¤]¤ñ¸û®e©ö±À¼s¨ì°ê¥~ªº¥«³õ. |
|
|
·|û¡G§Ú·R¿³Âd10147193 µoªí®É¶¡:2018/7/1 ¤U¤È 03:26:53²Ä 192 ½g¦^À³
|
³Ìªñ¤½¥qªÑ»ù§C°g,¬Ý¨Ó¦³´XÓ«ü¼Ð¥i°Ñ¦Ò: ¤@¬O,¤½¥q¤Ó¤[¨S¦³¥i¥H¿E°_ªÑ»ù®öªáªº®ø®§,´Nºâ¬O¤§«e¸ò¤¤°êÃļtñ¤F¨âÓ¦X¬ù(BH4§ÞÂà¾P°â¤Î¤fªA¯Ø®q¯À§ÞÂà¶}µo),¤]¦]¬°³o¤£¬Oµu®É¶¡´N¯à¨£¨ìÀ禬ªº¶µ¥Ø©Ò¥HªÑ²¼¦¨¥æ¶q¤@ª½³£¤£¦n ¤G¬O,¦b¤é²±¤g«°ªº³æ¤@ªÑªF±q5¤ë¥÷¶}©l´N©¹¥«³õ¤W©ßÄw½X,¤£ª¾¹D¦b·Q¤°»ò? ¦¨¥æ¶q§C®É©ßªÑ¥«½æ¤£¨ì¦n»ù¿úªº,¤£¹L®É¶¡¤Wªº¥©¦X±q5¤ëªì¨ì5¤ë27¸¹³£½æ9±i¥H¤U(²Å¦Xªk³W),5/28¸¹¥H«á´N½æ¦b9±i¥H¤W¤F.........³o¼ËÀ³¸Ó¤£Ãø±À´ú½æªÑªº¤j¤j¬O½Ö¤F?¤£¾¨Åý¤HÁp·Q¬O¤£¬O·QÂ÷¶}¥xÆW²¾¥Áµo®i§r...................¤£¹L³o¼Ë½æ¬O¤£¬O§ó©e©}¤F©O? ¤£¹L¥HÄw½X±¨Ó¬Ý,³o¥b¦~¨Ó¤@ª½¦³¦A¼W¥[«ùªÑªº´X¦ìªÑªF,±q5¤ëªì¶}©lÁÙ¬O¤@ª½¦A¼W¥[«ùªÑªº,(¤¸¤j®ç¶é,²Î¤@·s¦Ë,§»»·®ç¶é,²Î¤@¥x¤¤,.........) ®Ú¾Ú¸ê®Æ,¤µ¦~¤½¥q¼W¥[¤F3¦ì«ùªÑ³£±Nªñ1500±iªº·s¤jªÑªF,¦Ó¥B³o3¦ì«Ü¥©ªº³£¦P©m,·PÁÂ¥L̹綠¥qªº»{¦P 6/29,¤½¥q¤½§iµo¦æ1100±i·s¼W¸êªÑ´£¨Ñû¤u»{ÁÊ,¼W¸ê¤é´Á7/19,(³o¬On«H°UÂêªÑªºµo¦æ) §Æ±æ¤½¥q¯à¦h¦hÄÀ©ñ¥X¯à´£®¶ªÑ»ù¤h®ðªº¶}µo¾P°â¦n®ø®§¥H¤Î¥[³t¤¤ªF,¤¤°êBH4ªº¾P°â·~ÁZ..... ¦A¨Ó´N¬O·s¸³¨Æ,¦Ñ©ÛµPªº¤¤¥[§ë¸ê¯àÀ°¤½¥q¦h¤@¨ÇÀç¹B¨ÎÁZ...... |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/6/6 ¤W¤È 10:01:11²Ä 191 ½g¦^À³
|
Ãö©óC08001®³¨ìÃÄÃÒ¤@¨Æ,§Ú¬Ý¨ì¦~³ø®É¤]ı±oÅå³Y. ¤W¹Ãĸp¬d¸ß¨S¬Ý¨ì¦]µØ¦³³oÓÃÄÃÒ, ¤§«e¤]¨S¬Ý¨ìÃÄÃҥӽЩM®³¨ìªº®ø®§, ²z½×¤WY¦]µØn¥Ó½ÐÃÄÃÒÀ³¸Ónµ¹ªF¥ÍµØ¤@¨ÇÅv§Qª÷ ,¤]¨S¬Ý¨ìÃþ¦ü·s»D, ¤£ª¾¹D¦~³ø¬°¤°»ò·|³o¼Ë¼g? ¥t¥~³ÌªñªÑ»ù¯h®z°£¤F³æ¤@¤jªÑªFªº¶i¥X,¦³¤@ÂI§Ú¤]ı±o«ÜºÃ´b, ¤½¥q¤T¤ë¤½¥¬BH4©M¤¤°êÃļtñ¬ù,¦³Ã±¬ùª÷, ¦ý¤T¤ë©M¥|¤ëªºÀ禬³£¥u¦³´X¤Q¸U,ªí¥Üñ¬ùª÷«Ü¤Ö¶Ü?ÁÙ¬OÁÙ¨S¤J±b? Yñ¬ùª÷³o»ò¤Ö,¨º¦¹¦X¬ù¥i¥H±a¨ÓªºÀ禬¤]ÃøÅý¤H´Á«Ý. §Úª¾¹D¦³¨Ç¦X¬ù¬O§Cñ¬ùª÷°ª¾P°â¤ñ¨Ò¦^õX,¦ý¤Ö¨ì´X¤Q¸U¤]¤Ó¤Ö¤F! ³Ì«á¤£ª¾¹D¦³¤H¦³°Ñ¥[¦¹¦¸ªÑªF·|¶Ü?¹ï¥Ø«eÅã¼v¾¯ªº¶i«×ÁÙ¬O«Ü¦n©_. |
|
|
·|û¡Ginnopharma10146547 µoªí®É¶¡:2018/6/3 ¤U¤È 10:25:56²Ä 190 ½g¦^À³
|
106¦~ ¦~³øÄÀ©ñ¤@¨Ç°T®§ ¸³¨Æ·|107/03/07Á{®É°Êij ¾®§ë¸ê¥»¤½¥q®×p.45(who§ë¸ê ´Á«Ý) 107/04/10 ¥Ó½Ð¿Ä¸êÃB«×Äò¬ù®× C08001°ª¦åÀ£·sÃĤw¨ú±o¥xÆWÃÄÃÒp.64 (¤§«eªF¥ÍµØ¦VtfdaºM¥ó)¥Ø«e¬ü°ê°µBEªí¥Ü¦n¨Æ±Nªñ 107¦~1Q eps -0.36 p.93 |
|
|
·|û¡Ginnopharma10146547 µoªí®É¶¡:2018/5/25 ¤U¤È 10:35:44²Ä 189 ½g¦^À³
|
D07001-³n½¦Ån¦bG¸z¹DÀù¯g±wªÌ¾¯¶qÂX¤j´Á©M¾¯¶qÂX¤j´ÁÁx¹DÀù±wªÌ¤¤ªº¬ã¨s Principal Investigator: Li-Tzong Chen, Ph. D §Æ±æ¤j®a¦³ªÅ¬d¤@¤U³¯¥ß©v³Õ¤hªº¸g¾ú´Nª¾¹D·N«ä¤F ´¼Àº¯ØŦÀù·sÃÄ¥xÆWªº¸ÕÅçÁ`¥D«ù¤H´N¬O³¯¥ß©v±Ð±Â Á{§Épµe¥D«ù¤H§ä¹ï¤F´N¦¨¥\¤@¤j¥b |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/5/24 ¤W¤È 10:31:52²Ä 188 ½g¦^À³
|
¤@¨ÇÃö©óBH4¯Ê¥F¯g¦b¤¤°êª¬ªp·j´M°Ñ¦Ò¤@¤U......... ¥|氢¥Íª«½ºËï¯Ê¥F¯g³q过对·s¥Í¤I进¦æ¯e¯f筛¬d¡A检¥X°ªf¤þ®ò»Ä¦å¯g¦Z¥i±o¨ì进¤@¨BÚÌ诊¡C¦b¤¤国¤j陆¦a区¡A·s¥Í¤I°ªf¤þ®ò»Ä¦å¯gªº发¯f²v约为1.1ÉE¤À¤§¤@¡F¦Ó¦b°ªf¤þ®ò»Ä¦å¯g¤¤约¦³ªñ两¦¨¬OBH4¯Ê¥F¯g¡C«ö这个发¯f²v计ºâ¡A¦b¤¤国¨C¦~约2000ÉE·s¥Í¤I¤¤¥i¯à±wBH4¯Ê¥F¯gªº为100~200¤H¡C¥Ñ¤_BH4¯Ê¥F¯g¤À经¨å«¬©M«D经¨å«¬两Ïú¡A¦]¦¹¦´Á«Ü®e©ö误诊¡C ÕuNGO组织ªº¤£§¹¥þ统计¡A¥Ø«e国内约¦³12ÉE¦WPKU±w¤I¡A¨ä¤¤BH4¯Ê¥F¯g±wªÌ¤j约9600¦W¡A¦bªv¸sÊ^仅1ÉE¦h¤H¡Aªñ10ÉE¤Iµ£¤w经©Î濒临瘫痪边缘¡A还¦³«Ü¦h没统计¥X来ªº±wªÌ¡C专®a«ü¥X¡A¤@¤è±¡A¨u见¯f药ª«¨Ï¥Î¤H¸s¤Ö¡A开发¦¨¥»©~°ª¤£¤U¡F¥t¤@¤è±¡A国®a¨u见¯f帮§ß¬Fµ¦还¬OªÅ¥Õ¡A§Ú国¦}没¦³对¨u见¯f进¦æ¥ßªk¡A¯Ê¥F¤@个§¹µ½ªº±Ï§UÊ^¨t¡F¦A¦¸¡A医«O¨î«×¦}没¦³纳¤JPKUªv疗¡CPKU±wªÌ¨É¨ü¤£¨ì°ò¥»医疗«O»Ù¡A处¹Ò艰难¡C ¦¨¤H©M¤Iµ£BH4¯Ê¥F¯g±wªÌªº°_©l剂¶q为2-5mg/kgÊ^«¡A¨C¤é1¦¸¡C剂¶q调¾ã¥i¦Ü20mg/kg/¤Ñ¡C¤]¥i¥H®ÚÕu»Ýn将¨C¤é总剂¶q¤À为¨C¤Ñ2¦¸©Î3¦¸ªA¥Î¡A¥Hɬ¤Æªv疗®ÄªG¡C ¦ôºâ¤@¤U,¨Ì·Ó5/23¤¤°ê°ê®a¥X¥xªº©t¨àÃĵo®i¤Î¯f±w¸É§UÂX¤j¥ÎÃĪº¾÷·|¨Ó¬Ý, ¤¤°ê¥Ø«e¦³BH4¯Ê¥F¤H¤f¬ù10,000¤H,¨C¤H¨C¤é»ÝªA¥ÎÃĪ«¬ù300mg/30kg/¤Ñ¥H¤W,¨C³æ¦ìÃĬ° 100mg/900¤¸¥x¹ô(¤j³°¤ÎÁú°ê°â»ù§ó°ª) 10000x3x900x365=985,500¸U¤¸¥x¹ô/¦~ ¦]µØ»P¤¤°ê¤sªF·s®É¥NÃÄ·~¦³¤½¥q§Þ³N¦X§@¶Õ¥²®e©ö·f¤W¦¹¦¸¤¤°ê°ê®a©t¨àÃÄ¿n·¥µo®i¬Fµ¦,¥un¯à®³¤U³¡¤Àªº»Ý¨D,´N¬O¤£±o¤FÀ禬¤F |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/5/23 ¤U¤È 10:19:58²Ä 187 ½g¦^À³
|
BH4(¦]¸¿Õ): ¥Ø«e BioMarin Pharmaceuticalªº Kuvan®¡A¬O°ß¤@°w¹ï»²酶¦X¦¨¯Ê¥F«¬fଧ¿¯g¡A¥H¤ÎÂù²B³ãËïÁÙì酶¯Ê¥Ffଧ¿¯g±wªÌªºªvÀøÃĪ«¡A¨Ã¦Û 2008 ¦~°_¤w¸g¦b¼Ú¬ü¥Dn¥«³õ®Öã¤W¥«¡A¨Ã¦b 2015 ¦~³Ð³y¬ù 2.6 »õ¬ü¤¸ªº¾P°âÃB¡C¥Ñ©ó¦¹²£«~q»ù¬Û·í©ù¶Q¡A¨CÁû100mg ¬°·s¥x¹ô 900 ¤¸¥ª¥k¡A¹ï¯f±w¨Ó»¡¥²¶·²×¨¨C¤é¨ÓªA¥Î¦¹ÃÄ¡A¬O¤@µ§¬Û·í¤jªº¸gÀÙt¾á¡C¤S¥Ñ©óì¼t³]¸m³\¦h±M§Q»Ùê¡A¦]¦¹³y¦¨¥«³õ¥Ñì¼t¹è¥eªº±¡§Î¡C¦ý¬O¦nªº¨Æ¬OKuvanªº¥«³õ¿W¦û´ÁÀ³¸Ó¬O¦b2017¦~´NºI¤î¤F ®Ú¾Ú¥«³õ¤ÏÀ³¡A³\¦h¯f±w³£§Æ±æ¯à¦³»ù¿ú¸û¤j²³¤Æªº«~µP¥i°µ¿ï¾Ü¡A¦]¦¹¡A¦b¨ã¦³¦Û¨¼Ú¬ü±M§Q»sµ{«OÅ@¤U¡A¦]µØ¹w´Á¦]¸¿ÕTM ±N·|¥H cost-effectiveness °µ¬°°Ï¹j¡A¥H¸û¬°¤j²³¤Æªº©w»ù´£¨Ñ°ê¤º¥~fଧ¿¯gªº¯f±w¡A°£¤Fì¼tÃĪ«¤§¥~¡A°ß¤@§ó¨ã¸gÀٮįqªº¿ï¾Ü ¥Ø«en¬Ýªº´N¬O¤§«eñªº2Ó §ÞÂà®Éµ{¬O§_¯à¦p´Á§¹¦¨,¤£¹L¦b§¹¦¨¤§«eÁÙ¬O·|¥H²{¦bªº¼Ò¦¡¸ò¦]µØ®³³f,À禬ÁÙ¬O¦s¦b¥B¤j´T¦¨ªøªº ¤½¶}¸ê°TÆ[´ú¯¸«¤j°T®§¤½§i (4172)¦]µØ¤½§i¥»¤½¥q»P¼Ú¨È¦a°Ï³q¸ô¤Î²£«~»s³y°Óñq¨Ñ³f¤Î¦X§@¦X¬ù¡A±Ò°Ê·~°È©Ý®i 1.¨Æ¹êµo¥Í¤é:106/12/11 2.«´¬ù©Î©Ó¿Õ¬Û¹ï¤H:¼Ú¨È¦a°Ï³q¸ô¤Î²£«~»s³y°Ó 3.»P¤½¥qÃö«Y:µL 4.«´¬ù©Î©Ó¿Õ°_¨´¤é´Á(©Î¸Ñ°£¤é´Á):106/12/11 ¤½¶}¸ê°TÆ[´ú¯¸«¤j°T®§¤½§i (4172)¦]µØ-¤½§i¥»¤½¥q»P¤¤°ê¤sªF·s®É¥NÃÄ·~¦³¤½¥qñqÆQ»Ä¨F¤þ³ãËï¤ù¾¯(BH4¡F¦]¸¿Õ)§Þ³N±ÂÅv¦X¬ù®Ñ 1.¨Æ¹êµo¥Í¤é:107/03/26 2.«´¬ù©Î©Ó¿Õ¬Û¹ï¤H:¤¤°ê¤sªF·s®É¥NÃÄ·~¦³¤½¥q |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/5/23 ¤U¤È 09:58:16²Ä 186 ½g¦^À³
|
¤³¡门联¦X¡A²Ä¤@§å¨u见¯f¥Ø录发¥¬¡I ¤¤°ê国®aªº²Ä¤@§å¨u见¯f¥Ø录发¥¬¤F¡I(¤µ¤Ñ 5/23¤é ¥X»O) ªñ¤é¡A¤¤°ê国®a卫¥Í°·±d©e员会¡B¬ì学§Þ术³¡¡B¤u业©M«H®§¤Æ³¡¡B国®a药«~监·þºÞ²z§½¡B国®a¤¤医药ºÞ²z§½µ¥5³¡门联¦X发¥¬¤F²Ä¤@§å¨u见¯f¥Ø录¡C ²Ä¤@§å¨u见¯f¥Ø录¤½¥¬¤§¦Z¡A将«P进¬Û关药ª«ªº¬ã发¡B¤W¥«¡A为¨u见¯f±wªÌ´£¨Ñ§ó¦h¡B¦³®Ä¡B¥i负担ªºªv疗¤â¬q¡A§ïµ½¨u见¯f±wªÌªº¥Í¬¡质¶q¡C ¨ä¤¤²Ä113¶µ¬O ¥|²B¥Í³ãËï(tetrahydrobiopterin¡FBH4)¯Ê¥F¯g ¦b¥ý«eªº·s»D......... ¤½§i¥»¤½¥q»P¤¤°ê¤sªF·s®É¥NÃÄ·~¦³¤½¥q ñqÆQ»Ä¨F¤þ³ãËï¤ù¾¯(BH4¡F¦]¸¿Õ)§Þ³N±ÂÅv¦X¬ù®Ñ 1.¨Æ¹êµo¥Í¤é:107/03/26 2.«´¬ù©Î©Ó¿Õ¬Û¹ï¤H:¤¤°ê¤sªF·s®É¥NÃÄ·~¦³¤½¥q 3.»P¤½¥qÃö«Y:µL 4.«´¬ù©Î©Ó¿Õ°_¨´¤é´Á(©Î¸Ñ°£¤é´Á):107/03/26 5.¥Dn¤º®e(¸Ñ°£ªÌ¤£¾A¥Î): (1)°w¹ï¥»¤½¥qªº²£«~-¦]¸¿Õ(BH4)¤§±ÂÅv¦X¬ù¡C (2)¾P°â°Ï°ì¡G¥]§t¤¤°ê(§t»´ä¤Î¿Dªù)¤Î¦è¯Z¤ú¿W®a±ÂÅv¡C (3)¦X¬ù¥Dn±ø´Ú¡G§Ú¤è±NBH4¤§§Þ³N¿W®a±ÂÅv¤©¤¤°ê¤sªF·s®É¥NÃÄ·~©ó¤¤°ê¤Î¦è¯Z¤ú¦a °Ï¤§¶}µo¡B»s³y¡B¨Ï¥Î¡B¹ê¬I¡B¤W¥«¥Ó½Ð¤Î³c½æ¸Ó²£«~¡C (4)¦X¬ù´Á¶¡¡G¦Û¦X¬ùñq¤é°_¦@10¦~¡C (5)¥]§tBH4¤§±ÂÅvª÷¤Î¥¼¨ÓBH4ì®ÆÃĨѳf±ø¥ó¡C 6.¨î±ø´Ú(¸Ñ°£ªÌ¤£¾A¥Î):µL 7.¹ï¤½¥q°]°È¡B·~°È¤§¼vÅT(¸Ñ°£ªÌ¤£¾A¥Î):¦³§U©ó¤½¥q¦U¸Ó«~¶µ«áÄò¤¤°ê¤Î¦è¯Z¤ú¥«³õ ·~°È¤§±À°Ê¡C 8.¨ãÅé¥Øªº(¸Ñ°£ªÌ¤£¾A¥Î):©Ý®i¥»¤½¥q¤§¦]¸¿Õ¤§¤¤°ê¤Î¦è¯Z¤ú¥«³õ¾P°â¡C 9.¨ä¥LÀ³±Ô©ú¨Æ¶µ:¤¤°ê¤sªF·s®É¥NÃÄ·~¦³¤½¥q¬°¾|«n»sÃĶ°¹Î¤§¦¨û¤§¤@¡A¾|«n»sÃÄ ¶°¹Î¬O¶°¤¤ÃÄ¡B¤Æ¾ÇÃÄ«~¡B¥Íª«»s«~ªº¥Í²£¡B¬ì¬ã¡B¾P°â©ó¤@Å骺ºî¦X»sÃĶ°¹Î¡A¦ì ¦C¤¤°ê¤j¥ø·~¶°¹ÎÄvª§¤O500±j¡C ³o»ò»¡BH4±N·|¬O¤¤°ê¥þ¤O»²¾É¤W¥«ªº¨u¨£¯e¯f¥ÎÃÄ(©t¨àÃÄ) |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/5/22 ¤U¤È 02:23:02²Ä 185 ½g¦^À³
|
¦]µØ²×©ó§âÁxºÞÀù¸ÕÅç©ñ¨ì¬ü°êÁ{§É¹êÅçºô¯¸¤F¡A¥[ªo§a¡I Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase clinicaltrials.gov/ct2/show/NCT03531320?term=Innopharmax&rank=1 |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/5/17 ¤U¤È 10:23:51²Ä 184 ½g¦^À³
|
¤j¤j....... ·PÁ±zµ¹ªº¤@¦¸¾÷·|... |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/5/17 ¤U¤È 09:26:53²Ä 183 ½g¦^À³
|
¦~³ø¤w¸g©ñ¦b¤½¶}Æ[´ú¯¸¤F¡A¦³¿³½ìªº¥i¥H¬Ý¬Ý¡C |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/5/9 ¤W¤È 09:18:40²Ä 182 ½g¦^À³
|
½Ð°Ý±±½L¤jô±zÁÙn±±¦h¤[.....¤w¸g1500¤FÁÙnÀ£µÛ¦¬¶Ü? |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/5/7 ¤U¤È 01:49:11²Ä 181 ½g¦^À³
|
¦]µØ4/24¤½§G¤F¥h¦~°]³ø,5/2¤]§â³¡¤ÀªÑªF·|¤º®e©ñ¨ìºô¸ô¤W, µy·L¬Ý¤F¤]¸ò¥h¦~°]³ø¬Û¤ñ,¦³¤@¨Çȱo¤@´£ªº³¡¤À 1. ´¶Àù¨O¾P¶q¥Ñ105¦~¥|¤d¸U¥ª¥k¶^¨ì¤T¤d¨â¦Ê¸U,¤£¹L¤µ¦~¥i¯à·|¦³·s¾AÀ³¯g¾P¶qªº¥[¤J,À³¸Ó·|§ó¦n 2.¤½¥¬¥t¤@ºØÃĪ«¾P¶q¬°623¸U,¹ï¤ñ¤F¤@¤UÀ³¸Ó¬O¦]¸¿Õ. ¦P®É¤½¥¬¤½¥q¥h¦~¦bÁú°êªº¾P°âÁ`ÃB¬°623¸U, ¹ï¤ñ³o«h·s»D¥»¤½¥q©ó7/3»PÁú°êBL&H¤½¥qñq¦]¸¿Õ²£«~©óÁú°ê¦a°Ï¤§¨Ñ³f¦X¬ù¡C,À³¸Ó´N¬O¦bÁú°ê¾P°âªº¦]¸¿Õ. µM«á§Úµy·L¬d¤F¤@¤U,¡§Dipharma and Alvogen launch Diterin in South Korea, ¥t¤@®aÃļt¤]¦b¥h¦~ªì«Å¥¬¦bÁú°ê¾P°âkuvanªº¾Ç¦WÃÄ. ¦]µØ¥h¦~¤C¤ë¤~ñ¦X¬ù,¦bì¼tÃÄ©M¥t¤@®a¾Ç¦WÃļtÄvª§¤U´N¦³623¸Uªº¦n¦¨ÁZ, ¤×¨ä³Ìªñ¤~¸ò¤¤°êÃļtñ¤UBH4ªº¦X¬ù,Åý¤H¤Q¤À´Á«Ý³o±ø²£«~½u¤µ¦~ªº¾P¶q. 3.¦]µØ¤µ¦~Á{§É¹êÅç©e°U¦X¬ùªºÁ`ÃB¶W¹L¤@»õ¤¸(¥h¦~³oµ§¸g¶O¬°¥|¤d¦h¸U), ¤£ºÞ¤µ¦~³oµ§¬Oµ¹D07001,©Î¬ON11005,©Î¨âªÌ¬Ò¦³,ªí¥Ü¤½¥q¨Ã¨S¦³©ñ±¼´XÓ¤jÃĪº«áÄò¬ãµo. ªÑªF·|ªºÂ²©ö¤º®e¬Ý°_¨Ó¤FµL·s·N,´Á«Ý¥¿¦¡¦~³ø¥X¨Ó·|¦³§ó¶i¤@¨Bªº®ø®§. |
|
|
·|û¡Ginnopharma10146547 µoªí®É¶¡:2018/4/26 ¤U¤È 10:15:58²Ä 180 ½g¦^À³
|
107 ¦~«×ªÑªF±`·|©e°U®Ñ¼x¨D¤H 1.¤¤¥[§ë¸êµo®iªÑ¥÷¦³¤½¥q ®}¥ß¼w 2.°ê®aµo®i©eû·| ¥D¥ô¯µ®Ñ ´¿³·¦p (¿W¸³) 3.¤½¥qÁ`¸g²z °q¬°µØ |
|
|
·|û¡Gªö®f10138830 µoªí®É¶¡:2018/4/21 ¤U¤È 01:56:02²Ä 179 ½g¦^À³
|
¦]µØªÑ»ù¯u¥O¤H¥¢±æ |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/4/18 ¤W¤È 11:52:23²Ä 178 ½g¦^À³
|
¡i°]°T§Ö³ø¡þ¦ó¬ü¦p³ø¾É¡j¦]µØ(4172)ºË·Ç¤¤°ê°Ó¾÷¥þ¤O¥¬§½¡AÄ~¦]¸¿Õ(BH4)¦b3¤ë©³»P¤¤°ê¤sªF·s®É¥NÃÄ·~ñq¤¤°ê¤Î¦è¯Z¤ú¿W®a±ÂÅv¡A¬Q(17)¤é¤½§i»P©y©÷ªF¶§¥úªø¦¿ÃÄ·~(01558.HK)ñq¤fªA¯Ø®q¯À¶µ¥Ø±ÂÅv¦X¬ù¡A¸Ó²£«~¥Ø«eÁÙ¦b¤HÅéÁ{§É«e¶¥¬q¡A¹wpºÓ¨½µ{¸O¦³¾÷·|¦b¤µ¦~©³©Î©ú¦~ªì§¹¦¨¡A±NѺª`Àò§Q¡C ¦]µØ17¤é¤½§i¡A»P©y©÷ªF¶§¥úªø¦¿ÃÄ·~ñq¡A°w¹ï¤fªA¯Ø®q¯ÀN11005ªº¤¤°ê¤j³°°Ï¿W®a±ÂÅv¦X¬ù¡A¦]µØ±ÂÅv¹ï¤è¦b¤¤°ê¤j³°¦a°Ï¤§¬ãµo¡B¥Í²£¡B±À¼s©M¾P°â¡AÂù¤èñ¦³«O±K¨ó©w¡C ¤fªA¯Ø®q¯ÀN11005¥Ø«eÁÙ¦bÁ{§É«e°Êª«¸ÕÅ綥¬q¡A¾Ú¤F¸Ñ¡A¸Ó±ÂÅv¨S¦³Ã±¬ùª÷¡A¦ý¹ï¤è·|t³d¶}µo¶O¥Î¡A¥BÀHµÛ¶}µo¶i«×¹F¨ì¨½µ{¸O¡A±N¦³¨½µ{¸Oª÷°^Äm¡Aªk¤H¹w´Á¡AºÓ¨½µ{¸O¥i±æ¦b¦~©³©Î©ú¦~ªì§¹¦¨¡C ¦Ó¤µ¦~3¤ë©³Ã±qªº¦]¸¿Õ(BH4)¤§±ÂÅv¦X¬ù¡A¬O»P¤¤°ê¤sªF·s®É¥NÃÄ·~ñq¤¤°ê(§t»´ä¤Î¿Dªù)¤Î¦è¯Z¤ú¿W®a±ÂÅv¡A±NBH4¤§§Þ³N¿W®a±ÂÅv¤©¤¤°ê¤sªF·s®É¥NÃÄ·~©ó¤¤°ê¤Î¦è¯Z¤ú¦a°Ï¤§¶}µo¡B»s³y¡B¨Ï¥Î¡B¹ê¬I¡B¤W¥«¥Ó½Ð¤Î³c½æ¸Ó²£«~¡C ÁöµM¥u¬O¾ã²z«e¨âÓñ¬ù¡A¦ý¦n¤[¨S·s»D¤F |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/4/17 ¤U¤È 08:24:05²Ä 177 ½g¦^À³
|
¦n·¥¤F¡K¡K |
|
|
·|û¡Ginnopharma10146547 µoªí®É¶¡:2018/4/17 ¤U¤È 05:39:14²Ä 176 ½g¦^À³
|
1.¨Æ¹êµo¥Í¤é107/04/172.«´¬ù©Î©Ó¿Õ¬Û¹ï¤H©y©÷ªF¶§¥úªø¦¿ÃÄ·~ªÑ¥÷¦³¤½¥q4.«´¬ù©Î©Ó¿Õ°_¨´¤é´Á(©Î¸Ñ°£¤é´Á)107/04/17 5.¥Dn¤º®e(¸Ñ°£ªÌ¤£¾A¥Î)(1)°w¹ï¥»¤½¥qªº²£«~-¤fªA¯Ø®q¯À¤§±ÂÅv¦X¬ù¡C (2)¾P°â°Ï°ì:¤¤°ê¤j³°°Ï¿W®a±ÂÅv¡C (3)¦X¬ù¥Dn±ø´Ú:§Ú¤è±N¤fªA¯Ø®q¯À¤§§Þ³N¿W®a±ÂÅv¤©©y©÷ªF¶§¥úªø¦¿ÃÄ·~ªÑ¥÷¦³ ¤½¥q©ó¤¤°ê¤j³°¦a°Ï¤§¬ãµo¡B¥Í²£¡B±À¼s©M¾P°â¡C (4)¥]§t¤fªA¯Ø®q¯À¤§±ÂÅv±ø¥ó¡C6.¨î±ø´Ú(¸Ñ°£ªÌ¤£¾A¥Î)¨Ì¾Ú¦X¬ù¬ù©w¡AÂù¤è¹ï¥»¨ó©w¤º®et¦³«O±K¸q°È7.¹ï¤½¥q°]°È¡B·~°È¤§¼vÅT(¸Ñ°£ªÌ¤£¾A¥Î)¦³§U©ó¤½¥q¦U¸Ó«~¶µ«áÄò¤¤°ê¥«³õ·~°È¤§±À°Ê¡C8.¨ãÅé¥Øªº(¸Ñ°£ªÌ¤£¾A¥Î)©Ý®i¥»¤½¥q¤§¤fªA¯Ø®q¯À¤§¤¤°ê¥«³õ¶}µo¤Î¾P°â¡C9.¨ä¥LÀ³±Ô©ú¨Æ¶µ©y©÷ªF¶§¥úÃÄ·~ªÑ¥÷¦³¤½¥q(01558.HK)¬°»´ä¤W¥«¤½¥q¡A¤½¥q¦¨¥ß©ó2001¦~¡C |
|
|
·|û¡Ginnopharma10146547 µoªí®É¶¡:2018/4/14 ¤U¤È 03:01:18²Ä 175 ½g¦^À³
|
2007¦~12¤ëBioMarinªºÆQ»Ä¨F¤þ½ºËï¤ùÀò±oFDA§å㪺NDA(¥¿±`§åã)¡A°Ó«~¦W¬°KUVAN®¡A§åã³W®æ¬°100mg¡F¥«³õ¿W¦û´ÁºI¤î2017¦~10¤ë¡A¥Ø«e¤w¦³¤@Ó¥é»s¥ø·~Àò±o¹w§åã¡C ¦]¸¿ÕBH4ì®Æ»sµ{¨ú±o¥xÆW¡B¬ü°ê¡B¤¤°ê¡B¼Ú¬wµ¥¦U°ê±M§Q¡C |
|
|
·|û¡Ginnopharma10146547 µoªí®É¶¡:2018/4/13 ¤W¤È 12:43:08²Ä 174 ½g¦^À³
|
°ê®aÃĺÊÁ`§½(CFDA)©ó2017¦~5¤ë11¤éµo¥¬¡mÃö©ó¹ªÀyÃÄ«~ÂåÀø¾¹±ñ³Ð·s¥[§Ö·sÃÄÂåÀø¾¹±ñ¤W¥«¼fµû¼f§åªº¬ÛÃö¬Fµ¦¡nªº¼x¨D·N¨£½Z¡A¨ä¤¤«ÂI±j½Õ¤ä«ù¨u¨£¯fªvÀøÃĪ«¡A¥H¤Î¨u¨£¯f±wªÌ¹ïÁ{§É«æ»ÝªvÀø¤è®×ªº¢¤Á»Ý¨D¡A°ê®aÃĺÊÁ`§½(CFDA)¬ÛÄ~¥X¥x¦hÓ§Q¦n¬Fµ¦ªk³W¡A³o±N¶Õ¥²¼W±j¤¤°ê¦b¨u¨£¯f»â°ìªº¾ãÅéµo®i¡C |
|
|
·|û¡Ginnopharma10146547 µoªí®É¶¡:2018/4/11 ¤U¤È 12:17:50²Ä 173 ½g¦^À³
|
*United States Patent Application 20170360894 December 21, 2017 Oral Administration of Unstable or Poorly-Absorbed Drugs *United States Patent Application 20170348341 December 7, 2017 Metronomic Oral Gemcitabine for Cancer Therapy |
|
|
·|û¡Ginnopharma10146547 µoªí®É¶¡:2018/4/4 ¤U¤È 03:57:52²Ä 172 ½g¦^À³
|
Kuvanªº¦¬¤JÁÍ¶Õ ¦b²Ä¥|©u«×¡AKuvanªºÀ禬¬°1.074»õ¬ü¤¸¡A¦Ó2016¦~²Ä¥|©u«×¬°9,000¸U¬ü¤¸¡A¦P¤ñ¼Wªø¬ù19¢H¡AÀô¤ñ¼Wªø¬ù2¢H¡C 2017°]¦~¡AKuvanªº¦¬¤J¬°4.075»õ¬ü¤¸¡A¦Ó2016¦~¬°3.48»õ¬ü¤¸¡A¦P¤ñ¼Wªø¬ù17¢H¡C |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/3/27 ¤W¤È 01:00:29²Ä 171 ½g¦^À³
|
¤½§i¥»¤½¥q»P¤¤°ê¤sªF·s®É¥NÃÄ·~¦³¤½¥q ñqÆQ»Ä¨F¤þ³ãËï¤ù¾¯(BH4¡F¦]¸¿Õ)§Þ³N±ÂÅv¦X¬ù®Ñ 1.¨Æ¹êµo¥Í¤é:107/03/26 2.«´¬ù©Î©Ó¿Õ¬Û¹ï¤H:¤¤°ê¤sªF·s®É¥NÃÄ·~¦³¤½¥q 3.»P¤½¥qÃö«Y:µL 4.«´¬ù©Î©Ó¿Õ°_¨´¤é´Á(©Î¸Ñ°£¤é´Á):107/03/26 5.¥Dn¤º®e(¸Ñ°£ªÌ¤£¾A¥Î): (1)°w¹ï¥»¤½¥qªº²£«~-¦]¸¿Õ(BH4)¤§±ÂÅv¦X¬ù¡C (2)¾P°â°Ï°ì¡G¥]§t¤¤°ê(§t»´ä¤Î¿Dªù)¤Î¦è¯Z¤ú¿W®a±ÂÅv¡C (3)¦X¬ù¥Dn±ø´Ú¡G§Ú¤è±NBH4¤§§Þ³N¿W®a±ÂÅv¤©¤¤°ê¤sªF·s®É¥NÃÄ·~©ó¤¤°ê¤Î¦è¯Z¤ú¦a °Ï¤§¶}µo¡B»s³y¡B¨Ï¥Î¡B¹ê¬I¡B¤W¥«¥Ó½Ð¤Î³c½æ¸Ó²£«~¡C (4)¦X¬ù´Á¶¡¡G¦Û¦X¬ùñq¤é°_¦@10¦~¡C (5)¥]§tBH4¤§±ÂÅvª÷¤Î¥¼¨ÓBH4ì®ÆÃĨѳf±ø¥ó¡C 6.¨î±ø´Ú(¸Ñ°£ªÌ¤£¾A¥Î):µL 7.¹ï¤½¥q°]°È¡B·~°È¤§¼vÅT(¸Ñ°£ªÌ¤£¾A¥Î):¦³§U©ó¤½¥q¦U¸Ó«~¶µ«áÄò¤¤°ê¤Î¦è¯Z¤ú¥«³õ ·~°È¤§±À°Ê¡C 8.¨ãÅé¥Øªº(¸Ñ°£ªÌ¤£¾A¥Î):©Ý®i¥»¤½¥q¤§¦]¸¿Õ¤§¤¤°ê¤Î¦è¯Z¤ú¥«³õ¾P°â¡C 9.¨ä¥LÀ³±Ô©ú¨Æ¶µ:¤¤°ê¤sªF·s®É¥NÃÄ·~¦³¤½¥q¬°¾|«n»sÃĶ°¹Î¤§¦¨û¤§¤@¡A¾|«n»sÃÄ ¶°¹Î¬O¶°¤¤ÃÄ¡B¤Æ¾ÇÃÄ«~¡B¥Íª«»s«~ªº¥Í²£¡B¬ì¬ã¡B¾P°â©ó¤@Å骺ºî¦X»sÃĶ°¹Î¡A¦ì ¦C¤¤°ê¤j¥ø·~¶°¹ÎÄvª§¤O500±j¡C ³o»ò±ß¤½¥¬³oÓ®ø®§¡A¸Ü»¡¤½¥q¤½¥¬ªºÃ±¬ù®ø®§«Ü¤Ö¦³©ú½T«ü¥X±ÂÅvª÷ªº¡C ¤£ª¾¹D³o¦¸ªº±ÂÅvª÷¦h¤Ö¡Hþ®ÉÔ¤J±b¡H |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/3/11 ¤U¤È 12:18:17²Ä 170 ½g¦^À³
|
´£¨Ñ¤@¨Ç³o´X¤Ñ°µªº¥\½Ò 1.Äw½X±: ¥i¥H¬Ý¥X³o¤@°}¤l800±i¥H¤Wªº¤j¤á«ùÄò¦b¶R¶i,¦ý100~400±iªº§ë¸êªÌ½æ¥X«Ü¦h. ¼È®É½æ¤è¦û¤W·. 2.D07001: ¤½¥q¦ü¥G¤£°Ñ¥[2018¦~ASCO¦~·|¤F,¤§«eÁÙ¦³¬Ý¨ì,¤µ¤Ñ¦A¬d¤w¸g¤£¦b°Ñ»P¼t°Ó¦W³æ¤F ¤§«e¸ò¤j®a´£ªº¨È¤ÓÁxºÞÀù·|ij¤]¤£¦b°Ñ¥[¦W³æ¤F(¨È·à±d¤]¤£¦b¦W³æ¤¤¤F) ¥[¤W¤½¥q¿ð¿ð¤£¦b¬ü°êÁ{§É¹êÅçºô¯¸µn¿ý·sªºÁ{§É¹êÅç,¤Sµo¥Í³\«e°ÆÁ`Â÷¶}ªº¨Æ±¡, ¤£§KÅý¤H¾á¤ßD07001¬Æ¦ÜOralPas³oÓ§Þ³N¬O§_¥ÍÅÜ, ¦pªG¬O³o¼Ë,´N¯à¸ÑÄÀ³o¤@°}¤lªºªÑ»ù§C°g 3.Åã¼v¾¯ ¤§«e¶Ç¥X§tGadoliniumªºÅã¼v¾¯¦³´Ý¯d¦b¸£³¡ªººÃ¼{,¨Ã¥i¯à¶Ë®`¸£³¡, ¼Ú¬w¤w¼È°±³¡¤ÀÃþ¦üªºÅã¼v¾¯ªº¨Ï¥Î www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Gadolinium-containing_contrast_agents/human_referral_prac_000056.jsp&mid=WC0b01ac05805c516f ¹ïÀ³°_¨ÓMagnevist ==>¹Å¦h©ú Omniscan ==>¹Å¦hµø°· ¤£¹L¬ü°ê¤è±¥u¦³´£¥Xĵ§i,¨S¦³¸T¥Î,¦ýn¨DGBCAs(§tGadoliniumªºÅã¼v¾¯)²£«~»s³y°Ó»Ý´£¨Ñ¤HÅé¤Î°Êª«¸ÕÅç¬ÛÃö¬ã¨s¸ê®Æ ©Î³\¦]µØÅã¼v¾¯¬ü°ê¾Ç¦WÃÄÃÒ¦³¨ü¦¹¨Æ¼vÅT dl.tzuchi.com.tw/pharm/sites/dl.tzuchi.com.tw.med.pharm/files/photo/20171220Gadolinium-based%20Contrast%20Agents%20Drug%20Safety%20Communication.pdf §Úª¦¹L¤@¨Ç¤å³¹,½u©ÊªºGadoliniumÅã¼v¾¯¬r©Ê¸û¤j,¹Å¦h©ú©M¹Å¦hµø°·³£¬O¦¹Ãþ. ¤W¤@½g¤å³¹´£¥Xªºgadobutrol¬OÀô§Îªº¬r©Ê¸û§C,¤£¦b¼Ú¬w¸T¤î¦W³æ¤º. ¦ý¤£ª¾¨º«h·s»Dªº¯u°²,²¦³º¦]µØ¨Ã¨S¦³¤½¶}説©ú ¥t¥~¤½¥q³Ìªñ¤½¥¬¥Ñ°q°ÆÁ`¼È¥NÁ`¸g²z,¤S«Å§GªÑªF·|·|¥þ±§ï¿ï¸³¨Æ,¦ü¥G¦³¤s«B±ý¨Ó·º¡¼Óªº·Pı. ³Ì«á§Æ±æcstang¤j¤§«e´£¨Ñªº®ø®§,¤T¤ëªL¸³·|±a¨Ó¸êª÷ªºÑºª`¤£n¥ÍÅÜ. |
|
|
·|û¡G·RŪ®Ñ10030395 µoªí®É¶¡:2018/3/5 ¤U¤È 01:24:28²Ä 169 ½g¦^À³
|
¦pªGÅã¼v¾¯n¤j¥X³f§A»{¬°°]°Èªø·|¤£ª¾¹D¶Ü???°]°Èªø³o´XÓ¤ëªÑ²¼³£§Ö½æ¥ú¤F.... |
|
|
·|û¡Gmollycoddl10146316 µoªí®É¶¡:2018/3/5 ¤W¤È 10:09:32²Ä 168 ½g¦^À³
|
¨ì14¯u¥O¤H¶Ì²´⋯⋯ |
|
|
·|û¡G¤pÀs¤k10146282 µoªí®É¶¡:2018/3/1 ¤W¤È 09:25:56²Ä 167 ½g¦^À³
|
¥Îgoogle½Ķ·s»D¤º®e¬O³o¼Ë Enzychem Lifesciences¶g¤Gªí¥Ü¡A¥¦»PºÏ¦@®¶¦¨¹³¡]MRI¡^³y¼v¾¯Gadobutrolñ¸p¤F¤@¶µ815»õÁú¤¸¡]7530¸U¬ü¤¸¡^»P¥xÆWInnoPharmaxªº¥X¤f¨óij¡C ®Ú¾ÚEnzychemªº¼Æ¾Ú¡A³o¶µ»ùȼƦʸU¬ü¤¸ªº¥æ©ö±N©ó2020¦~¶}©l¹ê²{¦¬¤J¡A±À°Ê¤½¥q2016¦~ªº¾P°âÃB¼Wªø°ª¹F370¢H¡C ®Ú¾Ú¦X¦P¡AÁú°ê»sÃĤ½¥q±N¦b¥¼¨Ó¤Q¦~¤º¦VInnoPharmax´£¨Ñì§÷®Æ¡Aª½¨ì2029¦~©³¡C¥xÆW¶i¤f°Ó±N¥Í²£Gadobutrol¨Ã³q¹L¤@®a±Mªù¾P°âMRI³y¼v¾¯ªº¥¼¤½¶}ªº¬ü°ê¤½¥q¥X¤f¨ì¬ü°ê¡C ¸Ó¤½¥qªí¥Ü±N¿n·¥±À¾P¥þ²y¥«³õ¡C ¡§§ÚÌp¹º¦bÁú°ê©M¼Ú¬w¿n·¥±À¾P¥¦¡A¨Ã¦b§¹¦¨²£«~½è¶q»{ÃÒ«á¶i¤@¨BÂX®i¨ì¬ü°ê©M¤é¥»¡A¥H¤Î¿WÁpÅé°ê®a¡]¦p¿WÁpÅé°ê®a¡A¦p«Xù´µ¡^¡A¡¨Enzychemªº¤@¦ì©xû»¡¡C 钆¥¬¾J¬O¤@ºØ°ò©ó钆ªº³y¼v¾¯¡A¥Î©ó¦¨¤H©M¨àµ£ªº¶EÂ_©ÊMRI¡A¬ð¥XÅã¥Ü¤¤¼Ï¯«¸g¨t²Î¤¤¤w¸g¯}Ãa¦å¸£«Ì»Ù¡]BBB¡^©Î¦åºÞ²§±`ªº°Ï°ì¡C¥¦ÁÙ¥i¥Î©ó´¦¥Ü¨Å¸¢¯e¯fªº¦s¦b¡A¨ÃÀË´ú¤¤·©M¸~½FÄéª`µ¥¡C ¡§ÀHµÛMRI³y¼v¾¯¥«³õªºµo®iÁͶաA§Ų́M©w±NGadobutrol°Ó·~¤Æ¡A«áªÌÄÝ©ó§C·ÀIÃþ§O¡C§ÚÌ¥¿¦b·Ç³Æ¦V¬ü°ê¡A¼Ú¬w©M¤é¥»µ¥°ê®a¥X¤f¡A¡§¸Ó©xû»¡¡C Enzychem«ü¥X¡A¾¨ºÞ°·±d°ÝÃD¤é¯qÄY«¡A¦ýMRI³y¼v¾¯¤´µM¬O¥²nªº¶EÂ_¦¨¤À¡C¬ü°ê¹«~©MÃĪ«ºÞ²z§½µ¥½Ã¥ÍºÊºÞ³¡ªùµo¥¬¤Fĵ§i«H¡A¨Ã¸T¤î¯S©wªº钆³y¼v¾¯³y¦¨¤HÅ馺¤`¡C Áú°ê¹«~©MÃĪ«¦w¥þ³¡¤]©ó¶g¤Gµo¥¬¤F¤KºØ钆³y¼v¾¯§å㪬ºAªº×q³qª¾¡A¨ä¤¤¥]¬A¹w¶ñ¥Rª`®g¾¹©M¤p²~§Î¦¡ªº«ô¦Õ钆³y¼v¾¯¡§Gadavist¡¨¡C Enzychem¾¨ºÞ¦¨¥»°ª©ù¡A¦ý¤´¨M©w±NGadobutrol°Ó·~¤Æ¡A³o¬O°·±d°ÝÃDªº¤@Ó«nì¦]¡C¸Ó©xû«ü¥X¡A¥¦°í«ù¡§§C·ÀIMRI³y¼v¾¯¡¨ªºÃþ§O¡AµÇŦ¬r©Ê«Ü¤p¡C ¸Ó¦X¦PÁټлxµÛEnzychem¤½¥qűo¤F¥Ñ¤j«¬»sÃĤ½¥q¥D¾Éªº°ª«×Ävª§¥«³õªº¯à¤O¡A¸Ó©xû«ü¥XEnzychemªº¥é»s²£«~¦b¥Ñ«ô¦Õ¥ýÆFÂåÃÄ¡A®æº¸¨©¯S©MBracco S.p.Aµ¥¤½¥q¥D¾Éªº¥«³õ¤W¦¨¥\¹ê²{°Ó·~¤Æ¡C yjc@docdocdoc.co.kr <©Áú°ê¥Íª«Âå¾Çµû½×¡A«O¯d©Ò¦³Åv§Q> |
|
|
·|û¡G¤pÀs¤k10146282 µoªí®É¶¡:2018/3/1 ¤W¤È 09:08:07²Ä 166 ½g¦^À³
|
¤£¿ù®@~¦nªÑ´N¥i¥H¦s |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/2/28 ¤U¤È 05:44:56²Ä 165 ½g¦^À³
|
¬Q¤Ñ¦³³\¦hÁú°êªº·s»D³£¦³´£¨ì³oÓ®ø®§ ²{¦b¦³^¤åª©¥»ªº¤F www.koreabiomed.com/news/articleView.html?idxno=2675 ¤£¹L§Ú¦³¤@ÂI»~¸Ñ, ¦X¬ù¤º®e¤Ï¦Ó¬O«ü¦]µØ¦VEnzychem Lifesciences ÁʶRì®Æ¥Î©ó»s³yGadobutrol, µM«á¥X¤fµ¹¬ü°ê¼t°Ó(¦]¦X¬ù°ÝÃDµLªk´¦ÅS¬ü°ê¼t°Ó¦W¦r). ´N¦¹·s»D¤º®e¨Ó¬Ý,Gadobutrol¬O¬r©Ê¤ñ¥Ø«e±`¥ÎªºÅã¼v¾¯§Cªº¤@ºØÅã¼v¾¯, ¸ò¦]µØ¤§«e°UAkorn°eFDAªº¬O¤£¦P´Ú. ¦pªG¦¹¦X¬ù¬°¯u,¥úì®Æ¦b¤Q¦~¶¡¦]µØ´Nnªá7¤d¤¦Ê¸U¬üª÷,¦¨«~ªº¾P°âÃB´N§ó¥iÆ[¤F. ´N¬Ý¬Ý³o´X¤Ñ¤½¥q·|¤£·|µo§G®ø®§Åo~~ |
|
|
·|û¡G¤pÀs¤k10146282 µoªí®É¶¡:2018/2/27 ¤U¤È 08:48:37²Ä 164 ½g¦^À³
|
¦pªG·s»D¬O¯uªº¡A¤½¥q¥²¶·¤½§i¡A¤£µM·|³Q»@ |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/2/27 ¤W¤È 11:27:54²Ä 163 ½g¦^À³
|
èè¬Ý¨ì,¦]µØ¦ü¥G©MÁú°êENGEMCEM?¥Í©R¬ì¾Çñq¤FÅã¼v¾¯ªº¦X¬ù, ¥Ñ2020¦~¶}©l¨ÑÀ³¨ì2029¦~,¾P°â¦aÂI¬O¬ü°ê,Á`¾P°âª÷ÃB¬O¤C¤d¤¦Ê¸U¬üª÷. ì©l³sµ² vip.mk.co.kr/news/view/19/28/631854.html ¬OÁú¤åªº,§Ú¥Îgoogle½Ķ. ¦pªG¦¨¯u,¨C¦~®t¤£¦h¥i¥H´£¨Ñ¨â»õªºÀ禬,¦³¤j¤jª¾¹D§ó¦h®ø®§¶Ü? |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/2/16 ¤U¤È 08:57:14²Ä 162 ½g¦^À³
|
Cstang¤j¤j·s¦~§Ö¼Ö¡A¦]µØ¶^¤£¥ð¡A§A¥Ø¼Ðɲ·|¤£·|¸Ø±i¡A¦pªG¦³«e´ºªº¤½¥q¡AªÑ²¼¤@ª½¶^¡Aì¦]¥s¤H???©Ò¥H¤½¥q¤jªÑªF¤£¥XÁn¤F¡A¤@¯ë¤H¦óW²_¬°¨ä¥´¤â¡A¸gÀçªÌ³£¤£·R±¤¦Û¤vªÑ»ù¡A§A¦óWÀ°¤½¥q°²³]¥Ø¼Ð»ù¡A¦Û¤v¤ß¤¤·Q·Q´N¦n¡A¤½¶}³ÛÁÙ¦³8¿·|§l¤Þ«Ü¦h¤H¸õ¶i¥h¡A´N³o¼Ë§´·í¶Ü? |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/2/14 ¤U¤È 10:47:13²Ä 161 ½g¦^À³
|
¦U¦ì¤j¤j¦n, ¤p§Ì¯¬¦U¦ì¤j¤j·s¦~§Ö¼Ö,ª¯¦~¦æ¤j¹B¨Æ¨Æ¦ë³qÁȤj¿ú,¤]¯¬§Ú̪º¦]µØ·~ÁZªø¬õ·s¬K¤jµo,ª¯¦~¶¶§Q¤WÂd¥Ø¼Ð»ù®æ3¦ì¼Æ,¤j®aµo¤j°]!! |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/2/13 ¤W¤È 10:15:59²Ä 160 ½g¦^À³
|
¦Û°Ý¦Ûµª¤@¤U¡A è褽¶}Æ[´ú¯¸¤W¸ê®Æ¤w§ó·s¡A«e³\Á`¤´¬O¸³¨Æ¡A¦ý¤w¨S¦³¤½¥qªºÂ¾°È¡C Ãø¹D¤½¥q¦³¦b¬Ý³oÓ°Q½×°Ï¶Ü¡H |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/2/12 ¤W¤È 10:49:34²Ä 159 ½g¦^À³
|
·PÁÂcstang¤j¤j, ¤£¦n·N«ä§Ú¸É¥R¤@¤U¨âÂI ¥ÃX»PªFXX®×,³Ì«á¬O¥Ñ¥ÃX¥X¿ú¶R¦^Åv§Q,ªFXX¥i¥H¦¬Ã±¬ùª÷,¨½µ{ª÷©M¾P°âÅv§Qª÷, ¤£¬O§Ú¦b»¡,¤½¥q¦b°ê¤º¾P°â³oÃäÀ³¸Ó¬O®z¶µ,§g¤£¨£Åã¼v¾¯©M¦]¸¿Õ´X¥G¤£¨£¦b°ê¤º¾P°âªº¬ö¿ý, Y¤½¥q¶R¦^C08001ªº«áÄò³B²zÅv§Q,¤@¤è±¥i¯àÄw¤£¥X¿ú,¥t¤@¤è±Y¥´¤£¶}°ê¤º¥«³õ,¥i¯à´N½ß¤F¤Ò¤H¤S§é§L. ¥t¥~Y¥Ñ¦~³ø¨Ó¬Ý,³\Á`©M°q°ÆÁ`ªºÁ~¤ô¯Å¶Z¦b200~500¸U,¬ù²¤¬ì§Þ¼t°ò¼h¥DºÞ¨ì¤¤¶¥¥DºÞªºÁ`¦~¸ê¦Ó¤w(¬ì§Þ¼t¥i¯à¦³¤À¬õ¦ý¦]µØ¨S¦³), ¨C¦¸»{ªÑ»Ýn200~300¸U,¦pªG¤£É¿ú¥i¯à¤]»{¤£¤U¥h. ·íµMÁ`¸g²z±aÀY¤£»{µ¹¤HªºÆ[·P«D±`¤£¦n,¤£¹L¥H¤½¥q²{ªp,©Î³\³o¼Ë°µ¹ï¥L¦Û¨¤]¤ñ¸û¦n,§Ú¤£§ÔV³d. ³Ì«á§Ú¤@ª½¦³ÓºÃ°Ý,Y³o¦¸§ó´«Á`¸g²z¥u¬OªL¸³·QnÀ°¦£,·Pı¤]¬O©Ç©Çªº,ªL¸³¥»¨Ó´N¥i¥HÀ°¦£Äw¸ê©ÎºÞ²z,¨S¥²n´«Á`¸g²z§a! ¦³¤Hª¾¹D³\Á`¬OÂ÷¶}¤½¥q©Î¥u¬O´«Â¾ºÙ¶Ü? «e´X¤Ñ¦]µØ§â¤@¤ë¤Àªº¸³ºÊ«ùªÑ©ú²Ó¤½¥¬¤F,Á`¸g²zÁÙ¬O±¾³\Á`(Orz),¤]ÁÙ¬O¸³¨Æ,«ùªÑ¤]½æ±o¤£¦h, §Æ±æ¥LÁÙ¬O¥i¥HÄ~Äò«ÝµÛ¬ÝµÛ¦Û¤vªº¬ãµo¤ß¦å¶}ªáµ²ªG. |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/2/10 ¤U¤È 03:51:03²Ä 158 ½g¦^À³
|
Sorry¼g±o¦³ÂIªø ¦U¦ì¤j¤j, ¥H¤U¯ÂÄÝÓ¤H§ë¸ê¿³Âd¤Î¦]µØªº·Qªk,¸ò¤j®a¤À¨É¤@¤U(¥ý¥Í¦W¤p§Ì¤£¬Oû¤u,¤]¤£»{ÃѦ]µØ¬ÛÃöªº¤Hû,¬O¦b3C²£·~¤u§@,©Ò¥H¥u¦³¤À¨É,¤£±a§å§P³á) ¤U±¤@¥÷¼Æ¾Ú¤À¨É: «e10¤j¤jªÑªF«ùªÑ¤ñ: 105¦~4¤ë29¤é 106¦~6¤ë30¤é 106¦~12¤ë1¤é °·³ì(ªL¸³) 11,462 18.45% 15,269 21.82% 14,270 20.36% ¸gÀÙ³¡(¥üÂ×) 3,423 5.51% 3,013 4.31% 3,013 4.31% ±Ò¯è³Ð§ë 2,604 4.19% 2,604 3.72% 2,604 3.72% ³Ð·s¤u·~ 1,931 3.11% 1,931 2.76% 1,931 2.76% ¤jªÑªF¿à 1,059 1.51% 1,059 1.51% Áp°T³Ð§ë 1,097 1.77% ¤£ª¾¹D ¤é°ÓDCI 1,000 1.61% 1,000 1.43% 1,000 1.43% ¤¤°ê«H°U 1,000 1.61% 1,000 1.43% 1,000 1.43% ¤jªÑªFÒ\ 981 1.40% 981 1.40% ¤jªÑªFªL 918 1.31% ¤jªÑªF¶À 936 1.55% 895 1.28% 895 1.28% ¤jªÑªF°q(¦]µØ¬ãµo°ÆÁ`) 860 1.38% 806 1.15% ©M³q³Ð§ë 853 1.37% ³\ªø¤s«eÁ` 752 1.07% ªL¸³Ó¤H 494 0.71% ±q¤W±¨Ó¬Ý¨ä¹ê¤jªÑªFªº«ùªÑÅܰʬO¨Ã¤£¤jªº,°ß¤@¤ñ¸û¤jªºÅܰʬO°·³ì½æªÑ¹F999±i(5Ó¤ë,´N¬O¤j·§1¤Ñ9±i§K¥Ó³øªº¶q§a!),¤£¹L¸Ü»¡¦^¨Ó,°·³ì¬°¤°»òn³o»ò¤j¶O©P³¹ªº§C½Õ½æªÑ,§Ú̬ݬÝ107¦~ªº¼W¸ê®×,±q106¦~3¤ë¤½§i¨ì6¤ë©³¼W¸êµ²§ô,°·³ìì¥i»{ÁʼW¸êªÑ939±i,³Ì«á»{ÁÊ4,2685±i,¶WÃB»{ÁÊ3,329±i(¶WÃB¬ù6¤d¸U¤¸),°·³ì¬O¤@¶¡¤W¥«Âd¤½¥q,³oºØÁ{®ÉÃB¥~ªº¶O¥Î¬On¸³¨Æ·|¦P·N¦Ó¥BªÑªF·|¤£·|³Q½è¸ß¤~¦æªº,¤£¹L°·³ì(¦]µØ³Ì¤jªÑªF)¦pªG¤£»{·|«ç¼Ë©O?¥L¥i¥H¤£»{ªº©Î¬O¸³¨Æ·|¨ä¤¤¦³¸³¨Æ¬O¥i¥H¤Ï¹ïªº,¨º¦b¥h¦~¦]µØ´Nn¶}¤Ñµ¡¤F,©Ò¥H¹ï©ó°·³ì18¤¸¶R¶i¼W¸ê«á¨C¤é9±i½æ¥X¬O¤£¥i³Qµû½×ªº,¤ÏÆ[¨â¥ó¨Æ: (1) 106¦~ªº¦]µØ¼W¸ê®×,³\Á`¥i»{ÁÊÃB«×¬O222 ±i, ¥L«o§¹¥þ¨S»{ÁÊ, 105¦~ªº¦]µØ¼W¸ê®×,³\Á`¥i»{ÁÊÃB«×¬O119 ±i, ¥L»{Áʱi¼Æ¬O70 ±i, ¥H¤p§Ì¦b¤W¥«¤½¥q¤W¯Z¤Q¼Æ¦~,¹ï©ó¤¤°ª¶¥¥DºÞ¼W¸ê©ñ±ó»{Áʪº¦æ¬°¬O¤£³Q´Á«Ýªº,³o·|ÄY«¼vÅT¤½¥q¤h®ð(¦]¬°¼W¸êªº¿ú¤£´N¬O¤½¥qµo®i¸g¶O¤Îû¤uÁ~¸ê¶Ü?³o¤]¥]¬A¤FÁ`¸g²zªº°ªÃBÁ~¸ê¤ÎºÖ§Q¤£¬O¶Ü?) (2) 106¦~ªº¦]µØ¼W¸ê®×,°·³ì¶WÃB»{ÁÊ 3,329±i,(Á`»{ÁʼÆ4,268±i,¦û¥þ³¡µo¦æ±i¼Æ66.8%),«e10¤jªÑªF¯¸ªÑ¬ù40%,¥i»{Áʱi¼Æ¬ù¬°2,171±i(¤pªÑªF§A§Ú¬ù3,2575±i),«Ü©úÅ㪺¦b¥h¦~18¤¸ªº¼W¸ê¤pªÑ¤]«Ü¤£µ¹¤O,¨S°Ñ¥[¼W¸ê..... ¦b¤W¦¸¤p§Ì¦³´£¨ì106¦~¼W¸êª÷ÃBq©w«á(³Ì«á¹ê»Ú¦¬¤J¼W¸êª÷ÃB»Ppµe¬Ûµ¥),¦]µØªº·|p¦bÀç¹B³ø§i®Ñ¤º¦³°O¸ü,¨Ì·Ó¤½¥qªºÀ禬Àç¹Bª¬ªp,106¦~¼W¸ê´Ú¹wp¬O¨Ï¥Î¨ì107¦~1¤ë(¥u¦³¥b¦~.........§Úªº¤Ñ§r!!!),´N¥²¶·ÄwÁ~¸êª÷¤J±b(¦¹®É²{ª÷¤ô¦ì·|§C©ó·|p¦w¥þ³]©w¶q,¦]µØ¬O1»õ2¤d¸U),쥻¦]¸Ó¬On¥Î¥Ó½Ð¤WÂdµo¦æ·sªÑ¨ì¥«³õ¤W(«D²{¦æªÑªF»{Áʤ覡)Äw¸ê3»õ¤¸,¦ý«o¦]¬° ªF¥ÍµØ¤½§i¥»¤½¥q·s¾¯«¬·sÃÄCRTA04©ó¥Á°ê106¦~08¤ë03¤é¦V½Ã¥ÍºÖ§Q³¡¹«~ÃĪ«ºÞ²z¸p¥D°ÊºM¦^¡u·sÃĬdÅçµn°O(NDA)¡v¥Ó½Ð ³o¥ó¨Æ¨Ó¼vÅT¤WÂd¤Î¶°¸ê³o»ò«nªº¨Æ,¨Æ±¡µo¥Í¦b8¤ëªì,¥i¬O¤@ª½¨ì¼vÅT°e¥ó¤WÂd,5Ӥ볣¨Sª`·NÀ³¸Ón¦³ªº¹w¨¾±¹¬I! ¬Û¦Pªº®É¶¡, ¥ÃX ¤]³QªFXµØÂ\¤F¤@¹D,¥i¬O¥ÃX¦Ü¤Ö°Ê°_¨Ó¦³¶D³^,³Ì«áªFXµØn±N¥Ó½Ðªº¬ÛÃö¨Æ¶µ¤Î½Ð¨ìªºÃÄÃÒÂàÁÙµ¹¥ÃX, ©Ò¥H¤p§ÌÁÙ¬O²`«H°·³ì(ªL¸³),¬O«D±`®¼¦]µØªº,¯à°÷»¡ªA°·³ì¸³¨Æ·|¥ý¶WÃB»{ÁʼW¸êªÑÅý¦]µØ¯à¹BÂà(²¦³º¦]µØ¬O°·³ìªº¸q¤l,¯q±o¬O¿Ë¨à¤l,±q°·³ì¤Á³Î¥X¨Óªº,¦Ó¥B¯q±o¤]¨S¦³¸êª÷°ÝÃDÁöµM½ß¿ú), ¤p§Ì§ë¸ê¿³Âdªº¤p¤p·Qªk¬O,§ë¸êªÑ²¼¥»¨Ó´N¬O½ä³Õ,§ë¸ê¿³Âd·íµM·ÀI´N°ª¤F,¦]¬°¿³Âd(´N¬O·s¶Q§r!)·s¤½¥q·s¯à¤O°ªµo®i,·íµM¦b³oÓI«á°£¤Fn¦³¯à¤O¦Ó¥B¨ã¦³¨Ï©R·Pªº§Þ³N¤Hû¤§¥~,¦b³oÓ¤§¤Wªº¬O (1)¾a¤s,³Ì¦n¤j¦ÑÁó¬O¬ÛÃö²£·~ªº,¯àÀ´³oÓ²£·~¤å¤Æ,¯àÀH®É©Û¶°¸êª÷,·s¤½¥q¿N¿ú¬O¤@¬yªº (2)À´±oÀç¹BªºÁ`¸g²z,«Ü©È·s¤½¥qªºÁ`¸g²z¬O§¹¥þ§Þ³N©³¥X¨ªº,¦]¬°·|§Ñ¤F¥L¬O¸gÀçªÌ,©Ý®i·~°È,¹wª¾¥¼¨Ó·ÀIµo®i»P±±¨î¸êª÷¬y¤~¬O¦Û¨¤u§@,«Ü©ÈÁ`¸g²z§Þ³N¦n¤@¤ßÆp¶i¬ãµo¤Ï¦Ó§Ñ¤F¨C¤Ñ³£¦b¿N¿ú (3)¦³¾»ÀYªº°Ó«~ ·íªì¤p§Ì§ë¸ê¦]µØ´N¬O¦]¬°°·³ì§ë¸ê¦]µØ¥[¤WªvÀøÁx¹DÀùªº Gemcitabine¤fªA·sÃħ޳N(«D±`§l¤Þ¤Hªº¸ÜÃD),¥u¬O¨S®Æ¨ìªº¬O¤½¥q±q·í¦~·sÃĬɪº©_§Lº©¨B¨ì¤µ¤Ñ,¥u¯à»¡¯u¬OºÞ²zªÌªº³d¥ô,§ë¸ê¿³Âd¥»¨Ó´N¬Oº©º©ªø¸ô,¿³Âd¥»¨Ó´N¤£·|¦³¥ô¦óªº¸êª÷¦æ±¡,(¤×¨ä¦b¤§«e«Å¥¬¿³Âd°í«ùn½ÒÃÒ¨é¥æ©ö©Ò±oµ|, |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/2/9 ¤U¤È 09:23:33²Ä 157 ½g¦^À³
|
·RŪ®Ñ¤j¤j¯uªºÂI¥X¤F³\¦h°ÝÃD, ¤£¹LY»¡ªL¸³n©ñ±ó¦]µØ,ªá¤F¨º»ò¦h¿ú¶R¤U¤C¬P´N§ó¥O¤H¤£¸Ñ¤F. ³oÃ䦳¤@¨Ç§ÚºâªºÄw½X¤ÀªR(¥i¯à·|¦³¤@ÂI¤p»~®t) ¤ë¥÷ ¦Ê±i¤j¤á¦©°£°·³ì±i¼Æ ²Î¤@¶R½æ¶W 9 33497 543 10 33630 -161 11 33192 -268 12 33368 246 1 33552 607 ¥i¥H¬Ý¥X¤£ºÞ²Î¤@«ç»ò¶R½æ,¦Ê±i¤j¤á(¦©°£°·³ì«ùªÑ)ªº±i¼Æ³£¤£·|®t¤Ó¦h, ²³æ¨ÓÁ¿,´N¬O¦³¤H»P²Î¤@¹ï°µ(¥t¤@¤è±¨Ó»¡´N¬O´£¨ÑÄw½Xµ¹²Î¤@). ¦ý´N¥±`Æ[¹î¨Ó¬Ý,³q±`¦³¤j³æ¶R¶i,¨S¦h¤[´N³QÀ£¤U¨Ó,©Ò¥H¬Ý°_¨Ó¤ñ¸û¹³¬O¹ï°µ. ´N¤@¯ëµL¨}ªº¸gÀçªÌn¥X²æªÑ²¼,³q±`·|°t¦X´CÅéµo¥¬¦n®ø®§«á©Ô°ªªÑ»ù¤@¤f®ð§âªÑ²¼Ë¥X¨Ó, ¦]µØÃD§÷³o»ò¦h,n³o¼Ë°µªº¾÷·|«Ü¦h,«o¨S¦³µo¥Í³o¼Ëªº¨Æ. ¤Ï¦Ó¬O¥D¤O¤£Â_¦a¥´À£,n»¡¬O´²¤á¤H½ò¤H¤S¤£¤Ó¹³,Äw½X¨S¦³¤@ª½¶°¤¤ªººA¶Õ. ©Ò¥H§Ú»{¬°³o¬q®É¶¡¬O«D±`¨¸´cªº¬~½L,¦Ü©ón¬~¥Xþ¨ÇÄw½X¤~·|°±¤î,§Ú¤]¤£ª¾¹D. ÁÙ¬OÀR«Ý¤½¥q¬ãµo¦¨ªGµo»Ã,¥»¹Ú¤ñ´N¥ý¤£¥Î·Q¤F,Åý°ò¥»±¥ý¥X¨ÓªÑ»ù¦ÛµM¯à°l¤W. §Æ±æ¦³³o»ò¤@¤Ñ. |
|
|
·|û¡G·RŪ®Ñ10030395 µoªí®É¶¡:2018/2/9 ¤U¤È 06:34:00²Ä 156 ½g¦^À³
|
´XÓ°ÝÃD¨Ñ¤j®a«ä¦Ò: 1.¦P¬O°·³ìÂà§ë¸êªº¦]µØ©M¯q±o.¬°¦ó¦Û¤W¿³Âd«á¤£Â_½Õ¸`¦]µØ«o¨S¦³³B¤À¹L¯q±o©O? 2.°·³ì2017/6¤ë°Ñ»P¦]µØ¼W¸ê«ùªÑ+4268±i.¦ýÀH«á¦Û2017/7-2018/1¤ë²Ö¿n½æ¥X1221±i§¡»ù¬ù20¥ª¥k.¦ý«ÂI¬O¸³ºÊ¨Æ¦³©Ò¿×¤»Ó¤ëÂk¤JÅv°ÝÃD.¥ç§Y20-18(»{ÁÊ»ù)ªº¤¤¶¡Àò§Q»ù®tnÂk¦]µØ©Ò¦³.¦pªG°·³ì¬Ý¦n¦]µØ¥¼¨Óªº«e´º¦³»Ýn³o¼Ë°µ¶Ü??¦pªG§A¬O°·³ìªºªÑªF§A¯à»{¦P¶Ü? 3.쥻ªºCEO³\±`¤s³£¼õ¤F³o»ò¦h¦~¤F.¦pªG¤½¥q°¨¤Wn®i¯Í°ª¸¤F.¥L¦³»Ýn¦b³o®ÉÔÃ㾶Ü??ªÑªF¦³¥i¯à¤ñ³\±`¤s¤F¸Ñ¦]µØ¶Ü?? 4.²Î¤@·s¥x¤¤¤w¸g¶R¤F¤@¬û¤l¦ý¦]µØªÑ»ù«o¬O³Ð¤U5¦~·s§C.ì¦]¬O¤°»ò©O??¥xªÑ¤w¸g¨«¤F8¦~¦hÀY¥Ø«eÁÙ¦b¸UÂI.¥Ø«e¦]µØªºªÑ»ùªí²{¹ê¦b¥O¤HªÑªF¥¢±æÃø¹L. |
|
|
·|û¡G¦ÌÄ_10132489 µoªí®É¶¡:2018/2/9 ¤U¤È 04:07:44²Ä 155 ½g¦^À³
|
Hi mogwai¤j ¤p§Ì¤§«e´£¨ì3Ӥ뤺¦Ü¤Ö¥²¶·¦³¤@Ó¤ëÀ禬¤j©ó1000¸U «Y¦]ªñ´ÁÀ³¸Ó·|¦³´¶Àù¨O§å¦¸¶i³f ÁÙ¦³¦]¸¿Õ¦X§@¼t°Ó¸Õ¶q²£À禬°^Äm ¦Ó¤@¤ë¥÷À禬¬ù2500¸U»P¥h¦~¬Û·í ¤£ª¾«Y¦]¸¿ÕªºÀ禬? ´¶Àù¨OÀ禬? ©Î¬O¨âªÌ³£¦³°^Äm? ¦Ó¥H¥Ø«e¤½¥qªº¶i®i¨ÓÁ¿·Ó²z¥²¶·À禬¦³¤@©wµ{«×ªº¦¨ªø¤~¹ï ¬G¦b3Ӥ뤺¦³¤@Ó¤ëÀ禬¥²¶·¹F¨ì1000¸U«Y¤D³Ì§Cªºn¨D... ¥t¥~¦A»¡»¡D07001 °w¹ï¦¹¤@«~¶µ¦Ñ¹êÁ¿¤½¥q¬ÛÃöªº¶i®i¤Î§G§½¥O¤H«Ü¤ß«æ µS°O±o¤@¦~¦h«eªk»¡¤½¥q¤½§i¤U¤@¦¸Á{§Én°µ 2/3´ÁÁ{§É µ²ªG¨ì8¤ë¬ü°êfda®ÖãÁ{§É®É¤½§i¡G §ÜÀù·sÃĤG´ÁÁ{§É¸ÕÅç«á¡A±Nµø¨u¨£Àù¯g¤§Á{§ÉªvÀøµ²ªG¡A¨Ó¨M©wÂX¤jªvÀø¤H¼Æ©Î¦Ò¼{¦V¬ü°ê¹«~ÃĪ«ºÊ·þºÞ ²z§½´£¥X·sÃĥӽСC ³Ì«á¨ì¢°¢±¤ë©³®ÉÃĪ«Á{§É¹êÅç¸ê°Tºô¤½§i¤§¸ê®Æ©~µM¤SÅܦ¨n°õ¦æ¢°¢ê/2 ´ÁªºÁ{§É¹êÅç¡@ ©Z¥Õ·íªì¬Ý¨ì®É¬Û·íªº¥¢±æ¡@¤p¤½¥qn¨B¨B¬°Àç¬O¨S¿ù¡@ ¤£¹Lµuµu¤@¦~¦h®É¶¡Á{§É¹êÅç³W¹ºÅܧ󨺻ò¤j¥O¤Hı±oÃø¥H²z¸Ñ ¥B¤@¯ë¨ÓÁ¿¢î¢ì¢é®ÖãÁ{§É¹êÅç«á¡@¡@ ´XÓ¤ë«á¦b¡@¡@clinicaltrials.gov/¡@¡@ºô¯¸¤WÀ³¸Ó´Nn¥i¥H¬d¨ì¬ÛÃö¸ê°T¤F ¦Ó¥»®×¦Û¢·¤ë®Öã«á¨ì²{¦b¢±¤ë¦h¤F¤´µM¨S¦³¬ÛÃöªº¸ê°Tµn¿ý..... ¥[¤W¬Y§ëÅU¦b´£¨ìÁxºÞÀù¬ÛÃö¬ãµo¼t°Ó®É¡@¤§«e¤£ºÞ«ç»ò¼Ë²Ä¤@Ó´£¨ìªºÄvª§¹ï¤â¤@©w¬O¦]µØ ¤£¹Lªñ´Á°w¹ï«e°}¤l«Ü¬õªº¨º¤@ÀÉ°ê¥~¤½¥q³ø§i¤¤¤w¸g§¹¥þ¨S¦³´£¨ì¦]µØ¤F ¬Ý¤F¹ê¦b¬O¥O¤H¤ßµJ..... °w¹ï¤½¥q¥»¨¤£¥i§_»{ªº¥Ø«e¥«È¯uªº¬O·¥§C¡@ ¥un±z´£¨ìªº¬ÛÃö«~¶µ¥i¥H¶¶§Qµo®i´Nºâ¤£p·sÃĤ½¥q¤´µM¥i¥H¦³¬Û·í¤£¿ùªºµo®i... ¤£¹L¥Ø«e¤½¥q¥ý¦³«n¤H¨Æ²§°Ê¡@¡@«á¦³¦³¶Ò¸êµ¥ª¬ªp«Ý¸Ñ¨M¡@¡@ ¤p§Ìì«h¬O¥un¬O¤½¥q«n¤H¨Æ²§°Ê¤@©w·|¥ýÆ[±æ¤@°}¤l.... ¬G¥Ø«e¬O¥ý§â¤½¥q¦C¤JÆ[¹î¦W³æ¡@¡@±K¤ÁÆ[¹î¤@¨Ç«ü¼Ð¶i®iª¬ªp«á¦A¨Óµû¦ôª¬ªp¤F... |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/2/9 ¤W¤È 11:39:02²Ä 154 ½g¦^À³
|
·PÁ¦ÌÄ_¤j©Mcstang¤jªº¤À¨É, ±q§«ô¤@¶}©l¤½¥q´N¨S¦³¦A½æªÑ²¼¤F,¥i¥H¦AÆ[¹î¬Ý¬Ý. ¥t¥~¦³¤@®a¤j®i¦ÛÀ糡³o¨â¤Ñ½æ¤F79±i,¤£¹L³o®a¨é°Ó¦ü¥G¤£¬O»²¾É¨é°Ó,´N¥ý¬Ý¬Ý 2016 12¤ë ¤½¥qÀ禬¬ù0.15»õ 2017 1¤ë ¤½¥qÀ禬¬ù0.24»õ 2017 12¤ë ¤½¥qÀ禬¬ù0.01»õ 2018 1¤ë ¤½¥qÀ禬¬ù0.25»õ ¤ñ°_¨Ó®t¤F0.1»õ¦h,§Ú·Q¦ÌÄ_¤j¨ä¤¤¤@ÓÆ[¹î«ÂIÀ³¸Ó´N¬O¬Ý¬Ý¤½¥qÀ禬¬O§_·|¦³¤@P©Ê. ³Ì«á§Ú·Q²á²áD07001, D07001©ó2015¦~©³§¹¦¨1´ÁÁ{§É,®ø®§¶Ç¥XªÑ»ù¤@«×¿EÀyº¦¨ì70´X¶ô,ª½¨ì«e¤@°}¤l¤~¤S¶}©lÁxºÞÀùªº1/2´ÁÁ{§É. ¤j®a³£ª¾¹D Gemcitabine쥻¥u¯à¥Îª`®g,D07001§ï¦¨¥Î¤fªA, Gemcitabine쥻¬O¤@¦¸¥´¤J¤ñ¸û¦h¾¯¶qµM«á¥i¯à¤@¶g¥´¤@¦¸, D07001«h¬O¤@¤Ñ¤fªA¤@¦¸,¥Ñ©ó¨C¦¸¶q¸û¤Ö,°Æ§@¥Î¤]·|¤ñ¸û¤Ö,³o¬O«Ü¤jªº½æÂI. ¦ý¬O¥Ñ©ó¥ÎÃij~®|¥÷¶q¦³«Ü¤jªº§ïÅÜ,·Q¤]ª¾¹D¨S¿ìªkª½±µ¨ú¥N¥Ø«eGemcitabineªº¥Îªk,»Ýn§ä¥X¦n¥Îªk. ¦ý¤½¥q¦bD07001 2011¦~IND«á,¨Ã¨S¦³·Q¦n¤G´Á¸Ó¦p¦ó³]p,¥H¦Ü©óÅýÁ{§É¾ã¾ã©µÌX¤F¨â¦~. §Úı±o¤½¥q¦b¤@´Á¹êÅç´Á¶¡¨ú±o¤F³\¦h¼Æ¾Ú,²zÀ³¥i¥HÀ°§U¤½¥q§ä¨ì¤G´Áªº¤è¦V,¦Ó¤£¬O¤@´Á§@§¹¦Aªá¤F¾ã¾ã¨â¦~¨Ó³]p¤G´Á. ²{¦bÁxºÞÀù¤Sn«·s¥Ñ¤@´Á¶}©l,¤§«e²Ö¿nªº¼Æ¾Ú¯uªº¨Sªkªu¥Î¶Ü? ¤@´ÁÀ³¸Ó¬O¥Î¨Ó§ä¥X³Ì¤j¾¯¶q(¦w¥þ¾¯¶q),Ãø¹D¦]¬°©Û¶Òªº¯f¤HÃþ«¬¤£¤@¼Ë¤Sn«°µ¶Ü? ³o¨Ç¤½¥q§¹¥þ¨S¦³¹ï§ë¸êªÌ»¡©ú? ¤½¥q¤W¤@¦¸ªk»¡¤w¸g¬O¦b2016¦~©³,³Ìªñ¤@¦¸±Ä³X·s»D«h¬O¦b¥h¦~¤K¤ë. ³Ìªñ´«¤FÁ`¸g²z,D07001ÁxºÞÀù¹êÅç¤]«±Ò,§ë¸êªÌÀ³¸Ó«Ü·Qª¾¹D¤½¥q¥¼¨Óªº¨«¦V, §Æ±æ¤½¥q¯à§óª`«¤½Ãö,¤×¨äªL¸³À³¸Ó¬O¦¨¥\ªº°Ó¤H,¤£À³¸Ó¤£À´³o¥ó¨Æ,°£«D¥L¬O¬°¤F¬Y¨Ç¥Øªº¬G·N¬°¤§. ³Ì«á¯¬¤j®a·s¦~§Ö¼Ö |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/2/7 ¤U¤È 10:35:04²Ä 153 ½g¦^À³
|
¤j¤jÌ,¤p§Ì»{¬°, ´N¦p¦Pmogwai¤j»¡ªº,¤w¸g¦³¦¨ªGªº´¶Àù¨O,Åã¼v¾¯,BH4(¦]¸¿Õ)µ¥.¦b¤µ¦~2018´N¯àµo¥úµo¼ö.,´£¨Ñ¤@¥÷¼Æ¾Úµ¹¦U¦ì¤j¤j°Ñ¦Ò, 2016¦~ 2017¦~ ¥xÆW·s¼W²O¤ÚÀù±wªÌ¡]¤H¡^ 300 400 ·s¼W«D¦óªNª÷¤ó²O¤Ú½F±wªÌ¡]¤H¡^ 950 1200 ·s¼W«D¦óªNª÷¤ó²O¤Ú½FªvÀø¥«³õÈ 4600¦Ê¸U 5980¦Ê¸U ´¶Àù¨O¥Ø«e¤w¸g¬O°·«O¥ÎÃÄ, 2017 ¦~¤W¥b¦~´¶Àù¨O(Bendamustine)ªº°ê¤º¾P°â¥~¡AÀç·~¦¬¤J¤ñ« 75.23%, 2018¦~¹wp¥i¼W¥[·s¾AÀ³¯g¥Ó½Ð°·«Oµ¹¥I¼W¥[Àç·~ÃB BH4(¦]¸¿Õ): ¥Ø«e BioMarin Pharmaceuticalªº Kuvan®¡A¬O°ß¤@°w¹ï»²酶¦X¦¨¯Ê¥F «¬fଧ¿¯g¡A¥H¤ÎÂù²B³ãËïÁÙì酶¯Ê¥Ffଧ¿¯g±wªÌªºªvÀøÃĪ«¡A¨Ã ¦Û 2008 ¦~°_¤w¸g¦b¼Ú¬ü¥Dn¥«³õ®Öã¤W¥«¡A¨Ã¦b 2015 ¦~³Ð³y¬ù 2.6 »õ¬ü¤¸ªº¾P°âÃB¡C¥Ñ©ó¦¹²£«~q»ù¬Û·í©ù¶Q¡A¨CÁû100mg ¬°·s¥x ¹ô 900 ¤¸¥ª¥k¡A¹ï³\¦h¥²¶·²×¨ªA¥Î¦¹ÃĪº¯f±w¨Ó»¡¡A¬O¤@µ§¬Û·í¤j ªº¸gÀÙt¾á¡C¤S¥Ñ©óì¼t³]¸m³\¦h±M§Q»Ùê¡A¦]¦¹³y¦¨¥«³õ¥Ñì¼t¹è ¥eªº±¡§Î¡C®Ú¾Ú¥«³õ¤ÏÀ³¡A³\¦h¯f±w³£§Æ±æ¯à¦³»ù¿ú¸û¤j²³¤Æªº«~µP ¥i°µ¿ï¾Ü¡A¦]¦¹¡A¦b¨ã¦³¦Û¨¼Ú¬ü±M§Q»sµ{«OÅ@¤U¡A¦]µØ¹w´Á¦]¸¿Õ TM ±N·|¥H cost-effectiveness °µ¬°°Ï¹j¡A¥H¸û¬°¤j²³¤Æªº©w»ù´£¨Ñ°ê¤º ¥~fଧ¿¯gªº¯f±w¡A°£¤Fì¼tÃĪ«¤§¥~¡A°ß¤@§ó¨ã¸gÀٮįqªº¿ï¾Ü ¥Ø«en¬Ýªº´N¬O¤§«eñªº§ÞÂà®Éµ{¬O§_¯à¦p´Á§¹¦¨,¤£¹L¦b§¹¦¨¤§«eÁÙ¬O·|¥H²{¦bªº¼Ò¦¡¸ò¦]µØ®³³f,À禬ÁÙ¬O¦s¦b¥B¦¨ªøªº Åã¼v¾¯,,¥Ø«en¦³¤jªº¸õÅD¦¡¦¨ªøÁÙ¬On¬Ý¬ü°êÃÄÃÒ¦ó®É¤U¨ÓÅv§Qª÷ªº¦¬¤J, 2014¦~´£¥Xªº¥Ó½Ð,¤µ¦~À³¸Ó¬On¦³µ²ªG¤F( °·³ì©M¦]µØªá¤F10»õ¶R¤U¤C¬P,¤£·|¨S¦³¬Û¹ïªº§â´¤´N·F³oºØ¨Æ§a!!) ¤W¶g1000±i¥H¤Wªº¤jªÑªFÁÙ¬O¦b«ùÄò¶R¦^¦]µØªÑ²¼¼W¥[«ùªÑ³á!¦]¬°15~16¯uªº¬Û¹ï«K©y¤F.......³o¨â¤Ñ¸I¨ì¥þ²yªÑ¨a¦Ó¥B¤S§Ö¹L¦~¤F,¦]¬°¸êª÷¥XªÑªº¤HÀ³¸Ó¬O¦³ªº,¤£¹L°u¶q½wºC§C±µ¦]µØ,¤p§Ì»{¬°¬O¤£¿ùªº......... ¦]µØÀç¹B¸êª÷§Úı±o¤£À³¸Ó¬O°ÝÃDªº,3¤ë¥÷ªL¸³·|¦³¤jµ§ªº²{ª÷¤J³U..........¤j©ó¦]µØ쥻¹wpn¼W¸êªºª÷ÃB |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/2/7 ¤U¤È 10:31:53²Ä 152 ½g¦^À³
|
ÁÂÁ¦ÌÄ_¤j¤j´£¿ôÆ[¹îªº«ÂI¡C |
|
|
·|û¡G¦ÌÄ_10132489 µoªí®É¶¡:2018/2/7 ¤U¤È 09:12:14²Ä 151 ½g¦^À³
|
³oÀɤp§Ì³]©wªºÆ[¹î«ü¼Ð¦p¤U: 1.3Ӥ뤺¦Ü¤ÖÀ³¸Ó¥²»Ý¦³¤@Ó¤ëÀ禬¶W¹L1000¸U 2.³o´XӤ뤺¤½¥q¤½§iªº¶Ò¸ê¤è¦¡¬°©M?¥H¤Î¬O§_¯à°÷¶¶§Q§¹¦¨¶Ò¸ê 3.6¤ë©³«eÅã¼v¾¯¬O§_¯à°÷¦p´Á¨ú±o¬ü°ê¥«³õÃĵý ¥Ø«e´N¥ý«ùÄòÆ[¹îºO..... |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/2/7 ¤U¤È 04:29:00²Ä 150 ½g¦^À³
|
¦U¦ì¤j¤j·s¦~§Ö¼Ö!¦]µØ1¤ë¥÷À禬ÁÙ¤£¿ù¡A¦ý¤£ª¾¬°¤°»òªÑ»ù¤£º¦¤Ï¶^?¤£ª¾²{¦b¶i³õ¶R¦w¥þ¶Ü?«eÅ¥«e½ú»¡n¶Rµ¥15¤¸¡A²{¦b15¤¸»ù¦ì¯uªº¨ì¤F¡C½Ð±Ð¦U¦ì¥ý¶i¡A¦]µØ«á±°Ó¾÷¦n¶Ü?ÁÂÁ¦U¦ì¤j¤j¤£§[«ü¾É¡A·P®¦! |
|
|
·|û¡G¦ÌÄ_10132489 µoªí®É¶¡:2018/2/4 ¤U¤È 05:12:27²Ä 149 ½g¦^À³
|
JacK¤j¤£«È®ð «Ü°ª¿³¦³À°¤W¤@ÂI¦£ |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/2/2 ¤U¤È 01:10:03²Ä 148 ½g¦^À³
|
¦ÌÄ_¤j¤j«D±`·PÁ±z´£¿ô¡AÅý§Ú¥þ¨¦Ó°h¡C·P®¦!¤]ÁÂÁÂCstang¤j¤j»¡©ú¡C |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/2/1 ¤U¤È 05:43:44²Ä 147 ½g¦^À³
|
Jack¤j¡A¤£¦n·N«ä¡A¥i¯à§Ú¼gªº¤Ó²µuÅý±z»~¸Ñ¤F¡A§Ú»¡ªºÁ`¸g²z¬OÃÄX¤½¥qªºÁ`¸g²z¡A¨º¥ó¨Æ¬O2007¡ã2009¦~ªº¨Æ¤F¡A¦]¬°¥ÍÂå¬Éªº¤j¦Ñ¥X¨ÓÃö¤ß¡A©Ò¥H¨Æ±¡´N¤U¥h¤F¡K¡K |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/2/1 ¤U¤È 05:20:46²Ä 146 ½g¦^À³
|
Cstang¤j¤j±z¦n¡A½Ð±Ð±z¡A¦pÁ`¸g²z³gýv¤S¨S³Q²Â¾¡A¨º¹ï¦]µØ¸gÀç·|¤£·|¦³«Ü¤j«Â¯Ù?¤º³¡ºÞ±±¦n¶Ü¡H |
|
|
·|û¡Gcstang10139565 µoªí®É¶¡:2018/2/1 ¤U¤È 04:16:22²Ä 145 ½g¦^À³
|
ªL¸³´¿¬OÃÄXªº¸³¨Æªø¨S¿ù¡A¥i¬O«ü±±¥Lªº¬OÁ`¸g²z¡AÁ`¸g²z¦]³g¦Ã¡AÀݵoÁ~¸êµ¹¥¼¤W¯Zªº¿Ë¤Í¡A¤S±N¤½¥q¬ãµo½æµ¹¦Û¤v¨à¤l¡A¥»n³Q°±Â¾¡A«á¦]Ãö»¡ÀÁ¸m |
|
|
·|û¡G¤p¤ß10139342 µoªí®É¶¡:2018/2/1 ¤W¤È 12:23:47²Ä 144 ½g¦^À³
|
¦]X¬O¥H«eÃÄxxªº¸³¨Æªø¡A³oºØ¤½¥q§Ú¤£´±§ë资 |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/1/31 ¤U¤È 11:41:22²Ä 143 ½g¦^À³
|
Æg¦P¡A¨S¯à¤Oªº²^¨O¡A¦³¯à¤Oªº¸É¤W¨Ó¡A¤½¥q¤~¦³§Æ±æ¡C |
|
|
·|û¡GªL§Ó³Í10143927 µoªí®É¶¡:2018/1/31 ¤U¤È 10:52:57²Ä 142 ½g¦^À³
|
¦U¦ì¦n¡A¤§«e§Ú´N»¡¹L¡A¤°»òªF¦è³£¨S®ø¨S®§ªº¡F¦å¿}¾÷ÀqÀq¦a´N¨S¦³¤F¡BÅã¼v¾¯Á¿´X¦~¤F¡A¤]¬O¨S¥bÂI·Án¡A³»¦h¬Oºô¤Wªº¤j¤j¦b¤À¨É¡A¤½¥q±q¨S»¡¹L¤@¥y¸Ü¡A¦Ó¥BÅã¼v¾¯¦b¥xÆW¤£¬O¤w¸g¦³ÃÄÃÒ¤F¶Ü¡H¬°¦ó³£¨S¾P°â¶q¡A¨S¤Hı±o©_©Ç¶Ü¡H§Ú·PıºM´«Á`¸g²z¬O¹ïªº¡A³o¤G¤T¦~¦]µØ´X¥G¨S¤°»ò¶i®i¡C |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/1/31 ¤U¤È 01:01:48²Ä 141 ½g¦^À³
|
¨¼®f¤j¤j»¡ªº¹ï¡A¤jªÑªF¦p¤£¬Ã±¤¦Û¤vªÑ»ù¡A§Ṳ́p´²¤á¨S¦³²z¥Ñ¶i³õ·í¬¶¦Ç¡C |
|
|
·|û¡Gªö®f10138830 µoªí®É¶¡:2018/1/31 ¤U¤È 12:45:39²Ä 140 ½g¦^À³
|
ªÑ»ù¨C¤Ñ³£¦b¯}©³,¼u³£¼u¤£°_¨Ó,¤½¥q¤]¨S¶i¤@¨B®ø®§, ¤£¥´ºâ¥[½X |
|
|
·|û¡Gmogwai10144017 µoªí®É¶¡:2018/1/31 ¤W¤È 11:18:22²Ä 139 ½g¦^À³
|
¬Ý¨ìªÑ»ù³o¼Ë¹ê¦b¶WµL¨¥ªº, °h¤@¸U¨B¨ÓÁ¿,Y¤½¥q¯uªºµu®É¶¡¦]À³¤£¤F¸êª÷¤ä¥X, ´N§â·|¿N¿úªº¬ãµo°±±¼,D07001,C08001,N11005³o¨Ç¥ý¼È°±, ¥u¯d¤U¤w¸g¦³¦¨ªGªº´¶Àù¨O,Åã¼v¾¯,BH4µ¥. §â¬ãµo¤Hû©M¬ãµo¸êª÷§R¤@§R,°¨¤W´NÂàÁ«¬°¬Õ. ¤µ¦~À禬¦Ü¤Ö¸Ó¦³¤¤d¸U,Åã¼v¾¯©MBH4ºCºC¨Ó¥H«á¤]¥i¥H°^Äm¤T~¤»õªºÀ禬, ¥HªÑ¥»¤C»õ,À禬3~5»õ¦³Àò§QªºªÑ²¼,ªÑ»ù¸Ó¬O¦h¤Ö? D07001,C08001,N11005À³¸Ó¬O¥[¤ÀÃD,³»¦h§§¤hÂ_µÃ, ¥u¬O²{¦b¤]¨S¶Ç¥X¸êª÷¼µ¤£¤U¥hªº®ø®§,«ç»ò²{¦b¤@¥I¤½¥q§Ön˪º¼Ë¤l? ¤j®aÁÙ¬O·Q·Q§a! |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/1/30 ¤U¤È 12:04:23²Ä 138 ½g¦^À³
|
ÁÂÁ«¢ªÑ¤H¤j¤j«ü¤Þ¡A§Ú¤]¦bµ¥«Ý¥[½XÂI¡C |
|
|
·|û¡G«¢ªÑ¤H10141735 µoªí®É¶¡:2018/1/30 ¤W¤È 10:57:05²Ä 137 ½g¦^À³
|
¬Ý¨Ó«Ü§Ö¶Rªº¨ì15¥H¤U¡A¤j®a¤£n«æ^^ |
|
|
·|û¡GJacK10145269 µoªí®É¶¡:2018/1/30 ¤W¤È 12:19:16²Ä 136 ½g¦^À³
|
¯uªº¶Ü?«u!¬°¤°»ò·sÃĪѪº¦ÑÁó¨S¦³¤@Ӭñ¤¦Û¤vªºªÑɲ¡A´N¹³¬F©²¹ªÀy·sÃÄ¡A«oµL¹ê½è¤j¤O¤ä«ù¡A¥uÅý´²¤á½Ä²Ä¤@¡A¦pªG·sÃĦÑÁó³s¦Û¤v¤½¥qªÑɲ³£¤£·R±¤¡A15¤¸¯uªº¦³¥i¯à§r!»{¦P¤j¤j»¡ªk¡C |
|
|
·|û¡G«¢ªÑ¤H10141735 µoªí®É¶¡:2018/1/29 ¤U¤È 06:57:36²Ä 135 ½g¦^À³
|
40¦h¤¸¤@¸ô¬Ý¨ì²{¦b¡AÀ³¸ÓÁÙ·|¦³§CÂI¥X²{¡AÁÙ´±¶Rªº¦~«á¦A¨Ó¾ß¤]¤£¿ð¡A15³oºØ»ù«Ü§Ö´N¥X²{¤F¡A¬Æ¦Ü§ó§C |
|
|
·|û¡G·RŪ®Ñ10030395 µoªí®É¶¡:2018/1/29 ¤U¤È 06:03:10²Ä 134 ½g¦^À³
|
¸ô¹L..»Dµ¹¤j®a°Ñ¦Ò¤@¤U tw.appledaily.com/headline/daily/20090723/31806628 Á`¸g²zªL°êÄÁ©Z¨¥¡A¸³¨Æªø¹ï¬ãµo¡BÀç¹B¨S¦³¬Û·í¤ä«ù |
|
|
|
|